20-F

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 20-F

(Mark One)

o Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934

☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Fiscal Year Ended December 31, 2021

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

o Shell Company Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number 001-37669

Nomad Foods Limited

(Exact Name of Registrant as Specified in Its Charter)

British Virgin Islands

(Jurisdiction of Incorporation or Organization)

No. 1 New Square

Bedfont Lakes Business Park

Feltham, Middlesex TW14 8HA, United Kingdom

(Address of Principal Executive Offices)

Samy Zekhout

No. 1 New Square

Bedfont Lakes Business Park

Feltham, Middlesex TW14 8HA

Telephone:+(44) 208 918 3200

Facsimile:+(44) 208 918 3491

(Name, Telephone, E-mail and/or Facsimile Number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol (s)	Name of Each Exchange on which Registered
Ordinary Shares, no par value	NOMD	New York Stock Exchange

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: Preferred Shares, no par value

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 173,559,173 Ordinary Shares and 1,500,000 Preferred Shares.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  x Yes    o  No

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.  o  Yes    x  No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x  Yes     o  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  x  Yes    o  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer, accelerated filer, and emerging growth company” in Rule 12b-2 of the Exchange Act.:

Large accelerated filer        x            Accelerated filer      o               Non-accelerated filer     o    Emerging growth company ☐

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. o

†The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

   U.S. GAAPo International Financial Reporting Standards as Issued by the International Accounting Standards Boardx       Othero

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.  o  Item 17    o  Item 18

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ☐  Yes    x  No

TABLE OF CONTENTS

TERMS USED IN THIS REPORT			1
PRESENTATION OF FINANCIAL AND OTHER INFORMATION			1
INDUSTRY AND MARKET DATA			1
TRADEMARKS			2
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS			2
PART I			5
	Item 1:	Identity of Directors, Senior Management and Advisers	5
	Item 2:	Offer Statistics and Expected Timetable	5
	Item 3:	Key Information	5
	Item 4.	Information on the Company	33
	Item 4A.	Unresolved Staff Comments	49
	Item 5.	Operating and Financial Review and Prospects	50
	Item 6.	Directors, Senior Management and Employees	67
	Item 7.	Major Shareholders and Related Party Transactions	75
	Item 8.	Financial Information	77
	Item 9.	The Offer and Listing	78
	Item 10.	Additional Information	78
	Item 11.	Quantitative and Qualitative Disclosures About Market Risk	86
	Item 12.	Description of Securities Other than Equity Securities	86
	Item 13.	Defaults, Dividend Arrearages and Delinquencies	86
	Item 14.	Material Modifications to the Rights of Security Holders and Use of Proceeds	86
	Item 15.	Controls and Procedures	87
	Item 16A.	Audit Committee Financial Expert	88
	Item 16B.	Code of Ethics	88
	Item 16C.	Principal Accountant Fees and Services	88
	Item 16D.	Exemptions from the Listing Standards for Audit Committees	89
	Item 16E.	Purchases of Equity Securities by the Issuer and Affiliated Purchasers	90
	Item 16F.	Change in Registrants’ Certifying Accountant	90
	Item 16G.	Corporate Governance	91
	Item 16H.	Mine Safety Disclosure	97
	Item 17.	Financial Statements	97
	Item 18.	Financial Statements	98
	Item 19.	Exhibits

i

TERMS USED IN THIS REPORT

Unless the context otherwise requires, in this annual report, the term(s) “we,” “us,” “our,” “Company,” “Nomad” and “our business” refer to Nomad Foods Limited (formerly known as Nomad Holdings Limited) and its consolidated subsidiaries.

PRESENTATION OF FINANCIAL AND OTHER INFORMATION

In this annual report, references to “Euro” and “€” are to the single currency adopted by participating member states of the European Union ("EU") relating to Economic and Monetary Union, references to “$”, “US$” and “U.S. Dollars” are to the lawful currency of the United States of America, and references to “Pound Sterling”, “Sterling” and “£” are to the lawful currency of the United Kingdom ("UK").

The historical financial information for the Company has been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS IASB”) and International Financial Reporting Standards as endorsed by the European Union (together “IFRS”) which can differ in certain significant respects from U.S. GAAP.

Unless otherwise noted, all financial information for the Company provided in this annual report is denominated in Euros.

Historical Financial Information

This annual report includes our consolidated financial statements at and as of the years ended December 31, 2021 (the “Fiscal 2021 Period”), December 31, 2020 (the “Fiscal 2020 Period”) and December 31, 2019 (the “Fiscal 2019 Period”).

Non-IFRS Financial Measures

In this annual report, we present certain supplemental financial measures that are not recognized by IFRS. These financial measures are unaudited and have not been prepared in accordance with IFRS, SEC requirements or the accounting standards of any other jurisdiction. The non-IFRS financial measures used in this annual report are Adjusted EBITDA and Adjusted EBITDA margin. For additional information on why we present non-IFRS financial measures, the limitations associated with using non-IFRS financial measures and reconciliations of our non-IFRS financial measures to the most comparable applicable IFRS measure, see Item 5: Operating and Financial Review and Prospects.

INDUSTRY AND MARKET DATA

We obtained the industry, market and competitive position data throughout this annual report from our own internal estimates and research as well as from industry and general publications and research, surveys and studies conducted by Euromonitor. Industry surveys and publications generally state that the information contained therein has been obtained from sources believed to be reliable, but the accuracy and completeness of the information contained in industry publications is not guaranteed. While we believe that each of these studies and publications is reliable, we have not independently verified market and industry data from third-party sources. While we believe our internal company research is reliable and the definitions of our market and industry are appropriate, neither this research nor these definitions have been verified by any independent source. Further, while we believe the market opportunity information included in this annual report is generally reliable, such information is inherently imprecise. In addition, projections, assumptions and estimates of the future performance of the industry in which we operate and our future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in Item 3D: Key Information - Risk Factors. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us. See Cautionary Note Regarding Forward-Looking Statements.

Market share data presented throughout this annual report is measured by retail sales value. The frozen food market data we refer to throughout this annual report includes the following categories: Frozen Processed Meat, Frozen Processed Seafood, Frozen Meat Substitutes, Frozen Pizza, Frozen Ready Meals, Frozen Noodles, Frozen Soup, Frozen Potatoes, Frozen Baked Goods, Processed Frozen Vegetables and Ice Cream.

1

TRADEMARKS

We operate under a number of trademarks, including, among others, “Birds Eye”, "Findus", “iglo,” “Ledo” and “Frikom”, all of which are registered under applicable intellectual property laws. This annual report contains references to our trademarks and service marks and to those belonging to other entities. Solely for convenience, trademarks and trade names referred to in this annual report may appear without the ® or TM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent possible under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements in this annual report constitute forward-looking statements that do not directly or exclusively relate to historical facts. You should not place undue reliance on such statements because they are subject to numerous uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Forward-looking statements include information concerning our possible or assumed future results of operations, including descriptions of our business strategy. These statements often include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. Forward-looking statements included in this annual report include statements regarding:

•our beliefs and intentions regarding our strategic initiatives and their impact on the growth and

profitability of our business;

•our intent to profitably grow our business through our strategic initiatives;

•our intent to seek additional acquisition opportunities in food products and our expectation regarding competition for acquisitions;

•our beliefs regarding the impact of the exit by the UK from the EU ("Brexit") on our business;

•our expectations concerning our ability to fund our liquidity requirements and to raise cash through equity and debt offerings;

•our expectations concerning our capital expenditures in 2022;

•our beliefs regarding our sales, marketing and advertising strategies, competitive strengths and ability to successfully compete in the markets in which we participate;

•our expectations concerning consumer demand for our products, our future growth opportunities, market share and sales channels, including online channels;

•our beliefs and intentions regarding the impact of key industry trends on our business, our actions in response to such trends and the resulting impact on our profitability and competitive position;

•our future operating and financial performance;

•our intent to settle any Founder Preferred Shares Annual Dividend Amount (as defined herein) with equity;

•our belief that we have sufficient spare capacity to accommodate future growth in our main product categories and to accommodate the seasonal nature of some of our products;

•our beliefs and intentions regarding our sustainability program;

•our intent to rely on some of the available foreign private issuer exemptions to the New York Stock Exchange (the “NYSE”) corporate governance rules; and

•the accuracy of our estimates and key judgments regarding certain tax matters and accounting valuations.

The forward-looking statements contained in this annual report are based on assumptions that we have made in light of our management’s experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments and other factors that we believe are appropriate under the circumstances. As you read and consider this annual report, you should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although we believe that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect our actual financial results or results of operations and could cause actual results to differ materially from those in these forward-looking statements.

2

These factors include but are not limited to:

•the long-term impact of the COVID-19 pandemic on our business, suppliers, co-manufacturers, distributors, transportation or logistics providers, customers, consumers and employees;

•disruptions or inefficiencies in our operations or supply chain, including as a result of the COVID-19 pandemic, and our ability to maintain the health and safety of our workforce;

•the duration, spread and intensity of the COVID-19 pandemic and related government restrictions and other government responses;

•our ability to successfully implement our strategies and strategic initiatives and recognize the anticipated benefits of such strategic initiatives;

•the anticipated benefits from our recent acquisitions including the Fortenova Group's Frozen Food Business Group (the "Fortenova Acquisition") and Findus Switzerland business may take longer to realize and may cost more to achieve than expected, particularly since the Fortenova Acquisition represents entry into a new product category and new geographies;

•uncertainty about the potential adverse impact of Brexit on currency exchange rates, global economic conditions and cross-border agreements that affect our business;

•the loss of any of our executive officers or members of our senior management team or other key employees;

•the loss of any of our major customers or a decrease in demand for our products;

•changes in consumer preferences and our failure to anticipate and respond to such changes or to successfully develop and renovate products;

•our ability to successfully interpret and respond to key industry trends and to realize the expected benefits of our responsive actions;

•our ability to protect our brand names and trademarks;

•the commercial success of our Green Cuisine brand of products, including as a result of its expansion into continental Europe, and other innovations introduced to the markets, and other innovations introduced to the markets and our ability to accurately forecast the brand’s performance in light of COVID-19;

•our ability to effectively compete in our markets, including the ability of our Green Cuisine brand to effectively penetrate the markets in continental Europe;

•economic conditions that may affect our future performance including exchange rate fluctuations;

•fluctuations in the availability of food ingredients and packaging materials that we use in our products;

•our ability to effectively mitigate factors that negatively impact our supply of raw materials;

•disruptions in our information technology systems, whether as a result of cyber attack or otherwise, supply network, manufacturing and distribution facilities or our workforce or the workforce of our suppliers;

•our ability to continue to comply with covenants and the terms of our credit instruments and our ability to obtain additional financing, as needed, to fund our liquidity requirements and capital expenditures;

•availability of debt and equity financing under favorable terms;

•increases in operating costs, including labor costs, and our ability to manage our cost structure;

•the occurrence of liabilities not covered by our insurance;

•our ability to successfully implement, and engage other stakeholders in implementing, our sustainability program;

•the loss of our financial arrangements with respect to receivables factoring;

•the loss of our foreign private issuer status;

•the effects of reputational damage from unsafe or poor-quality food products, particularly if such issues involve products we manufactured or distributed;

•our failure to comply with, and liabilities related to, environmental, health and safety laws and regulations; and

•changes in applicable laws or regulations.

3

These and other factors are more fully discussed in Item 3D: Key Information - Risk Factors and elsewhere in this annual report. These risks could cause actual results to differ materially from those implied by forward-looking statements in this annual report.

All information contained in this annual report is materially accurate and complete as of the date of this annual report. You should keep in mind, however, that any forward-looking statement made by us in this annual report, or elsewhere, speaks only as of the date on which we make it. New risks and uncertainties come up from time to time, and it is impossible for us to predict these events or how they may affect us. We do not undertake any obligation to update or revise any forward-looking statements after the date of this annual report, whether as a result of new information, future events or otherwise, except as required by law. In light of these risks and uncertainties, you should keep in mind that any event described in a forward-looking statement made in this annual report or elsewhere might not occur.

4

PART I

Item 1:    Identity of Directors, Senior Management and Advisers

A.    Directors and Senior Management

Not applicable.

B.    Advisers

Not applicable.

C.    Auditors

Not applicable.

Item 2:    Offer Statistics and Expected Timetable

A.    Offer Statistics

Not applicable.

B.    Method and Expected Timetable

Not applicable.

Item 3:    Key Information

A.    Selected Financial Data

The following table sets forth selected historical consolidated financial and other data for the Company for the periods presented. The selected historical consolidated financial data below should be read in conjunction with our Audited Consolidated Financial Statements and related notes (Item 18), as well as Item 4: Information on the Company and Item 5: Operating and Financial Review and Prospects of this annual report.

The statement of income data for the Fiscal 2021 Period, Fiscal 2020 Period and Fiscal 2019 Period and the balance sheet data as of December 31, 2021 and 2020 have been derived from our audited consolidated financial statements included elsewhere in this annual report. 

5

	Year ended Dec 31 2021	Year ended Dec 31 2020	Year ended Dec 31 2019	Year ended Dec 31 2018	Year ended Dec 31 2017
	€m	€m	€m	€m	€m
Statement of Income data:
Revenue	2,606.6	2,515.9	2,324.3	2,172.8	1,956.6
Cost of sales	(1,862.3)	(1,753.4)	(1,626.4)	(1,519.3)	(1,357.2)
Gross profit	744.3	762.5	697.9	653.5	599.4
Other operating expenses	(356.3)	(382.7)	(359.9)	(352.7)	(319.3)
Exceptional items	(45.3)	(20.6)	(54.5)	(17.7)	(37.2)
Operating profit	342.7	359.2	283.5	283.1	242.9
Net finance costs	(106.0)	(63.7)	(73.2)	(56.0)	(74.4)
Profit before tax	236.7	295.5	210.3	227.1	168.5
Taxation	(55.7)	(70.4)	(56.7)	(56.6)	(32.0)
Profit for the period	181.0	225.1	153.6	170.5	136.5
Basic weighted number of shares	178,070,770	194,019,070	192,004,803	175,622,538	176,080,272
Diluted weighted number of shares	178,070,770	197,894,106	198,425,877	175,793,631	184,786,162
Basic earnings per share	1.02	1.16	0.80	0.97	0.78
Diluted earnings per share	1.02	1.14	0.78	0.97	0.74
Balance Sheet data:
Total assets*	6,170.8	5,580.6	5,904.5	5,340.8	4,601.7
Total equity	2,299.0	2,126.1	2,556.7	2,059.1	1,852.6
Share capital	—	—	—	—	—

*As disclosed in Note 14 "Acquisitions" to our consolidated financial statements in Item 18, values for total assets the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

B.    Capitalization and Indebtedness

Not applicable.

C.    Reasons for the Offer and Use of Proceeds

Not applicable.

6

D.    Risk Factors

An investment in our ordinary shares carries a significant degree of risk. You should carefully consider the following risks and other information in this annual report, including our consolidated financial statements and related notes included elsewhere in this annual report, before you decide to purchase our ordinary shares. Additional risks and uncertainties of which we are not presently aware or that we currently deem immaterial could also affect our business operations and financial condition. If any of these risks actually occur, our business, financial condition, results of operations or prospects could be materially affected. As a result, the trading price of our ordinary shares could decline, and you could lose part or all of your investment.

i.Risk Factor Summary

The risks described below include, but are not limited to, the following:

Risks Related to Our Business and Industry

•We operate in a highly competitive market

•Sales of our products are subject to changing consumer preferences and trends

•Our future results and competitive position are dependent on the successful development of new products and improvement of existing products.

•The COVID-19 pandemic could have a material adverse impact on our business, results of operations and financial condition.

•We are subject to the ongoing negotiations and implementation of the exit of the UK from the EU. We are exposed to macroeconomic and other trends that could adversely impact our operations in our Key Markets.

•We may not be able to achieve our sustainability targets to the extent we expect.

•We may not be able to source raw materials or other inputs of an acceptable type or quality.

•We may not be able to pass on price increases for materials or other inputs to our customers.

•We rely on sales to a limited number of large food retailers.

•We may be subject to increased distribution costs or disruption of transportation services.

•Failure to protect our brand names and trademarks could materially affect our business.

•Our business is dependent on third-party suppliers.

•Health concerns or adverse developments with respect to the safety or quality of our products may damage our reputation, increase our costs of operations and decrease demand for our products.

•A failure in our cold chain could lead to unsafe food conditions and increased costs.

•Potential liabilities and costs from litigation could adversely affect our business.

•The price of energy we consume in the manufacture, storage and distribution of our products is subject to volatile market conditions.

•Our supply network and manufacturing and distribution facilities could be disrupted by factors beyond our control.

•Seasonality impacts our business, and our revenue and working capital levels may vary quarter to quarter.

•We may be unable to realize the expected benefits of actions taken to align our resources, operate more efficiently and control costs.

•We may be subject to significant disruption in our workforce or the workforce of our suppliers.

•We are dependent upon key executives and highly qualified managers and we cannot assure their retention.

Risks Related to Our Acquisition Strategy

•We may not be able to consummate future acquisitions or successfully integrate acquisitions into our business.

•We may be subject to antitrust regulations with respect to future acquisition opportunities.

•Any due diligence by us in connection with agreed acquisitions or potential future acquisitions may not reveal all relevant considerations or liabilities of the target business.

•The Fortenova Acquisition represents entry into a new product category and new geographies for us.

7

Risks Related to Regulations

•We could incur material costs to address violations of, or liabilities under all applicable directives, regulations and laws.

•We are subject to complying with a variety of regulatory schemes.

•Changes in the European regulatory environment regarding privacy and data protection regulations could expose us to risks of noncompliance and costs associated with compliance.

Risks Related to Financial Management

•We have risks related to our indebtedness, including our ability to withstand adverse business conditions and to meet our debt service obligations.

•Our variable rate indebtedness subjects us to interest rate risk.

•Our indebtedness is subject to changes in interest reference rates including those related to the replacement of LIBOR and/or EURIBOR.

•We are exposed to exchange rate risks.

•Changes to our payment terms with both customers and suppliers may materially adversely affect our operating cash flows.

•Dividend payments and purchases made pursuant to announced share repurchase programs may have an impact on our cash flows and our ability to meet our debt service obligations.

•An impairment of the carrying value of goodwill or other intangible assets could negatively affect our consolidated operating results and net worth.

•We are exposed to risks in connection with our treasury and cash management activities.

•We face risks associated with certain pension obligations.

•We are a holding company whose principal source of operating cash is the income received from our subsidiaries.

•The Founders and/or the Founder Entities may in the future enter into related party transactions with us, which may give rise to conflicts of interest between us and some or all of the Founders and/or the Directors.

General Risk Factors

•We are subject to disruptions, failures or security breaches of our information technology systems.

•Changes in accounting standards and subjective assumptions, estimates and judgments by management related to accounting matters could significantly affect our financial results.

•If we fail to or are unable to implement and maintain effective internal controls over financial reporting, the accuracy and timeliness of our financial reporting may be adversely affected.

Risks Related to our Ordinary Shares

•We have various equity instruments outstanding that would require us to issue additional ordinary shares.

•Securities or industry analysts may not or may cease publishing research reports about us.

•As a foreign private issuer, we are subject to different U.S. securities laws and NYSE governance standards than domestic U.S. issuers.

•We may lose our foreign private issuer status in the future.

•The rights of shareholders under British Virgin Islands law differ from those under United States law.

•The laws of the British Virgin Islands provide limited protection for minority shareholders.

•British Virgin Islands companies may not be able to initiate shareholder derivative actions.

•Shareholders may experience a dilution of their percentage ownership if we make non-pre-emptive offers of ordinary shares in the future.

Risks Related to Taxation

•Failure to maintain our tax status may negatively affect our financial and operating results and shareholders.

•Disputes with tax authorities may give rise to unforeseen adjustments.

•If any dividend is declared in the future and paid in a foreign currency, U.S. holders may be taxed on a larger amount in U.S. Dollars than the U.S. Dollar amount actually received.

8

ii. Details of our Risk Factors

Risks Related to Our Business and Industry

We operate in a highly competitive market and our failure to compete effectively could adversely affect our results of operations.

The market for frozen food is highly competitive, and further consolidation in the industry would likely increase competition. Our competitors include retailers who promote private label products and well-established branded producers that operate on both a national and an international basis across single or multiple frozen food categories. We also face competition more generally from chilled food, distributors and retailers of fresh products, baked goods and ready-made meals. We may not successfully compete with our existing competitors and new competitors may enter the market. Discounters are supermarket retailers which offer a narrow range of food and grocery products at discounted prices and which typically focus on non-branded rather than branded products. A continued increase in discounter sales may adversely affect the sales of our branded products. We are increasing our investment in online sales (sales made through retailers’ online platforms). However, there is no guarantee we will achieve our expected return on investment from this strategy. The growth of online retailers, and the corresponding growth in our online sales, may also adversely affect our competitive position. Market dynamics continue to evolve and growth rates might change by channel and over time. In particular, during the COVID-19 pandemic we saw a shift in consumer behavior to online shopping as shoppers looked to avoid physical stores.

In addition, it is difficult to accurately predict the pricing or promotional actions of our competitors or their effect on consumer perceptions or the success of our own advertising and promotional efforts. Our competitors develop and launch products targeted to compete directly with our products. Our retail customers, most of which promote their own private label products, control the shelf space allocations within their stores. As a result, they may allocate more shelf space to private label products or to our branded competitors’ products in accordance with their respective promotional or pricing strategies. Decreases in shelf space allocated to our products, increases in competitor promotional activity, aggressive marketing strategies by competitors, changes to the strategies deployed by retailers or other factors may require us to reduce our prices or invest greater amounts in advertising and promotion of our products to ensure our products remain competitive.

Furthermore, some of our competitors may have substantially greater financial, marketing and other resources than we have. This creates competitive pressures that could cause us to lose market share or require us to lower prices, increase advertising expenditures or increase the use of discounting or promotional campaigns. These competitive factors may also restrict our ability to increase prices, including in response to commodity and other cost increases. If we are unable to continue to respond effectively to these and other competitive pressures, our customers may reduce orders of our products, may insist on prices that erode our margins or may allocate less shelf space and fewer displays for our products. These or other developments could materially and adversely affect our sales volumes and margins and result in a decrease in our operating results, which could have a material adverse effect on our business and financial condition.

Sales of our products are subject to changing consumer preferences and trends; if we do not correctly anticipate

such changes, our sales and profitability may decline.

There are a number of trends in consumer preferences which have an impact on us and the frozen food industry as a whole. These include, among others, preferences for speed, convenience and ease of food preparation; natural, nutritious and well-proportioned meals; products that are sustainably sourced and produced and are otherwise environmentally friendly and the recent trend towards meat substitutes. Concerns as to the health impacts and nutritional value of certain foods may increasingly result in food producers being encouraged or required to produce products with reduced levels of salt, sugar and fat and to eliminate trans-fatty acids and certain other ingredients, including gluten and animal products. Consumer preferences are also shaped by concern over waste reduction and the environmental impact of products.

The success of our business depends on both the continued appeal of our products and, given the varied backgrounds and tastes of our customer base, our ability to offer a sufficient range of products to satisfy a broad spectrum of preferences. Any shift in consumer preferences in the UK, Italy, Germany, France, Sweden or Austria (the “Key Markets”) could have a material adverse effect on our business.

Our competitiveness depends on our ability to predict and quickly adapt to consumer preferences and trends and to exploit profitable opportunities for product development without alienating our existing consumer base or focusing excessive resources or attention on unprofitable or short-lived trends. All of these efforts require significant

9

research and development and marketing investments. If we are unable to respond on a timely and appropriate basis to changes in demand or consumer preferences and trends, our sales volumes and margins could be materially adversely affected.

Activist groups have in the past, and may in the future, use pressure tactics to influence our decisions regarding commodities, raw materials and supply chains based on their stances regarding, for example, inhumane treatment of animals and deforestation by our suppliers. These groups may be able to coordinate their actions with other groups, threaten strikes or boycotts or enlist the support of well-known persons or organizations in order to increase the pressure on us to achieve their stated aims. In the future, these actions or the threat of these actions may force us to change our business practices or pricing policies, which may have a material adverse effect on our business, results of operations and financial condition.

Our future results and competitive position are dependent on the successful development of new products and improvement of existing products.

We aim to introduce new products and re-launch and extend existing product lines on a timely basis in order to counteract obsolescence and decreases in sales of existing products as well as to increase overall sales of our products. The launch and success of new or modified products are inherently uncertain, especially as to the products’ appeal to consumers, and there can be no assurance as to our continuing ability to develop and launch successful new products or variations of existing products. The failure to launch a product successfully can give rise to inventory write-offs and other costs, can affect consumer perception of our other products and can lead to erosion of brand equity. Market factors and the need to develop and provide modified or alternative products may also increase costs. In addition, launching new or modified products can result in cannibalization of sales of our existing products if consumers purchase the new product in place of our existing products. If we are unsuccessful in developing new products in response to changing consumer demands or preferences in an efficient and economical manner, or if our competitors respond more effectively than we do, demand for our products may decrease, which could materially and adversely affect our business, financial condition and results of operations Additionally, our ability to develop new and modified products and to gain distribution and advertising space for such new and modified products in order to sustain sales may be negatively impacted by COVID-19 restrictions as described below, which could impede our anticipated growth in this area. As a result, we may not be able to phase these planned innovations and execute our strategy as planned and may be forced to mitigate the risk by focusing on our core business.

The COVID-19 pandemic could have a material adverse impact on our business, results of operations and financial condition.

On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. The global outbreak has created significant volatility, uncertainty and economic disruption which has resulted in significant governmental measures being implemented in many European countries in which we operate, including lockdowns, closures, quarantines and travel bans, intended to control the spread of the virus. These measures continue to evolve as countries and local governments continue to adapt to the ongoing outbreak, with precautions including vaccination programs, lockdowns and self-isolation measures, requiring employees to work remotely and imposing travel restrictions. These restrictions, and future prevention and mitigation measures, have had and are continuing to have, an adverse impact on global economic conditions. This is particularly the case since further waves of COVID-19 outbreaks and the emergence of new variants of the virus may cause these restrictions to tighten and continue to have an adverse impact on global economic conditions, which could materially adversely affect our business and operating results. For example, in south-eastern Europe, a number of countries are still subject to high levels of restriction and certain other European countries have recently increased restrictions, including the Netherlands and Austria. Uncertainties regarding the ongoing economic impact of COVID-19 are likely to result in sustained market turmoil, which could also negatively impact our business, financial condition and cash flows.

While restrictions have been in place during the pandemic, we have experienced increased demand for our branded products as a result of a general increase in frozen food consumption. For example, as a result of unusually high demand during the fourth quarter of 2020 and the first quarter of 2021, we were unable to meet all sales demand, primarily due to a number of our production facilities already being highly utilized prior to that period of unusually high demand. If our suppliers, co-manufacturers, distributors or transportation and logistics providers are unable to keep pace with this increased demand, and we are unable either to access alternatives, or to access alternatives on commercially reasonable terms, this could negatively impact our market share, our ability to increase revenue, cause harm to our reputation and have a material adverse impact on our operating results. When the effect of the pandemic has significantly abated, this might lead to the reversal of such unusually high demand which could lead to lower demand, higher inventory which could negatively impact our market share, our ability to increase revenue and have a material adverse impact on our operating results. During the pandemic we have also experienced lower demand for our food

10

service products, which support commercial food establishments, due to governmental restrictions on the ability to eat out of home. Depending on the extent and length of such restrictions, this could see demand for such products to continually decline which could negatively impact our ability to increase revenue and have an adverse impact on our operating results and goodwill.

We operate production space in facilities across Europe. While we have not experienced any significant disruptions to our facilities, we could, in the future, be forced to close our facilities or reduce operations due to government responses to the pandemic or employee illness or health concerns, including as a result of sustained periods of employees working from home. If a significant percentage of our workforce is unable to work, including because of illness or travel or government restrictions in connection with COVID-19, or if we are required to shut down one or more of our facilities, this could have a material adverse effect on our revenue, operations and results of operations. For example, extended shutdowns or reduced operations could also result in an increase in operating costs in connection with our continuing to pay employees at non-operating facilities and higher costs associated with ensuring the continued health and safety of workers, which may include checking workers’ temperatures, providing personal protective equipment, deep cleaning facilities, and requiring sick workers to stay home by providing enhanced employee benefits.

The extent of COVID-19’s effect on our operational and financial performance will depend on future developments, including the duration, spread and intensity of the outbreak, the emergence of new variants of the virus, the availability and effectiveness of vaccines and government responses to the pandemic (including any further lockdowns, mandatory social distancing or other restrictive measures), all of which are uncertain and difficult to predict considering the rapidly evolving landscape. As a result, it is not currently possible to ascertain the overall impact of COVID-19 on our business. However, if the pandemic continues to evolve in such a way that its effects are likely to continue for a longer period than currently envisaged, the disease could exacerbate other risks we face, and also have a material adverse effect on our business, results of operations, financial condition and cash flows and adversely impact the trading price of our ordinary shares. Also, as restrictions are eased or lifted, this is now highlighting other trends which are proving to be difficult to predict in a rapidly evolving landscape. Examples of trends which are in part the result of COVID-19 restrictions include, the increase in the cost of sea freight partly driven by the dislocation of sea containers, increases in the cost of energy and raw materials and shortages of commercial truck drivers. These create challenges with the supply of our products to our customers as a result of the return to home drivers and the continued challenges of cross-border supply.

We are subject to the ongoing negotiations and implementation of the exit of the UK from the EU.

Since January 1, 2021, the UK has been trading as an independent country outside of the European Union following the UK electorate voting in favor of leaving the European Union (commonly referred to as “Brexit”) on June 23, 2016 and the conclusion of a new trading agreement between the European Union and the UK which was entered into on December 24, 2020. This means that new regulations are in place governing the import and export of goods between the UK and the European Union from this date which places a greater cost and administrative burden on us, for example by requiring veterinary certificates for exporting products of animal origin from the UK to the European Union. There are also additional regulations in place governing tariffs for products of non-EU origin when they are exported across the border from the UK to the European Union which also can place a greater cost and administrative burden on us. From July 1, 2022, veterinary certificates will additionally be required for importing products from the European Union to the UK (recently delayed from October 1, 2021) and negotiations continue over the ongoing trade relationship with Europe, for example, the ongoing negotiations in relation to the Northern Ireland Protocol, which could lead to further changes which could lead to increased tariffs, packaging changes and a greater cost and administrative burden on us.

For the year ended December 31, 2021, excluding sales from business included within the Fortenova acquisition, 93% of our revenue was derived from the EU and the UK (29% was derived from the UK). In addition, we have manufacturing facilities and employees in both the UK and other European countries. As a result of Brexit, we may experience adverse impacts on profitability in the UK and other markets. The new Brexit administration requirements could mean that the UK suffers as a result of losing commercially favorable access to the EU single market, or specific countries in the EU, resulting in a negative impact on the general and economic conditions in the UK and the EU which could in turn have a negative impact on our business and results of operations. Future changes may occur in regulations that we are required to comply with as well as amendments to treaties governing tax, duties, tariffs, etc. which could adversely impact our operations and require us to modify our financial and supply arrangements. To avoid such impacts, we may have to restructure or relocate some or all of our operations which would be costly and negatively impact our profitability, cash flow and financial condition.

11

We are exposed to macroeconomic and other trends that could adversely impact our operations in our Key Markets.

We conduct operations in our key markets of the UK, Italy, Germany, France, Sweden and Austria, from which approximately 78% of our revenue was generated during the year ended December 31, 2021 (the "Key Markets"). We are particularly influenced by economic developments and changes in consumer habits in those countries.

The geographic markets in which we compete have been affected by negative macroeconomic trends which have affected consumer confidence. For example, Brexit and the COVID-19 pandemic have created political and economic uncertainty both in the UK and the other geographies in which we operate. A deterioration in economic conditions could result in increased unemployment rates, increased short and long-term interest rates, consumer and commercial bankruptcy filings, a decline in the strength of national and local economies, and other results that negatively impact household incomes. This can result in consumers purchasing cheaper private label products instead of equivalent branded products. Such macroeconomic trends could, among other things, negatively impact global demand for branded and premium food products, which could result in a reduction of sales or pressure on margins of our branded products or cause an increasing transfer to lower priced product categories.

We may not be able to achieve our sustainability targets to the extent we expect.

We have adopted a sustainability strategy which sets out our role in supporting the change to how food is produced and consumed, in line with the UN Sustainable Development Goals and our corporate purpose. Our ability to successfully implement, and engage other stakeholders in implementing, our sustainability strategy, will depend on a number of factors which are beyond our control, including the extent to which our suppliers and other stakeholders prioritize sustainability initiatives themselves in their own businesses, the reaction of retailers and our customers to our sustainability strategy and broader macroeconomic and social trends. Further, unanticipated events, including changes in our ability to source sustainably produced food ingredients, may have an impact on the extent to which we can meet our own sustainability targets in any given year. If our expectations surrounding our sustainability strategy are not met and/or if consumers consider that we are not making sufficient progress with regards to our sustainability strategy, this could have an impact upon demand for our products and materially adversely affect our business, financial condition and results of operations.

We may not be able to source raw materials or other inputs of an acceptable type or quality.

We use significant quantities of food ingredients and packaging materials and are therefore vulnerable to fluctuations in the availability and price of such food ingredients, packaging materials and other supplies . In particular, raw materials have historically represented a significant portion of our cost of sales, and accordingly, adverse changes in raw material prices have in the past negatively impacted and may in future negatively impact our results of operations.

Specifically, the availability and the price of fish, vegetables and other agricultural commodities, including poultry and meat, can be volatile. We are also affected by the availability of quality raw materials, most notably fish, which can be impacted by the fishing and agricultural policies of the UK, European Union and other countries including national or international quotas that can limit volume of raw materials. General economic conditions, economic sanctions due to regional conflict, unanticipated demand, problems in manufacturing or distribution, natural disasters, weather conditions during the growing and harvesting seasons, plant, fish and livestock diseases, the availability of sustainably sourced raw materials, or national or international quarantines can all also adversely affect availability and prices of commodities in the long and short term.

While we attempt to negotiate fixed prices for certain materials with our suppliers for periods ranging from one month to a full year, we cannot guarantee that our strategy will be successful in managing input costs if prices increase for extended periods of time. Additionally, by entering fixed price agreements we may potentially be limiting our ability to benefit from possible price decreases. Moreover, there is no market for hedging against price volatility for certain raw materials and accordingly such materials are bought at the spot rate in the market.

Our ability to avoid the adverse effects of a pronounced, sustained price increase in raw materials is limited. Any increases in prices or scarcity of ingredients or packaging materials required for our products could increase our costs and disrupt our operations. If the availability of any of our inputs is constrained for any reason, we may not be able to obtain sufficient supplies or supplies of a suitable quality on favorable terms or at all. Such shortages could materially adversely affect our market share, business, financial condition and results of operations.

12

We may not be able to pass on price increases for materials or other inputs to our customers.

Our ability to pass through increases in the prices of raw materials, energy, packaging or freight and logistics costs to our customers depends, among others, on prevailing competitive conditions and pricing methods in the markets in which we operate, and we may not be able to pass through such price increases to our customers. Even if we are able to pass through increases in prices, there is typically a time lag between cost increases impacting our business and implementation of product price increases during which time our profit margin may be negatively impacted. Recovery of cost inflation, driven by both commodity cost increases or changes in the foreign exchange rate of the currency the commodity is denominated in, can also lead to disparities in retailers’ shelf-prices between different brands which can result in a competitive disadvantage and volume decline. During our negotiations to increase our prices to recover cost increases, customers may take actions which exacerbate the impact of such cost increases, for example by ceasing to offer our products or deferring orders until negotiations have ended. Our inability to pass through price increases in raw materials, energy, packaging or freight and logistics and preserve our profit margins in the future could materially adversely affect our business, financial condition and results of operations.

We rely on sales to a limited number of large food retailers and should they perform poorly or the buying power of these large retailers increase, our business could be adversely affected.

Our customers include supermarkets and large chain food retailers. Throughout our markets, the food retail segments are highly concentrated. For the year ended December 31, 2021, our top 10 customers accounted for 40% of revenue. In recent years, the major multiple (multi-channel) retailers in those countries have increased their share of the grocery market and price competition between retailers has intensified. The strength of the major multiple retailers’ bargaining position gives them significant leverage over their suppliers in negotiating pricing, product specification and the level of supplier participation in promotional campaigns and offers, which can reduce our margins. International alliances among retailers continue to become stronger, and the trend for consolidation in Europe at a local level and across borders is ongoing. Further consolidation among the major multiple retailers or disproportionate growth in relation to their competitors could increase their relative negotiating power and allow them to force a negative shift in our trade terms. Our results of operations could also be adversely affected if these retailers suffer a significant deterioration in sales performance, if we are required to reduce our prices or increase our promotional spending activity as a consequence, if we lose business from a major customer or if our relationship with a major customer deteriorates.

Our retail customers also offer private label products that compete directly with our products for retail shelf space and consumer purchases. Private label products typically have higher margins for retailers than other branded products. Accordingly, there is a risk that our customers may give higher priority to private label products or the branded products of our competitors as a result of a change in pricing strategy which would adversely affect sales of our products. Our major multiple retail customers are also expanding into non-food product lines in their stores, thereby exerting pressure on available shelf space for other categories including our products. We may be unable to adequately respond to these trends and, as a result, the volume of our sales may decrease, or we may need to lower the prices of our products.

As is typical in our industry, sales to our retail customers in our markets are made on a daily demand basis. We generally do not have long-term contractual commitments to supply such customers and must renegotiate supply and pricing terms of our products on a regular basis. Customarily, trade terms are renegotiated annually; however, ad hoc changes are often made on an informal basis, such as by email, to reflect discounts and promotional arrangements. Amounts paid can be subject to end of period reconciliations to reflect these informal arrangements. In some cases, our customers seek to claim reimbursement for informal discount arrangements going back multiple periods. In addition, we do not have written contractual arrangements with a number of our other customers. Most of our customer relationships or arrangements could be terminated or renegotiated at any time and, in some cases, without reasonable notice.

Our business is subject to the risks of non-payment and non-performance by our retail customers. We manage our exposure to credit risk through credit analysis and monitoring procedures, and sometimes use letters of credit, prepayments and guarantees. However, these procedures and policies cannot fully eliminate customer credit risk, and to the extent our policies and procedures prove to be inadequate, it could negatively affect our financial condition and results of operations. In addition, some of our customers may be highly leveraged and subject to their own operating and regulatory risks and, even if our credit review and analysis mechanisms work properly, we may experience financial losses in our dealings with such parties. Any future financial market disruptions or tightening of the credit markets could result in some of our customers experiencing a significant decline in profits and/or reduced liquidity. A significant adverse change in the financial position of a customer could require us to assume greater credit risk relating to that customer and could limit our ability to collect receivables. We do not maintain credit insurance to insure against customer credit risk.

13

Any of the above risk factors in relation to our retailers could have a material adverse effect on our business, financial condition and results of operations. In recent years, the major multiple (multi-channel) retailers in those countries have increased their share of the grocery market and price competition between retailers has intensified. The strength of the major multiple retailers’ bargaining position gives them significant leverage over their suppliers in negotiating pricing, product specification and the level of supplier participation in promotional campaigns and offers, which can reduce our margins. International alliances among retailers continue to become stronger, and the trend for consolidation in Europe at a local level and across borders is ongoing. Further consolidation among the major multiple retailers or disproportionate growth in relation to their competitors could increase their relative negotiating power and allow them to force a negative shift in our trade terms. Our results of operations could also be adversely affected if these retailers suffer a significant deterioration in sales performance, if we are required to reduce our prices or increase our promotional spending activity as a consequence, if we lose business from a major customer or if our relationship with a major customer deteriorates.

Our retail customers also offer private label products that compete directly with our products for retail shelf space and consumer purchases. Private label products typically have higher margins for retailers than other branded products. Accordingly, there is a risk that our customers may give higher priority to private label products or the branded products of our competitors as a result of a change in pricing strategy which would adversely affect sales of our products. Our major multiple retail customers are also expanding into non-food product lines in their stores, thereby exerting pressure on available shelf space for other categories including our products. We may be unable to adequately respond to these trends and, as a result, the volume of our sales may decrease, or we may need to lower the prices of our products.

As is typical in our industry, sales to our retail customers in our Key Markets are made on a daily demand basis. We generally do not have long-term contractual commitments to supply such customers and must renegotiate supply and pricing terms of our products on a regular basis. Customarily, trade terms are renegotiated annually; however, ad hoc changes are often made on an informal basis, such as by email, to reflect discounts and promotional arrangements. Amounts paid can be subject to end of period reconciliations to reflect these informal arrangements. In some cases, our customers seek to claim reimbursement for informal discount arrangements going back multiple periods. In addition, we do not have written contractual arrangements with a number of our other customers. Most of our customer relationships or arrangements could be terminated or renegotiated at any time and, in some cases, without reasonable notice.

Our business is subject to the risks of non-payment and non-performance by our retail customers. We manage our exposure to credit risk through credit analysis and monitoring procedures, and sometimes use letters of credit, prepayments and guarantees. However, these procedures and policies cannot fully eliminate customer credit risk, and to the extent our policies and procedures prove to be inadequate, it could negatively affect our financial condition and results of operations. In addition, some of our customers may be highly leveraged and subject to their own operating and regulatory risks and, even if our credit review and analysis mechanisms work properly, we may experience financial losses in our dealings with such parties. Any future financial market disruptions or tightening of the credit markets could result in some of our customers experiencing a significant decline in profits and/or reduced liquidity. A significant adverse change in the financial position of a customer could require us to assume greater credit risk relating to that customer and could limit our ability to collect receivables. We do not maintain credit insurance to insure against customer credit risk.

Any of the above risk factors in relation to our retailers could have a material adverse effect on our business, financial condition and results of operations.

14

We may be subject to increased distribution costs or disruption of transportation services.

We are dependent on third parties for almost all of our transportation and distribution requirements and distribution costs have historically fluctuated significantly over time. Increases in such costs could result in reduced profits. In addition, certain factors affecting distribution costs are controlled by our third-party carriers. To the extent that the market price for fuel or freight or the number or availability of carriers fluctuates, our distribution costs could be affected. Furthermore, temporary or long-term disruption of transportation services due to weather-related problems, impacts of COVID-19, strikes or other events could impair our ability to supply products affordably and in a timely manner or at all. Failure to receive our raw materials or to deliver our food products promptly could also result in inventory spoilage. These factors could impact our commercial reputation and result in our customers reducing their orders or ceasing to order our products. We require the use of refrigerated vehicles to ship our products and such distribution costs represent an important element of our cost structure. If we change the transportation services we use, we could face logistical difficulties that could delay deliveries, and we could incur costs and expend resources in connection with such change. Any increases in the cost of transportation, and any disruption in transportation, including the availability of suitable transportation (including the availability of suitable refrigerated transport, freight containers or lorry drivers), could have a material adverse effect on our business, financial condition and results of operations.

Failure to protect our brand names and trademarks could materially affect our business.

Our principal brand names and trademarks (including but not limited to Birds Eye, Iglo, Findus, Aunt Bessie's, Goodfella's, Ledo and Frikom) are key assets of our business and our success depends upon our ability to protect our intellectual property rights. We rely upon trademark laws to establish and protect our intellectual property rights but cannot be certain that the actions we have taken or will take in the future will be adequate to prevent violation of our proprietary rights. Litigation may be necessary to enforce our trademark or proprietary rights. In addition, the Birds Eye brand, which we use in the UK, is used by other producers in the United States and Australia. Even though the brands have different logos, adverse publicity from such other markets may negatively impact the perception of our brands in our respective markets. Adverse publicity, legal action or other factors could lead to substantial erosion in the value of our brands, which could lead to decreased consumer demand and could have a material adverse effect on our business, financial condition and results of operations.

There is also a risk that other parties may have intellectual property rights covering some of our brands, products or technology. If any third parties bring a claim of intellectual property infringement against us, we may be subject to costly and time-consuming litigation, diverting the attention of management and our employees. If we are unsuccessful in defending against such claims, we may be subject to, among other things, significant damages, injunctions against development and sale of certain products, or we may be required to enter into costly licensing agreements, any of which could have an adverse impact on our business, financial condition, and results of operations.

Our business is dependent on third-party suppliers.

We outsource some of our business functions to third-party suppliers, such as the processing of certain vegetables and other products, the manufacturing of products and packaging materials and distribution of our products. Our suppliers are subject to their own unique operational and financial risks, which are out of our control. Our suppliers may fail to meet timelines or contractual obligations or fail to provide us with sufficient products or services, which may adversely affect our business. For example, if a third party supplier is impacted by COVID-19, this could negatively affect the price and availability of our ingredients and/or packaging materials and may adversely impact our supply chain and operations. Moreover, there may be delays or shortages in procuring alternative suppliers, co-manufacturing capacity, or distribution capability.

Certain of our contracts with key suppliers, such as for the raw materials we use in our products, are short term, can be terminated by the supplier upon giving notice within a certain period and restrict us from using other suppliers. Also, a number of our supply contracts, including for fish and vegetables, may be terminated by the supplier upon a change in our ownership. Failure to appropriately structure or adequately manage our agreements with third parties may adversely affect our supply of raw materials or our supply of products to our customers. We are also subject to credit risk with respect to our third-party suppliers. If any such suppliers become insolvent, an appointed trustee could potentially ignore the service contracts we have in place with such party, resulting in increased charges or the termination of the service contracts. We may not be able to replace a service provider within a reasonable period of time, on as favorable terms or without disruption to our operations.

Any adverse changes to our relationships with third-party suppliers could have a material adverse effect on our image, brand and reputation, as well as on our business, financial condition and results of operations.

15

In addition, to the extent that our creditworthiness is impaired, or general economic conditions decline, certain of our key suppliers may demand different or onerous payment terms that could materially adversely affect our working capital position, or such suppliers may refuse to continue to supply to us. A number of our key suppliers have taken out trade credit insurance on our ability to pay them. To the extent that such trade credit insurance becomes unobtainable or more expensive due to market conditions, we may face adverse changes to payment terms by our key suppliers or they may refuse to continue to supply us.

Health concerns or adverse developments with respect to the safety or quality of products of the food industry may damage our reputation, increase our costs of operations and decrease demand for our products.

Food safety and the public’s perception that our products are safe and healthy are essential to our image and business. We sell food products for human consumption, which subjects us to safety risks such as product contamination, spoilage, misbranding or product tampering. Product contamination, including the presence of foreign objects, undeclared allergens, substances, chemicals or other agents or residues or the introduction of genetically modified organisms, could require product withdrawals or recalls or the destruction of inventory, and could result in negative publicity, reputational harm, temporary plant closures and substantial costs of compliance or remediation. In addition, food producers, including us, have been targeted by extortion attempts that threatened to contaminate products displayed in supermarkets. Such attempts can result in the temporary removal of products from shelf displays as a precautionary measure and result in lost revenue. We may also be impacted by publicity concerning any assertion that our products caused illness, injury or death. In addition, we could be subject to claims or lawsuits relating to an actual or alleged illness stemming from product contamination or any other incidents that compromise the safety and quality of our products. Any significant lawsuit or widespread product recall or other events leading to the loss of consumer confidence in the safety and quality of our products could damage our brand, reputation and image and negatively impact our sales, profitability and prospects for growth.

We could also be adversely affected if consumers lose confidence in the safety and quality of certain food products or ingredients, or the food safety system generally. If another company recalls or experiences negative publicity related to a product in a category in which we compete, consumers might reduce their overall consumption of products in this category or confuse our products with those of such company. Adverse publicity about these types of concerns, whether valid or not, may discourage consumers from buying our products or cause production and delivery disruptions. In addition, product recalls are difficult to foresee and prepare for and, in the event we are required to recall one or more of our products, such recall may result in loss of sales due to unavailability of our products and may take up a significant amount of our management’s time and attention. We cannot guarantee that our efforts to monitor food safety risks and such efforts of our suppliers will be successful or that such risks will not materialize, particularly since such systems are harder to implement and monitor in the context of the COVID-19 pandemic, which may continue to be the case after the pandemic has substantially abated. In addition, we cannot guarantee that our efforts, through contractual relationships and regular inspections, to control the risk of contamination caused by third parties in relation to the several manufacturing and distribution processes we outsource, will be successful or that contamination of our products by third parties will not materialize and have a material adverse effect on our business, financial condition and results of operations.

We are also subject to further risks affecting the food industry generally, including risks posed by widespread contamination and evolving nutritional, environmental/sustainability, social and health-related concerns. Regulatory authorities may limit the supply of or place prohibitive charges on certain types of food products in response to public health concerns and consumers may perceive certain products to be unsafe, unsustainable, unhealthy or otherwise undesirable. In addition, governmental regulations may require us to discontinue certain offerings or limit the range of products we offer. We may be unable to find substitutes that are as appealing to our customer base, or such substitutes may not be widely available or may be available only at increased costs. Such substitutions or limitations could also reduce demand for our products.

We could also be subject to claims or lawsuits relating to an actual or alleged illness or injury or death stemming from the consumption of a misbranded, altered, contaminated or spoiled product, even where such misbranding, alteration, contamination or spoilage is out of our control, which could negatively affect our reputation and business. Awards of damages, settlement amounts and fees and expenses resulting from such claims and the public relations implications of any such claims could be significant and have an adverse effect on our business. The availability and price of insurance to cover claims for damages are subject to market forces that we do not control, and such insurance may not cover all the costs of such claims and would not cover damage to our reputation. Even if product liability claims against us are not successful or fully pursued, these claims could be costly and time consuming, increase our insurance premiums and divert our management’s time and resources towards defending them rather than operating our business. In addition, any adverse publicity concerning such claims, even if unfounded, could cause customers to lose confidence in the safety and quality of our products and damage our reputation and brand image.

16

A failure in our cold chain could lead to unsafe food conditions and increased costs.

“Cold chain” requirements setting out the temperatures at which our ingredients and products are stored are established both by statute and by us to help guarantee the safety of our food products. The cold chain is maintained from the moment the ingredients arrive at, or are frozen by, our suppliers, through our manufacturing and transportation of products and ultimately to the time of sale in retail stores. These standards ensure the quality, freshness and safety of our products. A failure in the cold chain could lead to wastage, increased costs, food contamination, risks to the health of consumers, fines and damage to our brands and reputation, each of which could have a material adverse effect on our business, financial condition and results of operations.

Potential liabilities and costs from litigation could adversely affect our business.

We are subject to litigation, arbitration and regulatory proceedings, audits and investigations from time to time. There is no guarantee that we will be successful in defending ourselves in civil, criminal or regulatory actions, including under general, commercial, employment, intellectual property, food quality and safety, anti-trust and trade, tax, advertising and claims, and environmental laws and regulations, or in asserting our rights under various new and existing laws and regulations. For example, we could face allegations of false, misleading or deceptive advertising, claims or marketing or other criticisms which could result in litigation, arbitration or regulatory proceedings and result in potential liabilities or costs which may be significant and may damage our reputation. In addition, the defense of these lawsuits may divert our management’s attention from other business matters. The costs and other effects of potential and pending litigation and administrative actions against us, and new legal requirements, cannot be determined with certainty and may differ from expectations and may have a material adverse effect on our reputation, business, financial condition and results of operations.

We are exposed to local business and tax risks in many different countries.

Our business is subject to risks resulting from differing legal, political, social and regulatory requirements, economic conditions and unforeseeable developments in our markets, all or any of which could result in disruption of our activities. These risks include, among others, political instability , differing economic cycles, tariffs, duties and adverse economic conditions, changes in regulatory and legislative environments , currency exchange rate fluctuations, inability to collect payments or seek recourse under or comply with ambiguous or vague commercial or other laws, changes in distribution and supply channels, foreign exchange controls and restrictions on repatriation of funds, and difficulties in attracting and retaining qualified management and employees. Our overall success in the markets in which we operate depends, to a considerable extent, on our ability to effectively manage differing legal, political, social and regulatory requirements, economic conditions and both foreseeable and unforeseeable developments. We cannot guarantee that we will succeed in developing and implementing policies and strategies which will be effective in each location where we do business.

We must comply with complex and evolving tax regulations in the various jurisdictions in which we operate, which subjects us to international tax compliance risks. Some tax jurisdictions in which we operate have complex and subjective rules regarding income tax, value-added tax, sales or excise tax, tariffs, duties and transfer tax. From time to time, our foreign subsidiaries are subject to tax audits and may be required to pay additional taxes, interest or penalties should the taxing authority assert different interpretations, or different allocations or valuations of our services which could be material and could reduce our income and cash flow from our international subsidiaries. We currently have several pending tax assessments and audits in various jurisdictions including Germany and Italy. The agreements by which we acquired certain businesses provide for certain indemnifications of tax liabilities which may arise in certain jurisdictions which we believe are sufficient to address these specific tax matters as far as they relate to those businesses but our belief that these indemnities are sufficient may prove incorrect. We have also established, where appropriate, reserves and provisions for tax assessments which we believe to be adequate to address potential tax liabilities but our belief that these reserves and provisions are adequate may prove incorrect. However, it is possible that the tax audits referred to above could result in the volatility of timings of cash tax payment and recoveries. In addition, it is possible that countries will increase tax rates in the future, as a result of the COVID-19 pandemic.

The price of energy we consume in the manufacture, storage and distribution of our products is subject to volatile market conditions.

The price of electricity and other energy resources required in the manufacture, storage and distribution of our products is subject to volatile market conditions. These market conditions are often affected by political and economic factors beyond our control, including, for instance, the energy policies of the countries in which we operate. For example, the German government’s decision to phase out nuclear power generation by 2022 could cause electricity prices and price volatility in Germany to increase. Any sustained increases in energy costs could have an adverse effect

17

on the attractiveness of frozen food products for our customers and consumers and could affect our competitive position if our competitors’ energy costs do not increase at the same rate as ours. Such disruptions may also occur as a result of the loss of energy supply contracts or the inability to enter into new energy supply contracts on commercially attractive terms. Furthermore, natural catastrophes, regional conflicts or similar events could affect the electricity grid. Any such disruptions or increases in energy costs as a result of the aforementioned factors or otherwise, could have a material adverse effect on our business, financial condition and results of operations.

Our supply network and manufacturing and distribution facilities could be disrupted by factors beyond our control.

Severe weather conditions and natural disasters, such as storms, floods, droughts, frosts, earthquakes or pestilence, may affect the supply of the raw materials and energy resources that we use for the manufacturing of our products. For example, changing climate may cause flooding and drought in crop growing areas or changes in sea temperatures may affect marine biomass, fishing catch rates and overall fishing conditions. In addition, drought or floods may affect the feed supply for red meat and poultry, which in turn may affect the quality and availability of protein sources for our products. Adverse weather conditions and natural disasters can reduce crop size and crop quality, which in turn can reduce our supplies of raw materials, lower recoveries of usable raw materials, increase the prices of our raw materials, increase our cost of transporting and storing raw materials and finished goods, or disrupt our production schedules. Competing food producers can be affected differently by weather conditions and natural disasters depending on the location of their supply sources. If our supplies of raw materials are reduced, we may not be able to find adequate supplemental supply sources, if at all, on favorable terms, which could have a material adverse effect on our business, financial condition and results of operation.

Our supply network could also be adversely affected by the outbreak of various diseases or other public health crises, such as the current COVID-19 pandemic that may result in delays in procurement or an inability to access alternative supply on commercially reasonable terms, which may have an adverse impact on our operating results. In addition, a significant outbreak of a contagious disease in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could affect demand for our products and have a material adverse effect on our results of operations.

In addition, our manufacturing and distribution facilities may be subject to damage, disruption or closure resulting from fire, terrorist activity, natural disasters, health epidemics or other causes. For example, our Lowestoft and Bremerhaven manufacturing facilities are situated in regions which have historically been prone to flooding. Extensive damage to any of our fourteen major manufacturing facilities as a result of any of the foregoing reasons, could, to the extent that lost production could not be compensated for by unaffected facilities, severely affect our ability to conduct our business operations and, as a result, adversely affect our business, financial condition and results of operations.

Furthermore, as we lease parts of our Boulogne, Bremerhaven, Lowestoft, and Tonsberg manufacturing sites, the use of these properties is subject to certain terms and conditions, the breach of which could affect our ability to continue use of these properties which in turn may disrupt our operations and may materially adversely affect our results of operations.

Seasonality impacts our business, and our revenue and working capital levels may vary quarter to quarter.

Our sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for frozen food are slightly higher in cold or winter months, partly because there are fewer fresh alternatives available for vegetables and because our customers typically allocate more freezer space to the ice cream segment in summer or hotter months. The Fortenova Acquisition follows a different seasonality to the legacy business, with stronger performance through the summer months as a result of the ice-cream business. In addition, variable production costs, including costs for seasonal staff, and working capital requirements associated with the keeping of inventories, vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, inventory (and therefore net working capital) levels typically peak in August to September just after the pea harvest. If seasonal fluctuations are greater than anticipated, our business, financial condition and results of operations could be adversely affected.

18

We may be unable to realize the expected benefits of actions taken to align our resources, operate more efficiently and control costs.

When required we take actions, such as workforce reductions, plant closures and consolidations, and other cost reduction initiatives, to align our resources with our growth strategies, operate more efficiently and control costs. As these plans and actions are complex, unforeseen factors could result in expected savings and benefits to be delayed or not realized to the full extent planned, could negatively impact labor relations, including causing work stoppages, and could lead to disruptions in our business and operations and higher short-term costs related to severance and related capital expenditures.

We may be subject to significant disruption in our workforce or the workforce of our suppliers, which could adversely affect our business, financial condition and results of operations.

As of December 31, 2021, we employed approximately 8,002 employees, of which approximately 1,437 were located in Germany, 1,389 were located in the UK, 1,302 were located in Serbia, 853 were located in Croatia, , 494 were located in Italy, 378 were located in Sweden/Norway, 348 were located in Bosnia & Herzegovina, 333 were located in France and 1,468 employees in other locations. As of December 31, 2021, approximately 70% of our employees worked in our manufacturing operations. We have in the past, and may in the future, experience labor disputes and work stoppages at one or more of our manufacturing sites due to localized strikes or strikes in the larger retail food industry sector. We have also been involved in negotiations on collective bargaining agreements. A labor stoppage or other interruption at one of our nineteen manufacturing sites (or at the site of any of our suppliers) would impact our ability to supply our customers and could have a material adverse effect on such facility’s operations and, potentially, on our business, financial condition and results of operations.

Higher labor costs could adversely affect our business and financial results.

We compete with other producers for good and dependable employees. The supply of such employees is limited and competition to hire and retain them may result in higher labor costs. Furthermore, a number of our employees are subject to national minimum wage requirements. If legislation is enacted that has the effect of raising national minimum wage requirements, requires additional mandatory employee benefits or affects our ability to hire or dismiss employees, we could face substantially higher labor costs. High labor costs could adversely affect our profitability if we are not able to pass them on to our customers.

We are dependent upon key executives and highly qualified managers and we cannot assure their retention.

Our success depends, in part, upon the continued services of key members of our management. Our executives’ and managers’ knowledge of the market, our business and our Company represents a key strength of our business, which cannot be easily replicated. The success of our business strategy and our future growth also depend on our ability to attract, train, retain and motivate skilled managerial, sales, administration, development and operating personnel. There can be no assurance that our existing personnel will be adequate or qualified to carry out our strategy, or that we will be able to hire or retain experienced, qualified employees to carry out our strategy. The loss of one or more of our key management or operating personnel, or the failure to attract and retain additional key personnel, could have a material adverse effect on our business, financial condition and results of operations.

19

Risks Related to Our Acquisition Strategy

We may not be able to consummate future acquisitions or successfully integrate acquisitions into our business, which could result in unanticipated expenses and losses.

    Our acquisitions strategy is largely based on our ability to grow through acquisitions of additional businesses to build an integrated group. Consummating acquisitions of businesses, or our failure to integrate such businesses successfully into our existing businesses, could result in unanticipated expenses and losses. Furthermore, we may not be able to realize any of the anticipated benefits from completed acquisitions, including the Findus Switzerland and Fortenova acquisitions.

We anticipate that any future acquisitions we may pursue as part of our business strategy may be partially financed through additional debt or equity. Any future financial market disruptions or tightening of the credit markets may make it more difficult for us to obtain financing for acquisitions or increase the cost of obtaining financing. If new debt is added to current debt levels, or if we incur other liabilities, including contingent liabilities, in connection with an acquisition, the debt or liabilities could impose additional constraints and requirements on our business and operations, which could materially adversely affect our financial condition and results of operation. In addition, to the extent our ordinary shares are used for all or a portion of the consideration to be paid for future acquisitions, dilution may be experienced by existing shareholders.

In connection with our completed and future acquisitions, the process of integrating acquired operations into our existing group operations may result in unforeseen operating difficulties and may require significant financial resources that would otherwise be available for the ongoing development or expansion of existing operations. Some of the risks associated with acquisitions include:

•unexpected losses of key employees or customers of the acquired company;

•conforming the acquired company's standards, processes, procedures and controls with our operations;

•coordinating new product and process development;

•hiring additional management and other critical personnel;

•negotiating with labor unions; and

•increasing the scope, geographic diversity and complexity of our current operations.

We may encounter unforeseen obstacles or costs in the integration of businesses that we may acquire. For example, an acquisition may trigger change of control clauses entered into by the previous owner in which case the counterparties to such agreements may terminate their agreements requiring the acquired business to enter into new contracts, potentially on less favorable terms. In addition, general economic and market conditions or other factors outside of our control could make our operating strategies difficult or impossible to implement. Any such unforeseen obstacles or costs or failure to implement operational improvements successfully and/or the failure of any operational improvements to deliver the anticipated benefits could have a material adverse effect on our results of operations and financial condition.

Typically, when acquiring a business, the seller will provide certain warranties regarding its ownership of the acquired business as well as warranties regarding the business and operations of the acquired business. We may also obtain a warranty & indemnity insurance policy which provides coverage in respect of certain of these warranties. Any unexpected liabilities, individually or in the aggregate, which are not subject to such warranties or which are not recoverable under the such insurance policy, could have a material adverse effect on the business, financial condition and results of operations of the acquired business following the acquisition, whether or not such liabilities result from breaches of warranties. There can be no assurance that we will be able to enforce any claims against the seller relating to breaches of such warranties or successfully claim under our insurance policy. Moreover, even if we are ultimately able to recover any amounts from the seller or the insurer, we may be required to temporarily bear some or all of the losses which may arise from any breaches of warranties, which could have a material adverse effect on our financial condition and results of operations.

20

We may be subject to antitrust regulations with respect to future acquisition opportunities.

Many jurisdictions in which we operate have antitrust regulations which involve governmental filings for certain acquisitions, impose waiting periods and require approvals by government regulators. Governmental authorities may seek to challenge potential acquisitions or impose conditions, terms, obligations or restrictions that may delay completion of the acquisition or materially reduce the anticipated benefits (financial or otherwise) as a result of applying the relevant antitrust regulations. Our inability to consummate potential future acquisitions or to receive the full benefits of such acquisitions because of antitrust regulations could limit our ability to execute on our acquisition strategy which could have a material adverse effect on our financial condition and results of operations.

We may face significant competition for acquisition opportunities.

        There may be significant competition in some or all of the acquisition opportunities that we may explore. Such competition may for example come from strategic buyers, sovereign wealth funds, special purpose acquisition companies and public and private investment funds, many of which are well established and have extensive experience in identifying and completing acquisitions. Such competition may cause us to be unsuccessful in executing any acquisition or may result in a successful acquisition being made at a significantly higher price than would otherwise have been the case.

Any due diligence by us in connection with potential future acquisitions may not reveal all relevant considerations or liabilities of the target business, which could have a material adverse effect on our financial condition or results of operations.

We intend to conduct such due diligence as we deem reasonably practicable and appropriate based on the facts and circumstances applicable to any potential acquisition. The objective of the due diligence process will be to identify material issues which may affect the decision to proceed with any one particular acquisition target or the consideration payable for an acquisition. We also intend to use information revealed during the due diligence process to formulate our business and operational planning for, and our valuation of, any target company or business. While conducting due diligence and assessing a potential acquisition, we may rely on publicly available information, if any, information provided by the relevant target company to the extent such company is willing or able to provide such information and, in some circumstances, third party investigations where certain of our diligence efforts may be delayed or prohibited due to government or practical restrictions.

There can be no assurance that the due diligence undertaken with respect to an acquisition will reveal all relevant facts that may be necessary to evaluate such acquisition including the determination of the price we may pay for an acquisition target or to formulate a business strategy. Furthermore, the information provided during due diligence may be incomplete, inadequate or inaccurate. As part of the due diligence process, we will also make subjective judgments regarding the results of operations, financial condition and prospects of a potential target. If the due diligence investigation fails to correctly identify material issues and liabilities that may be present in a target company or business, or if we consider such material risks to be commercially acceptable relative to the opportunity, and we proceed with an acquisition, we may subsequently incur substantial impairment charges or other losses.

In addition, following any acquisition, we may be subject to significant, previously undisclosed liabilities of the acquired business that were not identified during due diligence and which could contribute to poor operational performance, undermine any attempt to restructure the acquired company or business in line with our business plan and have a material adverse effect on our financial condition and results of operations.

The Fortenova Acquisition represents entry into a new product category and new geographies for us.

The Fortenova Acquisition provides entry into a new product category (ice cream) and new geographies (in Central and Eastern Europe) in which we do not have previous experience. Our ability to successfully realize the benefits and synergies of the Fortenova Acquisition will depend in part upon maintaining and growing the business in this new product category and these new geographies, and integrating the Fortenova Acquisition into our wider business processes, for which we will be reliant upon the current management of the business. Consumer buying habits, preferences, seasonal trends and brand loyalty in these Central and Eastern European markets, among other things, may differ materially from our experience in our prevailing markets. For example, the promotion and advertising strategies used in our existing businesses may not be able to be replicated successfully in these new geographies and/or in the ice cream category. Any failure to maintain the existing market share of the Target Group, or any failure to fully deliver the anticipated benefits of the Fortenova Acquisition (which could result from the factors outlined above or other factors) could have a material adverse effect on our results of operations and financial condition.

21

Risks Related to Regulations

We could incur material costs to address violations of, or liabilities under all applicable directives, regulations and laws.

As a producer of food products for human consumption, we are subject to extensive regulation in our Key Markets and other countries in which we operate, at both a national and European Union level, that governs production, composition, manufacturing, storage, transport, advertising, packaging, quality, labeling, and distribution standards. It is unclear how such existing rules will be impacted as a result of Brexit but there may be changes and further regulations that we must adhere to. Any failure to comply with applicable laws and regulations could subject us to civil remedies, including fines, injunctions, product recalls or asset seizures, as well as potential criminal sanctions.

In addition, our facilities and our suppliers’ facilities are subject to licensing, reporting requirements and official quality controls by numerous governmental authorities. These governmental authorities include European, national and local health, environmental, labor relations, sanitation, building, zoning, and fire and safety departments. Difficulties in obtaining or failure to obtain the necessary licenses or approval could delay or prevent the development, expansion or operation of a given production or warehouse facility. Any changes in those regulations may require us or our suppliers to implement new quality controls and possibly invest in new equipment, which could delay the development of new products and increase our operating costs.

All of our products and production facilities must comply with strict national and international hygiene regulations. Our facilities and our suppliers’ facilities are subject to regular inspection by authorities for compliance with hygiene regulations applicable to the sale, storage and manufacturing of foodstuffs and the traceability of genetically modified organisms, meats and other raw materials. Additionally, in certain jurisdictions, food business operators, including those in the food storage, processing and distribution sectors, are required to trace all food, animal feed, and food-producing animals under their control using registration systems that track the source of the products through the supply chain. Despite the precautions we undertake, should any non-compliance with such regulations be discovered during an inspection or otherwise, authorities may temporarily shut down any of our facilities, demand a product recall and/or levy a fine for such non-compliance.

Our facilities and operations are subject to numerous health, safety and environmental regulations, including local and national laws, and European directives and regulations governing, among other things, water supply and use, water discharges, air emissions, chemical safety, solid and hazardous waste management and disposal, clean-up of contamination, energy use, noise pollution, and workplace health and safety. Health, safety and environmental legislation in Europe and elsewhere has generally become more comprehensive and restrictive and more rigid over time and enforcement has become more stringent. Failure to comply with applicable requirements, or the terms of required permits, can result in penalties or fines, clean-up costs, third party property damage and personal injury claims. In addition, if health, safety and environmental laws and regulations in our Key Markets and the other countries in which we operate or from which we source raw materials and ingredients become more stringent in the future, the extent and timing of investments required to maintain compliance may exceed our budgets or estimates and may limit the availability of funding for other investments.

Furthermore, under some environmental laws, we could be liable for costs incurred in investigating or remediating contamination at properties we own or occupy, even if the contamination was caused by a party unrelated to us or was not caused by us, and even if the activity which caused the contamination was legal at the time it occurred. The discovery of previously unknown contamination, or the imposition of new or more burdensome obligations to investigate or remediate contamination at our properties or at third-party sites, could result in substantial unanticipated costs.

In certain jurisdictions, we are also subject to legislation designed to significantly reduce industrial energy use, water use, carbon dioxide emissions and the emission of ozone depleting compounds more generally. If we fail to meet applicable standards for energy use reduction or are unable to decrease, and in some cases eliminate, certain emissions within the applicable period required by relevant laws and regulations, we could be subject to significant penalties or fines and temporary or long-term disruptions to production at our facilities.

Any failure to comply with any of the applicable directives, regulations and laws as set out in this section could have a material adverse effect on our business, financial condition, reputation and results of operations.

22

We are subject to a variety of regulatory schemes; failure to comply with applicable rules and regulations could adversely affect our business, results of operations and reputation.

Our operations are subject to a variety of regulatory schemes which require us to implement processes, procedures and controls to provide reasonable assurance that we are operating in compliance with applicable regulations, including the UK Bribery Act, the Modern Slavery Act 2015, the Foreign Corrupt Practices Act of 1977, the Trade Sanctions and Export Controls and GDPR. In addition, our business, including our ability to operate and continue to expand internationally, could be adversely affected if local and foreign laws or regulations are adopted, interpreted, or implemented in a manner that is inconsistent with our current business practices and that require rapid changes to these practices or our products, services, policies and procedures. If we are not able to adapt our business practices or strategies to changes in laws or regulations, it could subject us to liability, increased costs and reduced product demand. Additionally, the costs of compliance with laws and regulations may increase in the future as a result of changes in interpretation. Failure to comply (or any alleged failure to comply) with the regulations referenced above or any other regulations could result in civil and criminal, monetary and non-monetary penalties, and any such failure or alleged failure (or becoming subject to a regulatory enforcement investigation) could also damage our reputation, disrupt our business, result in loss of customers and cause us to incur significant legal and investigatory fees.

Changes in the European regulatory environment regarding privacy and data protection regulations could expose us to risks of noncompliance and costs associated with compliance.

On May 25, 2018, the EU’s GDPR became enforceable. The GDPR relates to the collection, use, retention, security, processing and transfer of personally identifiable information of residents of EU countries, and because of our operations in the EU and in the UK, we are subject to these heightened standards. The GDPR created a range of new compliance obligations and imposes significant fines and sanctions for violations. Among other things, the GDPR requires companies to meet stringent requirements regarding the handling of personal data of individuals located in the European Economic Area, or EEA. The GDPR imposes substantial fines for breaches and violations (up to the greater of €20 million or 4% of our annual global revenue). Furthermore, there is significant uncertainty with respect to compliance with privacy and data protection laws and regulations, including the GDPR, because they are continuously evolving and developing and may be interpreted and applied differently from country to country and may create inconsistent or conflicting requirements. Our efforts to comply with privacy and data protection laws in all our markets, including the GDPR, may impose significant costs and challenges that are likely to increase over time. Since January 1, 2021 the GDPR has ceased to have direct effect in the UK but with the implementation of the Data Protection, Privacy and Electronic Communications (Amendments etc) (EU Exit) Regulations 2019 in the UK, this ensures that the UK has in effect the same legal framework for data protection in place as under the GDPR.

Risks Related to Financial Management

We have risks related to our indebtedness, including our ability to withstand adverse business conditions and to meet our debt service obligations.

Our ability to make payments on and to refinance our indebtedness, and to fund our operations, working capital and capital expenditures, depends on our ability to generate cash. To a certain extent, our cash flow is subject to general economic, industry, financial, competitive, operating, legislative, regulatory and other factors, many of which are beyond our control.

We cannot assure you that our business will generate sufficient cash flow from operations or that future sources of cash will be available to us in an amount sufficient to enable us to pay amounts due on our indebtedness or to fund our other liquidity needs.

23

Additionally, if we incur additional indebtedness in connection with any future acquisitions or development projects or for any other purpose, our debt service obligations could increase. We may need to refinance all or a portion of our indebtedness before maturity. Our ability to refinance our indebtedness or obtain additional financing will depend on, among other things:

• our financial condition and market conditions at the time;

• restrictions in the agreements governing our indebtedness;

• general economic and capital market conditions;

• the availability of credit from banks or other lenders;

• investor confidence in us; and

• our results of operations.

In addition, a significant part of our indebtedness includes provisions with respect to maintaining and complying with certain financial and operational covenants. Our ability to comply with these covenants may be affected by events beyond our control. A breach of one or more of these covenants could result in an event of default and may give rise to an acceleration of the debt. In the longer term, such breach of covenants could have a material adverse effect on our operations and cash flows.

Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.

An increase in market interest rates may increase our interest expense arising on our existing and future floating rate indebtedness. Pursuant to the terms of the restated Senior Facilities Agreement as at June 24, 2021, the interest rate paid on indebtedness incurred under our senior loans and revolving credit facility varies based on a fixed margin over a base reference rate. If interest rates increase, our debt service obligations on the variable rate indebtedness will increase even though the amount borrowed remains the same, and our net income and cash flows, including cash available for operational or strategic purposes, will correspondingly decrease. Pursuant to our interest rate hedging policy, we may enter into interest rate derivatives that may involve the exchange of floating for fixed rate interest payments in order to reduce interest rate volatility. However, we may not maintain interest rate swaps with respect to all of our variable rate indebtedness, and any swaps we enter into may not fully mitigate our interest rate risk.

Our indebtedness is subject to changes in interest reference rates

Pursuant to the terms of the restated Senior Facilities Agreement as at June 24, 2021, the interest rate paid on indebtedness incurred under senior loans and our revolving credit facility varies based on a fixed margin over a base reference rate. As a result of the refinancing, fallback language has been included in the restated Senior Facilities Agreement in relation to our revolving credit facility, to include use of risk-free interest rates (RFR) when the existing rates are phased out. The Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately. The Secured Overnight Financing Rate (“SOFR”) will replace U.S. Dollar LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR.

The restated Senior Facilities Agreement does not include fallback language to address interest rates paid on indebtedness incurred under our Senior U.S. Dollar Loan or Senior Euro Loan. U.S. Dollar LIBOR rates are expected to be phased out between 2021 and 2023, and as such we will need to renegotiate the terms of our Senior Facilities Agreement with our lenders and amend the terms of linked interest rate hedging arrangements. As a result of these changes to underlying interest reference rates, we may be exposed to volatility with regards to interest costs on indebtedness and linked interest rate hedging arrangements. There is currently no indication of the timing of the phase-out of EURIBOR.

We are exposed to exchange rate risks.

We are exposed to exchange rate risk. Our reporting currency is the Euro. We are exposed to foreign exchange translation risk as we convert the Pound Sterling results of our UK business, the Norwegian Krone of our Norwegian business, Swedish Krona results of our Swedish business and Swiss Franc results of our Swiss business into our reporting currency of Euro. Pursuant to Company foreign exchange hedging policy, we have converted our USD term loan to EUR designated as a cash flow hedge. We are exposed to transactional exchange rate risk as many of our raw material purchases may be denominated in non-functional currencies of the purchasing entity, predominantly U.S.

24

Dollars and Euro. Company policy is to reduce this risk by using foreign exchange forward contracts that are designated as cash flow hedges. Hedging arrangements are subject to changes in Company policy, may not fully protect us against currency fluctuations and may or not achieve hedge effectiveness. Fluctuations and sustained strengthening of non-functional currencies against the functional currency of the operating entities may materially adversely affect our business, financial condition and results of operations.

Changes to our payment terms with both customers and suppliers may materially adversely affect our operating cash flows.

We may experience significant pressure from our key suppliers to reduce trade payable terms. At the same time, we may experience pressure from our customers to extend trade receivable terms. European and country legislation can also set conditions and restrictions related to payment terms between suppliers and purchasers at different levels of the supply chain, for example, Directive 2019/633 on unfair trading practices in business to business relationships in the agricultural and food supply chain, which was intended to be implemented by Member States by November 1, 2021. Any failure to comply with applicable laws and regulations could subject us to civil remedies, including fines, which could have a material adverse effect on our business, financial condition and results of operations. Any such changes in commercial arrangements regarding trade payable and trade receivable payment terms, as a result of changes in legislation or otherwise, may have a material adverse effect on our business, financial condition and results of operations.

Dividend payments and purchases made pursuant to announced share repurchase programs may have an impact on our cash flows and our ability to meet our debt service obligations.

We do not currently intend to pay dividends on our ordinary shares. We intend to pay such dividends only at such times, if any, and in such amounts, if any, as the board determines appropriate and in accordance with applicable law, and then only if we receive dividends from our operating subsidiaries. The board from time to time has announced share repurchase programs as set out further in the Financing and Acquisition section below. Our ability to make payments on and to refinance our indebtedness, and to fund our operations, working capital and capital expenditures, depends on cash flows. A significant part of our indebtedness includes provisions with respect to maintaining and complying with certain financial and operational covenants. In the event that we were to pay any dividends or to repurchase shares pursuant to any announced share repurchase programs, such dividends and share repurchases may have an impact on our cash flows and on our ability to make repayments on and refinance our indebtedness and to comply with those financial covenants.

An impairment of the carrying value of goodwill or other intangible assets could negatively affect our consolidated operating results and net worth.

Goodwill represents amounts arising from acquisitions and is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. Intangible assets can include computer software, brands, customer relationships and other acquired intangibles as of the acquisition date. Goodwill and other intangibles expected to contribute indefinitely to our cash flows are not amortized but must be evaluated by management at least annually for impairment. If carrying value exceeds its recoverable amount, the intangible is considered impaired and is reduced to fair value via a charge to earnings. Factors outside of our control which could result in an impairment include, but are not limited to: (i) reduced demand for our products; (ii) higher commodity prices; (iii) lower prices for our products or increased marketing as a result of increased competition; and (iv) significant disruptions to our operations as a result of both internal and external events. Should the value of one or more of the acquired intangibles become impaired, our consolidated profit or loss and net assets may be materially adversely affected. As of December 31, 2021, the carrying value of intangible assets totaled €4,555.1 million, of which €2,099.4 million was goodwill and €2,455.7 million represented brands, computer software, customer relationships and other acquired intangibles compared to total assets of €6,170.8 million.

We are exposed to risks in connection with our treasury and cash management activities.

From time to time we may acquire, various investment securities as part of our cash management and treasury activities. Factors beyond our control can significantly and adversely influence the fair value of our investment securities, including, but not limited to, the risk that the counterparty may not return the funds and that movements in financial, currency or interest rate markets may have an impact on the value of the investment securities. For example, fixed-rate securities are generally subject to decreases in market value when interest rates rise. Additional factors include, but are not limited to, rating agency downgrades of the securities, defaults by the issuer or individual borrowers with respect to the underlying securities, and instability in the credit markets. Any of the foregoing factors could cause other-than-temporary impairment in future periods and result in realized losses. The process for determining

25

whether impairment is other-than-temporary may require, subjective judgments about the future financial performance of the issuer and any collateral underlying the security in order to assess the probability of receiving all contractual principal and interest payments on the security.

In the ordinary course of treasury activities, whether entering into derivative hedging arrangements, cash account deposits or otherwise, we are exposed to the risk that the financial counterparty with whom we have conducted dealings will not be able to perform the agreed services and as a result may have a material adverse effect on our business, financial condition and results of operation.

We face risks associated with certain pension obligations.

The Company has a mixture of partially funded and unfunded post-employment defined benefit plans in Germany, Sweden, Switzerland and Austria as well as defined benefit indemnity arrangements in Italy and France. Deterioration in the value or lower than expected returns on investments may lead to an increase in our obligation to make contributions to these plans.

The obligations that arise from these plans are calculated using actuarial valuations which are based on assumptions linked to the performance of financial markets, interest rates and legislation which changes over time. Adverse changes to these assumptions will impact the obligations recognized and would lead to higher cash payments in the long term.

Our obligation to make contributions to the pension plans could reduce the cash available for operational and other corporate uses and may have a materially adverse impact on our operations, financial condition and liquidity.

We are exposed to risks related to our financial arrangements with respect to receivables factoring, reverse factoring and supply chain financing.

We may enter into factoring, reverse factoring or supply chain financing arrangements with financial institutions from time to time to sell certain of our accounts receivables from customers without recourse or to otherwise finance aspects of our supply chain. If we were to cease entering into such arrangements, our operating results, financial condition and cash flows could be adversely impacted. However, by entering into these arrangements we are exposed to additional risks. If any of these financial institutions or other counterparties experiences financial difficulties or is otherwise unable to honor the terms of our factoring, reverse factoring or supply chain financing arrangements with them, we may experience material financial losses due to the failure of such arrangements which could have an adverse impact upon our operating results, financial condition and cash flows.

We are a holding company whose principal source of operating cash is the income received from our subsidiaries.

We are a holding company and rely on the earnings and cash flows of our subsidiaries, which are paid to us by our subsidiaries in the form of dividends and other payments or distributions, to meet our debt service and other obligations, or, if applicable, to pay dividends on our ordinary shares. The ability of our subsidiaries to pay dividends or make other payments or distributions to us will depend on their respective operating results and may be restricted by, among other things, the laws of their jurisdiction of organization (which may limit the amount of funds available for the payment of dividends and other distributions to us), their constitutional documents, documents governing any existing indebtedness and the covenants of any future outstanding indebtedness that our subsidiaries incur, and other factors which may be outside our control.

The Founders and/or the Founder Entities may in the future enter into and/or amend related party transactions with us, which may give rise to conflicts of interest between us and some or all of the Founders and/or the Directors.

Our founders, Sir Martin Franklin and Noam Gottesman (the “Founders”) and/or one or more of their affiliates, including Mariposa Acquisition II, LLC and TOMS Acquisition I LLC (the “Founder Entities”) may in the future enter into and/or amend agreements with us that are not currently under contemplation. While we have implemented procedures to ensure we will not enter into any related party transaction without the approval of our Audit Committee, it is possible that the entering into of such an agreement might raise conflicts of interest between us and some or all of the Founders and/or the directors.

26

General Risk Factors

We are subject to disruptions, failures or security breaches of our information technology systems, or those of third parties on which we rely.

We are increasingly dependent upon on our information technology systems for communication among our suppliers, manufacturing plants, distribution functions, headquarters and customers. Our performance depends on the availability of accurate and timely data and other information from key software applications to aid day-to-day business and decision-making processes. We may be adversely affected if our controls designed to manage information technology operational risks fail to contain such risks. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology infrastructure and to maintain the related automated and manual control processes, we could be subject to adverse effects including billing and collection errors, business disruptions, in particular concerning our manufacturing and logistics functions, issues with or errors in system's maintenance and security and migration of applications to the cloud and security breaches. Any disruption caused by failings in our information technology infrastructure equipment or of communication networks, could delay or otherwise impact our day-to-day business and decision-making processes and negatively impact our performance. In addition, we are reliant on third parties to service parts of our IT infrastructure. Failure on their part to provide good and timely service may have an adverse impact on our information technology network. Furthermore, we do not control the facilities or operations of our suppliers or third parties. An interruption of operations at any of their or our facilities or any failure by them to deliver on their contractual commitments may have a material adverse effect on our business, financial condition and results of operations.

Although our information technology systems are protected through physical and software safeguards, it is difficult to protect against the possibility of damage or breach created by cyber-attacks or other security attacks in every potential circumstance that may arise. In addition, governmental authorities have warned that cybercriminals will take advantage of the uncertainty created by COVID-19 and federal and state mandated quarantines to launch cybersecurity attacks. The risks could include more frequent malicious cybersecurity and fraudulent activities, as well as schemes which attempt to take advantage of employees’ use of various technologies to enable remote work activities. We believe the COVID-19 outbreak has incrementally increased our cyber risk profile, but we are unable to predict the extent or impacts of those risks at this time. As cyber-attacks are increasing in frequency and sophistication, it becomes even more difficult to protect against a breach of our information technology systems. Cybersecurity incidents that impact the availability, reliability, speed, accuracy, or other proper functioning of these information technology systems could have a significant impact on our operations. If we are unable to prevent physical and electronic break-ins, cyber-attacks and other information security breaches, we may suffer financial and reputational damage, be subject to litigation or incur remediation costs or penalties because of the unauthorized disclosure of confidential information belonging to us or to our customers, suppliers or employees. The mishandling or inappropriate disclosure of non-public sensitive or protected information could lead to the loss of intellectual property, negatively impact planned corporate transactions or damage our reputation and brand image. Misuse, leakage or falsification of legally protected information could also result in a violation of data privacy laws and regulations and have a negative impact on our reputation, business, financial condition and results of operations.

Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect our financial results.

Generally accepted accounting principles and related accounting pronouncements, implementation guidelines and interpretations with regard to a wide range of matters that are relevant to our business, including but not limited to revenue recognition, leases, estimating valuation allowances and accrued liabilities (including allowances for returns, doubtful accounts and obsolete and damaged inventory), accounting for income taxes, valuation of long-lived and intangible assets and goodwill, stock-based compensation and loss contingencies, are highly complex and involve many subjective assumptions, estimates and judgments by our management. Changes in these rules or their interpretation or changes in underlying assumptions, estimates or judgments by our management could significantly change our reported or expected financial performance, and could have a material adverse effect on our business.

Management continues to assess new accounting pronouncements and their impact on the Company prior to their adoption dates.

27

We may incur liabilities that are not covered by insurance.

While we seek to maintain appropriate levels of insurance, not all claims are insurable, and we may experience major incidents of a nature that are not covered by insurance. Our insurance policies cover, among other things, employee-related accidents and injuries, property damage and liability deriving from our activities. In particular, our Lowestoft and Bremerhaven manufacturing facilities are situated in regions that have historically been affected by flooding. We may not be able to obtain flood insurance on reasonable terms or at all with respect to those facilities. We maintain an amount of insurance protection that we believe is adequate, but there can be no assurance that such insurance will continue to be available on acceptable terms or that our insurance coverage will be sufficient or effective under all circumstances and against all liabilities to which we may be subject. We could, for example, be subject to substantial claims for damages upon the occurrence of several events within one calendar year. In addition, our insurance costs may increase over time in response to any negative development in our claims history or due to material price increases in the insurance market in general.

If we fail to or are unable to implement and maintain effective internal controls over financial reporting, the accuracy and timeliness of our financial reporting may be adversely affected.

We are subject to reporting obligations under U.S. securities laws. The SEC, as required under Section 404 of the Sarbanes-Oxley Act of 2002, has adopted rules requiring every public company to include a report of management on the effectiveness of such company's internal control over financial reporting in its annual report. In addition, an independent registered public accounting firm must issue an attestation report on the effectiveness of the company's internal control over financial reporting.

We recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. If we fail to maintain effective internal control over financial reporting in the future, we and our independent registered public accounting firm may not be able to conclude that we have effective internal control over financial reporting at a reasonable assurance level. This could in turn result in the loss of investor confidence in the reliability of our financial statements. Furthermore, we have incurred and anticipate that we will continue to incur considerable costs and use significant management time and other resources in an effort to comply with Section 404 and other requirements of the Sarbanes-Oxley Act. If we are not able to continue to meet the requirements of Section 404 in a timely manner or with adequate compliance, we might be subject to sanctions or investigation by the SEC, the NYSE or other regulatory authorities. Any such action could adversely affect the accuracy and timeliness of our financial reporting.

28

Risks Related to our Ordinary Shares

We have various equity instruments outstanding that would require us to issue additional ordinary shares. Therefore, you may experience significant dilution of your ownership interests and the future issuance of additional ordinary shares, or the anticipation of such issuances, could have an adverse effect on our share price.

We currently have various equity instruments outstanding that would require us to issue additional ordinary shares for no or a fixed amount of additional consideration. Specifically, as of February 17, 2022, we had outstanding the following: 

•1,500,000 Founder Preferred Shares held by the Founder Entities, which are controlled by the Founders. The preferred shares held by the Founder Entities (the “Founder Preferred Shares”) will automatically convert into ordinary shares on a one for one basis (subject to adjustment in accordance with our Memorandum and Articles of Association) on December 31, 2022 and some or all of them may be converted following written request from the holder; and

•4,558,487 equity awards that have either been issued to participants or been granted and are outstanding under the LTIP, which may be converted into ordinary shares subject, in most cases, to meeting certain performance conditions.

We currently have 11,181,376 ordinary shares currently available for issuance under our LTIP.

Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Annual Dividend Amount”). The payment of the Founder Preferred Shares Annual Dividend Amount became mandatory after January 1, 2015 if certain share price performance conditions are met for any given year. At our discretion, we may settle the Founder Preferred Shares Annual Dividend Amount by issuing shares or by cash payment, but we intend to equity settle. For the year ended December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was payable pursuant to the terms of the Founder Preferred Shares. In 2022, the Founder Preferred Shares Annual Dividend Amount will be calculated based upon the volume weighted average share price for the last ten trading days of the financial year and the resulting appreciated average share price compared to the highest price previously used in calculating the Founder Preferred Shares Annual Dividend Amount, which was the previously achieved 2020 Dividend Price of $25.2127. The issuance of ordinary shares pursuant to the terms of the Founder Preferred Shares will reduce (by the applicable proportion) the percentage shareholdings of those shareholders holding ordinary shares prior to such issuance which may reduce your net return on your investment in our ordinary shares.

Our ordinary share price may be volatile, and as a result, you could lose a significant portion or all of your investment.

The market price of the ordinary shares on the NYSE may fluctuate as a result of several factors, including the following:

•variations in our quarterly operating results;

•volatility in our industry, the industries of our customers and suppliers and the global securities markets;

•risks relating to our business and industry, including those discussed above;

•strategic actions by us or our competitors;

•reputational damage from unsafe or poor-quality food products;

•actual or expected changes in our growth rates or our competitors’ growth rates;

•investor perception of us, the industry in which we operate, the investment opportunity associated with the ordinary shares and our future performance;

•addition or departure of our executive officers;

•changes in financial estimates or publication of research reports by analysts regarding our ordinary shares, other comparable companies or our industry generally;

•trading volume of our ordinary shares;

•future issuances or purchases of our ordinary shares by us or our shareholders;

29

•domestic and international economic, legal and regulatory factors unrelated to our performance; or

•the release or expiration of lock-up or other transfer restrictions on our outstanding ordinary shares.

Furthermore, the stock markets often experience significant price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions or interest rate changes may cause the market price of ordinary shares to decline.

If securities or industry analysts do not publish or cease publishing research reports about us, if they adversely change their recommendations regarding our ordinary shares or if our operating results do not meet their expectations, the price of our ordinary shares could decline.

The trading market for our ordinary shares will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market or our competitors. Securities and industry analysts currently publish limited research on us. If there is limited or no securities or industry analyst coverage of our company, the market price and trading volume of our ordinary shares would likely be negatively impacted. Moreover, if any of the analysts who may cover us downgrade our ordinary shares, provide more favorable relative recommendations about our competitors or if our operating results or prospects do not meet their expectations, the market price of our ordinary shares could decline. If any of the analysts who may cover us were to cease coverage or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our share price or trading volume to decline.

As a foreign private issuer, we are subject to different U.S. securities laws and NYSE governance standards than domestic U.S. issuers, which may afford less protection to holders of our ordinary shares. 

As a foreign private issuer, the rules governing the information that we disclose differ from those governing U.S. corporations pursuant to the Exchange Act. Although we report quarterly financial results and certain material events, we are not required to file quarterly reports on Form 10-Q or provide current reports on Form 8-K disclosing significant events within four days of their occurrence and our quarterly or current reports may contain less information than required for domestic issuers. In addition, we are exempt from the SEC’s proxy rules, and proxy statements that we distribute will not be subject to review by the SEC. Our exemption from Section 16 rules regarding sales of ordinary shares by insiders means that you will have less data in this regard than shareholders of U.S. companies that are subject to the Exchange Act. As a result, you may not have all the data that you are accustomed to having when making investment decisions with respect to U.S. public companies.

As a foreign private issuer, we are exempt from complying with certain corporate governance requirements of the NYSE applicable to a U.S. issuer, including the requirement that a majority of our board of directors consist of independent directors. As the corporate governance standards applicable to us are different than those applicable to domestic U.S. issuers, you may not have the same protections afforded under U.S. law and the NYSE rules as shareholders of companies that do not have such exemptions. See Item 16G: Corporate Governance.

We may lose our foreign private issuer status in the future, which could result in significant additional costs and

expenses.

We could cease to be a foreign private issuer if a majority of our outstanding voting securities are directly or indirectly held of record by U.S. residents and we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly higher than costs we incur as a foreign private issuer, which could have a material adverse effect on our business and financial results.

30

The rights of shareholders under British Virgin Islands law differ from those under United States law, you

may have fewer protections as a shareholder.

Our corporate affairs are governed by our Memorandum and Articles of Association, the BVI Business Companies Act, 2004 (as amended, the “BVI Act”) and the common law of the British Virgin Islands. The rights of shareholders to take legal action against our directors, actions by minority shareholders and the fiduciary responsibilities of our directors under British Virgin Islands law are to a large extent governed by the common law of the British Virgin Islands and by the BVI Act. The common law of the British Virgin Islands is derived in part from comparatively limited judicial precedent in the British Virgin Islands as well as from English common law, which has persuasive, but not binding, authority on a court in the British Virgin Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under British Virgin Islands law are not as clearly established as they would be under statutes or judicial precedents in some jurisdictions in the United States. In particular, the British Virgin Islands has a less developed body of securities laws as compared to the United States, and some states (such as Delaware) have more fully developed and judicially interpreted bodies of corporate law. As a result of the foregoing, holders of our ordinary shares may have more difficulty in protecting their interests through actions against our management, directors or major shareholders than they would as shareholders of a U.S. company. See Item 16G: Corporate Governance.

The laws of the British Virgin Islands provide limited protection for minority shareholders. Minority shareholders

will have limited or no recourse if they are dissatisfied with the conduct of our affairs

Under the laws of the British Virgin Islands, there is limited statutory law for the protection of minority shareholders other than the provisions of the BVI Act dealing with shareholder remedies (as summarized under Item 16G: Corporate Governance). The principal protection under statutory law is that shareholders may bring an action to enforce the constituent documents of the Company and are entitled to have the affairs of the Company conducted in accordance with the BVI Act and the memorandum and articles of association of the Company. As such, if those who control the Company have persistently disregarded the requirements of the BVI Act or the provisions of the Company’s memorandum and articles of association, then the courts will likely grant relief. Generally, the areas in which the courts will intervene are the following: (i) an act complained of which is outside the scope of the authorized business or is illegal or not capable of ratification by the majority; (ii) acts that constitute fraud on the minority where the wrongdoers control the Company; (iii) acts that infringe on the personal rights of the shareholders, such as the right to vote; and (iv) acts where the Company has not complied with provisions requiring approval of a special or extraordinary majority of shareholders, which are more limited than the rights afforded minority shareholders under the laws of many states in the United States.

To the extent allowed by law, the rights and obligations among or between us, any of our current or former directors, officers and employees and any current or former shareholder will be governed exclusively by the laws of the British Virgin Islands and subject to the jurisdiction of the British Virgin Islands courts, unless those rights or obligations do not relate to or arise out of their capacities as such. Although there is doubt as to whether United States courts would enforce these provisions in an action brought in the United States under United States securities laws, these provisions could make judgments obtained outside of the British Virgin Islands more difficult to enforce against our assets in the British Virgin Islands or jurisdictions that would apply British Virgin Islands law.

31

British Virgin Islands companies may not be able to initiate shareholder derivative actions, thereby depriving

shareholders of one avenue to protect their interests

British Virgin Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States. The circumstances in which any such an action may be brought, and the procedures and defenses that may be available in respect of any such action, may result in the rights of shareholders of a British Virgin Islands company being more limited than those of shareholders of a company organized in the United States. Accordingly, shareholders may have fewer alternatives available to them if they believe that corporate wrongdoing has occurred. The British Virgin Islands courts are also unlikely to recognize or enforce judgments of courts in the United States based on certain liability provisions of United States securities law or to impose liabilities, in original actions brought in the British Virgin Islands, based on certain liability provisions of the United States securities laws that are penal in nature. There is no statutory recognition in the British Virgin Islands of judgments obtained in the United States, although the courts of the British Virgin Islands will generally recognize and enforce the non-penal judgment of a foreign court of competent jurisdiction without retrial on the merits. This means that even if shareholders were to sue us successfully, they may not be able to recover anything to make up for the losses suffered.

Shareholders may experience a dilution of their percentage ownership if we make non-pre-emptive offers of ordinary shares in the future.

We have opted-out of statutory pre-emptive rights pursuant to the terms of our Memorandum and Articles of Association. No pre-emption rights therefore exist in respect of future issuance of ordinary shares whether or not for cash. Should we decide to offer additional ordinary shares on a non-pre-emptive basis in the future, this could dilute the interests of shareholders and/or have an adverse effect on the market price of the ordinary shares.

Risks Related to Taxation

Changes in tax law and practice may reduce any net returns for shareholders.

The tax treatment of the Company, our shareholders and any subsidiary of ours (including Iglo and its subsidiaries), any special purpose vehicle that we may establish and any other company which we may acquire are all subject to changes in tax laws or practices in the British Virgin Islands, the UK, the U.S. and any other relevant jurisdiction. Any change may reduce the value of your investment in our ordinary shares.

Failure to maintain our tax status may negatively affect our financial and operating results and shareholders.

If we were to be considered to be resident in or to carry on a trade or business within the United States for U.S. taxation purposes or in any other country in which we are not currently treated as having a taxable presence, we could be subject to U.S. income tax or taxes in such other country on all or a portion of our profits, as the case may be, which may negatively affect our financial and operating results.

Taxation of returns from subsidiaries may reduce any net return to shareholders.

We and our subsidiaries are subject to taxes in a number of jurisdictions. It is possible that any return we receive from any present or future subsidiary may be reduced by irrecoverable withholding or other local taxes, including those arising from future changes in legislation and other local rules and this may reduce the value of your investment in our ordinary shares.

If any dividend is declared in the future and paid in a foreign currency, U.S. holders may be taxed on a larger amount in U.S. Dollars than the U.S. Dollar amount actually received.

U.S. holders will be taxed on the U.S. Dollar value of dividends at the time they are received, even if they are not converted to U.S. Dollars or are converted at a time when the U.S. Dollar value of the dividends has fallen. The U.S. Dollar value of the payments made in the foreign currency will be determined for tax purposes at the spot rate of the foreign currency to the U.S. Dollar on the date the dividend distribution is deemed included in such U.S. holder’s income, regardless of whether or when the payment is in fact converted into U.S. Dollars.

32

Item 4.    Information on the Company

A.    History and Development of the Company

We are Europe's leading frozen foods company based on net sales value. We were incorporated with limited liability under the laws of the British Virgin Islands under the BVI Companies Act on April 1, 2014 under the name Nomad Holdings Limited.

Our principal executive offices are located at No. 1 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA. Our telephone number is +(44) 208 918 3200 and our fax number is +(44) 208 918 3491. Our registered office is located at Ritter House, Wickhams Cay II, Road Town, Tortola, VG1110 British Virgin Islands and its telephone number is (284) 852-7900. Our registered agent in the United States is Mariposa Capital, LLC, 500 South Pointe Drive, Suite 240 Miami Beach, Florida 33139.

The SEC maintains an Internet website that contains reports, proxy and information statements, and other information regarding the Company and other issuers that file electronically with the SEC. The SEC's Internet website address is http://www.sec.gov. Our Internet website can be found at www.nomadfoods.com.

See Item 5B: Operating and Financial Review and Prospects—Liquidity and Capital Resources for information regarding our capital expenditures for the past three fiscal years and principal capital expenditures currently in progress.

B.    Business Overview

Our Company

We are Europe's leading frozen food company with a portfolio of best-in-class food brands within the frozen category, including fish, vegetables, poultry, meals, pizza and ice cream. Our products are sold primarily through large grocery retailers under the “Birds Eye” brand in the UK and Ireland, “Findus” in Italy, France, Spain, Sweden, Switzerland and Norway, “Iglo” in Germany and other continental markets, “La Cocinera” in Spain, "Ledo" in south-eastern Europe and "Frikom" in Serbia and North Macedonia. The majority of our products are in the savory frozen food market, where according to Nielsen, our market share in the countries we operate stood at 17.9% in 2021 (2020: 18.2%). For the categories in which we operate, we maintain the number one position in sixteen European geographies, namely the UK, Italy, Germany, France, Sweden, Austria, Norway, Switzerland, Belgium, The Netherlands, Portugal, Ireland, Croatia, Serbia, Bosnia & Herzegovina and North Macedonia. The countries representing our top six markets, collectively UK, Italy, Germany, France, Sweden and Austria, represented approximately 79% of the total European Savory frozen food markets. For a description of the principal markets in which we compete and related revenue, see Note 5 “Segment reporting” to our audited consolidated financial statements which appear elsewhere in this annual report.

Savory Frozen Food Market

The European savory frozen food market is served by a number of national and international producers, both with branded and private label offerings, and within single or multiple product categories. We have the broadest participation by category and geography in Europe.

According to Nielsen, the market for savory frozen food in categories which the Company competes in across Europe is estimated to have generated close to €20 billion in retail sales value in 2021.

Frozen food products are particularly attractive because they address important global food trends. Consumers increasingly prefer products that allow them to prepare meals quickly and with confidence and expect products to be healthy and good value for money. In addition, consumers are increasingly focused on reducing food waste. Frozen food products can have all of these characteristics. They are easy to prepare, they reduce the need for artificial preservatives, they are often better value for money than chilled alternatives and they reduce waste at all points in the supply chain and also in-home (due to the long shelf life, and the ease of portionability).

33

Over the last seven years the European savory frozen food market has grown on average 1% per year, driven by the aforementioned ability to address global food consumption trends. Furthermore, the amount of space that frozen food as a category occupies within the grocery retail environment is relatively stable due to the fixed amount of freezer space at the retailer that is not exposed to reductions in shelf space in favor of other categories or formats, as can be the case in shelf-stable parts of the retailer.

Our Brands

Our brands are household names with long histories and local heritage in their respective markets. Our Birds Eye brand was established in 1922 and is primarily marketed in the UK and Ireland. The Findus brand, which is marketed in Italy, France, Spain, Sweden, Switzerland and Norway, was formed in Italy in 1941 and has a loyal following in each of its respective geographies. Iglo, founded in 1956, has a long-standing history and is marketed in Germany and other continental European countries. Recently acquired Ledo (established in 1958) and Frikom (established in 1975) are the lead brands with strong heritage in south-eastern Europe.

Our Competitive Strengths

We believe the following competitive strengths differentiate us from our competitors and contribute to our ongoing success.

Market leader with solid European platform and strong acquisition opportunities.

As the leading branded savory frozen food producer in Europe, we benefit from economies of scale and have developed a strong platform for our products throughout Europe in 2021. We are market leaders in the savory categories where we offer products in sixteen geographies and have a 17.9% market share in the savory frozen food market in the countries we operate. We benefit from longstanding relationships with our customers which provide access to our diversified distribution channels, including supermarkets, discount retailers, the food service channel and other food retailers that sell directly to consumers. We benefit from a diverse category and geographic mix and believe our strong existing platforms facilitate our expansion within a large addressable market and provide a broad set of potential acquisition targets in various food categories and geographic markets.

Effective brand equity strategy to leverage and expand well-known brands.

Our brands are well-established household names with long histories and local heritage in their respective markets. We possess several iconic brand assets and focus on our local "hero" platforms that are designed to leverage these iconic assets such as the “Captain”. Each of the Birds Eye, iglo, Findus, Ledo and Frikom brands holds a leading position in terms of spontaneous brand awareness in certain European markets. Our leading brand recognition, broad product offering, and local provenance of these brands are key drivers of consumer trust and result in demand for our products.

Experienced management team and Board with a proven track record.

Our management team has extensive experience in the food industry and other fast-moving consumer goods markets and has worked with leading multinational consumer goods companies globally. Our management team is complemented by an experienced Board of Directors, and collectively, they have a proven track record of successfully acquiring, integrating and managing consumer businesses. We believe our management team and Board of Directors’ collective industry knowledge, coupled with our track record of achieving growth and responding to challenging market conditions, will enable us to continue to generate profitable growth.

Optimized sourcing through established platform and diversified supplier base.

We operate an efficient and centralized procurement and supply chain function which is closely aligned with our geographic footprint, allowing us to optimize our supply arrangements and reduce distribution costs. We source our products globally from a diverse supplier base and, as a result, we minimize our dependency on any one supplier. Our relationships with diverse suppliers enable us to safeguard the security of our supply and raw materials as well as enhance the quality and sustainability of such materials, while also delivering competitive pricing and limiting exposure to geographic risk and adverse currency movements.

34

Strategic and geographically diversified manufacturing facilities.

We own and operate an efficient network of nineteen manufacturing facilities with low capital expenditure requirements, all of which are located near the major markets we serve, providing for a balance between manufacturing and logistics costs and allowing for high levels of customer service. These facilities have what we believe to be sufficient spare capacity to accommodate future growth in our main product categories.

Commitment to innovation and research and development.

Innovation is core to our growth model. Our R&D team actively scan new and emerging technologies, alongside consumer trends and unmet needs. The intersection of these insights leads us to identify new opportunities to drive penetration and frequency. In addition, we regularly benchmark our existing ranges to ensure that these continue to deliver experiences that delight our consumers. In response to these insights we establish multifunctional project teams that design new and improved products and packaging delivered through our core Must Win Battles for fish, veg, poultry, pizza and meat replacements. Each time we create a new product or pack we apply the principles of sustainable by design. To ensure the development and introduction of successful products, we follow a robust process through which we move from idea generation, concept screening, concept and product development, to scale up and final validation before launch.

Our Strategy

Our strategy is underpinned by three fundamental pillars which are to expand the category, grow the core and accelerate innovation. In addition, we have developed and made significant progress in implementing the following strategic initiatives:

1. Build an integrated group of best-in-class food companies and brands within existing and related food categories and expand our geographic footprint through strategic acquisitions.

Our goal is to transform our Company into an integrated best-in-class, global manufacturer, marketer and distributor of food products, within the frozen food category and the broader food sector. We believe there are significant growth opportunities in the European and North American markets and that our acquisitions provide a strong platform on which to grow our business and expand and enhance our market share in the food industry in key geographic markets.

2. Focus on “Core” products as a foundation for long-term growth.

We continue our strategy which is rooted in relentless focus on our Core products which, prior to the Fortenova Acquisition, represented approximately 72% of our branded channel sales. These strategies include improving product quality, packaging renovation and executing in-store initiatives such as ensuring the right product assortment, display strategies and promotional efficiencies. We believe focusing on these Core product initiatives will accelerate growth, lead to margin expansion and improve our return on investment. To further accelerate growth, we continue to pursue innovation which leverages consumer trends such as health, wellness and convenience, but which are anchored in our core categories.

3. Align our business with consumer preferences and trends.

Our goal is to create and acquire food businesses and brands that strongly align with consumer needs and preferences that have high growth and margin potential and that leverage our existing portfolio of brands.  In addition, we seek to align our product innovation strategies with consumer trends such as increased demand for nutrition-packed meals that can be prepared in shorter times, vegetarian options, meat substitutes and sustainably sourced and produced food.

35

4. Leverage our acquisition expertise, strong management team and access to capital to identify and evaluate attractive growth opportunities.

Our Founders and CEO have significant experience and expertise, and have been highly successful, in identifying, acquiring and integrating value-added businesses. We believe that this expertise, our access to capital and the deep industry knowledge of our management team will position us to acquire related and complementary food businesses that can enhance our market position, create synergies and fully leverage our existing marketing, manufacturing and supply chain capabilities, which we believe will allow us to deliver sustained profitable growth and maximize shareholder value. For example, in 2018 we completed (i) the Goodfella's Acquisition including the "Goodfella's" and "San Marco" brands, which enlarged our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities and (ii) the Aunt Bessie’s acquisition including the "Aunt Bessie's" brand, which enlarged our portfolio of brands to include the number one and number two market share positions, respectively, within frozen Yorkshire puddings and frozen potatoes, which combine to represent the majority of its revenues. On December 31, 2020 we completed the acquisition of Findus Switzerland. Findus is the leading frozen food brand in Switzerland with a portfolio of value-added frozen products across categories including fish, vegetables and ready meals. The acquisition expands Nomad Foods' geographic reach into Switzerland, a new and sizeable market, providing a natural extension for our Findus product offering and brand family with an attractive entry for Green Cuisine. The transaction unifies Nomad Foods' ownership of the iconic Findus brand across Europe. In September 2021 we acquired Fortenova Group’s Frozen Food Business Group, which brings a leading European frozen food portfolio operating in attractive new markets for Nomad Foods, including Croatia, Serbia, Bosnia & Herzegovina, Hungary, Slovenia, Kosovo, North Macedonia and Montenegro. Its two anchor brands, "Ledo" and "Frikom", have No 1 market share in many of these markets and offer a broad range of frozen food products including fish, fruits, vegetables, ready meals, pastry and ice cream. The acquisition creates a platform for future expansion into Central and Eastern Europe and introduces us to ice-cream which opens new potential avenues for growth.

5. Respond to changing consumer shopping habits and drive advertising efficiency and impact.

We are responding to the growing consumer shift to digital and mobile technologies, apparent across all of our markets, by investing in technology platforms and partnering with both existing and emerging retailer partners who are executing their own e-commerce strategies to meet changing consumer habits. Online sales represented approximately 8% of our total sales as of December 31, 2021 (compared to 7% in 2020 and 4% in 2019). COVID-19 dynamics have played a part in accelerating existing consumer shopping behavior trends. The need of social distancing measures due to COVID-19 resulted in many new consumers trialing Online grocery shopping channels for the first time, and accelerated the expansion of other models, such as Quick Commerce in large cities across Europe. We believe that the full Digital Commerce channel will continue to provide further opportunities to drive market share gains through improved product content, allowing us to more fully share the benefits of the Frozen category directly to consumers, and driving our mealtime solution programs. In addition, our strategies are evolving in response to other consumer shopping trends such as increased purchases through the hard discounter channel, which has been growing significantly in the UK and Southern Europe.

6. Generate strong margins and cash flow through disciplined net revenue management, supply chain optimization and disciplined cost management.

We continue to increase our margins and cash flows by strengthening our net revenue management capabilities and focusing on supply chain optimization and disciplined cost management. These efforts, which will be implemented over time, will include developing stronger promotional programs, price pack architecture and trade terms as well as continuing our focus on lean manufacturing, factory footprint optimization, and procurement productivity.

36

Products

During the past three fiscal years, we have manufactured, marketed and distributed the following frozen food products:

    Fish: includes frozen fish products such as fish fingers, coated fish and natural fish. These products were the largest contributor to our revenues in 2021, 2020 and 2019.

    Vegetables: includes ready to cook vegetable products such as peas and spinach.

    Meals: includes ready to cook noodles, pasta, lasagna, pancakes and other ready-made meals under the iglo, Findus and La Cocinera brand names.

    Poultry: includes frozen poultry and meat products such as nuggets, grills and burgers.

    Ice Cream: following the Fortenova Acquisition, includes in home and out of home ice cream.

Others: includes a variety of other offerings such as soups, pizza, bakery goods and meat substitutes.

We continue to place a strong emphasis on renovation of our existing Core products, which include fish, vegetables, meals and poultry, in order to overcome penetration barriers and continue to build loyalty. For example, in 2019, we introduced under our new innovation platforms our Artisan (coated fish assortment), Veggie Power (modern vegetable blends) and Green Cuisine (pea protein sub-brand). We manage renovation and innovation centrally on European common product platforms and have more local involvement where products are differentiated and country specific. Our research and development continues to be centralized, allowing us to leverage our research and development investment across our markets and focus on our largest Core products.

Customers

Our customers are typically supermarkets and large food retail chains supplying food products directly to consumers. Each key market in which we operate has its own distinct retail landscape. We consider our key retailer clients to be, in the UK, Tesco, Asda and Sainsbury’s; in Italy, Coop, Conad and Esselunga; in Germany, Rewe and Edeka; in Sweden, ICA, Axfood and Coop; and in France, Carrefour, Auchan and E.Leclerc. For the year ended December 31, 2021, our top ten customers (in terms of revenue) accounted for 40% of revenues.

The majority of our sales are to established retailers and we expect this channel to remain our most significant channel for the foreseeable future. We partner with traditional retailers when we identify commercial or marketing opportunities that can be of interest for both businesses. In addition, we are selectively building partnerships and are increasing our presence in the growing discounter channel.

We are increasing our investment in online sales, which represented approximately 8% of our total sales as of December 31, 2021. The online grocery retail channel is growing faster than established grocery retail formats across developed markets, partially as a result of the COVID-19 pandemic. Frozen foods particularly benefit from the online channel as the advantages to the consumer of outsourcing transportation of frozen food to the retailer are greater than in other categories, and also because some of the barriers to purchasing in-store (e.g. colder aisles) are removed for the consumer online.

Approximately 4% of our total sales for the year ended December 31, 2021 were through the food service channel. The majority of these sales were in Sweden and consist primarily of sales of institutional and public sector customers such as schools and hospitals as well as privately run work canteens and quick service restaurants. COVID-19 dynamics and governmental restrictions in Europe have adversely impacted food service sales since early 2020, as we have experienced lower demand for our food service products, which supports commercial food establishments, due to governmental restrictions on the consumers’ ability to eat out of home, for example, at restaurants, cafes, bars and work canteens. There was a modest sales increase in 2021 as COVID-19 governmental restrictions across Europe were eased.

37

Nomad Foods International (formerly Exports) accounted for 1.7% of our total sales in 2021. In Western Europe, Nomad Foods International supplies to food service distributors which are not covered by our non-Nomad Foods International channels.

Sales, Marketing and Pricing

Our commercial strategy is centered around our Core products and our growth model focuses on three core elements: creating distinctive brands through leveraging our iconic brand assets, innovating to break penetration barriers balanced between renovation and innovation, and executing in store through category leadership driving the right assortment, display and promotional efficiency.

Our brand equity strategy aims to further increase brand awareness. We are utilizing our core iconic assets at all consumer touchpoints including traditional media, digital media, point of sale and packaging. Furthermore, we have invested and will continue to seek to invest at sufficient levels of media on all our Core products.

We maintain sales teams in each of our Key Markets and all other markets in which our products are sold with the exception of the Central and Eastern Europe markets where we operate via a distribution model. Our sales force is resourced to provide good store coverage. We have been chosen to lead category management projects by several leading supermarkets in each of our main product categories and have developed innovative presentations of our frozen food products and in-store marketing concepts with supermarkets in a number of our markets in order to increase shopper traffic and sales. Most recently, we have developed and are executing our “Perfect Store” concept which focuses on improving a consumer’s in-store shopping experience through presentation, layout and signage.

Manufacturing

We own and operate nineteen manufacturing facilities which are located in Lowestoft and Hull (UK), Bremerhaven and Reken (Germany), Cisterna (Italy), Loftahammar and Bralanda (Sweden), Tonsberg and Larvik (Norway), Boulogne-sur-Mer (France), Valladolid (Spain), Longford and Naas (Republic of Ireland), Rorschach (Switzerland), Zagreb, Sesvete, and Daruvar (Croatia), Belgrade (Serbia) and Čitluk (Bosnia and Herzegovina). These facilities produce approximately 671 kilo tonnes of frozen product per year, representing approximately 80% of the total volumes of our sales. The manufacturing facilities are located near the major markets we serve, providing for a balance between manufacturing and logistics costs and customer service. Our manufacturing facilities are focused on in house manufacturing of our main product categories and emphasize quality and efficiency through scale. We have also invested in automated lines, such as fish fingers, poultry and spinach lines.

Although capacity differs per product line and facility, we estimate that we have sufficient spare capacity available to accommodate future growth in our main product categories and as necessary to accommodate the seasonal nature of some of our products, particularly vegetables.

In 2021, through the Fortenova Acquisition we took on five new manufacturing sites in south-eastern Europe. These are Zagreb, Sesvete, and Daruvar (Croatia), Belgrade (Serbia) and Čitluk (Bosnia and Herzegovina).

Procurement

Our procurement functions are structured around primes and indirect raw materials (materials used in manufacturing which form a part of the end product, such as fish, vegetables, meat, other ingredients and packaging), non-production items (items purchased and services used to design, market and distribute the product, such as logistics, operations, including maintenance, sales and marketing) and co-pack (finished products bought from third parties, such as most vegetables other than peas and spinach).

We have an efficient and centralized supply chain which is closely aligned with our geographic footprint, allowing us to optimize our supply arrangements and reduce distribution costs. We operate a centralized procurement function, with all procurement of primes and the majority of non-production items and co-pack procurement activities centralized to maximize scale efficiencies.

38

We operate a global sourcing platform. Fish is sourced mainly from the United States, Russia and China, vegetables are sourced predominantly from Europe and poultry is sourced largely from South America (but also from Thailand and Eastern Europe). We have contracts in place with pea and spinach growers and third-party pea processors in regions close to the location of pea growers. In addition, we utilize various co-pack suppliers for vegetables other than peas and spinach. The contract terms we enter into with various suppliers differ extensively with respect to length and provisions. 

We aim to maintain an appropriately diverse supplier base to safeguard the security of our supply of raw materials as well as enhance the quality and sustainability of such materials, while also delivering competitive pricing.

We segregate vendors into “strategic” and “tactical” categories based on criteria such as bargaining power or opportunistic procurement. On that basis, we have identified a number of strategic suppliers with whom we maintain close relationships, particularly in relation to main product categories for which security of supply is critical. Raw materials are mostly directly shipped to our manufacturing facilities.

The price of fish, vegetables and other agricultural commodities, including poultry and meat, can be volatile. We limit our exposure to price increases of raw materials by contractually securing prices for periods ranging from one month to a full year. Prices of raw materials that are harvested annually are generally fixed for a full year. Prices for certain other products, such as fish, dairy products and potatoes, are fixed for several months in line with industry practice.

Logistics

Our distribution network is made up of our manufacturing facilities, warehouses, local distribution centers and third-party providers of services (such as co-packers & transport). We outsource the majority of our distribution processes to third parties seeking to collaborate with shared sites and integrated transport networks. Our distribution network is well consolidated and aligned with our manufacturing footprint in the UK, Ireland, Germany, Italy, Sweden, France, Norway, Spain, Croatia, Serbia, and Bosnia & Herzegovina. From our manufacturing plants, our products are sent to regional distribution centers to be further distributed to local markets. Our primary distribution centers are used to consolidate both local production and imported products to be sold locally. These sites include Wisbech in the UK, Naas in Ireland, Reken in Germany, Capua, Latina and Parma in Italy, Bjuv in Sweden, Brussels in Belgium, Vantaa in Finland, Froneri in Switzerland, Vienna in Austria, Lognes in France, Tonsberg and Moss in Norway, Lisbon in Portugal, Madrid in Spain. With our newly acquired DC’s in Podgorica in Montenegro, Skpoje in Macedonia, Milosheve in Kosovo, Szada in Hungary, Ljubljana in Slovenia, Sarejevo, Tuzla and Banja Luka in Bosnia & Herzegovina, Novi Beograd and Nis in Serbia, and Zagreb, Osijek and Slavonski Brod in Croatia.

Seasonality

Our sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for frozen food are slightly higher in colder or winter months and variable production costs and working capital will vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, inventory levels typically peak in August to September just after the pea harvest and as a result, more working capital is required during those months. The Fortenova Acquisition follows a different seasonality to the legacy business, with stronger performance through the summer months behind the ice-cream business.

Corporate Social Responsibility

We continuously review our position to mitigate supply chain risks, working to meet relevant ethical, environmental and social obligations. We seek to source, manufacture and sell our food to consumers in a responsible way. We operate a sustainability program called Eating for the planet that reflects our commitments.

We do this by endeavoring to:

•Meet all relevant food and safety regulations

•Uphold international sustainability standards

•Lead, manage and review our approach, regularly assessing progress

•Report progress annually through the Nomad Foods’ Sustainability report

39

We also encourage all our suppliers to have or work towards a culture of continuous improvement.

Our sustainability program is based on the concepts of materiality and salience and aligned with the UN Sustainability Development Goals (SDGs). It consists of three pillars, securing a “farm to fork” approach:

    1. Better Sourcing

•We focus on sustainably, responsibly sourced fish and seafood using independent sustainable standards, such as the Marine Stewardship Council standard (MSC) and Agriculture Stewardship Council (ASC). Our sustainable farming standards are expanding from regional practices to global standards with the introduction of the FSA standard (Farm Sustainability Assessment) from the Sustainable Agriculture Initiative (SAI).  

•We are committed to ethical trading, sourcing and procurement, upholding fundamental international standards. We are committed to require all suppliers to comply with applicable human rights laws and regulations. We request our direct suppliers to register to Sedex, one of the world’s largest collaborative platforms for sharing responsible sourcing data on supply chains.  

•We believe we are in compliance with all relevant environmental laws and regulations and we expect all suppliers to do the same.

    2. Better Nutrition

Every day our customers serve our food to their families. We want to inspire them to eat a more balanced diet and live healthier lifestyles.

•We continuously work to improve our product portfolio, applying a nutrition strategy informed by an independent Nutritional Advisory Board and assessing our products using an externally verified Nutrient Profiling Tool. We also apply on pack nutritional labeling claims in markets where this is relevant, favoring the NutriScore model where applicable.

•We assess any new product development to drive higher sustainability across the portfolio.

•We empower consumers to make their own decisions, communicating the nutritional values of our products on pack.

    3. Better Operations

•We recognize the importance of reducing the impact we have on the environment and are committed to achieve net zero across our supply chain well before 2050 and are members of the UN Race to zero.

•We consider the total packaging system when designing packaging, recognizing packaging plays an important role in terms of food safety, securing shelf life, convenience, communication as well as sustainability. We aim to minimize packaging material use. We work towards making all consumer packaging material recyclable and prioritize packaging material from sustainable origins.

•We believe that our people make the difference and make sure they have an active voice through the ‘Our Voice’ employee survey. Sustainability is important for our employees and we involve them in the work and encourage them to live our values every day as part of our corporate purpose, Serving the World with Better Food.

•We actively work to engage with and add value to the broader communities we operate in, while contributing to our wider sustainability agenda. We encourage our local businesses to support social causes in their regions, engaging at a local level. For example, a majority of our businesses contribute our products to local food banks and charities.

40

Further details on these topics can be found in our latest Annual Sustainability Report found on our website https://www.nomadfoods.com/eating-for-the-planet/sustainability-reports/

Information Technology

Our IT systems are critical to operating and growing our business, in particular to our general operations and logistics functions but also to enable our teams to work from remote locations. A single SAP tool underpins the processes to support the majority of our operations and management reporting across countries with new tools being introduced to support Sales planning, S&OP and Net Revenue Management activities.

The IT architecture is designed as a consolidation platform enabling integration of future acquisitions. During 2021, Nomad started the integration of the Findus Switzerland businesses onto the Nomad platform and the IT team are looking at ways to accelerate future integrations. We believe that the role of data and analytics will continue to increase in importance in decision-making, and we therefore intend to continue to enhance our capability to use such data and analytics in our decision-making process.

Nomad foods have started project phoenix which is a business transformation project underpinned by an upgrade to the latest SAP S4/HANA. This has started and will continue throughout 2022/23 and finish in 2024. This program will enable integration of new acquisitions quickly with little or no adverse business impact, while maintaining the low cost of ownership. Additionally, we utilize an new outsourced infrastructure service provider, maintaining best in class IT cost alongside improved capability to scale in line with business developments.

Intellectual Property

Good brand protection continues to be of significant importance to our business as we rely on our brands to implement our master brand strategy. We have a substantial trademark portfolio with around 1,630 trademarks across all of our markets including new export countries such as the US, Australia and New Zealand and the Middle East. This year has also seen a dedicated drive to protect the business’ innovations, and capture valuable intellectual property rights as early as possible, resulting in patent protection in the areas of our plant-based food products and packaging processes. Our intellectual property is managed centrally, and we work closely with a specialist team of trade mark and patent attorneys and intellectual property solicitors in respect of filings, renewals, recordings and the prosecution and enforcement of intellectual property matters internationally.

We own EU trade mark rights across the EU as well as trade mark rights in all other commercial countries of interest to the business in "Birds Eye", "iglo" and "Findus". We continue to own "Belviva" (formerly "Lutosa") in Belgium, "La Cocinera" in Spain and Andorra, "Goodfella's" and "Aunt Bessie's" across the EU and in other key markets, and we have secured registration for "Nomad Food" across the EU, United Kingdom, Norway, China and the US.

Registered protection for "Green Cuisine" continues to grow in line with the importance of the brand, with registrations in place in the UK, New Zealand and Liechtenstein, and pending applications across the EU and other markets of interest around the world.

This year has also seen the successful acquisition of the Fortenova Group’s frozen food business, acquiring key brands such as "Frikom" and "Ledo" across Eastern Europe and resulting in an increase in our overall trade mark portfolio size by over 250 registrations.

Material Contracts

Each material contract to which we have been a party for the preceding two years, other than those entered into in the ordinary course of business, is listed as an exhibit to this annual report and is summarized elsewhere herein.

41

Pensions

We operate a number of different pension schemes across our various countries of operation, the majority of which are defined contribution schemes. We operate defined benefit pension plans in Germany, Sweden, Italy, Switzerland and Austria which are all closed to new entrants, as well as various defined contribution plans in other countries, the largest of which include Sweden and the UK. Long term service awards and other employee benefits are also in operation in a number of countries.

Regulatory Matters

Our activities are subject to laws and regulations regarding food safety, the environment and occupational health and safety.

Food Safety Regulation

As a manufacturer of foods intended for human consumption, we are subject to extensive legislation and regulation both from the European Union, the EU Member States and European free trade association (EFTA) members, UK adopted legislation and other European countries in which we operate. For the European Union, The European Commission, Directorate-General for Health and Food Safety is responsible for EU policy on food safety and health and for monitoring the implementation of related laws. The European Food Safety Authority advises the European Commission, the European Parliament and the EU Member States on food safety matters. EU Member States must ensure adequate enforcement, control and supervision of principles set forth in numerous EU Directives and Regulations and may be allowed to maintain or establish more stringent measures in their own legislation. Other European countries may follow the EU Directives and Regulations as is the case currently in the UK through the adopted legislation process following Brexit, but it may be that there are additional regulations to comply with on a country by country basis. We expect the UK to start generating its’ own regulatory matters as time progresses and as a UK based entity, we will be duty bound to follow these. These regulations govern the composition, manufacture, storage, handling, packaging, labeling, marketing and safety of our products. These regulations generally impose on food business operators an obligation to ensure that the operations under their control satisfy the relevant food law requirements and impose a mandatory traceability requirement along the food chain. The tracing information must be kept for a period of five years and upon request, must be made available to the relevant authorities.

In addition, we are subject to specific food hygiene legislation that establishes rules and procedures governing the hygiene of food products. This legislation sets forth specific rules governing the proper hygiene for food products of animal origin and sets forth microbiological criteria for food products. In addition, there are a number of other specific EU, adopted UK and local country requirements relating to specific matters such as contaminants, packaging materials and additives. The new Brexit Trade Agreement has resulted in substantial delays at Border Control Points for all food businesses due to the new level of documentation and checking which accompany food shipments across the UK to EU. Nomad products are frozen and maintained at a temperature below 18 degrees therefore there are no issues with food hygiene due to any delays or blockages which we may experience.

We are also subject to a broad range of European directives and regulations and local country requirements regarding the manufacture and sale of frozen foods for human consumption. These directives and regulations define technical standards of production, transport and storage of frozen foods intended for human consumption and require us to assure internal quality control at each stage of the “cold chain” and to implement any standards, as established by public authorities. These directives and regulations have in all areas of food safety been translated into UK statutory instruments as written.

Listed below are the various internal due diligence procedures we have established to ensure continuous compliance with all relevant regulatory and food safety standards:

•Implementing food hygiene principles across all production sites in accordance with food hygiene regulations;

42

•Annual external auditing of our production sites conducted by independent compliance companies applying the British Retail Consortium Global Standard for Food Safety Issue 8, its European equivalent, the International Food Standard or the Global Food Safety Initiative. Currently 93% of our suppliers are also certified to one or more of these food safety management systems and it is our long-term objective to achieve 100% certification;

•Ensuring that our Group’s Quality Management Systems comply with ISO 9001 with external audits to ISO or BRC standard;

•Conducting internal audits covering all production sites as part of our internal audit program (including cross-audits where one site's audit team audits another's system);

•Maintaining a risk-based microbiological and contaminant screening program, including screening for allergens, that covers raw materials and finished products; and

•Holding monthly regulatory updates to assess emerging risk areas, update policies and review outstanding issues as part of the quality forum meeting which is attended by functional heads.

Tariffs and Trade

We are subject to specific trade requirements regarding fish and poultry, two main ingredients for our products.

Food Labeling Regulation

Pre-packaged food products must comply with provisions on labeling, which are harmonized throughout the European Union. Pre-packaged food products must also comply with provisions on nutrition labeling, which are also harmonized throughout the European Union. Under the Food Information for Consumers Regulation nutrition labeling is mandatory unless exempted.

In addition to general and nutrition requirements, pre-packaged food products must bear a lot mark declaration via a manufacturing or packaging lot reference, which is also a harmonized system throughout the European Union. The lot reference allows consumers and businesses to trace the product in the event of a product withdrawal or recall.

There are also specific labeling requirements for certain ingredients we use in our products. Local laws may also impose additional requirements with which we must comply.

Packaging

Our packaging protects the product against contamination, is designed to optimize logistics, helps with portion sizes, carries information for customers, and, by maintaining the quality of products for the duration of their shelf life, also helps to reduce food waste. However, packaging, in particular plastic packaging, has been in the spotlight because of its environmental impacts. Poor management of recycling or waste disposal of plastic packaging can result in plastic leaking from the waste management cycle into the ocean, threatening

the lives of sea birds and marine animals, and disrupting ecosystems.

We primarily design our packaging around food safety needs and environmental impact concerns, ensuring that the packaging protects the product but does not waste natural resources. Our focus is on moving to recyclable materials. However, in some places we do need to use flexible materials such as plastic where innovation is required to find recyclable alternatives.

We expect packaging to be a focus for environmental law in the coming years, with the emergence of taxes or bans on the use of single-use plastic.

43

Environmental Law

The European Commission, Directorate-General for the Environment is responsible for EU policy on the environment and for monitoring the implementation of related laws. The European Union has issued numerous directives relating to environmental protection, including those aimed at improving the quality of water, addressing air and noise pollution, assuring the safety of chemicals and setting standards for waste disposal and clean-up of contamination. European directives are given effect by specific regulations in Member States and applicable regulations have been implemented in each of the countries in which we conduct our manufacturing activities. In addition, there may also be further regulations implemented at a country level in other countries in which we operate. Accordingly, our facilities must obtain permits for certain operations and must comply with requirements relating to, among others, water supply and use, water discharges and air emissions, solid and hazardous waste storage, management and disposal of waste, clean-up of contamination and noise pollution.

We are also subject to legislation designed to reduce energy usage and carbon dioxide emissions and also restrictions on the use of ozone depleting substances such as hydrochlorofluorocarbons ("HCFCs"). HCFCs are used in refrigeration systems and their use will be phased out as part of our normal maintenance, repair and replacement activities and we do not expect a need for significant incremental capital expenditures for this purpose.

Compliance with environmental laws and regulations is managed at the facility level. The majority of our manufacturing facilities have a detailed environmental management system which are externally audited on an annual basis for compliance with ISO 14001 or BRC.

In addition, under some environmental laws and regulations, we could be responsible for contamination we may have caused and investigating or remediating contamination at properties we own or occupy, even if the contamination was caused by a prior owner or other third party or was not due to our fault, and even if the activity which resulted in the contamination was legal at the time it occurred.

Occupational Health and Safety

We have a legal responsibility to protect the health and safety of our employees, customers and any other persons who may be affected by our operations. We strive to provide a safe workplace; controlling and eliminating risks to health and well-being; ensuring that our facilities and the equipment within them are safe and that the environmental, health and safety procedures are both established and adhered to. We strive to ensure that dangerous articles and substances are transported, stored and used safely; provide adequate welfare facilities; provide workers with the information, instruction, training and supervision necessary to preserve and improve their health and safety; and consult with workers on health and safety matters. The COVID-19 pandemic has not impacted the majority of our occupational health compliance programs but due to the need to follow local government guidelines, the programs for the health monitoring of employees have needed to be suspended until such time as government guidelines will allow the programs to resume safely. This could give rise to an increased risk of health issues of employees not being picked up in a timely fashion as a result of the programs being suspended.

We aim to meet the European Framework Directive on Safety and Health at Work (89/391 EEC) ensuring we comply with all the local and European legislation in all the countries we have a presence, ensuring we share best practices and procedures across our business to continuously improve our safety and environmental performance whilst driving a positive safety culture.

We have established a Health and Safety Management System modeled on the international Occupational Health & Safety management system specification ISO 45001. Our manufacturing facilities continue to strive for accreditation in ISO 45001 and many have already achieved this recognition and many more continue to work towards it across our network.

Compliance Programs

We have established policies and procedures aimed at compliance with applicable legislation and regulations, including policies for Anti-Bribery and Corruption as well as Trade Sanctions. In addition, our Code of Business Principles is designed to ensure compliance with applicable legal and regulatory requirements to drive a strong compliance culture. A breach of the Code of Business Principles can lead to disciplinary action, including termination of employment.

44

Our SafeCall Line, which is operated by an external service provider, allows employees to report issues anonymously. Compliance at the local level is based in large part on building strong local companies and developing a proper approach in coping with operational dilemmas within the boundaries of applicable laws and responsible conduct. Local management, assisted by the Internal Audit department, carries out reviews to identify compliance risks and to ensure that adequate systems to manage those risks are in place. We continually analyze and assess changes in applicable laws and regulations, and implement appropriate adaptations are implemented when necessary.

Insurance

We have a comprehensive Global Insurance Program covering all territories that the organization operates within and undertake regular risk reviews. We continually assess business risks as part of the review to ensure we maintain an effect insurance program covering risk exposures.

The Global Insurance Program encompasses coverages such as directors and officers, property damage and business interruption, public liability, product liability, employer's liability, personal accident and travel, advertising, motor and marine.

Human Capital management

1.Leadership Development and Talent Management.

Recruiting, developing and engaging our workforce is critical to executing our strategy and achieving business success. The board oversees and is updated on the company’s leadership development and talent management strategies designed to recruit, attract, develop and retain business leaders who can drive financial and strategic growth objectives and build long-term shareholder value. The board has also reviewed succession plans for the Chief Executive Officer and his direct reports.

2. Culture and Employee Engagement.

The board is keenly interested in ensuring that the company maintains and promotes a culture that fosters the values, behavior and attributes necessary to advance the company’s business strategy and purpose and encourage employee engagement and commitment. We regularly seek colleagues views and feedback on how successfully we are doing this through our annual survey.

3. Human Capital Management

The efficient production of high-quality products and successful execution of our strategy requires a talented, skilled and engaged team of employees. We aim to give our colleagues training to do their jobs, as well as opportunities to expand their skills and contributions over time. We are also committed to maintaining a safe and secure workplace for our employees and have recently set specific safety standards to identify and manage critical risks. We prohibit workplace discrimination, and we do not tolerate abusive conduct or harassment. We also believe that respect for human rights is fundamental to our purpose of Serving the World with Better Food and to our commitment to ethical business conduct. Our code of Business Conduct is set out in our ‘Code of Business Principles’ and is available on our website.

4. Diversity and Inclusion

We believe that fostering a culture of inclusion and belonging strengthens our ability to recruit talent and allows all of our employees to thrive and succeed. We actively cultivate a culture that acknowledges, respects and values all dimensions of diversity - including gender, race, sexual orientation, ability, backgrounds and beliefs. Ensuring diversity of input and perspectives is core to our business strategy, and we are committed to recruiting, retaining, developing and advancing a workforce that reflects the diversity of the consumers we serve. We have an active Inclusion plan and are working to embed our culture of inclusion and belonging into our day-to-day ways of working through: Shine (Support program aimed at improving internal female talent pipeline), a growing number of networks promoting representation and inclusion and enabling our employees to have space for debate and growth and continuing with our program of Inclusive leadership and Inclusive hiring training.

45

Supporting Our Workforce During the COVID-19 pandemic, Nomad Foods implemented an enterprise-wide response to ensure the health and safety of all of our colleagues. In our manufacturing facilities, we enacted social distancing protocols, temperature checks, enhanced sanitation, mask use and other protective equipment and practices. Our layered protections, combined with robust contact tracing and exclusion protocols, enable the continued operation of our manufacturing and distribution facilities without significant disruption. During the pandemic, our office staff shifted primarily to working remotely as dictated by local conditions.

46

C.    Organizational Structure

We (Nomad Foods Limited) are a holding company with 51 subsidiaries, all of which are wholly-owned by us. The following table provides a list of all of our significant subsidiaries and country of incorporation.

Name	Activity	Country of incorporation	Ownership as of December 31, 2021
Nomad Foods Europe Holdings Limited	Holding	England	100%
Nomad Foods Europe Holdco Limited	Holding	England	100%
Nomad Foods Europe Finco Limited	Holding	England	100%
Nomad Foods Europe Midco Limited	Holding/Finance	England	100%
Nomad Foods Bondco Plc	Finance	England	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	100%
Nomad Foods Europe Limited	Management	England	100%
Birds Eye Limited	Trading	England	100%
Nomad Foods Europe Finance Limited	Finance	England	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	100%
Iglo Holding GmbH	Holding	Germany	100%
Iglo Nederland B.V.	Trading	Netherlands	100%
Iglo Belgium S.A.	Trading	Belgium	100%
Iglo Portugal	Trading	Portugal	100%
Iglo Austria Holdings GmbH	Holding	Austria	100%
C.S.I. Compagnia Surgelati Italiana S.R.L.	Trading	Italy	100%
Findus Sverige Holdings AB	Holding	Sweden	100%
Iglo GmbH	Trading	Germany	100%
Frozen Fish International GmbH	Trading	Germany	100%
Liberator Germany Newco GmbH	Property	Germany	100%
Iglo Austria GmbH	Trading	Austria	100%
Findus Sverige AB	Trading	Sweden	100%
Frionor Sverige AB	Holding	Sweden	100%
Findus Holdings France SAS	Holding	France	100%
Findus France SAS	Trading	France	100%
Findus Espana SLU	Trading	Spain	100%
Findus Danmark A/S	Trading	Denmark	100%
Findus Finland Oy	Trading	Finland	100%
Findus Norge AS	Trading	Norway	100%
Findus Norge Holding AS	Holding	Norway	100%
Toppfrys AB	Trading	Sweden	100%
Findus Switzerland AG	Trading	Switzerland	100%
LEDO plus d.o.o.	Trading	Croatia	100%
INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD	Trading	Serbia	100%
LEDO d.o.o. Čitluk	Trading	Bosnia & Herzegovina	100%
IRIDA d.o.o.	Trading	Croatia	100%
LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság	Trading	Hungary	100%
Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.)	Trading	Slovenia	100%

47

Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga “Ledo” d.o.o. Podgorica)	Trading	Montenegro	100%
Ledo Sh.p.k.	Trading	Kosovo	100%
FRIKOM BEOGRAD DOOEL Cucer Sandevo	Trading	North Macedonia	100%

48

D.    Property, Plant and Equipment

The following table sets forth information on the main manufacturing sites used by us in our business:

Facility	Products	Production (ktons)	Utilization %	Freehold/ Leasehold	Footprint
Belgrade, Serbia	Ice cream, Pastry Products, Vegetables, Fruits	36	52%	Freehold	Site: 116,500 m2 Buildings: 8,100 m2
Boulogne, France	Fish Products	19	71%	Leasehold	Buildings: 11,000 m2
Bralanda, Sweden	Vegetables	10	71%	Freehold	Site: 80,000m2 Buildings: 40,000m2
Bremerhaven, Germany	Fish Products	108	97%	Leasehold	Site: 90,000 m2 Buildings: 30,000 m2
Cisterna, Italy	Vegetables, Free Flow Meals, Fish Fingers, Sofficini	80	77%	Freehold	Site: 269,560 m2 Buildings: 69,198 m2
Citluk, Bosnia & Herzegovina	Fish Products, Fruits, Vegetables	2	47%	Freehold	Site: 12,694 m2 Buildings: 6,552 m2
Daruvar, Croatia	Fish Products	3	59%	Freehold	Site: 30,223 m2 Buildings: 2,589 m2
Hull, UK	Yorkshire Puddings, Accompaniments & Desserts	23	72%	Freehold	Site: 39,000 m2 Buildings: 15,000 m2
Larvik, Norway	Vegetables, Free Flow Meals, Ready Meals	8	30%	Freehold	Site: 57,968 m2 Buildings: 7,246 m2
Loftahammar, Sweden	Bakery Products	2	47%	Freehold	Buildings: 5,300 m2 Site: 21,000 m2
Longford, ROI	Frozen Pizza Products	18	91%	Freehold	Buildings: 6,200 m2
Lowestoft, UK	Vegetables, Fish Products, Poultry, Potato, Beef Burgers	127	92%	Mixed	Buildings: 45,000 m2 Site: 99,000 m2
Naas, ROI	Frozen Pizza Products	42	93%	Freehold	Buildings: 12,000 m2 Site: 20,000 m2
Reken, Germany	Vegetables, Free Flow Meals, Ready Meals, Special Foods	111	90%	Freehold	Buildings: 118,000 m2 Site: 43,000 m2
Rorschach, Switzerland	Pancakes, Ready Meals	5	65%	Freehold	Buildings: 8,500 m2 Site: 11,000 m2
Sesvete, Croatia	Fruits, Vegetables	8	63%	Leasehold	Site: 2,208 m2 Buildings: 11,208 m2
Tonsberg, Norway	French Fries, Vegetables, Free Flow Meals	29	68%	Leasehold	Buildings: 30,000 m2 Site: 58,000 m2
Valladolid, Spain	Vegetables, Free Flow Meals, Ready Meals, Pastry Products, Pizza	17	60%	Freehold	Buildings: 50,000 m2 Site: 80,000 m2
Zagreb, Croatia	Ice cream, Pastry Products	23	48%	Freehold	Site: 23,129 m2 Buildings: 9,739 m2

For more information on property, plant and equipment see Note 12 “Property, plant and equipment”. We lease our principal executive offices located at No. 1 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA, which is 36,549 square feet in size.

Item 4A.    Unresolved Staff Comments

None.

49

Item 5.     Operating and Financial Review and Prospects

The following is a discussion of the financial condition and results of operations for the years ended December 31, 2021 and 2020. Discussion regarding our financial condition and results of operations for the year ended December 31, 2020 as compared to the year ended December 31, 2019 is included in Item 5 of our Annual Report on Form 20-F for the year ended December 31, 2020, filed with the SEC on February 25, 2021 (the "2020 Form 20-F").

Some of the information contained in this discussion and analysis or set forth elsewhere in this annual report, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in Item 3 Key Information-D. Risk Factors of this annual report, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. This discussion should be read in conjunction with our audited historical consolidated financial statements and other financial information included elsewhere in this annual report.

The historical financial information has been prepared in accordance with IFRS. 

Overview

Nomad operates in the European frozen food market, selling its products primarily to large grocery retailers either directly or through distribution arrangements primarily in the UK, Italy, Germany, France, Sweden, and Austria.

The countries representing our top six markets collectively represented approximately 79% of the total European Savory frozen food markets (in terms of retail sales value) and generated 78% of our revenue in 2021. We also sell our products in Ireland, Austria, Belgium, Finland, Ireland, Portugal, Switzerland, Denmark, The Netherlands and Spain. The brands under which we sell our products are “Birds Eye”, "Aunt Bessie's" and "Goodfella's" in the UK and Ireland, "San Marco" in the UK, “Findus” in Italy, France, Spain, Sweden, Switzerland and Norway, “iglo” in Germany and other continental markets, "Ledo" in south-eastern Europe and "Frikom" in Serbia and North Macedonia.

We currently operate nineteen manufacturing plants, three in Croatia, two in Germany, two in Sweden, two in Norway, two in Ireland, two in the UK and one each in Spain, Italy, France, Serbia, Bosnia & Herzegovina and Switzerland.

COVID-19

With the spread of COVID-19, we have experienced a significant increase in demand and revenue growth, as consumers have increased their frozen food purchases for in-home consumption. One of our main objectives as this crisis unfolds is to maintain the availability of our products to meet the needs of our consumers. In response to increased demand, we have increased production. To date, we have not experienced material disruptions in our supply chain or operations, although we cannot assure you that this will not occur in the future. We were not materially affected by mandated lockdowns and other related restrictions and only experienced temporary disruptions in operations that were not material to our consolidated results for the year ended December 31, 2020 or the year ended December 31, 2021.

We believe the steps we have taken to enhance our capital structure and liquidity over the last several years and months have strengthened our ability to operate through current conditions and we have not had to take any steps to access additional credit or capital as a result of COVID-19.

The business and economic environment is changing rapidly, and additional impacts may arise that we cannot currently anticipate. While there is still significant uncertainty about the ongoing impacts of the COVID-19 outbreak on the global economy and on our business, barring material business disruptions in our supply chain or otherwise or other negative developments discussed in our Risk Factors, including shutdowns of our facilities or reduced operations due to outbreaks of the virus, we anticipate continuing to meet the demand of consumers for our frozen food products. We continue to communicate with and support our employees and customers, monitor and take steps to further safeguard our supply chain, operations, technology and assets, protect our liquidity and financial position, work toward our strategic priorities and monitor our financial performance as we seek to position the Company to withstand the current uncertainty related to this pandemic.

50

Financings and Acquisitions

On March 22, 2019 we issued 20,000,000 ordinary shares in a public offering at $20.00 per share for aggregate gross proceeds of $400.0 million (€353.6 million). Directly attributed transaction costs of €11.1 million were incurred.

On March 13, 2020, the Company announced a share repurchase program to purchase up to an aggregate of $300.0 million of the Company’s ordinary shares. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open-market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. After the announcement, the Company entered into a series of open-market repurchases. During 2020, 11,913,682 ordinary shares at an average price of $21.04, for aggregate gross costs of $250.9 million (€217.4 million) had been repurchased and canceled. Directly attributed transaction costs of €0.2 million were incurred. During 2021, a further 507,396 ordinary shares were repurchased and cancelled at an average price of $25.29 for aggregate gross costs of $12.8 million (€10.5 million).

On September 15, 2020, the Company repurchased by way of a Dutch auction a total of 18,061,952 shares at a clearing price of $25.50 per share amounting to the purchase price of $460.6 million (€389.3 million) which was paid to the prevailing shareholders with all shares canceled as of the same date. Directly attributed transaction costs of €1.9 million were incurred.

On December 31, 2020, we completed the Findus Switzerland AG acquisition for consideration of €112.8 million which produces and sells frozen food in Switzerland. The deal extends the geographical reach of this brand, complementing the existing business model. The acquisition also included a production facility in Rorschach, Switzerland.

On June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to the EURIBOR with a zero floor plus a margin of 2.5%, and replace the existing €80 million revolving credit facility with a new €175 million facility, paying interest rate applicable to the respective drawn down currency plus 2.25%. Per the restated Senior Facilities Agreement, the Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately if there is a drawdown on the facility. The Secured Overnight Financing Rate (“SOFR”) will replace U.S. Dollar LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR, when existing benchmark rates are replaced. The revolving credit facility also includes margin ratchets linked to the future leverage of the Group, and achievement of the ESG linked KPI's.

On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028. Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. Subsequent to the Initial Bond Offering, on July 9, 2021 the Company completed a subsequent private offering of €50.0 million aggregate principal amount of 2.5% senior secured notes due 2028, issued at a price of €100.75.

On August 5, 2021, the Company announced a new share repurchase program to purchase up to an aggregate of $500.0 million of the Company’s ordinary shares to be executed. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions, at the Company's discretion, as permitted by securities law and other legal requirements. Pursuant to the program, as at December 31, 2021, 3,090,082 ordinary shares had been repurchased and cancelled at an average price of $24.50, for aggregate gross costs of $75.8 million (€67.1 million). Directly attributed transaction costs of €0.1 million were incurred.

On September 30, 2021, the Company announced the completion of the acquisition of the Fortenova Group’s Frozen Food Business Group (FFBG) for consideration of €640.1 million. FFBG is a leading European frozen food portfolio operating in attractive markets new to Nomad, including Croatia, Serbia, Bosnia & Herzegovina, Hungary, Slovenia, Kosovo, North Macedonia and Montenegro. Its two anchor brands, Ledo and Frikom, have unparalleled consumer awareness and number one market share in many of these markets and offer a broad range of frozen food products including fish, fruits, vegetables, ready meals, pastry and ice cream.

51

Accounting for the Findus Switzerland Acquisition

We have reflected the Findus Switzerland acquisition in our consolidated financial statements prepared in accordance with IFRS from the date of the acquisition, December 31, 2020.

We have accounted for the acquisition using the purchase method as required by IFRS 3 "Business Combinations" which allows the Company a year after the acquisition date in which to finalize the valuation of identifiable assets acquired as well as liabilities assumed on the acquisition date. Due to the timing of the acquisition, the valuation of the business had not been completed within the 2020 Form 20-F, with the difference between the consideration paid and the book value of assets valued being provisionally allocated to goodwill. The Company has since completed the exercise, resulting in a corresponding adjustment to Goodwill. These adjustments have resulted in a restatement of the previously reported Statement of Financial Position as of December 31, 2020 as disclosed in Note 14 "Acquisitions" within Item 18.

Accounting for the Fortenova Acquisition

We have reflected the Fortenova acquisition in our consolidated financial statements prepared in accordance with IFRS from the date of the acquisition, September 30, 2021.

We have accounted for the acquisition using the purchase method as required by IFRS 3 "Business Combinations" which allows the Company a year after the acquisition date in which to finalize the valuation of identifiable assets acquired as well as liabilities assumed on the acquisition date. The Company has performed a preliminary exercise to fair value the acquired assets and liabilities as disclosed in Note 14 "Acquisitions" within Item 18.

Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS

Information relating to “IFRSs recently issued and not yet adopted” are described in detail and are reported in Note 2 to the Financial Statements.

52

A.    Operating Results

Overview of Results

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Statement of Income data:
Revenue	2,606.6	2,515.9
Cost of sales	(1,862.3)	(1,753.4)
Gross profit	744.3	762.5
Other operating expenses	(356.3)	(382.7)
Exceptional items	(45.3)	(20.6)
Operating profit	342.7	359.2
Finance income	0.1	4.7
Finance costs	(106.1)	(68.4)
Net finance costs	(106.0)	(63.7)
Profit before tax	236.7	295.5
Taxation	(55.7)	(70.4)
Profit for the period	181.0	225.1

The table below presents certain additional key performance indicators:

	Year ended December 31, 2021		Year ended December 31, 2020
(€ in millions, except percentages)	€m		€m
Adjusted Gross Margin(1)	28.9	%	30.3	%
Adjusted EBITDA(2)	486.7		466.8
Adjusted EBITDA Margin(3)	18.7	%	18.6	%

(1)Adjusted Gross Margin. Represents Adjusted Gross Profit as a percentage of revenue for the relevant period. Adjusted Gross Profit and Adjusted Gross Margin exclude acquisition purchase price adjustments within cost of goods sold. Adjusted Gross Profit and Adjusted Gross Margin are non-IFRS financial measures and you should exercise caution in comparing our Adjusted Gross Profit and Adjusted Gross Margin with similarly titled measures of other companies, as the definition may not be comparable.

(2)Adjusted EBITDA. EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization. Adjusted EBITDA is EBITDA adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments, and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share-based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis. Accordingly, the information has been disclosed in this annual report to permit a more complete and comprehensive analysis of our operating performance. You should exercise caution in comparing our Adjusted EBITDA with similarly titled measures of other companies, as the definition may not be comparable. Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company’s operating performance.

(3)Adjusted EBITDA Margin. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of revenue for the relevant period. Adjusted EBITDA and Adjusted EBITDA margin are non-IFRS measures and you should not consider them an alternative or substitute to operating profit or operating margin as a measure of operating performance.

53

The following table reconciles revenue to Adjusted Gross Profit and Adjusted Gross Margin for the periods presented:

	Year ended December 31, 2021		Year ended December 31, 2020		Year ended December 31, 2019 (1)
	€m		€m		€m
Revenue	2,606.6		2,515.9		2,324.3
Cost of sales	(1,862.3)		(1,753.4)		(1,626.4)
Gross Profit	744.3		762.5		697.9
Gross Margin (2)	28.6	%	30.3	%	30.0	%
Cost of sales adjustments (3)	8.4		—		—
Adjusted Gross Profit	752.7		762.5		697.9
Adjusted Gross Margin (4)	28.9	%	30.3	%	30.0	%

(1)The 2020 Form 20-F used Gross Margin as a Key Performance Indicator. Adjusted Gross Margin for the comparative periods was identical to Gross Margin.

(2)Gross margin represents gross profit as a percentage of revenue for the relevant period.

(3)Cost of sales adjustments relate to acquisition purchase price adjustments within cost of goods sold.

(4)Adjusted Gross Margin represents Adjusted Gross Profit as a percentage of revenue for the relevant period.

The following table reconciles profit for the period to Adjusted EBITDA for the relevant period as follows:

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Profit for the period	181.0	225.1
Taxation	55.7	70.4
Net financing costs	106.0	63.7
Depreciation and amortization	71.6	67.6
Acquisition purchase price adjustments (1)	8.4	—
Exceptional items (2)	45.3	20.6
Other add-backs (3)	18.7	19.4
Adjusted EBITDA	486.7	466.8

(1)Relates to acquisition purchase price adjustments within cost of goods sold.

(2)Elimination of exceptional items which management believes are non-recurring and do not have a continuing impact. Details of what has been identified as exceptional is included in the Results of Operations for each reporting period as set out in this item and in Item 5 of the 2020 Form 20-F.

(3)Represents the elimination of share-based payment charges and related employer payroll expense of €5.8 million (2020: €12.1 million) and elimination of non-operating M&A related costs, professional fees, transaction costs and purchase accounting related valuations of €12.9 million (2020: €7.3 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

Description of Key Line Items and Certain Key Performance Indicators

Set forth below is a brief description of key items from our consolidated statements of income. For additional information, see Note 3 to our audited consolidated financial statements which appear elsewhere in this annual report.

54

Revenue. Revenue is comprised of sales of goods after deduction of discounts and sales taxes. It does not include sales between Nomad subsidiaries. Discounts given by us include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. At each end date of a reporting period, any discount incurred, but not yet invoiced, is estimated and accrued. Revenue is recognized when control of the products has transferred, being when the products are delivered to the customer in accordance with the contractual arrangements. This is usually upon either the dispatch of a shipment or the delivery of goods to the customer but is dependent upon contractual terms that have been agreed with a customer. Sales discounts incurred but not yet invoiced are established based on management’s best estimate at the end of the reporting period.

Cost of Sales. Cost of Sales are comprised of the cost of the inventories and distribution costs. Cost of inventories includes expenses related to the procurement and purchase of raw materials, as well as conversion costs including labor costs, depreciation of production assets, fuel, electricity, equipment maintenance and inspection.

Other Operating Expenses. Other operating expenses are comprised of advertising and promotions and indirect costs. Indirect costs include staff costs, selling and marketing expenses, administration expenses, research and development expenses, amortization of software, amortization of brands and other expenses.

Exceptional items. The separate reporting of exceptional items which are presented as exceptional within the relevant income statement category helps provide an indication of our underlying business performance. Exceptional items have been identified and adjusted by virtue of their size, nature or incidence. In determining whether an event or transaction is exceptional, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence.

Finance Income. Finance income is comprised of interest income, other financing related income and net foreign exchange gains on translations of financial assets and liabilities held for financing purposes in currencies other than the Company’s functional currency.

Finance Costs. Finance costs are comprised of interest expenses, net interest on net defined pension plan obligations, amortization of borrowing costs, net foreign exchange costs on translations of financial assets and liabilities held for financing purposes in currencies other than the Company’s functional currency, financing costs incurred as a result of amendments of debt terms and other financing related costs.

Taxation. Taxation is comprised of current tax expenses and deferred tax movements.

Gross Margin. Gross margin is gross profit as a percentage of revenue.

We also utilize certain additional key performance indicators, as described below. We believe these measures provide an important alternative measure with which to assess our underlying operating performance on a constant basis. Our calculation of Adjusted EBITDA and Adjusted EBITDA margin may be different from the calculations used by other companies and therefore comparability may be limited. Adjusted EBITDA and Adjusted EBITDA margin are non-IFRS measures and you should not consider them an alternative or substitute to operating profit or operating margin as a measure of operating performance.

Adjusted Gross Margin. Adjusted Gross Margin represents Adjusted Gross Profit as a percentage of revenue for the relevant period. Adjusted Gross Profit and Adjusted Gross Margin exclude acquisition purchase price adjustments within cost of goods sold.

Adjusted EBITDA. Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share-based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.

Adjusted EBITDA Margin. Adjusted EBITDA margin is Adjusted EBITDA as a percentage of revenue.

55

Currency

Our consolidated financial statements have been presented in Euro, which is our functional currency. Unless specifically stated otherwise herein, transactions in foreign currencies have been translated at the foreign exchange rate at the date of the relevant transaction.

Changes in foreign currency rates have a translation impact on our reported operating results.

A significant portion of our operations have functional currencies other than Euro (including Pound Sterling, Norwegian Krone, Swedish Krona and Swiss Franc). In preparing our financial statements, translations in currencies other than our functional currency are recognized at the rates of exchange prevailing at the dates of transaction. Accordingly, our results for each of the periods presented below have been impacted by fluctuations in foreign exchange rates. Where material, the impact of translation of currency on results has been provided. For a discussion on strategies to mitigate the effect of these fluctuations see Note 33 "Financial risk management".

Results of Operations for the Year Ended December 31, 2021 and the Year Ended December 31, 2020

	Year ended December 31, 2021	Year ended December 31, 2020
Statement of Income data:	€m	€m
Revenue	2,606.6	2,515.9
Cost of sales	(1,862.3)	(1,753.4)
Gross profit	744.3	762.5
Other operating expenses	(356.3)	(382.7)
Exceptional items	(45.3)	(20.6)
Operating profit	342.7	359.2
Finance income	0.1	4.7
Finance costs	(106.1)	(68.4)
Net finance costs	(106.0)	(63.7)
Profit before tax	236.7	295.5
Taxation	(55.7)	(70.4)
Profit for the period	181.0	225.1

Revenue for the year ended December 31, 2021 was €2,606.6 million (year ended December 31, 2020: €2,515.9 million). The 3.6% revenue increase was driven by acquisitions, offset by organic revenue decline of 2.1%, a measure which excludes the impact of the additional day in the comparative year (Leap Year) and the impact of translational foreign exchange compared to the year ended December 31, 2020.

Gross profit, defined as revenue less cost of sales, decreased €18.2 million to €744.3 million for the year ended December 31, 2021 from €762.5 million for the year ended December 31, 2020. The decrease in gross profit was driven by the increase in revenue and a reduction in gross margin. Gross Margin, defined as gross profit as a percentage of revenue, reduced by 170 basis points to 28.6% from 30.3% in the year ended December 31, 2020 primarily due to:

•A 70 basis point decrease relating to the underlying lower margin rates on the acquired businesses (Findus Switzerland and the Fortenova Acquisition).

•A 30 basis point decrease relating to the unwinding of the non-cash fair value uplift of inventory recorded as part of the Findus Switzerland and Fortenova Acquisitions.

•A 10 basis points decrease from pricing, promotional investments and product mix.

•A 60 basis points decrease due to cost of goods inflation.

Other operating expenses decreased to €356.3 million for the year ended December 31, 2021 (year ended December 31, 2020: €382.7 million). The decrease of €26.4 million was driven by decreased Advertising and Promotion linked to the reduction in our organic sales, and by a decrease in Indirect costs as a result of the Company's employee incentive program.

56

Exceptional items of €45.3 million were incurred in the year ended December 31, 2021 (year ended December 31, 2020: €20.6 million). Included in this charge are (i) a charge of €5.0 million from the release of indemnification assets (year ended December 31, 2020: €17.8 million), (ii) expenses related to integrating the Fortenova Acquisition of €3.5 million, (iii) expenses for an Information Technology Transformation Program of €4.2 million, (iv) expenses of €4.9 million relating to a factory optimization program which was initiated in 2018 (year ended December 31, 2020: €10.0 million), (v) expenses related to preparations for, and responding to, changes impacting our supply chain of the United Kingdom exiting the European Union ("Brexit") of €5.3 million (year ended December 31, 2020: €1.6 million), (vi) expenses associated with a multi-year, enterprise-wide transformation and optimization program that began in 2020 of €18.8 million (year ended December 31, 2020: €2.3 million), and (vii) expenses related to the integration of the Findus Switzerland business of €6.2 million (year ended December 31, 2020: €0.3 million). In the year ended December 31, 2020, expenses of €4.0 million related to integrating the Goodfella's pizza business and Aunt Bessie's business.

Offsetting these charges are a net income on settlement of legacy matters relating to periods prior to acquisition of businesses by the Company of €2.6 million (year ended December 31, 2020: income of €2.9 million). In the year ended December 31, 2020 a net income of €12.5 million was recognized on reaching an agreement to end the leasehold on a cold store in Sweden.

Net finance costs of €106.0 million in the year ended December 31, 2021 (year ended December 31, 2020: €63.7 million) include €58.2 million of interest payable on long term borrowings, lease liabilities and other cash pay interest expenses net of hedges (year ended December 31, 2020: €58.1 million), financing costs incurred in amending terms of debt of €17.9 million, losses on derivatives designated as fair value through profit and loss of €13.7 million (year ended December 31, 2020: €5.6 million), a net impairment loss on short-term investments of €8.6 million, a loss of €4.0 million resulting from the translation of foreign currency-denominated financial assets and liabilities into Euros (year ended December 31, 2020: gain of €4.0 million), €1.7 million of other interest and finance costs (year ended December 31, 2020: €2.7 million) and a €2.0 million of amortization of capitalized borrowing costs (year ended December 31, 2020: €2.0 million). This is offset by finance income of €0.1 million (year ended December 31, 2020: €0.7 million).

There was a tax charge in the year ended December 31, 2021 of €55.7 million based on the underlying taxable profits. A taxation charge of €70.4 million was booked in the year ended December 31, 2020. This difference is principally caused by lower profits and the impact of the reversal of a deferred tax liability and recognition of a deferred tax asset due to implementation of a local tax incentive, partly offset by an increase in tax rates on deferred tax balances and provisions for uncertain tax positions.

As noted in Item 3:D. Risk Factors, the future performance of the business is affected by a range of governmental economic, fiscal, monetary and political factors. In particular, the duration, spread and intensity of the COVID-19 pandemic and the outcome of Brexit agreements could have a material impact on the future results of the business.

B.    Liquidity and Capital Resources

Overview

We believe that cash flow from operating activities, available cash and cash equivalents and our access to our revolving credit facility will be sufficient to fund our liquidity and other requirements for at least the next 12 months. At December 31, 2021, we had €426.4 million of total liquidity, comprising €254.2 million in cash, and €172.2 million of available borrowings under our revolving credit facility. We also continue to expect to be able to raise capital through equity and debt offerings to support the strategic aims of the Company when it is advisable to do so and market conditions allow. In addition, we may enter into working capital related facilities including receivables financing, reverse factoring and supply chain financing to support the requirements of the business. Our principal liquidity requirements are for working capital and general corporate purposes, including capital expenditures and debt service, as well as to identify and effect strategic acquisitions, including the Fortenova Acquisition.

As a holding company, we depend on our receipt of cash dividends from our operating subsidiaries. For more information, see Item 3D: Key Information - Risk Factors - We are a holding company whose principal source of operating cash is the income received from our subsidiaries.

57

Restricted Cash

Nomad had cash and cash equivalents of €254.2 million at December 31, 2021, of which €0.2 million was restricted. This compares with cash and cash equivalents of €393.2 million at December 31, 2020 of which €0.1 million was restricted. Cash may be restricted for reasons including, but not limited to collateral as support for issuance of guarantees.

Cash Flows

Our primary sources of liquidity for the periods reported were cash flow from operations and financing activities, including: borrowings under credit facilities and high yield notes, together with cash raised through the issuance of shares. Our liquidity requirements arise primarily from the need to meet debt service requirements, to fund capital expenditures, to meet working capital requirements and to fund pension and tax obligations. Cash flows generated from operating activities together with cash flows generated from financing activities, have historically been sufficient to meet our liquidity needs and are expected to remain so for the foreseeable future.

The following table summarizes net cash flows with respect to our operating, investing and financing activities for the periods indicated:

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Net cash provided by operating activities	306.3	457.0
Net cash used in investing activities	(660.0)	(171.4)
Net cash provided by/(used in) financing activities	214.4	(714.8)
Net decrease in cash and cash equivalents	(139.3)	(429.2)
Cash and cash equivalents at end of the period	254.2	382.5

Net Cash Provided by Operating Activities

Net cash provided by operating activities was €306.3 million for the year ended December 31, 2021, was down from €457.0 million for the year ended December 31, 2020. The €150.7 million decrease was primarily due to working capital changes of €118.2 million, cash flows relating to exceptional items of €48.8 million compared to €12.1 million in the year ended December 31, 2020, as well as cash flows relating to tax of €95.2 million compared to €82.9 million in the year ended December 31, 2020. Operating cash flows for the year ended December 31, 2020 were helped by higher sales and earnings driven by increased demand for frozen food during the COVID-19 pandemic.

Net Cash Used in Investing Activities

Net cash used in investing activities was €660.0 million for the year ended December 31, 2021, compared to €171.4 million for the year ended December 31, 2020. The outflow in the year ended December 31, 2021 includes €597.3 million related to acquisitions, almost all of which relates to the Fortenova Acquisition as well as capital expenditures, offset in part by proceeds of €16.5 million from the redemption of investments. The outflow in the year ended December 31, 2020 includes the purchase of Findus Switzerland for €112.0 million as well as capital expenditures.

Net Cash Provided by Financing Activities

Net cash provided by financing activities was €214.4 million for the year ended December 31, 2021, compared to net cash used of €714.8 million for the year ended December 31, 2020. The net cash inflow in the year ended December 31, 2021 is primarily the result of refinancing activities in which borrowings saw a net increase of €391.3 million, offset in part by the payment of €77.6 million for the repurchase of ordinary shares, €22.6 million for payments related to shares withheld for taxes and financing fees of €18.7 million. The outflow in the year ended December 31, 2020 relates primarily to the purchase of our ordinary shares of €608.6 million, as well as €19.2 million for payments related to shares withheld for taxes.

58

Capital Expenditures

Our capital expenditures as of December 31, 2021 consisted, and in 2022 we expect to consist of, primarily expenditures for factory capacity expansion and maintenance, cost savings projects, information systems, innovation, regulatory compliance and other items. Capital expenditure is expected to increase in 2022 as the Company continues to grow but also due to the ongoing execution of its multi-year business transformation program which will include the implementation of new systems.

Capital commitments as of December 31, 2021 are not considered to be significant and are presented within Note 36 “Capital commitments” to our consolidated financial statements in Item 18. The anticipated source of such funds for such capital expenditures are cash flow from operating activities, available cash and cash equivalents and our revolving credit facility.

The following table sets forth our capital expenditures for the periods indicated, including as a percentage of revenue:

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Capital expenditures	79.2	58.7
Capital expenditure as a % of revenue	3.0%	2.3%

Trade Receivables - Factoring

To assist in managing operating cash flow, we have historically entered into non-recourse factoring arrangements whereby we may sell specific account receivables to one or more external financial institutions. Under the terms of such arrangements, the Company may continue to collect the cash from the customer receivables sold, albeit acting solely as a collecting agent on behalf of the purchaser of receivables. The Company retains no credit loss exposure to the receivables following sale. As a consequence, the risks and rewards of ownership are considered to have been transferred at the date of sale. Factoring fees associated with the sale of factored receivables for the year ended December 31, 2021 were minimal (2020: minimal). All factoring facilities have been cancelled during 2021 and no receivables were factored at the end of December 31, 2021 (2020: €nil), due to sufficient liquidity resources available to the Company. However, such facilities may be entered into and continue to be drawn in future periods for strategic purposes.

Registration Statement

On June 4, 2018, we filed with the SEC an automatic shelf registration statement for well-known seasoned issuers on Form F-3ASR. This registration statement enables us to issue ordinary shares, preferred shares, debt securities or warrants, either separately or as units that include any of these securities. Under the rules governing automatic shelf registration statements, we will file a prospectus supplement and advise the SEC of the amount and type of securities each time we issue securities under this registration statement. On March 22, 2019, we issued 20,000,000 ordinary shares under this registration statement at $20.00 per share for aggregate gross proceeds of $400.0 million (€353.6 million).

Funding and treasury policies

The Company uses centralized financial management to oversee access to financial markets, monitor and manage financial risks, and control liquid assets. This process is conducted according to a policy that applies to all group entities. All financial risk management strategies employed are for the purposes of risk mitigation and not for speculation.

The primary objective of our capital structure management is to maintain a strong financial profile for investor, creditor and customer confidence, and to support the growth of our business. We believe that the liquid assets of the Company, together with undrawn credit facilities and projections for future cash flows from operations, are sufficient to support the Company strategy. Access to external financing markets will be considered if funds are required other than from free cash flow to support the viability and growth of the business (e.g. supporting acquisitions).

59

Debt

Senior Facilities Agreement

We maintain a syndicated senior facilities agreement with certain finance parties and lenders, originally dated July 3, 2014, as subsequently amended and restated on June 24, 2021 (the “Senior Facilities Agreement”). Credit Suisse AG, London Branch, is currently both the facility agent and security agent.

The Senior Facilities Agreement governs our term loan facilities and our revolving credit facility.

Term Loan Facilities

U.S. Dollar Denominated Term Loan Facility

The U.S. Dollar (USD) denominated term loan facility consists of term loans in an aggregate principal amount of $916.4 million. The USD denominated term loans bear interest at a rate per annum equal to LIBOR (subject to a zero floor) plus 2.25% per annum. As of December 31, 2021, the amount outstanding under the USD denominated term loan facility was accruing interest at a rate of 2.25% per annum plus LIBOR (subject to a zero floor).

The USD denominated term loan facility is fully drawn and matures on May 15, 2024.

Euro Denominated Term Loan Facility

The Euro (EUR) denominated term loan facility consists of term loans in an aggregate principal amount of €553.2 million. The EUR denominated term loans bear interest at a rate per annum equal to EURIBOR (subject to a zero floor) plus 2.5% per annum payable at the end of each Interest Period. As of December 31, 2021, the amount outstanding under the EUR denominated term loan facility was accruing interest at a rate of 2.5% per annum plus EURIBOR (subject to a zero floor).

The EUR denominated term loan facility is fully drawn and matures on June 24, 2028.

Revolving Credit Facility

The Senior Facilities Agreement provides for an €175.0 million revolving credit facility, of which up to €50 million can be used for the issuance of letters of credit and other ancillary facilities. The revolving credit facility matures on June 24, 2026 and bears interest at a rate per annum equal to the underlying reference rate, plus the applicable margin of 2.25% per annum, payable at the end of each interest period. The Revolving Credit Facility also includes a margin ratchet linked to the future leverage of the Group and achievement of linked ESG target KPI's. As of December 31, 2021, there was no cash drawn from the revolving facility, with €2.8 million outstanding by way of issued letters of credit and bank guarantees.

Indebtedness at December 31, 2021

As of December 31, 2021, we had approximately €2,155.9 million (December 31, 2020: €1,695.3 million) of indebtedness outstanding under our term loan facilities and no amounts outstanding under our revolving credit facility, other than €2.8 million (December 31, 2020: €16.1 million) in relation to stand-by letters of credit and bank guarantees.

60

Terms of the Senior Facilities Agreement

The Senior Facilities Agreement contains certain customary operating covenants (certain of which are not applicable depending on the ratio of Consolidated Total Net Debt to Consolidated EBITDA) and other customary provisions relating to events of default, including non-payment of principal, interest or fees, misrepresentations, breach of covenants, creditor process, cross default to other indebtedness of the borrowers and its subsidiaries. If, in respect of any Relevant Period, the aggregate amount of: (i) all Revolving Facility Loans; (ii) drawn Letters of Credit; and (iii) Ancillary Outstanding’s (but excluding Ancillary Outstanding’s by way of undrawn letters of credit and undrawn bank guarantees under the relevant Ancillary Facility) calculated as at the last day of each such Relevant Period, is equal to or exceeds 40% of the Total Revolving Facility Commitments as at such date, Debt Cover in respect of that Relevant Period shall not exceed 7.25:1. (Each of the foregoing terms is defined in the Senior Facilities Agreement). As of December 31, 2021, we were in compliance with all financial and other covenants contained in our Senior Facilities Agreement.

The USD denominated term loans include the requirement to repay 1% of original issued notional per annum. In addition to the mandatory 1% per annum amortization, the Senior Facilities Agreement also includes an excess cash flow calculation whereupon an amount of principal shall be repaid based upon terms including cash generated during the year and Company leverage. As of December 31, 2021, no excess cash is expected to be paid out in 2022 related to 2021.

Hedging

In order to mitigate underlying foreign exchange exposure, reduce overall interest charge, and mitigate interest rate risk, the Company has entered into a number of cross-currency interest rate swaps. In exchange for receiving cash flows in U.S. Dollar matching all of the payments of principal and interest due under the Senior U.S. Dollar debt, the Company pays fixed amounts of interest and principal on notional amounts of EUR. All USD to EUR swaps have been designated as a cash flow hedge. During the 2021 reporting period, cross-currency interest rate swaps that had previously exchanged fixed cash flows in EUR into fixed GBP cash flows and had been designated as a net investment hedge of the UK business have been extinguished.

As a result of decisions taken by national regulators, GBP LIBOR and certain U.S. Dollar LIBOR time periods will become phased out at the end of December 2021 and replaced by an alternative reference index (SONIA and SOFR). There are no current plans to phase out EURIBOR. If EURIBOR ceases to exist, we will need to renegotiate the interest rate payable on Euro denominated portion of our Senior Facilities Agreement with our lenders and on the USD LIBOR leg of the cross currency interest rate swaps. Our expectation is that both debt agreements and hedging contracts will be aligned to the new benchmarks as they become known, and as such it is highly probable that the existing hedging relationships can be continued. It is expected that the transition to the new benchmarks, to the extent not already reflected in the current financing facilities, will occur during the amendment and extension of the U.S. Dollar Term Loan.

Fixed Rate Senior Secured Notes due 2028     

On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028. Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022.

On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75.

The Fixed Rate Senior Secured Notes are currently admitted to the Official List of the Luxembourg Stock Exchange and for trading on the Euro MTF Market. As of December 31, 2021, we had €800.0 million of Fixed Rate Senior Secured Notes outstanding.

61

The indenture contains customary events of default and customary covenants including limitations on indebtedness, restricted payments, liens, restrictions on distributions from restricted subsidiaries, sales of assets and subsidiary stock, affiliate transactions, our activities, such as merger, conveyance, transfer or lease of all or substantially all of our assets, and compliance requirements with respect to additional guarantees, reporting, additional intercreditor agreements, payment of notes, withholding taxes, change of control, compliance certificate, payments for consent and listing requirements. The Fixed Rate Senior Secured Notes are redeemable at our option in whole or in part on the terms detailed in the indenture.

Intercreditor Agreement

The finance parties under the Senior Facilities Agreement and the holders of the Fixed Rate Senior Secured Notes share the benefit of a security and guarantee package. The rights and obligations of the senior creditors and other creditors (including intra-group creditors) between themselves is controlled by an Intercreditor Agreement originally dated June 3, 2014, as subsequently amended and restated on April 28, 2017.

Pension Plans

We maintain defined benefit pension plans in Germany, Sweden, Switzerland, Italy and Austria as well as various defined contribution plans in other countries. In addition, an unfunded post-retirement medical plan is operated in Austria. The defined benefit pension plans are partially funded in Germany and Austria and unfunded in Sweden and Italy. In Switzerland, the plan obligations are met via a contract with a collective foundation that offers a fully insured solution to provide a contribution-based cash balance retirement plan. With the exception of Switzerland, the defined benefit pension plans are closed to new entrants and there is no current requirement to fund the deficit in any plan. We also maintain various defined contribution pension plans in other countries, the largest of which include Sweden and the UK. In most countries, long term service awards are in operation.

For accounting purposes, as of December 31, 2021 (based on the assumptions used), the deficit for the net employee benefit obligations equaled €244.2 million (December 31, 2020: €276.2 million).

For the year ended December 31, 2021 pension costs related to defined benefit, defined contributions and long-term benefit plans equated to €19.8 million (2020: €17.3 million; 2019: €16.8 million). This includes all costs related to the pension schemes and other long-term benefits plans as well as associated interest costs.

For additional information, see Note 23 “Employee benefits” to our consolidated financial statements in Item 18.

A description of our principal accounting policies, critical accounting estimates and judgments is set out in Note 3 and Note 4 to our audited consolidated statements which appear elsewhere in this annual report.

Other cash commitments

We are contractually obliged to short and long term commitments regarding raw material expenditures as well as for purchases of finished or semi-finished products. Agreements with co-packers that require significant investment from the counterparty are generally negotiated to cover several years of our operational needs. Furthermore, a high proportion of Advertising and promotional expenditure is negotiated and committed to through annual contracts. We also have long term service contracts which we have committed to make but which are not yet payable. These include those for the provision of logistical operations as well as software and IT support which typically cover a number of years. All of these purchase commitments represent a modest proportion of our annual expenditure. As of December 31, 2021 these commitments total €723.3 million.

Furthermore, a number of our tangible fixed assets are leased under short and long term contracts for which a maturity profile is presented within Note 33 “Financial Risk Management” to our consolidated financial statements in Item 18.

62

C.    Research and development, patents and licenses, etc.

Growing our core through our Must Win Battle strategy is our focus across fish, vegetables and local battles, e.g., chicken and pizza. Innovation is key to this and we have a strong pipeline of activities. Innovation is a key driver of growth for our Green Cuisine business, development of meat alternatives. Our focus is to create competitive advantage through delivery of innovations that leverage science and technology. To achieve this we are embedding innovation in our strategy and seeking to ensure that technologies are fully protected to maintain differentiation.

We are committed to ensuring product superiority on all our Must Win battles by focussing on taste, health and sustainability. We invest in external benchmarking activities to track product performance and renovation programs are in place to ensure that our core continues to delight our consumers.

To support this, we operate a clear governance process with a “Central Monthly Operating Review Board” (“CMOR”) which is responsible for reviewing and approving innovations across the Company in our core areas that stretch across multiple markets. "Local Monthly Operating Reviews" ("LMOR") occur within each market on areas within local control, e.g. local Must Win Battles. Our research and development team has global and local teams. This allows us to leverage our investment in research and development across our markets where scale can be achieved and move fast within individual markets to address local opportunities, thus maximizing our ability to deliver to consumer needs efficiently.

D.    Trend information

We are subject to the following key industry trends and challenges which have impacted, and may continue to impact, our business, operations and financial performance:

1.Consumer needs and preferences. Consumer needs within in home meal occasions drive demand for our products. There are a number of macro trends which impact our consumer and customers’ needs which impact on us and the frozen food industry as a whole. These include needs for convenient and tasty meals including ease of meal preparation; healthy and nutritious meals; and brands that are sustainably sourced and produced and are otherwise environmentally friendly. In 2021 26% of European consumers were ‘eco activists’, those who will make choices based on sustainable credential of a brand, we expect this to rise to 36% by 2026 and 50% by 2029. Our results of operation depend in large part on the continued appeal of our products and, given the varying needs and preferences of our consumer base, our ability to offer a suitable range of products to satisfy a broad spectrum of needs and preferences. For example, there is a growing trend towards eating healthier and nutritious meals leading to greater consumption of vegetarian and plant based foods, which resulted in 41% of households in the UK purchasing meat free products in 2021, an increase of 9.9% in 2021, and 16.2% in Germany with an increase of 18.2% in 2021. In order to address consumer needs and ensure the continued success of our products, we aim to introduce new products, renovate core products and extend existing product lines on a timely basis.

2.Competition. In addition to the competition we face from traditional, well-established branded frozen food manufacturers, over the last few years we have seen increased competition from the discounter channel and, during COVID our branded competitors, consumers looked for the quality and safety of buying well know brand, though we do expect some shoppers to switch back to discounters as the restriction of COVID and increases prices, due to inflation, impact all grocery products. The counter of this trend is the growth of e-commerce and on line purchasing which has accelerated during the COVID restrictions and we expect this to stay as shoppers enjoy the convenience of shopping online. In 2021 9.3% of consumer purchases in the retail channel were online, up 14% compared to 2020. To address this growing trend, we continue to pursue opportunities to increase our presence in online retailers, particularly in UK and France, which already have highly developed online sales.

63

3.Shopping Habits. Consumers behaviors/attitudes in the current ‘living with Covid’ phase of the pandemic presents significant opportunities in the Frozen category. Nielsen estimates that two in three consumers will continue to be financially ‘constrained’ as well as concerns about inflation resulting in more in-home meals and consumers trading into Frozen to save money. There will continue to be elevated levels of in-home consumption, primarily driven by hybrid working and the structural shifts in the adoption of the e-commerce channel and experiential media will continue. The pre-COVID trends of health and sustainability have accelerated and are rapidly becoming table stakes for consumers.    

4.Inflation. We are facing unprecedented levels of cost inflation in the market where we will be taking appropriate pricing actions to cover cost inflation. This is in line with other Consumer Packaged Goods companies who are forecasting anywhere between mid-single digit to mid-double digit impact on their cost base in 2022. We have programs in place across net revenue management and Sales that support this process but customer retaliation remains a significant risk.

E.    Critical Accounting Estimates and Judgments

Information relating to “Critical Accounting Estimates and Judgments” are described in Note 4 to the Financial Statements. The following is a review of the more significant assumptions and estimates as well as accounting policies we used to prepare our consolidated financial statements.

Discounts and trade promotions

Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has a unique agreement that is governed by a combination of observable and unobservable performance conditions.

Trade promotions comprise of amounts paid to retailers for programs designed to promote Company products and include pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The estimated ultimate cost of the program is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends.

At each financial year end date, any discount or trade promotion expense incurred but not yet invoiced is estimated and accrued for. In certain cases, the estimate for discounts and trade promotions requires the use of forecast information for future trading periods and therefore a degree of estimation uncertainty exists. These estimates are sensitive to variances between actual results and forecasts. The estimate is based on accumulated experience and the principle that revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. Management use judgment when considering when accruals can be released.

Business combinations

The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves a judgment as to what intangible assets can be separately identified as well as an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable estimation in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management.

Significant areas of judgment and estimation include valuing tangible and intangible assets, including the determination of their remaining useful lives, as well as the consideration of liabilities, including uncertain tax positions. Where such items are material to the financial statements, we engage third-party valuation firms to assist in the valuation. The valuation of these assets and liabilities is based on the assumptions and criteria which include, in some cases, estimates of future cash flows discounted at the appropriate rates. The choice of assumptions and valuation technique can lead to significant differences in the valuation. We believe that the assumptions and techniques applied are reasonable based on information available on the date of acquisition.

64

As disclosed in Note 14 in Item 18, one significant acquisition was made in 2021. The accounting for this is provisional and will be finalized within twelve months of the acquisition date. During 2021, the accounting for a significant acquisition made in 2020 was finalized.

Carrying value of goodwill and brands

As of December 31, 2021, the Company has reported Goodwill of €2,099.4 million as well as indefinite-lived brands of €2,413.0 million. The Company’s goodwill and brand values have been allocated based on the enterprise value at acquisition of each cash generating unit. Goodwill is monitored at an operating segment level for which Nomad has one reporting and operating segment, ‘Frozen'. As required by IAS 36 “Impairment of Assets”, an annual review of the carrying amount of the goodwill and the indefinite life brands is carried out to identify whether there is any impairment to these carrying values. This is performed in the fourth quarter of each year. A qualitative review is performed to coincide with all interim reporting periods, which is extended to a full review where indicators of impairment are identified. Indicators of impairment include a sustained decrease in our market capitalization or sustained deterioration in any factor that affects profitability, such as market share or competition. The review is performed using the discounted cash flows model whereby a comparison of the carrying values to the value in use is made. As there is one reporting and operating segment, value in use is calculated as the net present value of the projected risk-adjusted cash flows of the Company as a whole.

The estimation of the value in use calculation requires the entity to estimate the future cash flows expected to arise from the Company and apply a suitable discount rate in order to calculate present value. This requires us to make assumptions and estimates regarding historical information, future plans and external sources. Assumptions used are consistent with internal projections and we believe these are comparable to those used by other participants in the market. Unanticipated changes to the market or wider economy may affect the assumptions made and lead to reduced cash flows or higher discount rates, which could lead to an impairment being recognized.

The discount rate is calculated using a capital asset pricing model to determine a weighted average cost of capital expected by a market participant. Observable market data is used, including available information on comparable companies, such as expected rates of return and equity structure. These variables are influenced by macroeconomic factors and an increase in these variables could reduce the present values of future cash flows in the model. A pre-tax discount rate of 6.4% was applied to the cash flows in the 2021 review, as well as a long-term growth rate of 1.0%. Neither of these assumptions reflect the long-term assumptions used by the Company for investment planning.

Impairment was not required as at December 31, 2021. Valuations derived from the discounted cash flow model indicate a sufficient amount of headroom for which any reasonably possible change to key assumptions is unlikely to result in an impairment of the related goodwill and brands.

Employee benefit obligation

The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each scheme has an actuarial valuation performed and is dependent on a series of assumptions to estimate the projected obligations. The assumptions include variables which are revised periodically, that include discount rates, expected salary increases, inflation, employee turnover, retirement age, mortality and medical care costs. Our assumptions reflect historical experience and management's best judgment regarding future obligations. The assumptions used affect the current service cost and interest expense as well as changes in the obligation recognized. Net actuarial gains or losses arising from changes in assumptions and from experience are recognized in other comprehensive income/(loss).

Since defined benefit pension schemes and post-employment benefit schemes are measured on a discounted basis, the discount rate applied has an impact on the expense and obligation recognized. These discount rates are determined by reference to market yields at the end of the reporting period on high quality corporate bonds, except for Sweden where a deep market does not exist, where mortgage bonds are used. Our significant schemes operate in Germany and Sweden, where discount rates of 1.1% and 1.8% have been applied. A 1% increase in discount rates used throughout the Company would decrease the obligation by €54.6 million, whilst a 1% decrease in discount rates would increase the obligation by €71.9 million. The impact on profit before tax in either scenario is not significant. Management consider the discount rate to be the most significant assumption. Note 23 in Item 18 contains additional details on the schemes and obligation, including a sensitivity analysis over other key assumptions.

65

Uncertain tax positions

The Company actively seeks to manage tax exposures by proactively engaging with local tax authorities and applying for Advanced Pricing Agreements where appropriate. Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on best estimates with regard to the amounts expected to be paid to the relevant tax authority. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals. The factors considered include the progress of discussions with the tax authorities and the level of documentary support for historical positions taken by previous owners.

66

Item 6.    Directors, Senior Management and Employees

A.    Executive Officers and Directors

The following table lists each of our executive officers and directors and their respective ages and positions as of February 17, 2022.

Name	Director since	Age	Position
Sir Martin E. Franklin	April 4, 2014	57	Co-Chairman
Noam Gottesman	April 4, 2014	60	Co-Chairman
Ian G.H. Ashken	June 16, 2016	61	Director
Stéfan Descheemaeker	June 1, 2015	61	Chief Executive Officer and Director
Golnar Khosrowshahi	May 4, 2021	50	Director
James E. Lillie	May 28, 2015	60	Director
Stuart M. MacFarlane	May 8, 2019	54	Director
Victoria Parry	February 16, 2016	56	Director
Melanie Stack	May 4, 2021	60	Director
Samy Zekhout	April 1, 2018	59	Chief Financial Officer and Director

Set forth below is a brief biography of each of our executive officers and directors.

Sir Martin Ellis Franklin, KGCN, our co-founder and co-Chairman is the founder and CEO of Mariposa Capital, LLC, a Miami-based family investment firm focused on long-term value creation across various industries, and Chairman and controlling shareholder of Royal Oak Enterprises, LLC. Sir Martin is also the Founder and Executive Chairman of Element Solutions Inc, and co-Chairman of APi Group Corporation. Sir Martin was the co-founder and Chairman of Jarden Corporation (“Jarden”) from 2001 until April 2016 when Jarden merged with Newell Brands Inc (“Newell”). Sir Martin became Chairman and Chief Executive Officer of Jarden in 2001, and served as Chairman and Chief Executive Officer until 2011, at which time he began service as Executive Chairman. Prior to founding Jarden in 2001, Sir Martin served as the Chairman and/or Chief Executive Officer of three public companies: Benson Eyecare Corporation, Lumen Technologies, Inc., and Bollé Inc. between 1992 and 2000. In the last five years, Sir Martin served as a director of the following public companies: Newell and Restaurant Brands International Inc.

Noam Gottesman, our co-founder and co-Chairman is the Founder and Managing Partner of TOMS Capital LLC, which he founded in 2012. Mr. Gottesman is also co-CEO and director and founder of Go Acquisition Corp., a Delaware blank check company. Mr. Gottesman serves as a non-executive director of Radius Global Infrastructure Inc. (previously known as Digital Landscape Group, Inc. and prior to that known as Landscape Acquisition Holdings Limited), a global aggregator of real property interests underlying wireless telecommunications cell sites. Mr. Gottesman was the co-founder of GLG Partners Inc. and its predecessor entities where he served in various chief executive capacities until January 2012. Mr. Gottesman served as GLG’s chief executive officer from September 2000 until September 2005, and then as its co-chief executive officer from September 2005 until January 2012. Mr. Gottesman was also chairman of the board of GLG following its merger with Freedom Acquisition Holdings Inc. and prior to its acquisition by Man Group plc. Mr. Gottesman co-founded GLG as a division of Lehman Brothers International (Europe) in 1995 where he was a Managing Director. Prior to 1995, Mr. Gottesman was an executive director of Goldman Sachs International, where he managed global equity portfolios in the private client group.

Ian G.H. Ashken serves as a director of APi Group Corporation (since 2017) and Element Solutions Inc. (since 2013). Previously, he was the co-founder of Jarden and served as its Vice Chairman and President until the consummation of Jarden’s business combination with Newell in April 2016. Mr. Ashken was appointed to the Jarden board on June 25, 2001 and served as Vice Chairman, Chief Financial Officer and Secretary from September 24, 2001. Mr. Ashken was Secretary of Jarden until February 15, 2007 and Chief Financial Officer until June 12, 2014. Prior to Jarden, Mr. Ashken served as the Vice Chairman and/or Chief Financial Officer of three public companies, Benson Eyecare Corporation, Lumen Technologies, Inc. and Bollé Inc. between 1992 and 2000. Mr. Ashken is also a director or trustee of a number of private companies and charitable institutions. During the last five years, Mr. Ashken also previously served as a director of Newell.

67

Stéfan Descheemaeker was appointed as the Chief Executive Officer of the Company on June 1, 2015. He was previously at Delhaize Group SA, the international food retailer, where he was Chief Financial Officer between 2008 and 2011 before becoming Chief Executive Officer of its European division until October 2013. Since leaving Delhaize Group SA, Mr. Descheemaeker held board positions with Telenet Group Holdings N.V. and Group Psychologies, served as an industry advisor to Bain Capital and is currently a professor at the Université Libre de Bruxelles. Between 1996 and 2008, Mr. Descheemaeker was at Interbrew (now Anheuser-Busch InBev "ABInBev") where he was Head of Strategy & External Growth responsible for managing M&A and strategy, during the time of the merger of Interbrew and AmBev in 2004, and prior to that he held operational management roles as Zone President in the U.S., Central and Eastern Europe, and Western Europe. Mr. Descheemaeker started his career with Cobepa, at that time the Benelux investment company of BNP-Paribas. Mr. Descheemaeker served as a Director on the Board of ABInBev, a position he has held from 2008 to 2019. Since June 2019, SDS Invest S.A represented by Mr. Descheemaeker has served as Chairman of the Board of Verlinvest.

Golnar Khosrowshahi has served as the Chief Executive Officer of Reservoir, an award-winning independent music company based in New York with offices in Los Angeles, Nashville, London, Toronto, and Abu Dhabi, since July 2007. Prior to that, Ms. Khosrowshahi worked in a number of different roles in advertising, design and experiential marketing, including as the Global Brand Manager at Euro RSCG, a division of Havas Advertising, for Fortune 500 companies such as Philips Electronics and MCI Telecommunications. Ms. Khosrowshahi serves as a Director on the board of Restaurant Brands International, as current Director and former Board Chair at Silkroad, a musical collective founded by cellist Yo-Yo Ma in 1998 (since September 2013), and as a Director on the Board of the National Music Publishers Association, a trade association representing all American music publishers and their songwriting partners (since June 2015). She also served on the Steering Committee for the Asia Society’s Triennial of Asia and the ASCAP Board of Review.

James E. Lillie has served as co-Chairman of APi Group Corporation since October 2019, and previously served as its director from October 2017. Mr. Lillie has also served on the board of directors of Tiffany & Co. from February 2017 to January 2021. He served as Jarden’s Chief Executive Officer from June 2011 until the consummation of Jarden’s business combination with Newell in April 2016. He joined Jarden in 2003 as Chief Operating Officer and was named President in 2004 and CEO in June 2011. From 2000 to 2003, Mr. Lillie served as Executive Vice President of Operations at Moore Corporation, Limited. From 1999 to 2000, he served as Executive Vice President of Operations at Walter Industries, Inc., a Kohlberg, Kravis, Roberts & Company (KKR) portfolio company. From 1990 to 1999, Mr. Lillie held a succession of senior level management positions across a variety of disciplines including human resources, manufacturing, finance and operations at World Color, Inc., another KKR portfolio company.

Stuart M. MacFarlane joined the Whitbread Beer Company in 1992, which was later acquired by Interbrew and, subsequently ABInBev. At ABInBev, Mr. MacFarlane held various senior roles throughout the course of his career, including in Finance, Marketing, Sales and as Managing Director for the company’s business in Ireland. He was appointed President of ABInBev UK & Ireland in 2008 and in 2012 became a member of the Executive Board of Management, serving as President of Central & Eastern Europe. Mr. MacFarlane most recently served as ABInBev’s President of a combined Europe & Middle East from 2014 to May 2019. Mr. MacFarlane served as a director and member of the Corporate Governance Committee of Anadolu EFES, a brewer company, until May 28, 2019. He previously served as a director of ABI-EFES Russia & Ukraine, a joint venture of Anadolu EFES and ABInBev. Mr. MacFarlane has a degree in Business Studies from Sheffield University in the UK and is also a qualified Chartered Management Accountant.

Victoria Parry was Global Head of Product Legal for Man Group plc until April 2013 and now acts as an independent non-executive director to the funds industry. Prior to the merger of Man Group plc with GLG Partners, Inc. in 2010, she was Senior Legal Counsel for GLG Partners LP. Ms. Parry joined Lehman Brothers International (Europe) in April 1996 where she was Legal Counsel with responsibility for inter alia the activities of the GLG Partners division and left Lehman Brothers in September 2000 upon the establishment of GLG Partners LP. Prior to joining Lehman Brothers in 1996 Ms. Parry practiced as a solicitor with a leading London based firm of solicitors. Ms. Parry graduated from University College Cardiff, with a LLB (Hons) in 1986. Ms. Parry is a non-practicing solicitor and a member of the Law Society of England and Wales. Ms. Parry is a director of a number of other companies.

68

Melanie Stack Melanie Stack has served as President and Chief Executive Officer of Ideal Protein, a medically-based weight-loss company, since November 2018. Prior to joining Ideal Protein, Ms. Stack served as President EMEA of Newell Home Fragrance Division from May 2014 to September 2018. Prior to that, Ms. Stack served as a Non-Executive Director of Bromley Healthcare, a leading provider of community health services in the United Kingdom, from May 2013 to May 2014, in various roles at Weight Watchers International, a leading provider of weight management services, from December 2003 to May 2013, ran the UK-based toy, game and trading card operations for Hasbro, Inc. from January 2002 to November 2003 and served as the Vice President for WeightWatchers.com from November 2000 to January 2002. Prior to joining WeightWatchers.com, Ms. Stack was Managing Director, Hedstrom, U.K. from August 1998 to October 2000, and from July 1989 to July 1998 she held various marketing positions at Mattel UK Ltd., including Group Marketing Director. Ms. Stack is a business graduate of Manchester Metropolitan University.

Samy Zekhout has served as Chief Financial Officer of Nomad since April 1, 2018. Prior to joining the Company, Mr. Zekhout most recently served as CFO and Vice President of Global Grooming at Procter & Gamble since 2007. Mr. Zekhout has held various finance roles at Procter & Gamble throughout the course of his more than 30-year career at that company. From February 2021, Mr Zekhout became a board member of Algama, a French food-tech start-up.

B.    Compensation of Executive Officers and Directors

This section sets forth for the year ended December 31, 2021: (i) the compensation and benefits provided to our executive officers, (ii) a brief description of the bonus programs in which our executive officers participated, and (iii) the total amounts set aside for pension, retirement and similar benefits for our executive officers. This section also describes the Nomad Foods Amended and Restated Long Term 2015 Incentive Plan (“LTIP”) including a summary of the material terms of the LTIP, a description of current executive employment agreements and equity awards granted thereunder, and a description of our director compensation program.

Executive Compensation

Executive Officer Compensation and Benefits for the year ended December 31, 2021

For the year ended December 31, 2021, Nomad’s executive officers received total compensation, including base salary, cash and equity bonus, and certain perquisites, equal to €4.0 million in the aggregate.

Pension, Retirement and Similar Benefits

Our executive officers who participate in our money purchase pension plans do so on generally the same terms as our other employees. The aggregate amount of the employer contributions to this plan for our executive officers during the year ended December 31, 2021 was less than €0.1 million.

Employment Agreements

Chief Executive Officer. Stéfan Descheemaeker was appointed as the Chief Executive Officer of the Company and as a Director of the Company effective on June 1, 2015. He entered into his Service Agreement with us on June 17, 2015. He entered into a new Service Agreement with the Company on May 1, 2020. Under the agreement, Mr. Descheemaeker will receive an annual salary that will be reviewed, but not necessarily increased, on an annual basis. Mr. Descheemaeker's salary was reviewed in 2021 resulting in an increased salary of £784,000. Mr. Descheemaeker is entitled to receive the following benefits under the terms of his agreement:

(a)an annual contribution of 10% of his salary paid either to a pension plan or to Mr. Descheemaeker directly (as he so directs);

(b)eligibility for performance-related discretionary cash bonuses (target performance equating to 100% of salary), subject to the achievement of financial and other performance targets as the Company may decide;

(c)the Company will annually advise Mr. Descheemaeker by letter of the award that he will be granted under the Company's Long Term Incentive Plan (as amended, the "LTIP") in the third year following the date of such letter (subject to the LTIP and vesting and performance provisions); and

69

(d)an annual car allowance of £14,400, death in service benefit (three times salary), group income protection (offering 75% of base salary less £5,000) and family medical insurance.

We have the right to place Mr. Descheemaeker on paid leave for up to six months of his 12 month notice period. Mr. Descheemaeker is subject to confidentiality provisions and to non-competition and non-solicitation restrictive covenants for a period of between six and 12 months after the termination of his employment, subject to an off-set for paid leave. We may terminate Mr. Descheemaeker’s employment at any time by serving a notice stating that we will pay to Mr. Descheemaeker within 14 days a sum equal to the basic salary (as at the date of the employment agreement), pension payment and car allowance in lieu of any required period of notice less certain deductions. We may also terminate Mr. Descheemaeker’s employment agreement without any payment of compensation, damages, payment in lieu of notice or otherwise under certain circumstances, including, among other things, gross misconduct, material breach of the terms of such agreement or charge or conviction of a criminal offence.

Chief Financial Officer. Samy Zekhout was appointed as the Chief Financial Officer of the Company and as a Director of the Company effective on April 1, 2018. He entered into his Service Agreement with us on February 15, 2018. Under the agreement, Mr. Zekhout will receive an annual salary that will be reviewed, but not necessarily increased, on an annual basis. A review took place in February 2021, with a base salary increase of 2.47% effective April 1, 2021, which took his annual salary to £457,000. Mr. Zekhout was or is entitled to receive the following benefits under the terms of his agreement:

(a)     an annual contribution of 10% of his base salary, paid either to a pension plan or to Mr. Zekhout directly (as he so directs);

(b)     eligibility for performance-related discretionary cash bonuses (up to 100% of salary with an opportunity to increase this to 200% depending on business performance), subject to the achievement of financial and other performance targets as the Company may decide;

(c)     a one-time award of 300,000 ordinary shares as incentive compensation under the Company's LTIP, subject to performance-based vesting conditions and the other terms and conditions set forth in a share grant award agreement; and

(d)     an annual car allowance of £13,200, death in service benefit (three times salary), group income protection (offering 75% of base salary less £5,000) and family medical insurance.

    We have the right to place Mr. Zekhout on paid leave for his notice period. Mr. Zekhout is subject to confidentiality provisions and to non-competition and non-solicitation restrictive covenants for a period of 12 months after the termination of his employment, subject to an off-set for paid leave. We have the right to terminate Mr. Zekhout’s employment at any time by serving a notice stating that we will pay to Mr. Zekhout within 14 days a sum equal to the basic salary (as at the date of the employment agreement), in lieu of any required period of notice less certain deductions. We also have the right to terminate Mr. Zekhout’s employment agreement without any payment of compensation, damages, payment in lieu of notice or otherwise under certain circumstances, including, among other things, gross misconduct, material breach of the terms of such agreement or charge or conviction of a criminal offence.

Nomad Foods Limited Amended and Restated Long Term 2015 Incentive Plan (“LTIP”)

Eligibility

The LTIP is discretionary and will enable the Compensation Committee to make grants (“Awards”) to any director or employee of the Company, although the current intention of the Committee is that Awards be granted only to directors and senior management.

Awards

Under the LTIP, the Committee or Board may grant Awards in the form of rights over ordinary shares. Where an Award vests, the participant will receive ordinary shares free and clear of any restrictions, other than those imposed by applicable securities laws.

70

Performance conditions

The vesting of Awards will be subject to conditions determined by the Committee. The current policy of the Committee is for vesting to be both time-based and related to the financial performance of the Company. Generally, the vesting period (i.e. the period over which performance is to be measured) will be between three and five years, and the ordinary shares subject to the Award will vest subject to the participant remaining an employee of the Company and any performance targets relating to the Award having been fulfilled (and in some circumstances an Award will lapse on the participant giving or receiving notice).

Permitted dilution

No Award may be granted on any date if, as a result, the total number of ordinary shares issued or remaining issuable pursuant to Awards or options granted in the previous ten years under the LTIP or any other employees’ share plan operated by the Company would exceed 10% of the issued ordinary share capital of the Company on that date.

Awards may at the discretion of the Committee be satisfied out of new issue shares, treasury shares or shares provided out of an employee trust. Ordinary shares issued will rank pari passu with ordinary shares in issue at that time, save in relation to rights arising by reference to a record date before the date of issue. Participants will not be entitled to votes or dividends on the ordinary shares subject to Awards until such Awards vest.

Early vesting

Unless otherwise determined by the Committee, if a participant ceases to be employed by the Company due to death, disability, or otherwise as a good leaver, as determined by the Committee Awards will vest to the extent performance targets (adapted, if necessary, at the discretion of the Committee, to take into account the shortened vesting period) have been achieved and subject to the Committee’s discretion to waive the performance targets in whole or in part. If a participant ceases employment for any other reason their Award(s) will lapse to the extent unvested at the date of cessation.

Change of Control

Unless otherwise determined by the Committee, in the event of a Change of Control or winding up of the Company (including by reason of an offer or scheme of arrangement), Awards will vest in accordance with the performance targets applied at the date of the Change of Control, subject to the Committee’s discretion to waive such targets in whole or in part.

Variation in share capital

The Committee may make such adjustments to Awards as it considers appropriate to preserve their value in the event of any variation in the ordinary share capital of the Company or to take account of any demerger or special dividend paid (or similar event which materially affects the market price of ordinary shares).

Amendments

The Committee may amend the LTIP as it considers appropriate, subject to the written consent of participants to changes to their disadvantage to existing Awards. Shareholder approval is required to increase the permitted dilution limits.

General

Benefits under the LTIP will not be pensionable. Awards are not transferable except to the participant’s personal representatives on death.

71

Director Compensation

In 2021, each of our non-executive directors (other than Messrs. Gottesman and Franklin) received, and are entitled to receive in 2021, $50,000 per year together with an annual restricted stock grant issued under the LTIP equal to $100,000 of ordinary shares valued at the date of issue, which vest on the earlier of the date of the following year’s annual meeting of shareholders or 12 months from the issuance date. For those Directors who are members of board committees, each member is entitled to receive an additional $2,000 per year. The chairman of the Audit Committee, currently, is entitled to receive $10,000 per year and the chairmen of the Compensation and Nominating and Corporate Governance Committees, currently and respectively, are entitled to receive $7,500 per year. Messrs. Gottesman and Franklin will not receive a fee in relation to their services as Directors.

Director fees are payable quarterly in arrears. In addition, all of the Directors are entitled to be reimbursed by us for travel, hotel and other expenses incurred by them in the course of their directors’ duties.

C.    Board Practices

Board Composition and Election of Directors

Our board of directors currently consists of ten members. Our Memorandum and Articles of Association provides that our board of directors must be composed of at least one director. The number of directors is determined from time to time by resolution of our board of directors. Messrs. Gottesman and Franklin serve as Co-Chairmen of our board of directors. The Co-Chairmen have primary responsibility for providing leadership and guidance to our board and for managing the affairs of our board. Lord Myners served as our lead independent director until his passing in January 2022. Our board of directors expects to name a new lead independent director in 2022.

Pursuant to our Memorandum and Articles of Association, our directors are appointed at the annual meeting of shareholders for a one-year term, with each director serving until the annual meeting of shareholders following their election. In addition, for so long as an initial holder of Founder Preferred Shares holds 20% or more of the Founder Preferred Shares in issue, such holder is entitled to nominate, and the directors are required to appoint, a person as director. For additional information regarding our board of directors, see Item 6A: Directors, Senior Management and Employees - Executive Officers and Directors.

Our non-executive directors do not have service contracts with us or any of our subsidiaries providing for benefits upon termination of employment.

Committees of the Board of Directors

Our board of directors has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee.

Audit Committee

As of December 31, 2021, our Audit Committee consisted of three directors: Messrs. Lillie, Ashken and MacFarlane, and Mr. Lillie served as its chairman. Our Audit Committee is responsible for, among other things, assisting the board of directors in its oversight of the integrity of our financial statements, of our compliance with legal and regulatory requirements, and of the independence, qualifications and performance of our independent auditors. In addition, it focuses on compliance with accounting policies and ensuring that an effective system of internal and external audit and financial controls is maintained, and oversees our policies and procedures with respect to risk assessment and risk management. Our Audit Committee will meet at least quarterly with management and the independent auditors and report on such meetings to the board of directors. The responsibilities of our Audit Committee as set forth in its charter include oversight of the following: external audit, financial reporting, public disclosure, internal controls, risk management and compliance and whistleblowing.

Compensation Committee

As of December 31, 2021, our Compensation Committee consisted of three directors: Mr. Ashken, Lord Myners and Ms. Parry, and Mr. Ashken served as its chairman. Our Compensation Committee is responsible for determining the compensation of our executive officers. The responsibilities of our Compensation Committee as set forth in its charter include the following: assisting the board in evaluating potential candidates for executive positions, determining the compensation of our chief executive officer, making recommendations to the board

72

with respect to the compensation of other executive officers, reviewing our incentive compensation and other equity-based plans, and reviewing, on a periodic basis, director compensation.

Nominating and Corporate Governance Committee

As of December 31, 2021, our Nominating and Corporate Governance Committee (the “N&CG Committee”) consisted of three directors: Lord Myners, Ms. Parry, and Mr. Lillie and Lord Myners served as its chairman.

Our N&CG Committee is responsible for considering and making recommendations to the board of directors in respect of appointments to the board. The responsibility of our N&CG Committee as set forth in its Charter include the following: recommending directors to the board to serve as members of each committee, developing and recommending a set of corporate governance principles applicable to our company and overseeing board evaluations. It is also responsible for regularly reviewing the structure, size and composition of the board and making recommendations to the board with regard to any changes it deems necessary.

D.    Employees

As of December 31, 2021, we had approximately 8,002 employees, including 684 temporary staff. In addition, we employed approximately 826 agency workers in 2021. We source the majority of our temporary workers from agencies to allow us to quickly respond and adapt to production demands. Approximately 70% of our employees work in our manufacturing operations, with the remaining employees involved in sales, marketing, finance, administration, procurement, logistics, product development, IT and other areas. Following are the number of employees by region for the last three years:

Region	2021	2020	2019
Germany	1,437	1,374	1,412
United Kingdom	1,389	1,333	1,222
Serbia	1,302	—	—
Croatia	853	—	—
Italy	494	479	478
Sweden/Norway	378	397	421
Bosnia & Herzegovina	348	—	—
France	333	343	345
Other	1,468	964	897
Total	8,002	4,890	4,775

A number of our employees are members of trade unions in the UK, Germany, Italy, France, Sweden, Norway or Spain. Trade union membership is not required to be disclosed by employees. Many of our plants are governed by collective agreements with the respective unions. Our relationships with the trade unions are currently stable.

E.    Share Ownership

The following table sets forth, as of February 17, 2022, certain information regarding the beneficial ownership of our ordinary shares by:

•each of our current directors;

•each of our named executive officers for the fiscal year ended December 31, 2021; and

•all of our current directors and current executive officers as a group.

Percentages are based on the 172,398,626 ordinary shares that were issued and outstanding on February 17, 2022.

73

Director and Executive Officers:	Number		Percentage
Sir Martin E. Franklin	11,983,617	(1)	7.0
Noam Gottesman	12,818,221	(2)	7.4
Ian G.H. Ashken	425,656	(3)	*
Stéfan Descheemaeker	3,742,401	(4)	2.2
Golnar Khosrowshahi	—	(5)	*
James E. Lillie	783,810	(6)	*
Stuart MacFarlane	5,455	(7)	*
Victoria Parry	19,437	(8)	*
Melanie Stack	—	(9)	*
Samy Zekhout	16,393	(10)	*
Directors and Executive Officers as a Group (10 persons)	29,794,990		17.3

*    Represents beneficial ownership of less than one percent of ordinary shares outstanding.

(1)Consists of (i) 6,392,212 ordinary shares held indirectly through the Martin E. Franklin Revocable Trust, (ii) 750,000 Founder Preferred Shares held indirectly through Mariposa Acquisition II, LLC (which are convertible at any time at the option of the holder into ordinary shares on a one-for-one basis) , (iii) 3,353,751 ordinary shares held indirectly through RSMA, LLC and (iv) 1,209,466 ordinary shares held by other members of Mariposa Acquisition II, LLC, respectively, which Sir Martin has the sole power to vote pursuant to irrevocable proxy agreements. In addition, Sir Martin indirectly owns 69% of Mariposa Acquisition II, representing 517,500 Founder Preferred Shares. Sir Martin disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

(2)Includes (i) 9,496,772 ordinary shares of which 1,273,560 are held by TOMS Acquisition I LLC, 6,708,560 are held by TOMS Capital Investments LLC and 1,514,652 are held indirectly by Mr. Gottesman through a wholly owned entity, (ii) 750,000 Founder Preferred Shares which are convertible at any time at the option of the holder into ordinary shares on a one-for-one basis and all of which are held by TOMS Acquisition I LLC (iii) an aggregate of 1,821,449 ordinary shares held by the members of TOMS Acquisition I LLC that are subject to an irrevocable proxy agreement granted to Mr. Gottesman and (iv) 750,000 ordinary shares held by Lavender Fiduciary Management Inc., as a trustee of various trusts established by certain members of TOMS Acquisition I LLC, that are subject to an irrevocable proxy agreement granted to Mr. Gottesman. Mr. Gottesman is the managing member and majority owner of TOMS Acquisition I LLC and TOMS Capital Investments LLC and may be considered to have beneficial ownership of TOMS Acquisition I LLC’s and TOMS Capital Investments LLC’s interests in the Company. In addition, Mr. Gottesman owns or controls, directly or indirectly, 77.5% of TOMS Acquisition I LLC and 100% of TOMS Capital Investments LLC. Mr. Gottesman disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

(3)Includes (i) 421,065 ordinary shares held by Tasburgh, LLC and (ii) 4,591 held by The Ian G.H. Ashken Living Trust of which Mr. Ashken is the sole settlor and trustee, all of which are subject to an irrevocable proxy agreement granted to Sir Martin (see note 1 above). Mr. Ashken is the Managing Manager of Tasburgh, LLC. Excludes an indirect pecuniary interest in 56,250 Founder Preferred Shares (which are convertible at any time at the option of the holder into ordinary shares on a one-for-one basis) held by Mariposa Acquisition II, LLC. Also excludes 3,537 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2022 or (ii) July 30, 2022.

(4)Includes 2,543,897 ordinary shares held indirectly through Olidipoli Sprl, a company owned by Mr. Descheemaeker. Excludes (i) 300,000 ordinary shares issuable under the LTIP which will vest on February 1, 2023 and (ii) 300,000 ordinary shares issuable under the LTIP, which will vest on February 1, 2024, both of which will vest subject to performance based vesting conditions (and in each of cases (i) and (ii), subject to further vesting conditions relating to Mr. Descheemaeker’s tenure as Chief Executive Officer).

(5)Excludes 3,537 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2022 or (ii) July 30, 2022.

(6)Includes 783,810 ordinary shares held directly by Mr. Lillie and his spouse, all of which are subject to an irrevocable proxy agreement granted to Sir Martin (see note 1 above). Excludes an indirect pecuniary interest in 56,250 Founder Preferred Shares (which are convertible at any time at the option of the holder into ordinary

74

shares on a one-for-one basis) held by Mariposa Acquisition II, LLC. Also excludes 3,537 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2022 or (ii) July 30, 2022.

(7)Excludes 3,537 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2022 or (ii) July 30, 2022.

(8)Excludes 3,537 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2022 or (ii) July 30, 2022.

(9)Excludes 3,537 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2022 or (ii) July 30, 2022.

(10)Excludes 273,750 ordinary shares issuable under the LTIP, which will vest subject to performance based vesting conditions (and subject to further vesting conditions relating to Mr. Zekhout's tenure as Chief Financial Officer).

There are no arrangements for involving the employees in the capital of the Company, including any arrangement that involves the issue or grant of options or shares or securities of the Company, other than those described under Item 6. Directors, Senior Management and Employees—B. Compensation of Executive Officers and Directors—Nomad Foods Limited Amended and Restated Long Term 2015 Incentive Plan (“LTIP").

Item 7.    Major Shareholders and Related Party Transactions

A.    Major Shareholders

The following table sets forth certain information regarding the beneficial ownership of our ordinary shares by each person known by us to be a beneficial owner of more than 5% of the ordinary shares. Currently we only have one class of listed shares issued and outstanding, that being ordinary shares, which have no par value. All of our ordinary shares have the same voting rights. Percentages are based on the 172,398,626 ordinary shares that were issued and outstanding on February 17, 2022.

	Ordinary Shares Beneficially Owned
Name of Beneficial Owner:	Number		Percentage
5% Shareholders:
Wellington Management Group LLP c/o Wellington Management Company LLP   280 Congress Street   Boston, MA 02210	14,073,168	(1)	8.2
Noam Gottesman c/o TOMS Acquisition I LLC    450 W. 14th Street, 13th Floor    New York, NY 10014	12,818,221	(2)	7.4
Martin E. Franklin c/o Mariposa Capital, LLC    500 South Pointe Drive, Suite 240    Miami Beach, FL 33139	11,983,617	(3)	7.0
Allspring Global Investments Holdings, LLC   420 Montgomery Street   San Francisco, CA 94163	9,899,243	(4)	5.7
FMR LLC   245 Summer Street   Boston, MA 02210	9,132,956	(5)	5.3

75

(1)Based on a Schedule 13G/A filed by Wellington Management Group LLP on February 4, 2022

(2)Based on a Schedule 13D/A filed by Mr. Gottesman, TOMS Acquisition I LLC and the other reporting persons described therein on May 25, 2021.

(3)Based on a Schedule 13D/A filed by Sir Martin Franklin, Martin E. Franklin Revocable Trust and the other reporting persons described therein on January 6, 2021.

(4)Based on a Schedule 13G filed by Allspring Global Investments Holdings, LLC on January 18, 2022.g

(5)Based on a Schedule 13G filed by FMR LLC on February 9, 2022

On January 18, 2022, Allspring Global Investments Holdings, LLC filed a Schedule 13G to report that it beneficially owned 5.61% of our ordinary shares. Prior to its sale on November, 1, 2021, Allspring Global Investments Holdings, LLC was a subsidiary of Wells Fargo & Company, and prior to that date, its holdings were included on Schedules 13G filed by Wells Fargo & Company, LLC.

On January 27, 2022, Wells Fargo & Company filed a Schedule 13G/A to report that its ownership in our ordinary shares decreased from 5.47% to 0.11% as of January 27, 2022.

On February 4, 2022, Wellington Management Group LLP filed a Schedule 13G/A to report that its percentage ownership in our ordinary shares increased from 7.33% as of February 4, 2021 to 7.98% as of February 4, 2022.

On February 9, 2022, FMR LLC filed a Schedule 13G to report that it beneficially owned 5.17% of our ordinary shares.

As of February 17, 2022, (i) approximately 172,354,384 of our outstanding ordinary shares were held by one United States record holder (Cede and Company) and (ii) all 1,500,000 of our outstanding preferred shares (Founder Preferred Shares), which have the same voting rights as the ordinary shares, were held in equal amounts by two United States record holders (Mariposa Acquisition II, LLC and TOMS Acquisition I LLC).

Except for the foregoing, no major shareholder has disclosed a significant change in its percentage ownership of our ordinary shares during the three years ended December 31, 2021.

B.    Related Party Transactions

For a description of our related party transactions, see Note 37, Related Parties, to our audited consolidated financial statements which appear elsewhere in this annual report.

On January 1, 2022, the Company entered into an Amended and Restated Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of Sir Martin, and TOMS Capital LLC, an affiliate of Mr. Gottesman. Pursuant to the terms of the Amended and Restated Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC provide high-level strategic advice and guidance to the Company. Under the terms of the Amended and Restated Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC are entitled to receive an aggregate annual fee equal to $4.0 million, payable in quarterly installments. This agreement expires on January 1st annually and will be automatically renewed for successive one-year terms unless any party notifies the other parties in writing of its intention not to renew the agreement no later than 90 days prior to the expiration of the term. The agreement may only be terminated by the Company upon a vote of a majority of its directors. In the event that the agreement is terminated by the Company, the effective date of the termination will be 6 months following the expiration of the initial term or a renewal term, as the case may be.

Related Party Transactions Procedures

The Audit Committee Charter provides that the Audit Committee shall review all related party transactions, as defined under Item 404 of Regulation S-K under the Securities Act of 1933, as amended. Following such review, the Audit Committee determines whether such transaction should be approved based on the terms of the transaction, the business purpose for the transaction and whether the transaction is in the best interest of the Company and its shareholders.

No member of the Audit Committee shall participate in any review, consideration or approval of any related party transaction with respect to which such member or any of his or her immediate family members is the related party.

76

Item 8.    Financial Information

A.    Consolidated Statements and Other Financial Information

Financial Statements

Please see Item 18 below.

Export Sales

For a description of our export sales which constitute all of our sales, please see Geographical information - External revenue by geography in Item 18, Note 5 below.

Legal Proceedings

We are not currently subject to any legal proceedings, nor to the best of our knowledge, is any proceeding threatened, the results of which would have a material impact on our properties, results of operation, or financial condition. Tax audits are taking place in a number of countries. Whenever there is a difference in view between local tax authorities and the Company, to the extent deemed necessary, provisions are made for exposures for which it will be probable that they will lead to additional tax liabilities. To the best of our knowledge, none of our officers or directors is involved in any legal proceedings in which we are an adverse party.

Dividend Policy

We have not declared or paid any dividends on our ordinary shares since our inception on April 1, 2014, and have no current plans to pay dividends on our ordinary shares. The declaration and payment of future dividends to holders of our ordinary shares will be at the discretion of our board of directors and will depend upon many factors, including our financial condition, earnings, legal requirements, restrictions in our debt agreements and other factors deemed relevant by our board of directors. In addition, as a holding company, our ability to pay dividends depends on our receipt of cash dividends from our operating subsidiaries, which may further restrict our ability to pay dividends as a result of the laws of their respective jurisdictions of organization, agreements of our subsidiaries or covenants under future indebtedness that we or they may incur. See Item 3D: Key Information - Risk Factors - Risks Related to our Ordinary Shares - Dividend payments on our ordinary shares are not expected, and for a discussion of taxation of any dividends, see Item 10E: Additional Information - Taxation.

The Founder Preferred Shares are entitled to receive an annual stock dividend based on the market price of our ordinary shares if such market price exceeds certain trading price minimums and to participate in any dividends on the ordinary shares. For the year ended December 31, 2021, no Founder Preferred Shares Annual

Dividend Amount was payable pursuant to the terms of the Founder Preferred Shares. For the year ended December 31, 2020, we approved a 2020 Founder Preferred Share Dividend in an aggregate of 3,875,036 ordinary shares. The dividend price used to calculate the 2020 Founder Preferred Shares Annual Dividend Amount was $25.2127 and the Ordinary Shares were issued on January 2, 2020. For the year ended December 31, 2019, we approved a 2019 Founder Preferred Share Dividend in an aggregate of 6,421,074 ordinary shares. The dividend price used to calculate the 2019 Founder preferred Shares Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten trading days of 2019) and the Ordinary Shares were issued on January 2, 2019. In 2022, the Founder Preferred Shares Annual Dividend Amount will be calculated based upon the volume weighted average price for the last ten trading days of the year and the appreciated average share price compared to the highest price previously used in calculating the Founder Preferred Shares Annual Dividend Amount. We currently expect to retain all our future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends for the foreseeable future. The declaration and payment of future dividends to holders of our ordinary shares will be at the discretion of our board of directors and will depend upon many factors, including our financial condition, earnings, legal requirements, and restrictions in our debt agreements, including the Senior Facility Agreement, and other factors deemed relevant by our board of directors. As a holding company, our ability to pay dividends depends on our receipt of cash dividends from our operating subsidiaries, which may further restrict our ability to pay dividends as a result of the laws of their respective jurisdictions of organization, agreements of our subsidiaries or covenants under future indebtedness that we or they may incur. Furthermore, under British Virgin Islands law, we may pay dividends to our shareholders only if, immediately after the dividend, the value of our assets would exceed our liabilities and we would be able to pay our debts as they fall due.

77

B.    Significant Changes

No significant change has occurred since the date of the annual financial statements included in this annual report.

Item 9.    The Offer and Listing

A.    Offer and Listing Details

Our ordinary shares are currently listed for trading on the NYSE under the symbol “NOMD”.

There is no public market for our preferred shares and the preferred shares will not be listed for trading on any exchange.

Item 10.    Additional Information

A.    Share Capital

Not applicable.

B.    Memorandum and Articles of Association

A copy of our Memorandum and Articles of Association have been previously filed as Exhibit 99.1 to our Report of Foreign Private Issuer on Form 6-K (File No. 001-37669), filed with the SEC on January 14, 2016, and is incorporated by reference into this annual report. The information called for by this Item 10B: Additional Information - Memorandum and Articles of Association has been reported previously in our Registration Statement on Form F-3 (File No. 333-225402), filed with the SEC on June 4, 2018 (the “Registration Statement”), under the heading “Description of Share Capital,” and is incorporated by reference into this annual report. There are no limitations on the rights to own securities, including the rights of non-resident or foreign shareholders to hold or exercise voting rights on the securities imposed by the laws of the British Virgin Islands or by our Memorandum.

C.    Material Contracts

Each material contract to which the Company has been a party for the preceding two years, other than those entered into in the ordinary course of business, is listed as an exhibit to the Registration Statement and is summarized elsewhere herein.

D.    Exchange Controls

We are not aware of any governmental laws, decrees, regulations or other legislation in the British Virgin Islands that restrict the export or import of capital, including the availability of cash and cash equivalents for use by our affiliated companies, or that affect the remittance of dividends, interest or other payments to non-resident holders of our securities.

E.    Taxation

U.S. Federal Income Taxation

General

The following discussion is a summary of certain U.S. federal income tax issues relevant to the acquisition, holding and disposition of the ordinary shares. Additional tax issues may exist that are not addressed in this discussion and that could affect the U.S. federal income tax treatment of the acquisition, holding and disposition of the ordinary shares.

This discussion does not address any tax consequences other than U.S. federal income tax consequences, such as U.S. state and local tax consequences, U.S. estate and gift tax consequences, or non-U.S. tax consequences. The discussion applies, unless indicated otherwise, only to holders of ordinary shares who acquire the ordinary shares as capital assets. It does not address special classes of holders that may be subject to different treatment under the Internal Revenue Code of 1986, as amended (the “Code”), such as:

78

•certain financial institutions, insurance companies, underwriters, real estate investment trusts, or regulated investment companies;

•controlled foreign corporations or passive foreign investment companies;

•dealers and traders in securities;

•persons holding ordinary shares as part of a hedge, straddle, conversion or other integrated transaction;

•partnerships or other entities or arrangements classified as partnerships for U.S. federal income tax purposes;

•persons liable for the alternative minimum tax;

•tax-exempt organizations, qualified retirement plans, individual retirement accounts, or other tax-deferred accounts;

•certain U.S. expatriates or former long-term residents of the United States;

•a person that is required to accelerate the recognition of any item of gross income with respect to ordinary shares as a result of such income being recognized on an applicable financial statement;

•a person that acquired ordinary shares as compensation for services;

•persons holding ordinary shares that own or are deemed to own 10 percent or more (by vote or value) of the Company’s stock; or

•persons that do not use the U.S. Dollar as their functional currency.

This section is based on the Code, its legislative history, existing and proposed Treasury regulations, published rulings by the Internal Revenue Service (“IRS”) and court decisions, all as currently in effect. These laws are subject to change, possibly on a retroactive basis. Holders of ordinary shares should consult their own tax advisers concerning the U.S. federal, state, local and non-U.S. tax consequences of acquiring, holding and disposing of ordinary shares in their particular circumstances.

As used herein, a “U.S. Holder” is a beneficial owner of ordinary shares that is, for U.S. federal income tax purposes: (i) an individual who is a citizen or resident of the United States; (ii) a corporation or other entity taxable as a corporation, created or organized in or under the laws of the United States or any political subdivision thereof; (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source; or (iv) a trust if (1) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more “United States persons” (within the meaning of the Code) have the authority to control all substantial decisions of the trust, or (2) it has a valid election in effect under applicable Treasury regulations to be treated as a “United States person”.

This discussion does not consider the tax treatment of partnerships or other pass-through entities that hold ordinary shares, or of persons who hold ordinary shares through such entities. If a partnership (or other entity or arrangement classified as a partnership for U.S. federal income tax purposes) is the beneficial owner of ordinary shares, the U.S. federal income tax treatment of a partner in the partnership will generally depend on the status of the partner and the activities of the partnership.

This discussion is based upon certain understandings and assumptions with respect to the business, assets and shareholders, including that the Company is not, does not expect to become, nor at any time has been, a controlled foreign corporation as defined in Section 957 of the Code (a “CFC”). The Company believes that it is not and has never been a CFC, and does not expect to become a CFC. In the event that one or more of such understandings and assumptions proves to be inaccurate, the following discussion may not apply, and material adverse U.S. federal income tax consequences may result to U.S. Holders.

79

Passive Foreign Investment Company (“PFIC”) Considerations

The U.S. federal income tax treatment of U.S. Holders will differ depending on whether the Company is considered a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes.

In general, the Company will be considered a PFIC for any taxable year in which: (i) 75 percent or more of its gross income consists of passive income; or (ii) 50 percent or more of the average quarterly market value of its assets in that year are assets (including cash) that produce, or are held for the production of, passive income. For purposes of the above calculations, if the Company, directly or indirectly, owns at least 25 percent by value of the stock of another corporation, then the Company generally would be treated as if it held its proportionate share of the assets of such other corporation and received directly its proportionate share of the income of such other corporation. Passive income generally includes, among other things, dividends, interest, rents, royalties, certain gains from the sale of stock and securities, and certain other investment income.

Based on the current and anticipated composition of the income, assets and operations of the Company and its subsidiaries, the Company believes that it will not be a PFIC in its current taxable year and is not likely to be a PFIC in future taxable years. However, there is no assurance that the Company will not be a PFIC in any taxable year because PFIC status is factual in nature, depends upon factors not wholly within the Company's control, generally cannot be determined until the close of the taxable year in question, and is determined annually. If the Company is a PFIC for any taxable year during which a U.S. Holder holds (or, in the case of a lower-tier PFIC, is deemed to hold) its ordinary shares, such U.S. Holder will be subject to significant adverse U.S. federal income tax rules. U.S. Holders should consult their tax advisors on the U.S. federal income tax consequences of the Company being treated as a PFIC.

Tax Consequences for U.S. Holders if the Company is not a PFIC

Dividends

In general, subject to the PFIC rules discussed above, a distribution on an ordinary share will constitute a dividend for U.S. federal income tax purposes to the extent that it is made from the Company’s current or accumulated earnings and profits as determined under U.S. federal income tax principles. If a distribution exceeds the Company’s current and accumulated earnings and profits, it will be treated as a non-taxable reduction of basis to the extent of the U.S. Holder’s tax basis in the ordinary share on which it is paid, and to the extent it exceeds that basis it will be treated as capital gain. For purposes of this discussion, the term “dividend” means a distribution that constitutes a dividend for U.S. federal income tax purposes. However, it is not expected that the Company will maintain calculations of its earnings and profits in accordance with U.S. federal income tax principles. U.S. Holders should therefore assume that any distribution by the Company with respect to the Company’s ordinary shares will be reported as dividend income. U.S. Holders should consult their own tax advisors with respect to the appropriate U.S. federal income tax treatment of any distribution received from the Company.

The gross amount of any dividend on an ordinary share (which will include the amount of any foreign taxes withheld) generally will be subject to U.S. federal income tax as foreign source dividend income, and generally will not be eligible for the corporate dividends received deduction allowed to corporations in respect of dividends received from U.S. corporations. The amount of a dividend paid in foreign currency will be its value in U.S. Dollars based on the prevailing spot market exchange rate in effect on the day the U.S. Holder receives the dividend. A U.S. Holder will have a tax basis in any distributed foreign currency equal to its U.S. Dollar amount on the date of receipt, and any gain or loss realized on a subsequent conversion or other disposition of foreign currency generally will be treated as U.S. source ordinary income or loss. If dividends paid in foreign currency are converted into U.S. Dollars on the date they are received by a U.S. Holder, the U.S. Holder generally should not be required to recognize foreign currency gain or loss in respect of the dividend income.

80

Subject to certain exceptions for short-term and hedged positions, a dividend that a non-corporate holder receives on an ordinary share will be subject to a maximum federal income tax rate of 20 percent if the dividend is a “qualified dividend” not including the Medicare Contribution Tax described below. A dividend on an ordinary share will be a qualified dividend if (i) either (a) the ordinary shares are readily tradable on an established market in the United States or (b) the Company is eligible for the benefits of a comprehensive income tax treaty with the United States that the Secretary of the Treasury determines is satisfactory for purposes of these rules and that includes an exchange of information program, and (ii) the Company was not, in the year prior to the year the dividend was paid, and is not, in the year the dividend is paid, a PFIC. Since the ordinary shares are listed on the New York Stock Exchange, the ordinary shares should be treated as readily tradable on an established securities market in the United States. Even if dividends on the ordinary shares would otherwise be eligible for qualified dividend treatment, in order to qualify for the reduced qualified dividend tax rates, a non-corporate holder must hold the ordinary share on which a dividend is paid for more than 60 days during the 120-day period beginning 60 days before the ex-dividend date, disregarding for this purpose any period during which the non-corporate holder has an option to sell, is under a contractual obligation to sell or has made (and not closed) a short sale of substantially identical stock or securities, is the grantor of an option to buy substantially identical stock or securities or, pursuant to Treasury regulations, has diminished its risk of loss by holding one or more other positions with respect to substantially similar or related property. In addition, to qualify for the reduced qualified dividend tax rates, the non-corporate holder must not be obligated to make related payments with respect to positions in substantially similar or related property. Payments in lieu of dividends from short sales or other similar transactions will not qualify for the reduced qualified dividend tax rates.

A non-corporate holder that receives an extraordinary dividend eligible for the reduced qualified dividend rates must treat any loss on the sale of the stock as a long-term capital loss to the extent of the dividend. For purposes of determining the amount of a non-corporate holder’s deductible investment interest expense, a dividend is treated as investment income only if the non-corporate holder elects to treat the dividend as not eligible for the reduced qualified dividend tax rates. Special limitations on foreign tax credits with respect to dividends subject to the reduced qualified dividend tax rates apply to reflect the reduced rates of tax.

The U.S. Treasury has announced its intention to promulgate rules pursuant to which non-corporate holders of stock of non-U.S. corporations, and intermediaries through whom the stock is held, will be permitted to rely on certifications from issuers to establish that dividends are treated as qualified dividends. Because those procedures have not yet been issued, it is not clear whether the Company will be able to comply with them.

Non-corporate holders of ordinary shares are urged to consult their own tax advisers regarding the availability of the reduced qualified dividend tax rates with respect to dividends received on the ordinary shares in light of their own particular circumstances.

Capital Gains

Subject to the PFIC rules discussed above, on a sale or other taxable disposition of an ordinary share, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between the U.S. Holder’s adjusted basis in the ordinary share and the amount realized on the sale or other disposition, each determined in U.S. Dollars. Such capital gain or loss will be long-term capital gain or loss if at the time of the sale or other taxable disposition the ordinary share has been held for more than one year. In general, any adjusted net capital gain of an individual is subject to a maximum federal income tax rate of 20 percent, not including the Medicare Contribution Tax, discussed below. Capital gains recognized by corporate U.S. holders generally are subject to U.S. federal income tax at the same rate as ordinary income. The deductibility of capital losses is subject to limitations.

Any gain a U.S. Holder recognizes generally will be U.S. source income for U.S. foreign tax credit purposes, and, subject to certain exceptions, any loss will generally be a U.S. source loss. If a non-U.S. income tax is paid on a sale or other disposition of an ordinary share, the amount realized will include the gross amount of the proceeds of that sale or disposition before deduction of the non-U.S. tax. The generally applicable limitations under U.S. federal income tax law on crediting foreign income taxes may preclude a U.S. Holder from obtaining a foreign tax credit for any non-U.S. tax paid on a sale or other disposition of an ordinary share. The rules relating to the determination of the foreign tax credit are complex, and U.S. holders are urged to consult with their own tax advisers regarding the application of such rules. Alternatively, any non-U.S. income tax paid on the sale or other disposition of an ordinary share may be taken as a deduction against taxable income, provided the U.S. Holder takes a deduction and not a credit for all foreign income taxes paid or accrued in the same taxable year.

81

Medicare Contribution Tax

Dividends received with respect to ordinary shares and capital gains from the sale or other taxable disposition of the ordinary shares recognized by certain non-corporate U.S. Holders will be includable in computing net investment income of such U.S. Holder for purposes of the 3.8 percent Medicare Contribution Tax.

Tax Consequences for Non-U.S. Holders of Ordinary Shares

As used herein, a "non-U.S. Holder" is a beneficial owner of ordinary shares that is neither a U.S. Holder nor a partnership (or entity or arrangement classified as a partnership) for U.S. federal income tax purposes.

Dividends

A non-U.S. Holder generally will not be subject to U.S. federal income tax or withholding on dividends received from the Company with respect to ordinary shares, other than in certain specific circumstances where such income is deemed effectively connected with the conduct by the non-U.S. Holder of a trade or business in the United States. If a non-U.S. Holder is entitled to the benefits of a U.S. income tax treaty with respect to those dividends, that income is generally subject to U.S. federal income tax only if it is attributable to a permanent establishment maintained by the non-U.S. Holder in the United States. A non-U.S. Holder that is subject to U.S. federal income tax on dividend income under the foregoing exception generally will be taxed with respect to such dividend income on a net basis in the same manner as a U.S. Holder unless otherwise provided in an applicable income tax treaty; a non-U.S. Holder that is a corporation for U.S. federal income tax purposes may also be subject to a branch profits tax with respect to such dividend income at a rate of 30 percent (or at a reduced rate under an applicable income tax treaty).

Sale, Exchange or Other Taxable Disposition of Ordinary Shares

A non-U.S. Holder generally will not be subject to U.S. federal income tax or withholding with respect to any gain recognized on a sale, exchange or other taxable disposition of ordinary shares unless:

•the gain is treated as effectively connected with the conduct by the non-U.S. Holder of a trade or business in the United States (and, if an applicable income tax treaty so requires, such gain is attributable to a permanent establishment maintained by the non-U.S. Holder in the United States); or

•the non-U.S. Holder is an individual and is present in the United States for 183 or more days in the taxable year of the sale, exchange or other taxable disposition, and meets certain other requirements.

If the first exception applies, the non-U.S. Holder generally will be subject to U.S. federal income tax with respect to such gain on a net basis in the same manner as a U.S. Holder unless otherwise provided in an applicable income tax treaty; a non-U.S. Holder that is a corporation for U.S. federal income tax purposes may also be subject to a branch profits tax with respect to such gain at a rate of 30 percent (or at a reduced rate under an applicable income tax treaty). If the second exception applies, the non-U.S. Holder generally will be subject to U.S. federal income tax at a rate of 30 percent (or at a reduced rate under an applicable income tax treaty) on the amount by which such non-U.S. Holder’s capital gains allocable to U.S. sources exceed capital losses allocable to U.S. sources during the taxable year of disposition of the ordinary shares.

Information Reporting and Backup Withholding

Under U.S. federal income tax laws, certain categories of U.S. Holders must file information returns with respect to their investment in, or involvement in, a foreign corporation (including IRS Forms 926). Persons who are required to file these information returns and fail to do so may be subject to substantial penalties. Pursuant to Section 1298(f) of the Code, for any year in which the Company is a PFIC, each U.S. Holder will be required to file an information statement, Form 8621, regarding such U.S. Holder’s ownership interest in the Company. U.S. Holders of ordinary shares should consult with their own tax advisers regarding the requirements of filing information returns.

82

Furthermore, certain U.S. Holders who are individuals and to the extent provided in future regulations, certain entities, will be required to report information with respect to such U.S. Holder’s investment in “foreign financial assets” on IRS Form 8938. An interest in the Company constitutes a foreign financial asset for these purposes. Persons who are required to report foreign financial assets and fail to do so may be subject to substantial penalties. Potential shareholders are urged to consult with their own tax advisers regarding the foreign financial asset reporting obligations and their application to an investment in ordinary shares.

Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries generally are subject to information reporting and to backup withholding unless the U.S. Holder is a corporation or other exempt recipient, or, in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that no loss of exemption from backup withholding has occurred. The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against the U.S. Holder’s U.S. federal income tax liability and may entitle such U.S. Holder to a refund, provided that the required information is furnished to the IRS.

Non-U.S. Holders generally are not subject to information reporting or backup withholding with respect to dividends paid on ordinary shares, or the proceeds from the sale, exchange or other disposition of ordinary shares, provided that each such non-U.S. Holder certifies as to its foreign status on the applicable duly executed IRS Form W-8 or otherwise establishes an exemption.

Foreign Account Tax Compliance Act

Under certain circumstances, the Company or its paying agent may be required, pursuant to the Foreign Account Tax Compliance Act ("FATCA"), to withhold U.S. tax at a 30 percent rate on all or a portion of payments of dividends or other corporate distributions to holders of ordinary shares that are treated as "foreign pass-thru payments" made on or after the date that is two years after the issuance of final regulations concerning such foreign pass-thru payments are published, if such payments are not in compliance with FATCA. Such regulations have not yet been issued. The rules regarding FATCA and "foreign pass-thru payments," including the treatment of proceeds from the disposition of ordinary shares, are complex and holders of ordinary shares are encouraged to consult their own tax advisers regarding the impact of the FATCA rules on them.

This summary is for general information only and it is not intended to be, nor should it be construed to be, tax or legal advice to any prospective shareholder. Further, this summary is not intended to constitute a complete analysis of all U.S. federal income tax consequences relating to holders of their acquisition, ownership and disposition of the ordinary shares. Accordingly, prospective holders of ordinary shares should consult their own tax advisers about the U.S. federal, state, local and non-U.S. tax consequences of the acquisition, ownership and disposition of the ordinary shares.

British Virgin Islands Taxation

The Company

We are not subject to any income, withholding or capital gains taxes in the British Virgin Islands. No capital or stamp duties are levied in the British Virgin Islands on the issue, transfer or redemption of ordinary shares.

Shareholders

Shareholders who are not tax resident in the British Virgin Islands will not be subject to any income, withholding or capital gains taxes in the British Virgin Islands, with respect to the ordinary shares of the Company owned by them and dividends received on such ordinary shares, nor will they be subject to any estate or inheritance taxes in the British Virgin Islands.

83

United Kingdom Taxation

General

The following is a general summary of material UK tax considerations relating to the ownership and disposal of our ordinary shares. The comments set out below are based on current UK tax law as of the date of this summary, which is subject to change, possibly with retrospective effect. This summary does not constitute legal or tax advice and applies only to shareholders holding our ordinary shares as an investment and who are the beneficial owners thereof, whose ordinary shares are not held through an individual savings account or a self-invested personal pension and who have not acquired their or another person’s ordinary shares by reason of their or another person’s employment. These comments may not apply to certain classes of persons, including dealers in securities, insurance companies and collective investment schemes.

This summary is for general information only and is not intended to be, nor should it be considered to be, legal or tax advice to any particular investor. It does not address all of the tax considerations that may be relevant to specific investors in light of their particular circumstances or to investors subject to special treatment under UK tax law. Potential investors should consult their own tax advisers concerning the overall tax consequences of acquiring, holding and disposing of our ordinary shares in their particular circumstances.

The Company

As previously stated, on January 12, 2016, we became centrally managed and controlled in the UK and therefore became resident in the UK for UK taxation purposes.

Accordingly, since that date, we are subject to UK taxation on our income and gains, except where an exemption applies. Dividend income will generally be exempt from UK corporation tax on income if certain conditions are met.

We may be treated as a dual resident company for UK tax purposes. As a result, our right to claim certain reliefs from UK tax may be restricted, and changes in law or practice in the UK could result in the imposition of further restrictions on our right to claim UK tax reliefs.

Shareholders

Sale, Exchange or Other Taxable Disposition of Ordinary Shares

Subject to their individual circumstances, shareholders who are resident in the UK for UK taxation purposes will potentially be liable to UK taxation, as further explained below, on any gains which accrue to them on a sale or other disposition of their ordinary shares which constitutes a “disposal” for UK taxation purposes.

A shareholder who is not resident in the UK for UK tax purposes will not generally be subject to UK tax on chargeable gains on a disposal of ordinary shares unless such a shareholder carries on a trade, profession or vocation in the UK through a branch or agency or, in the case of a corporate shareholder, a permanent establishment. For shareholders in such circumstances, a gain on a disposal of our ordinary shares may be subject to UK taxation.

An individual shareholder who acquires ordinary shares while UK resident, who temporarily ceases to be UK resident or becomes resident in a territory outside the UK for the purposes of double taxation relief arrangements, and who disposes of our ordinary shares during that period of temporary non-UK residence, may on his or her return to the UK be liable to UK capital gains tax on any chargeable gain realized on that disposal.

For an individual shareholder within the charge to capital gains tax, a disposal of ordinary shares may give rise to a chargeable gain or allowable loss for the purposes of UK capital gains tax. The rate of capital gains tax is 10% for individuals who are subject to income tax at the basic rate and 20% to the extent that an individual shareholder’s chargeable gains, when aggregated with his or her income chargeable to income tax, exceeds the basic rate band for income tax purposes. However, an individual shareholder is entitled to realize £12,300 of gains (the annual exempt amount) in the UK tax year ended April 5, 2021, without being liable to tax.

84

For a shareholder within the charge to UK corporation tax, a disposal (or deemed disposal) of ordinary shares may give rise to a chargeable gain or allowable loss for the purposes of UK corporation tax. Corporation tax is charged on chargeable gains at the rate applicable to that company, subject to any available exemption or relief. Indexation allowance may reduce the amount of chargeable gain that is subject to corporation tax (but may not give rise to or increase an allowable loss). No indexation allowance is available in respect of any period of ownership falling after December 2017.

Dividends on Ordinary Shares

No UK tax will be withheld or deducted at source from dividends paid by us on our ordinary shares.

Shareholders who are resident in the UK for tax purposes may, subject to their individual circumstances, be liable to UK income tax or, as the case may be, UK corporation tax on dividends paid to them by us.

The UK Government has introduced an annual dividend tax allowance per tax year. For the year ended April 5, 2021, it is £2,000. If and to the extent that an individual shareholder who is subject to UK income tax receives dividends in each tax year which, in aggregate, do not exceed that allowance, the individual will not be liable to UK income tax on those dividends. If and to the extent that an individual shareholder who is subject to UK income tax receives dividends in each tax year which, in aggregate, exceed that allowance, the individual will be subject to UK income tax on those dividends at the rate of 7.5% (in the case of basic rate taxpayers), 32.5% (in the case of higher rate taxpayers) and 38.1% (in the case of additional rate taxpayers), and the individual will not be entitled to any tax credit in respect of those dividends.

Shareholders who are within the charge to UK corporation tax are generally likely to be exempt from corporation tax on dividends they receive from us, provided the dividends fall within an exempt class and certain conditions are met.

Stamp duty/stamp duty reserve tax

(i) Issue of Ordinary Shares

No UK stamp duty or stamp duty reserve tax will be payable on the issue of ordinary shares.

(ii) Transfers of Ordinary Shares

UK stamp duty will in principle be payable on any instrument of transfer of our ordinary shares that is executed in the UK or that relates to any property situated, or to any matter or thing done or to be done, in the UK. An exemption from stamp duty is available on an instrument transferring ordinary shares where the amount or value of the consideration is £1,000 or less and it is certified on the instrument that the transaction effected by the instrument does not form part of a larger transaction or series of transactions in respect of which the aggregate amount or value of the consideration exceeds £1,000. Shareholders should be aware that, even where an instrument of transfer is in principle subject to stamp duty, stamp duty is not required to be paid unless it is necessary to rely on the instrument for legal purposes, for example to register a change of ownership or in litigation in a UK court. An instrument of transfer need not be stamped in order for the British Virgin Islands register of ordinary shares to be updated, and the register is conclusive proof of legal ownership.

Provided that the ordinary shares are not registered in any register maintained in the UK by or on behalf of us and are not paired with any shares issued by a UK incorporated company, any agreement to transfer ordinary shares will not be subject to UK stamp duty reserve tax.

We currently do not intend that any register of our ordinary shares will be maintained in the UK.

F.    Dividends and Paying Agents

Not applicable.

G.    Statements by Experts

Not applicable.

85

H.    Documents on Display

Documents concerning us that are referred to herein may be inspected at our principal executive offices at: No. 1 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA. Those documents, which include our registration statements, periodic reports and other documents which were filed with the SEC, may be obtained electronically from the Investor section of our website at www.nomadfoods.com or from the SEC’s website at www.sec.gov. We do not incorporate the information contained on, or accessible through, our website into this annual report, and you should not consider it a part of this annual report.

I.    Subsidiary Information

Not applicable.

Item 11.    Quantitative and Qualitative Disclosures About Market Risk

We are exposed to certain market risks during the normal course of our business, such as risk arising from fluctuations in foreign currency exchange rates, as well as fluctuations in interest rates. In attempts to manage these risks, we employ certain strategies to mitigate the effect of these fluctuations. For a detailed discussion of these risks, see Note 33 “Financial risk management” to our audited consolidated financial statements which appear elsewhere in this annual report.

Item 12.    Description of Securities Other than Equity Securities

Not applicable.

Item 13.    Defaults, Dividend Arrearages and Delinquencies

None.

Item 14.    Material Modifications to the Rights of Security Holders and Use of Proceeds

None.

Use of Proceeds

None.

86

Item 15.    Controls and Procedures

Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d - 15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report in providing a reasonable level of assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods in SEC rules and forms, including providing a reasonable level of assurance that information required to be disclosed by us in such reports is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in internal control over financial reporting

During the period covered by this report, there have been no changes to our internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management’s annual report on internal control over financial reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets, (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of the Company’s management and directors, and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2021 using criteria described in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Based on this assessment, management concluded that the internal control over financial reporting was effective as of December 31, 2021 based on the criteria established in this Internal Control-Integrated Framework (2013).

On September 30, 2021, the Company completed the Fortenova Acquisition, whereby the Company acquired 9 additional wholly-owned subsidiaries. These are: Ledo Plus d.o.o, Ledo d.o.o. Čitluk, IRIDA d.o.o., Ledo Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság, Ledo d.o.o, Ledo d.o.o Podgorica, Ledo Sh.p.k, Industrija Smrznute Hrane Frikom Doo Beograd, and Frikom Beograd Dooel Cucer Sandevo. The Company is in the process of evaluating the existing controls and procedures in these subsidiaries and integrating them into the Company’s internal control over financial reporting. In accordance with SEC Staff guidance permitting a company to exclude an acquired business from management’s assessment of the effectiveness of internal control over financial reporting for the year in which the acquisition is completed, the Company has excluded this business from its assessment of the effectiveness of internal control over financial reporting as of December 31, 2021. The business acquired represented 3.9% of the Company’s total assets as of December 31, 2021 and 1.6% of the Company's revenues for the year ended December 31, 2021.

87

Attestation report of the independent registered public accounting firm

The effectiveness of the Company's internal control over financial reporting as of December 31, 2021 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears herein.

Item 16A.    Audit Committee Financial Expert

The board of directors has determined that Mr. Lillie qualifies as an audit committee financial expert as defined in Item 16A of Form 20-F, and that he is also “independent,” as defined in Rule 10A-3 under the Exchange Act and applicable NYSE standards. For more information about Mr. Lillie, see Item 6A: Directors, Senior Management and Employees - Executive Officers and Directors.

Item 16B.    Code of Ethics

We have adopted a Code of Ethics that applies to our Chief Executive Officer and all senior financial officers. The Code of Ethics is located on our Internet website at www.nomadfoods.com under "Investor Relations - Corporate Governance".

We intend to provide disclosure of any amendments or waivers of our Code of Ethics on our website within five business days following the date of the amendment or waiver.

Item 16C.    Principal Accountant Fees and Services

PricewaterhouseCoopers LLP (“PwC”) acted as our independent auditor for the years ended December 31, 2021 and 2020. The table below sets out the total amount billed to us by PwC, for services performed in the years ended December 31, 2021 and 2020, and breaks down these amounts by category of service: 

(€ in millions)	For the year ended December 31, 2021	For the year ended December 31, 2020
Audit fees	4.4	3.7
Audit-related fees	0.3	—
Tax fees	1.0	1.2
All other fees	0.1	0.1
Total	5.8	5.0

Audit Fees

Audit fees in the years ended December 31, 2021 and 2020 are related to the audit of our consolidated financial statements and other audit or interim review services provided in connection with statutory and regulatory filings or engagements.

Audit-Related Fees

Audit-related fees in the year ended December 31, 2021 are related to other assurance services on capital market transactions.

Tax Fees

Tax fees in the years ended December 31, 2021 and 2020 are related to tax compliance and other tax related services.

All Other Fees

Other fees in the years ended December 31, 2021 and 2020 relate to other non-audit assurance services.

88

Pre-Approval Policies and Procedures

The advance approval of the Audit Committee or members thereof, to whom approval authority has been delegated, is required for all audit and non-audit services provided by our auditors.

All services provided by our auditors are approved in advance by either the Audit Committee or members thereof, to whom authority has been delegated, in accordance with the Audit Committee’s pre-approval policy. No such services were approved pursuant to the procedures described in Rule 2-01(c)(7)(i)(C) of Regulation S-X, which waives the general requirement for pre-approval in certain circumstances.

Item 16D.    Exemptions from the Listing Standards for Audit Committees

None.

89

Item 16E.    Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The table below presents a summary of the ordinary shares repurchased by the Company in 2021:

Period	Total Number of Ordinary Shares Purchased	Average Price Paid per Ordinary Share (USD)	Total Number of Ordinary Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Approximate Value of Shares that may yet be purchased under the Plans or Programs in USD
$300m repurchase program1
As of December 31, 2020	11,913,682	21.04	11,913,682	$	49,364,929
January 1, 2021 – January 31, 2021	507,396	25.29	507,396	$	36,523,187
Total	12,421,078	24.62	12,421,078	$	—	2
$500m repurchase program3
October 1, 2021 – October 31, 2021	4,995	26.96	4,995	499,865,223
November 1, 2021 – November 30, 2021	499,942	24.24	504,937	487,737,834
December 1, 2021 – December 31, 2021	2,585,145	24.55	3,090,082	424,224,433
Total	3,090,082	24.50	3,090,082	$	424,224,433	4

Item 16F.    Change in Registrants’ Certifying Accountant

Not applicable.

1 On March 13, 2020, the Company announced a share repurchase program to purchase up to an aggregate of $300 million of the Company’s ordinary shares. Up until December 31, 2020, 11,913,682 had been repurchased with approximately $49 million remaining. Since December 31, 2020, the Company has repurchased shares worth $12.8 million before concluding the program.

2 The program has concluded.

3 On August 5, 2021, the Company announced its Board of Directors authorized a share repurchase program to purchase up to an aggregate $500 million of the Company's ordinary shares over 3 years. Acquisitions pursuant to the share repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions, at the Company's discretion, as permitted by securities laws and other legal requirements.

4 As of December 31, 2021, the maximum number of shares that may yet be purchased under the share repurchase program is approximately $424.2 million. Since December 31, 2021, the Company has repurchased shares worth $30.5 million.

90

Item 16G.    Corporate Governance

Comparison of Shareholder Rights

We are incorporated under, and are governed by, the laws of the British Virgin Islands. The following discussion summarizes material differences between the rights of holders of our ordinary shares and the rights of common shareholders of a typical corporation incorporated under the laws of the State of Delaware.

Director’s Fiduciary Duties

Under Delaware corporate law, a director of a solvent Delaware corporation owes fiduciary duties to the corporation and its shareholders. These duties have two components: the duty of care and the duty of loyalty. The duty of care requires that a director inform himself of all material information regarding a decision. The duty of loyalty requires that a director act in a manner he reasonably believes to be in the best interests of the corporation and its shareholders. A director must not use his corporate position for personal gain or advantage. The duty of loyalty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder that is not shared by the shareholders generally. In general, the “business judgment rule” presumes that actions of the board of directors are made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation and its shareholders. This presumption may be rebutted by evidence of a breach of the directors’ fiduciary duties. If this presumption is rebutted, the board of directors bear the burden of proving that the actions were “entirely fair” to the corporation or its minority shareholders. In addition, Delaware common law imposes “heightened” judicial scrutiny on actions of directors in certain circumstances, such as upon a sale of the corporation.

British Virgin Islands law provides that every director of a British Virgin Islands company in exercising his powers or performing his duties, shall act honestly and in good faith and in what the director believes to be in the best interests of the company. Additionally, the director shall exercise the care, diligence, and skill that a reasonable director would exercise in the same circumstances taking into account the nature of the company, the nature of the decision and the position of the director and his responsibilities. In addition, British Virgin Islands law provides that a director shall exercise his powers as a director for a proper purpose and shall not act, or agree to the company acting, in a manner that contravenes British Virgin Islands law or the memorandum and articles of association of the company.

Amendment of Governing Documents

Under Delaware corporate law, with very limited exceptions, a vote of the shareholders of a corporation is required to amend the certificate of incorporation. In addition, Delaware corporate law provides that shareholders have the right to amend the corporation’s bylaws, but the certificate of incorporation may also confer such right on the directors of the corporation.

Consent in Lieu of Meeting

Under Delaware corporate law, a consent in lieu of a meeting of the directors must be unanimous to take effect. Under British Virgin Islands law and our Memorandum and Articles, only a majority of the directors are required to sign a written consent.

Under Delaware corporate law, unless otherwise provided in the certificate of incorporation, any action to be taken at any annual or special meeting of shareholders of a corporation may be taken without a meeting by consent of the holders of outstanding stock having not less than the minimum number of votes that would be necessary to take that action at a meeting at which all shareholders entitled to vote were present and voted. If any shareholder action is taken by less than unanimous consent, notice of such action must be given to those shareholders who have not consented and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if the record date for notice of such meeting had been the date that consents signed by a sufficient number of shareholders were delivered to the corporation.

Our Memorandum and Articles provides that any shareholder action permitted to be taken at a shareholder meeting may also be taken by written consent of a majority of the votes of shares entitled to vote thereon. If any shareholder resolution is adopted otherwise than by the unanimous written consent of all shareholders, a copy of such resolution shall be sent to all shareholders not consenting to such resolution.

91

Shareholder Proposals

Under Delaware corporate law, a shareholder has the right to put any proposal before the annual meeting of shareholders, provided it complies with the relevant provisions (if any) in the corporation’s certificate of incorporation or bylaws. A meeting of shareholders may be called by the board of directors or any other person authorized to do so by the corporation’s certificate of incorporation or bylaws; shareholders may be precluded therein from calling special meetings. British Virgin Islands law and our Memorandum and Articles provide that our directors shall call a meeting of the shareholders if requested in writing to do so by shareholders entitled to exercise at least 30% of the voting rights in respect of the matter for which the meeting is requested.

Sale of Assets

Under Delaware corporate law, a vote of the shareholders is required to approve a sale, lease or exchange of property and assets of a corporation (including property and assets of its qualifying subsidiaries) only when all or substantially all of the corporation’s property and assets are being sold other than to a qualifying subsidiary of the corporation. Under British Virgin Islands law generally, shareholder approval is required when more than 50% of a company’s total assets by value are being disposed of or sold to any person if not made in the usual or regular course of the business carried out by the company. Under our Memorandum and Articles, this requirement of British Virgin Islands law has been disapplied and accordingly no shareholder approval is required in relation to such a disposal or sale.

Redemption of Shares

Under Delaware corporate law, by provision of the certificate of incorporation, any class or series of stock may be made subject to redemption by the corporation at its option, at the option of the holders of that stock or upon the happening of a specified event, provided that after such redemption shares of a class or series of stock with full voting power remain outstanding. The class or series of stock may, by provision of the certificate of incorporation, be made redeemable for cash, property or rights, as specified in the certificate of incorporation or in the resolution of the board of directors providing for the issue of the stock pursuant to the power expressly vested in the board of directors by the certificate of incorporation. Under Delaware corporate law, shares also may be repurchased with the consent of both the corporation and the holder, except that shares may not be repurchased for more than the price at which such shares may then be redeemed at the option of the corporation. Both the redemption and repurchase of shares of a Delaware corporation are subject to certain solvency limitations established by Delaware corporate law and Delaware common law. As permitted by British Virgin Islands law and our Memorandum and Articles, shares may be repurchased, redeemed or otherwise acquired by us. However, the consent of the shareholder whose shares are to be repurchased, redeemed or otherwise acquired must be obtained, except as specified in the terms of the applicable class or series of shares.

Squeeze-Out Merger

Under the Delaware General Corporation Law § 253, in a process known as a “short form” merger, a corporation that owns at least 90% of the outstanding shares of each class of voting stock of another corporation and where at least one of the corporations is a Delaware corporation and the laws of the jurisdiction of the other corporation don’t prohibit such action, may either merge the other corporation into itself or merge itself into the other corporation by executing, acknowledging and filing with the Delaware Secretary of State a certificate of ownership and merger setting forth a copy of the resolution of its board of directors authorizing such merger. If the parent corporation is a Delaware corporation that is not the surviving corporation, the merger also must be approved by a majority of the outstanding stock of the parent corporation entitled to vote thereon and the resolution must include provision for the pro rata issuance of stock of the surviving corporation to the holders of the stock of the parent corporation on surrender of any certificate therefor. If the parent corporation does not own all of the stock of the subsidiary corporation immediately prior to the merger, the minority shareholders of the subsidiary corporation party to the merger have appraisal rights as set forth in § 262 of the Delaware General Corporation Law.

Under the BVI Act, subject to any limitations in a company’s memorandum and articles of association, members holding 90% of the votes of the outstanding shares entitled to vote, and members holding 90% of the votes of the outstanding shares of each class of shares entitled to vote, may give a written instruction to the company directing the company to redeem the shares held by the remaining members. In our Memorandum and Articles, we have opted out of the BVI Act’s squeeze out provisions.

92

Variation of Rights of Shares

Under Delaware corporate law, a corporation may vary the rights of a class of stock with the approval of a majority of the outstanding shares entitled to vote thereon, and, in certain circumstances, including if such variation would change the rights of such class so as to affect them adversely, with the approval of a majority of the outstanding shares of such class, voting separately as a single class.

As permitted by British Virgin Islands law and our Memorandum and Articles, we may vary the rights attached to any class with the written consent of at least 50% of the holders of each class of shares affected or by a resolution passed by at least 50% of the votes cast by eligible holders of the issued shares of the affected class at a separate meeting of the holders of that class.

Election of Directors

Under Delaware corporate law generally, unless otherwise specified in the certificate of incorporation or bylaws of a corporation, directors are elected by a plurality of the votes of the shares entitled to vote on the election of directors and vacancies and newly created directorships resulting from an increase in the number of directors may be filled by a majority of the directors then in office (although less than a quorum) or by the sole remaining director. Subject to the BVI Act and pursuant to our Memorandum and Articles, directors shall be appointed at any time, and from time to time, by our directors, without the approval of shareholders, either to fill a vacancy or as an alternate or additional director. The shareholders may, by a majority vote, appoint any person as a director. In addition, for so long as an initial holder of Founder Preferred Shares holds 20% or more of the Founder Preferred Shares in issue, such holder is entitled to nominate, and the directors are required to appoint, a person as director. If such holder notifies the Company to remove any director nominated by him or her, the other directors shall remove such director, and the holder will have the right to nominate a director to fill the resulting vacancy. In the event an initial holder ceases to be a holder of Founder Preferred Shares or holds less than 20% of the Founder Preferred Shares in issue, such initial holder will no longer be entitled to nominate a person as a director, and the holders of a majority of the Founder Preferred Shares in issue will be entitled to exercise that initial holder’s former rights to appoint a director instead.

Removal of Directors

Under Delaware corporate law generally, a director of a corporation without a classified board may be removed, with or without cause, by the holders of a majority (or such larger portion set forth in the certificate of incorporation) of the outstanding shares entitled to vote at an election of directors. Under Delaware corporate law, generally a director of a corporation with a classified board may be removed only for cause with the approval of a majority (or such larger portion set forth in the certificate of incorporation) of the outstanding shares entitled to vote at an election of directors, unless the certificate of incorporation provides otherwise. Under Delaware corporate law, generally a director may resign at any time upon notice given in writing or by electronic transmission to the corporation.

Our Memorandum and Articles provide that a director may be removed at any time if: (i) he resigns by written notice to the Company; (ii) he is requested to resign by written notice of all of the other directors; (iii) he ceases to be a director by virtue of any provision of law or becomes prohibited by law from or is disqualified from being a director; (iv) he becomes bankrupt or makes any arrangement or composition with his creditors generally or otherwise has any judgment executed on any of his assets; (v) he becomes of unsound mind or incapable; (vi) he is absent from meetings of directors for a consecutive period of 12 months and the other directors resolve that his office shall be vacated; (vii) he dies; or (viii) a resolution of shareholders is approved by a majority of the shares entitled to vote on such matter passed at a meeting of shareholders called for the purposes of removing the director or for purposes including the removal of the director or a written special resolution of shareholders is passed by at least 75% of the votes of shares entitled to vote thereon.

93

Mergers

Under Delaware corporate law, one or more constituent corporations may merge into and become part of another constituent corporation in a process known as a merger. A Delaware corporation may merge with a foreign corporation as long as the law of the foreign jurisdiction permits such a merger. To effect a merger under Delaware General Corporation Law § 251, an agreement of merger must be properly adopted and the agreement of merger or a certificate of merger must be filed with the Delaware Secretary of State. In order to be properly adopted, the agreement of merger must be adopted by the board of directors of each constituent Delaware corporation by a resolution or unanimous consent in lieu of a meeting. In addition, the agreement of merger generally must be approved at a meeting of shareholders of each constituent Delaware corporation by a majority of the outstanding stock of such corporation entitled to vote, unless the certificate of incorporation provides for a supermajority vote. In general, the surviving corporation is vested in all of the assets and liabilities of the disappearing corporation or corporations as a result of the merger.

Under the BVI Act, two or more companies may merge or consolidate in accordance with the statutory provisions. A merger means the merging of two or more constituent companies into one of the constituent companies, and a consolidation means the uniting of two or more constituent companies into a new company. In order to merge or consolidate, the directors of each constituent company must approve a written plan of merger or consolidation, which must be authorized by a resolution of shareholders. One or more companies may also merge or consolidate with one or more companies incorporated under the laws of jurisdictions outside the British Virgin Islands if the merger or consolidation is permitted by the laws of the jurisdictions in which the companies incorporated outside the British Virgin Islands are incorporated. In respect of such a merger or consolidation, a British Virgin Islands company is required to comply with the provisions of the BVI Act, and a company incorporated outside the British Virgin Islands is required to comply with the laws of its jurisdiction of incorporation.

Shareholders not otherwise entitled to vote on the merger or consolidation may still acquire the right to vote if the plan of merger or consolidation contains any provision that, if proposed as an amendment to the memorandum and articles of association, would entitle them to vote as a class or series on the proposed amendment. In any event, all shareholders must be given a copy of the plan of merger or consolidation irrespective of whether they are entitled to vote at the meeting or consent to the written resolution to approve the plan of merger or consolidation.

Inspection of Books and Records

Under Delaware corporate law, any shareholder of a corporation may, upon proper demand, and for any proper purpose, inspect or make copies of the corporation’s stock ledger, list of shareholders and other books and records. Members of the public, on payment of the requisite fee, can obtain a copy of a Delaware corporation’s certificate of incorporation.

Under British Virgin Islands law, members of the general public, on payment of a nominal fee, can obtain copies of the public records of a company available at the office of the British Virgin Islands Registrar of Corporate Affairs, including the company’s certificate of incorporation, its memorandum and articles of association (with any amendments), records of license fees paid to date, any articles of dissolution, any articles of merger and a register of charges if the company has elected to file such a register.

A shareholder of a company is entitled, on giving written notice to the company, to inspect:

(a)the memorandum and articles of association;

(b)the register of members;

(c)the register of directors; and

(d)the minutes of meetings and resolutions of shareholders and of those classes of shares

                of which he is a shareholder.

In addition, a shareholder may make copies of or take extracts from the documents and records referred to in (a) through (d) above. However, subject to the memorandum and articles of association of the company, the directors may, if they are satisfied that it would be contrary to the company’s interests to allow a shareholder to inspect any document, or part of any document, specified in (b), (c) or (d) above, refuse to permit the shareholder to inspect the document or limit the inspection of the document, including limiting the making of copies or the taking of extracts from the records. Where a company fails or refuses to permit a shareholder to inspect a document or permits a shareholder to inspect a document subject to limitations, that shareholder may apply to the court for an order that he should be permitted to inspect the document or to inspect the document without limitation.

94

Where a company keeps a copy of the register of members or the register of directors at the office of its registered agent, it is required to notify the registered agent of any changes to the originals of such registers, in writing, within 15 days of any change; and to provide the registered agent with a written record of the physical address of the place or places at which the original register of members or the original register of directors is kept. Where the place at which the original register of members or the original register of directors is changed, the company is required to provide the registered agent with the physical address of the new location of the records within 14 days of the change of location.

A company is also required to keep at the office of its registered agent or at such other place or places, within or outside the British Virgin Islands, as the directors determine the minutes of meetings and resolutions of shareholders and of classes of shareholders, and the minutes of meetings and resolutions of directors and committees of directors. If such records are kept at a place other than at the office of the company’s registered agent, the company is required to provide the registered agent with a written record of the physical address of the place or places at which the records are kept and to notify the registered agent, within 14 days, of the physical address of any new location where such records may be kept. The Company’s registered agent in the British Virgin Islands is: Intertrust Corporate Services (BVI) Limited, Ritter House, Wickhams Cay II, Road Town, Tortola, British Virgin Islands.

Conflict of Interest

Under Delaware corporate law, a contract or transaction between a corporation and a director or officer, or between a corporation and any other organization in which a director or officer has a financial interest or is a director or officer, is not void or voidable as long as (i) the material facts as to the director’s or officer’s relationship or interest are disclosed or known and either (A) a majority of the disinterested directors authorizes the contract or transaction in good faith or (B) the shareholders vote in good faith to approve the contract or transaction or (ii) the contract or transaction is fair to the corporation when it is authorized, approved or ratified by the board of directors, a committee thereof or the shareholders. Delaware corporate law permits the corporation to renounce, in its certificate of incorporation or by action of its board of directors, any interest or expectancy of the corporation in, or in being offered an opportunity to participate in, specified business opportunities or specified classes or categories of business opportunities that are presented to the corporation or one or more of its officers, directors or stockholders.

The BVI Act provides that a director shall, forthwith after becoming aware that he is interested in a transaction entered into or to be entered into by the company, disclose that interest to the board of directors of the company. The failure of a director to disclose that interest does not affect the validity of a transaction entered into by the director or the company, so long as the director’s interest was disclosed to the board prior to the company’s entry into the transaction or was not required to be disclosed because the transaction is between the company and the director himself and is otherwise in the ordinary course of business and on usual terms and conditions. As permitted by British Virgin Islands law and our Memorandum and Articles, a director interested in a particular transaction may vote on it, attend meetings at which it is considered and sign documents on our behalf that relate to the transaction. In addition, if our directors have other fiduciary obligations, including to other companies on whose board of directors they presently sit and to other companies whose board of directors they may join in the future, to the extent that they identify business opportunities that may be suitable for us or other companies on whose board of directors they may sit, our directors are permitted to honor those pre-existing fiduciary obligations ahead of their obligations to us. Accordingly, they may refrain from presenting certain opportunities to us that come to their attention in the performance of their duties as directors of such other entities unless the other companies have declined to accept such opportunities or clearly lack the resources to take advantage of such opportunities.

Transactions with “Interested Stockholders”

Delaware corporate law contains a business combination statute applicable to Delaware public corporations whereby, unless the corporation has specifically elected not to be governed by that statute by appropriate action, it is prohibited from engaging in certain business combinations with an “interested stockholder” for three years following the date that the person becomes an “interested stockholder.” An “interested stockholder” generally is a person or group that owns or owned 15% or more of the company’s outstanding voting stock within the past three years. This statute has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the company in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which the shareholder becomes an “interested stockholder,” the board of directors approves either the business combination or the transaction that resulted in the person becoming an “interested stockholder.”

British Virgin Islands law has no comparable provision. However, although British Virgin Islands law does not regulate transactions between a company and its significant shareholders, it does provide that these transactions must be entered into in the bona fide best interests of the company and not with the effect of constituting a fraud on the minority shareholders.

95

Independent Directors

There are no provisions under Delaware corporate law or under the BVI Act that require a majority of our directors to be independent.

Cumulative Voting

Under Delaware corporate law, cumulative voting for elections of directors is not permitted unless the company’s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder’s voting power with respect to electing such director. There are no prohibitions on cumulative voting under the laws of the British Virgin Islands, but our Memorandum and Articles do not provide for cumulative voting.

Shareholders’ Rights under British Virgin Islands Law Generally

The BVI Act provides for certain remedies that may be available to shareholders. Where a company incorporated under the BVI Act or any of its directors engages in, or proposes to engage in, conduct that contravenes the BVI Act or the company’s memorandum and articles of association, British Virgin Islands courts can issue a restraining or compliance order. However, shareholders cannot also bring derivative, personal and representative actions under certain circumstances. The traditional English basis for shareholders’ remedies has also been incorporated into the BVI Act: where a shareholder of a company considers that the affairs of the company have been, are being or are likely to be conducted in a manner likely to be oppressive, unfairly discriminating or unfairly prejudicial to him, he may apply to the court for an order based on such conduct. In addition, any shareholder of a company may apply to the courts for the appointment of a liquidator of the company and the court may appoint a liquidator of the company if it is of the opinion that it is just and equitable to do so.

The BVI Act also provides that any shareholder of a company is entitled to payment of the fair value of his shares upon dissenting from any of the following: (i) a merger, if the company is a constituent company, unless the company is the surviving company and the shareholder continues to hold the same or similar shares; (ii) a consolidation, if the company is a constituent company; (iii) any sale, transfer, lease, exchange or other disposition of more than 50% in value of the assets or business of the company if not made in the usual or regular course of the business carried on by the company but not including (a) a disposition pursuant to an order of the court having jurisdiction in the matter, (b) a disposition for money on terms requiring all or substantially all net proceeds to be distributed to the shareholders in accordance with their respective interest within one year after the date of disposition, or (c) a transfer pursuant to the power of the directors to transfer assets for the protection thereof; (iv) a redemption of 10% or fewer of the issued shares of the company required by the holders of 90% or more of the shares of the company pursuant to the terms of the BVI Act; and (v) an arrangement, if permitted by the court.

Generally, any other claims against a company by its shareholders must be based on the general laws of contract or tort applicable in the British Virgin Islands or their individual rights as shareholders as established by a company’s memorandum and articles of association.

Foreign Private Issuer Exemption

As a “foreign private issuer,” as defined by the SEC, we are permitted to follow certain corporate governance practices of our home country, the British Virgin Islands, instead of those otherwise required under the NYSE for domestic issuers. While we voluntarily follow most NYSE corporate governance rules, we intend to take advantage of the following limited exemptions:

•Unlike NYSE corporate governance rules, under BVI law, there is no requirement that our board of directors consist of a majority of independent directors and our independent directors are not required to hold executive sessions. Currently, however only six out of our ten board members are independent based on NYSE independence standards. Also, while our board’s non-management directors will meet regularly in executive session without management, our board does not intend to hold an executive session of only independent directors at least once a year as called for by the NYSE.

96

•The NYSE rules applicable to domestic issuers require disclosure within four business days of any determination to grant a waiver of the code of business conduct and ethics to directors and officers. Although we will require board approval of any such waiver, we may choose not to disclose the waiver in the manner set forth in the NYSE rules, as permitted by the foreign private issuer exemption.

•We are exempt from the rules and regulations under the Exchange Act and NYSE related to the furnishing and content of proxy statements. Therefore, we intend to hold annual shareholder meetings in accordance with the corporate governance practices of the British Virgin Islands and our Memorandum and Articles of Association. Similarly, with respect to matters on which shareholders will have a right to vote, we intend to comply with corporate governance practices of the British Virgin Islands and the voting requirements under the NYSE rules applicable to foreign private issuers.

Item 16H.    Mine Safety Disclosure

None.

Item 17.    Financial Statements

Not Applicable.

97

Item 18.    Financial Statements

The following financial statements, together with the report of PricewaterhouseCoopers LLP thereon, are filed as part of this annual report:

NOMAD FOODS LIMITED AND SUBSIDIARIES

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

	Page
Report of Independent Registered Public Accounting Firm	F-1
Consolidated Statements of Financial Position	F-5
Consolidated Statements of Profit or Loss	F-6
Consolidated Statements of Comprehensive Income	F-7
Consolidated Statements of Changes in Equity	F-8
Consolidated Statements of Cash Flows	F-11
Notes to the Consolidated Financial Statements	F-12

98

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Nomad Foods Limited

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying Consolidated Statements of Financial Position of Nomad Foods Limited and its subsidiaries (the “Company”) as of December 31, 2021 and 2020, and the related Consolidated Statements of Profit or Loss, Consolidated Statements of Comprehensive Income, Consolidated Statements of Changes in Equity, and Consolidated Statements of Cash Flows for each of the three years in the period ended December 31, 2021, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board and International Financial Reporting Standards as adopted by the European Union. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Change in Accounting Principle

As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for hedge accounting in 2021.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control over Financial Reporting appearing under item 15. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

As described in Management’s Annual Report on Internal Control over Financial Reporting, management has excluded Ledo Plus d.o.o., Ledo d.o.o. Čitluk, IRIDA d.o.o., Ledo d.o.o., Ledo Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság, Ledo d.o.o. Podgorica, Ledo Sh.p.k, Industrija Smirznute Hrane Frikom Doo Beograd, and Frikom Beograd Dooel Cucer Sandevo (together known as “the Fortenova entities”) from its assessment of internal control over financial reporting as of December 31, 2021 because they were acquired by the Company in a purchase business combination during 2021. We have also excluded the Fortenova entities from our

F-1

audit of internal control over financial reporting. The Fortenova entities represent nine wholly-owned subsidiaries whose total assets and total revenues are excluded from management’s assessment and our audit of internal control over financial reporting represent 3.9% and, 1.6% respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2021.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and Directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Impairment assessment for goodwill on the Group’s cash generating units

As described in Note 3, 4 and 13 to the consolidated financial statements, the Company’s consolidated goodwill balance was €2,099.4 million at December 31, 2021. Management performs an annual review of the carrying amount of the goodwill to identify whether there is any impairment to these carrying values. Potential impairment is identified by comparing the value in use of the Frozen segment, being the level at which Goodwill is monitored, to its carrying value. Value in use is calculated as the net present value of the estimated risk adjusted cash flows of each cash generating unit. Estimating value in use requires various judgements and assumptions including estimating future revenue and profit margin growth rates, long-term growth rate and discount rate.

The principal considerations for our determination that performing procedures relating to the goodwill impairment assessment is a critical audit matter are that there is inherent estimation uncertainty requiring judgement by management when developing the value in use using the discounted cash flow model. This in turn led to a degree of auditor judgement, subjectivity, and effort in performing procedures and evaluating audit evidence obtained related to management’s cash flow forecasts and significant assumptions, including estimated revenue and profit margin growth rates, long-term growth rate and discount rate. In addition, the audit of the discount rate and long-term growth rate involved the use of professionals with expert skill and knowledge to assist in performing these procedures and evaluating the audit evidence obtained.

F-2

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill impairment assessment, including controls over the discounted cash flow model. These procedures also included, among others, testing management’s process for developing the value in use estimates; evaluating the appropriateness of the discounted cash flow model; testing the completeness, accuracy and relevance of underlying data used in the model; and evaluating the reasonableness of the significant assumptions used by management including the estimated revenue and profit margin growth rates, long-term growth rate and discount rate. Evaluating the reasonableness of management’s assumptions related to the Company’s cash flow forecasts involved evaluating whether the estimated revenue and profit margin growth rates were reasonable considering (i) the current and past performance of the Group, (ii) the consistency with external market and industry data, (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit and (iv) performing sensitivity analyses.

Uncertain tax positions

As described in Note 3, 4 and 11 to the consolidated financial statements, the Company operates in many different jurisdictions and in some of these certain tax matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments, appeals and refunds. Where tax exposures can be quantified, a provision is made based on management’s estimates and judgements with regard to the amounts expected to be paid to the relevant tax authority. As of December 31, 2021, the current tax payables of €198.5 million and deferred tax assets of €128.3 million included €163.4m million of provisions for tax uncertainties. As management has further disclosed, given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these accruals.

The principal considerations for our determination that performing procedures relating to uncertain tax positions is a critical audit matter are that there was significant judgement by management when determining uncertain tax positions, including a high degree of estimation uncertainty relative to the complexity of tax laws across various jurisdictions, frequency of tax audits, and potential for significant adjustments as a result of such audits. This in turn led to a high degree of auditor judgement, subjectivity, and effort in performing procedures to evaluate the timely identification and accurate measurement of uncertain tax positions. Also, the evaluation of audit evidence available to support the tax liabilities for uncertain tax positions was complex and required significant auditor judgement as the nature of the evidence is often highly subjective, and the audit effort involved the use of professionals with specialized skill and knowledge to assist in evaluating the audit evidence obtained.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the identification and recognition of the liability for uncertain tax positions, and controls addressing completeness of the uncertain tax positions, as well as controls over measurement of the liability. These procedures also included, among others, (i) testing the information used in the calculation of the liability for uncertain tax positions; (ii) testing the calculation of the liability for uncertain tax positions by jurisdiction, including management’s assessment of the technical merits of tax positions and estimates of the amount of tax benefit expected to be sustained; (iii) testing the completeness of management’s assessment of both the identification of uncertain tax positions and possible outcomes of each uncertain tax position; (iv) assessing whether the uncertain tax positions remain appropriate to recognise when considering the tax laws in the relevant jurisdiction; and (v) evaluating the status and results of income tax audits with the relevant tax authorities. Professionals with specialized skill and knowledge were used to assist in the evaluation of the completeness and measurement of the Company’s uncertain tax positions, including evaluating the reasonableness of management’s assessment of whether tax positions are more likely- than-not of being sustained and the amount of potential benefit to be realized, the application of relevant tax laws, and estimated interest and penalties.

Business acquisitions

As described in Note 14 to the consolidated financial statements, the Company completed the acquisition of the Fortenova Group’s Frozen Food Business Group (“Fortenova Acquisition”) on September 30, 2021 for consideration of €640.1 million and further completed the Purchase Price Allocation for this acquisition in the last quarter of 2021. In addition to this, the Purchase Price Allocation for Findus Switzerland, that had been acquired on 31 December 2020, was finalised in 2021. The Company recognised Goodwill of €192.6 million and €40.1 million and Intangible assets of €301.9 million and €66.1 million with regard to the Fortenova and Findus Switzerland acquisitions respectively. In both instances, as described in Notes 3 and 4 to the consolidated financial statements, the valuation methods required various judgements and assumptions including estimating future profitability and the expected useful economic lives of acquired intangible and tangible assets.

F-3

The principal considerations behind our determination that performing procedures relating to the acquisition accounting is a critical audit matter were a result of the significant judgements required by management in estimating the fair values and identifying the useful lives of the intangible assets at the acquisition date. This in turn led to a high degree of auditor judgement, subjectivity, and effort in performing procedures and evaluating audit evidence obtained related to management’s judgements. This included: cash flow forecasts, judgements on the assets’ useful economic lives, and significant assumptions, including estimated future profitability that are included in the valuation reports. In addition, the audit of the valuation models and of significant assumptions involved the use of professionals with expert skill and knowledge to assist in performing these procedures and evaluating the audit evidence obtained.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the acquisitions; reviewing the Sale and Purchase Agreements including any other supporting agreements that may enhance our understanding of key terms related to the acquisitions; reviewing the valuation reports and evaluating the appropriateness of the valuation models used by management with the support of our internal valuation experts; testing the completeness, accuracy and relevance of underlying data used in the models; and evaluating the reasonableness of the significant assumptions used by management.

/s/ PricewaterhouseCoopers LLP (Firm ID: 876)

London, United Kingdom

March 3, 2022

We have served as the Company’s or its predecessor's1 auditor since 2006.

1Nomad Foods Europe Holdings Limited (previously Iglo Foods Holdings Limited) and its subsidiaries

F-4

Consolidated Statements of Financial Position

		December 31, 2021	December 31, 2020 Restated (see note 14)
	Note	€m	€m
Non-current assets
Goodwill	13	2,099.4	1,902.5
Intangibles	13	2,455.7	2,155.7
Property, plant and equipment	12	549.4	422.2
Other non-current assets	18	8.9	1.1
Derivative financial instruments	34	—	17.2
Deferred tax assets	16	128.3	113.5
Total non-current assets		5,241.7	4,612.2
Current assets
Cash and cash equivalents	20	254.2	393.2
Inventories	17	410.6	344.3
Trade and other receivables	18	234.6	185.0
Indemnification assets	19	9.5	15.4
Short-term investments	34	—	25.0
Derivative financial instruments	34	20.2	5.5
Total current assets		929.1	968.4
Total assets		6,170.8	5,580.6
Current liabilities
Trade and other payables	22	692.0	647.2
Current tax payable		198.5	166.2
Provisions	24	39.3	45.7
Loans and borrowings	21	29.1	22.5
Derivative financial instruments	34	7.3	35.5
Total current liabilities		966.2	917.1
Non-current liabilities
Loans and borrowings	21	2,198.3	1,736.3
Employee benefits	23	244.2	276.2
Other non-current liabilities	22	1.8	2.2
Provisions	24	2.9	6.1
Derivative financial instruments	34	20.8	89.5
Deferred tax liabilities	16	437.6	427.1
Total non-current liabilities		2,905.6	2,537.4
Total liabilities		3,871.8	3,454.5
Net assets		2,299.0	2,126.1
Equity
Share capital and capital reserve	25	1,623.1	1,620.5
Share-based compensation reserve	26	6.9	8.3
Founder Preferred Shares Dividend Reserve	27	166.0	245.5
Translation reserve	28	105.1	84.7
Other reserves	29	10.5	(24.5)
Retained earnings		387.4	191.6
Total equity		2,299.0	2,126.1

The accompanying notes are an integral part of these consolidated financial statements.

F-5

Consolidated Statements of Profit or Loss

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Revenue	5	2,606.6	2,515.9	2,324.3
Cost of sales		(1,862.3)	(1,753.4)	(1,626.4)
Gross profit		744.3	762.5	697.9
Other operating expenses		(356.3)	(382.7)	(359.9)
Exceptional items	7	(45.3)	(20.6)	(54.5)
Operating profit	6	342.7	359.2	283.5
Finance income	10	0.1	4.7	2.5
Finance costs	10	(106.1)	(68.4)	(75.7)
Net financing costs		(106.0)	(63.7)	(73.2)
Profit before tax		236.7	295.5	210.3
Taxation	11	(55.7)	(70.4)	(56.7)
Profit for the period		181.0	225.1	153.6
Attributable to:
Equity owners of the parent		181.0	225.2	154
Non-controlling interests		—	(0.1)	(0.4)
		181.0	225.1	153.6
Earnings per share:
Basic earnings per share	30	€1.02	€1.16	€0.80
Diluted earnings per share	30	€1.02	€1.14	€0.78

The accompanying notes are an integral part of these consolidated financial statements.

F-6

Consolidated Statements of Comprehensive Income

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Profit for the period		181.0	225.1	153.6
Other comprehensive income/(loss):
Actuarial gains/(losses) on defined benefit pension plans	23	36.1	(27.8)	(35.9)
Taxation (charge)/credit on remeasurement of defined benefit pension plans	11	(10.2)	8.3	6.7
Items not reclassified to the Consolidated Statement of Profit or Loss		25.9	(19.5)	(29.2)
Gain/(loss) on investment in foreign subsidiary, net of hedge		18.8	(10.1)	6.0
Effective portion of changes in fair value of cash flow hedges	29	22.6	(17.3)	(27.3)
Taxation (charge)/credit relating to components of other comprehensive income	11	(13.6)	6.0	5.6
Items that may be subsequently reclassified to the Consolidated Statement of Profit or Loss		27.8	(21.4)	(15.7)
Other comprehensive income/(loss) for the period, net of tax		53.7	(40.9)	(44.9)
Total comprehensive income for the period		234.7	184.2	108.7
Attributable to:
Equity owners of the parent		234.7	184.3	109.1
Non-controlling interests		—	(0.1)	(0.4)
		234.7	184.2	108.7

The accompanying notes are an integral part of these consolidated financial statements.

F-7

Consolidated Statements of Changes in Equity

		Share capital and capital reserve	Share-based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Other reserves*	Accumulated deficit reserve	Equity attributable to owners of the parent	Non-controlling interests	Total Equity
	Note	€m	€m	€m	€m	€m	€m	€m	€m	€m
Balance at January 1, 2019		1,748.5	9.4	372.6	88.8	8.5	(167.9)	2,059.9	(0.8)	2,059.1
Change in accounting policy (IFRS 16)		—	—	—	—	—	31.3	31.3	—	31.3
Restated Equity as at January 1, 2019		1,748.5	9.4	372.6	88.8	8.5	(136.6)	2,091.2	(0.8)	2,090.4
Profit/(loss) for the year		—	—	—	—	—	154.0	154.0	(0.4)	153.6
Other comprehensive income/(loss) for the year		—	—	—	6.0	(21.7)	(29.2)	(44.9)	—	(44.9)
Total comprehensive income/(loss) for the year		—	—	—	6.0	(21.7)	124.8	109.1	(0.4)	108.7
Founder Preferred Shares Annual Dividend Amount	27	2.5	—	(2.5)	—	—	—	—	—	—
Vesting of Non-Executive Restricted Stock award	8	—	(0.8)	—	—	—	—	(0.8)	—	(0.8)
Issue of ordinary shares	25	355.5	(1.3)	—	—	—	—	354.2	—	354.2
Listing and share transaction costs	25	(11.1)	—	—	—	—	—	(11.1)	—	(11.1)
Share based payment charge	8	—	14.9	—	—	—	—	14.9	—	14.9
Reclassification of awards for settlement of tax liabilities	26	—	0.4	—	—	—	—	0.4	—	0.4
Total transactions with owners, recognized directly in equity		346.9	13.2	(2.5)	—	—	—	357.6	—	357.6
Balance as of December 31, 2019		2,095.4	22.6	370.1	94.8	(13.2)	(11.8)	2,557.9	(1.2)	2,556.7

* As detailed in Note 2, on the adoption of IFRS 9 for hedge accounting on January 1, 2021, the cash flow hedge reserve and newly created 'cost of hedging reserve' were combined in the Statement of Financial Position into 'Other reserves'. The cash flow hedge reserve presented in prior periods has been renamed to conform to the current name in the Statement of Financial Position.

F-8

Consolidated Statements of Changes in Equity (Continued)

		Share capital and capital reserve	Share-based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Other reserves*	(Accumulated deficit reserve)/ Retained earnings	Equity attributable to owners of the parent	Non-controlling interests	Total Equity
	Note	€m	€m	€m	€m	€m	€m	€m	€m	€m
Balance at January 1, 2020		2,095.4	22.6	370.1	94.8	(13.2)	(11.8)	2,557.9	(1.2)	2,556.7
Profit/(loss) for the year		—	—	—	—	—	225.2	225.2	(0.1)	225.1
Other comprehensive income/(loss) for the period		—	—	—	(10.1)	(11.3)	(19.5)	(40.9)	—	(40.9)
Total comprehensive income/(loss) for the period		—	—	—	(10.1)	(11.3)	205.7	184.3	(0.1)	184.2
Founder Preferred Shares Annual Dividend Amount	27	124.6	—	(124.6)	—	—	—	—	—	—
Vesting of Non-Executive Restricted Stock award	8	0.7	(0.7)	—	—	—	—	—	—	—
Issue of ordinary shares	25	8.4	(7.9)	—	—	—	—	0.5	—	0.5
Repurchase of ordinary shares	25	(608.6)	—	—	—	—	—	(608.6)	—	(608.6)
Share based payment charge	8	—	9.0	—	—	—	—	9.0	—	9.0
Reclassification of awards for settlement of tax liabilities	26	—	(14.7)	—	—	—	—	(14.7)	—	(14.7)
Non-controlling interests extinguished on acquisition of subsidiary		—	—	—	—	—	(2.3)	(2.3)	1.3	(1.0)
Total transactions with owners, recognized directly in equity		(474.9)	(14.3)	(124.6)	—	—	(2.3)	(616.1)	1.3	(614.8)
Balance as of December 31, 2020		1,620.5	8.3	245.5	84.7	(24.5)	191.6	2,126.1	—	2,126.1

* As detailed in Note 2, on the adoption of IFRS 9 for hedge accounting on January 1, 2021, the cash flow hedge reserve and newly created 'cost of hedging reserve' were combined in the Statement of Financial Position into 'Other reserves'. The cash flow hedge reserve presented in prior periods has been renamed to conform to the current name in the Statement of Financial Position.

F-9

Consolidated Statements of Changes in Equity (continued)

		Share capital and capital reserve	Share-based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Other reserves *	Retained earnings	Total Equity
	Note	€m	€m	€m	€m	€m	€m	€m
Balance at December 31, 2020		1,620.5	8.3	245.5	84.7	(24.5)	191.6	2,126.1
Adjustment on adoption of hedge accounting under IFRS 9	2	—	—	—	1.6	(1.6)	—	—
Balance at January 1, 2021		1,620.5	8.3	245.5	86.3	(26.1)	191.6	2,126.1
Profit for the year		—	—	—	—	—	181.0	181.0
Other comprehensive profit for the year		—	—	—	18.8	9.0	25.9	53.7
Total comprehensive income for the year		—	—	—	18.8	9.0	206.9	234.7
Deferred hedging gains transferred to the carrying value of inventory		—	—	—	—	27.6	—	27.6
Transactions with owners, recognized directly in equity
Founder Preferred Shares Annual Dividend Amount	27	79.5	—	(79.5)	—	—	—	—
Vesting of Non-Executive Restricted Stock award	8	0.6	(0.6)	—	—	—	—	—
Issue of ordinary shares	25	0.1	(0.1)	—	—	—	—	—
Repurchase of ordinary shares	25	(77.6)	—	—	—	—	—	(77.6)
Share based payment charge	8	—	5.1	—	—	—	—	5.1
Reclassification of awards for settlement of tax liabilities	26	—	(5.8)	—	—	—	(11.1)	(16.9)
Total transactions with owners, recognized directly in equity		2.6	(1.4)	(79.5)	—	—	(11.1)	(89.4)
Balance as of December 31, 2021		1,623.1	6.9	166.0	105.1	10.5	387.4	2,299.0

* A cost of hedging reserve has arisen on adoption of hedge accounting under IFRS 9. This reserve and cash flow hedge reserve have been combined into 'Other Reserves'. See Note 2 for further details.

The accompanying notes are an integral part of these consolidated financial statements.

F-10

Consolidated Statements of Cash Flows

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Cash generated from operations before tax and exceptional items	32	450.3	552.0	376.9
Cash flows relating to exceptional items		(48.8)	(12.1)	(15.9)
Tax paid		(95.2)	(82.9)	(45.6)
Net cash flows from operating activities		306.3	457.0	315.4
Cash flows from investing activities
Business combinations, net of cash acquired	14	(597.3)	(112.9)	(1.5)
Purchase of property, plant and equipment and intangibles		(79.2)	(58.7)	(47.3)
Purchase of investments		—	(25.0)	(25.0)
Redemption of investments		16.5	25.2	—
Net cash used in investing activities		(660.0)	(171.4)	(73.8)
Cash flows from financing activities
Proceeds from issuance of Ordinary Shares	25	—	0.6	354.1
Share issuance costs	25	—	—	(11.1)
Repurchase of Ordinary Shares	25	(77.6)	(608.6)	—
Payments related to shares withheld for tax	26	(22.6)	(19.2)	—
Proceeds from new loans and notes		800.0	—	2.0
Repayment of loan principal		(408.7)	(11.7)	(22.2)
Payment of lease liabilities		(19.4)	(20.3)	(21.8)
Payment of financing fees		(18.7)	—	—
Interest paid		(36.7)	(50.2)	(48.4)
Interest received		0.1	0.7	2.4
Other financing cash flows		(2.0)	(6.1)	(3.6)
Net cash provided by/(used in) financing activities		214.4	(714.8)	251.4
Net (decrease)/increase in cash and cash equivalents		(139.3)	(429.2)	493.0
Cash and cash equivalents at beginning of period	20	382.5	824.8	327.6
Effect of exchange rate fluctuations		11.0	(13.1)	4.2
Cash and cash equivalents at end of period	20	254.2	382.5	824.8

The accompanying notes are an integral part of these consolidated financial statements.

F-11

Notes to the Consolidated Financial Statements

1)General information

Nomad Foods Limited (the “Company” or “Nomad”) was incorporated in the British Virgin Islands on April 1, 2014. The address of Nomad’s registered office is Ritter House, Wickhams Cay II, Road Town, Tortola, VG1110 British Virgin. The Company is domiciled for tax in the United Kingdom.

Nomad Foods Limited (NYSE: NOMD) is Europe's leading frozen foods company. Nomad Foods Limited's (the “Company” or “Nomad”) portfolio of iconic brands, which includes Birds Eye, Findus, iglo, Ledo and Frikom, have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.

2)Basis of preparation

The consolidated financial statements of Nomad and its subsidiaries (the “Company” or “Nomad”) have been prepared in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board. These consolidated financial statements are also in accordance with International Financial Reporting Standards as adopted by the European Union.

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as current economic conditions in light of the COVID-19 pandemic. Actual results could differ from these estimates. In preparing cash flow forecasts, management consider severe but plausible downside scenarios taking into consideration the Company's key risks, including the impacts of the COVID-19 pandemic. Having considered these risks in their assessment, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these financial statements.

Adoption of new accounting standards - IFRS 9 'Financial Instruments'

IFRS 9 ‘Financial Instruments’ was issued in July 2014 and replaced IAS 39 ‘Financial Instruments: Recognition and Measurement.’ The Company had previously elected to continue hedge accounting under IAS 39 as was allowed by the standard. On January 1, 2021, the Company adopted hedge accounting under IFRS 9, as the hedge accounting requirements have been simplified and are more closely aligned to the Company's risk management strategy. Under IFRS 9 all existing hedging relationships qualified as continuing hedging relationships.

The Company applied IFRS 9 hedge accounting prospectively, "except for application of the cost of hedging approach". The Company has elected the cost of hedging approach for the fair value movement of all hedging instruments, whereby the movements will be recognized within equity, to the extent that they relate to the hedged item. As permitted by the standard, adjustments required as a result of adopting the cost of hedging approach, have been made to the opening Consolidated Statement of Changes in Equity. As such, prior year comparatives have not been restated. A summary of adjustments arising from application of IFRS 9 for hedge accounting as of January 1, 2021 are as follows:

	Opening Balance January 1, 2021 (IAS 39) €m	Impact of change in policy €m	Opening Balance January 1, 2021 (IFRS 9) €m
Cash flow hedge reserve	(24.5)	2.8	(21.7)
Cost of hedging reserve	—	(4.4)	(4.4)
Other reserves	(24.5)	(1.6)	(26.1)
Translation reserve	84.7	1.6	86.3

The Company's policy is to reduce its risk of foreign exchange movements on forecasted transactions (such as purchases of raw materials) in currencies other than the operating entity's functional currency using forward foreign exchange contracts designated as cash flow hedges. Under IFRS 9, in cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow

F-12

hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The Company has elected to apply this accounting policy prospectively and therefore as at January 1, 2021 any existing hedges of non-financial items (such as inventory) that were already recognized in the Consolidated Statement of Financial Position, did not result in an opening balance transfer out of equity to the non-financial item as a result of the transition to IFRS 9. For the year ended December 31, 2021, €27.6 million was recognized as deferred hedging gains transferred to the carrying value of inventory. This is not a reclassification adjustment and will not be recognized in the Consolidated Statement of Other Comprehensive Income for the period.

Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 – Interest Rate Benchmark Reform (Phase 2)

In August 2020, the IASB issued Interest Rate Benchmark Reform (Phase 2), which amends other IFRS standards. The amendments provide temporary reliefs which address the financial reporting effects when an interbank offered rate (IBOR) is replaced with an alternative nearly risk-free interest rate (RFR). The amendments in this final phase relate to practical expedient for particular changes in contractual cash flows, relief from specific hedge accounting requirements and certain disclosure requirement.

On June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing revolving credit facility of €80.0 million and replace it with a new €175.0 million facility, paying interest rate applicable to the respective drawn down currency. Per the restated Senior Facilities Agreement, the Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately if there is a drawdown on the facility. The Secured Overnight Financing Rate (“SOFR”) will replace USD LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR, when existing benchmark rates are replaced and borrowings are requested under the Facility.

Equally, on June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. There is currently no indication of the timing of the phase-out of EURIBOR. The Company continues to assess changes in underlying markets and expects to be able to refinance its Senior EUR Loan once replacement reference rates become confirmed.

The existing senior USD loan of $916.4 million (the "Senior USD Loan") paying interest at a rate per annum equal to LIBOR (subject to a zero floor) plus 2.25% per annum has not been refinanced during 2021. The Company uses cross currency interest rate swaps to convert cash flows payable under the Senior USD Loan into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. The USD LIBOR phase out is expected to be completed by June 2023, and therefore in due course the Company will need to renegotiate the terms of our Senior Facilities Agreement with our lenders and amend the terms of linked interest rate hedging arrangements. Such an amendment is expected to be able to be achieved without material financial impact on the Company.

The Amendments are effective for annual periods beginning on or after January 1, 2021. Phase 2 amendments will require the Company to account for a change in the basis for determining the cash flows of a financial asset or a financial liability measured at amortized cost, by updating the effective interest rates as required by IBOR reform. Management continues to assess implications as a result of these amendments on the wider business. These amendments had no impact on the financial statements of the Company for the year ended December 31, 2021. The Company intends to use the practical expedients in future periods as they become applicable.

Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS

Amendments to IAS 12 - Deferred Tax related to Assets and Liabilities arising from a Single Transaction

In May 2021, the International Accounting Standards Board issued targeted amendments to IAS 12, Income Taxes. The amendments are effective for annual periods beginning on or after January 1, 2023, although earlier application is permitted. With a view to reducing diversity in reporting, the amendments will clarify that companies are required to recognize deferred taxes on transactions where both assets and liabilities are recognized, such as with leases and asset retirement (decommissioning) obligations. Based upon our current facts and circumstances, we do not expect our financial performance or disclosure to be materially affected by the application of the amended standard.

Other

The consolidated financial statements and notes are presented in the reporting currency of millions of Euros. All financial information has been rounded to the nearest €0.1 million, except where otherwise indicated.

F-13

The consolidated financial statements were approved for issuance by the Board of Directors of Nomad Foods Limited on March 2, 2022. The Directors have, at the time of approving the financial statements, a reasonable expectation that Nomad has adequate resources to continue in operational existence for the foreseeable future given the cash funds available and the current forecast cash outflows. Thus, Nomad continues to adopt the going concern basis of accounting in preparing the financial statements.

3)    Accounting policies

The accounting policies set out below have, unless otherwise stated, been applied consistently. Judgments made by the Directors in the application of these accounting policies that have a significant effect on the financial statements and key sources of estimation uncertainty are discussed in Note 4.

3.1    Measurement convention

The financial statements are prepared on the historical cost basis with the exception of derivative financial instruments, business combinations, share based payments, and founder preferred shares which are stated at fair value.

3.2    Business combination

The Company uses the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred and the equity interest issued by the Company. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred.

Non-controlling interests arise from business combinations in which the Company acquires less than a 100 per cent interest. Non-controlling interests are initially measured at either fair value or at the non-controlling interest’s proportionate share of the fair value of the acquiree’s identifiable net assets. Nomad determines on a transaction by transaction basis which measurement method is used.

The excess of the consideration transferred, the amount of any non-controlling interests in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree over the fair value of the identifiable net assets is recorded as goodwill.

Where selling shareholders have contractually agreed to indemnify Nomad Foods Limited for contingent liabilities, an indemnification asset is recognized equivalent to the fair value of the liability recognized by Nomad. The indemnification asset is deducted from consideration transferred for the business combination. The indemnification asset value will subsequently be revised where revisions are made to the value of the liability or where there are doubts over the ability to recover losses from the selling shareholders.

3.3    Basis of consolidation

The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions, and any unrealized income and expenses arising from intra-group transactions are eliminated. Accounting policies are applied consistently across the Company.

Subsidiaries are all entities (including structured entities) over which Nomad has control; directly or indirectly. The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases.

Where the Company owns less than a 100 per cent interest in a subsidiary, a non-controlling interest is recognized. The carrying amount of non-controlling interests is increased or decreased by the non-controlling interest’s share of subsequent changes in equity and payments to the non-controlling interest. Total comprehensive income is attributed to the non-controlling interests even if this results in the non-controlling interests having a negative balance.

F-14

3.4    Foreign currency

i)    Foreign currency transactions

Transactions in foreign currencies (currencies other than the functional currency of the transacting entity) are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the foreign exchange rate ruling the financial year end. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are generally recognized in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges, qualifying net investment hedges or are attributable to part of a net investment in a foreign operation.

Non-monetary assets and liabilities in a foreign currency are translated into the functional currency to establish historical cost, using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated at foreign exchange rates ruling at the date the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss.

The revenues and expenses of foreign operations are translated at an average rate for the period (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transaction).

ii)    Assets and liabilities of foreign operations

For the purposes of presenting consolidated financial statements, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated at foreign exchange rates ruling at the financial year ended December 31, 2021 of £1:€1.19 (December 31, 2020: £1:€1.11). The revenues and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rates ruling at the dates of the transactions. The average rate used for year ended December 31, 2021 is £1:€1.16 (year ended December 31, 2020: £1:€1.13, year ended December 31, 2019: £1:€1.14).

Foreign exchange gains and losses that relate to these assets and liabilities are presented in the Consolidated Statement of Profit or Loss within ‘finance income or costs’, except where hedge accounting applies.

iii)    Net investment in foreign operations

Exchange differences arising from the translation of foreign operations and of any related qualifying hedges are taken directly to the translation reserve within equity. They are realized through the Consolidated Statement of Profit or Loss upon disposal of the related foreign operation.

3.5    Goodwill

Goodwill represents amounts arising on acquisition of subsidiaries. Goodwill is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired.

Goodwill is stated at cost less any accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

Goodwill is not monitored below the operating segment. Goodwill is not amortized but is tested annually for impairment. 

F-15

3.6    Other intangible assets

Intangible assets acquired separately are recorded at cost and those acquired as part of a business combination are recorded at fair value as at the date of acquisition.

i)    Computer software

Capitalized software costs include the cost of acquired computer software licenses and costs that are directly associated with the design, construction and testing of such software where this relates to a major business system. Costs associated with identifying, sourcing, evaluating or maintaining computer software are recognized as an expense within other operating expenses as incurred.

The assets are stated at cost less accumulated amortization and impairment losses. Software costs are amortized by equal monthly installments over their estimated useful economic life of five to ten years once the software is capable of being brought into use.

ii)    Brands

Our largest brands, including Birds Eye, Iglo, Findus, Ledo and Frikom are considered to have indefinite lives. This is based on the market position of the brands, the significant levels of investment in advertising and promoting the brands, and the fact that they have been established for at least 20 years. Therefore these brands are not amortized, but instead held at historical cost less provision for any impairment.

Brands that are deemed to not have an indefinite life are being amortized by equal monthly installments within other operating expenses over the course of their remaining useful economic life.

iii)    Customer relationships

Long standing Food Service customer relationships have been identified as intangible assets as part of business combinations. These are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over their expected lives. The most significant of these assets were acquired as part of the Findus Acquisition in 2015 and are being amortized over 14 years.

3.7    Impairment of non-current assets

The carrying amounts of the Company’s non-current assets are reviewed annually to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated. Impairment losses are recognized in the Consolidated Statement of Profit or Loss in the period in which they arise. For goodwill and assets that have an indefinite useful life an impairment review is performed at least annually.

Assets that are subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the net carrying amount may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount.

i)    Calculation of recoverable amount

Recoverable amount is the greater of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows of the business are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

F-16

ii)    Allocation of impairment losses

Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating units, then to reduce the carrying amount of the other assets in the unit on a pro rata basis. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

iii)    Reversals of impairment

An impairment loss in respect of goodwill is not reversed. In respect of other assets, an impairment loss is reversed when there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

3.8    Property, plant and equipment

i)    Owned assets

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use.

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

ii)    Leased assets

The Company leases various properties, equipment and cars. The Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

Where a contract contains both lease and non-lease components, the Group has elected to account for the contract as a single lease.

Leases are recognized as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the group. Each lease payment is allocated between the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The right-of-use asset is classified within property, plant and equipment and is depreciated over the shorter of the asset's useful life or the lease term on a straight-line basis.

Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities are presented within loans and borrowings and include the net present value of expected lease payments, including those from extension options if the Company reasonably expects to exercise them. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be determined, otherwise the Company’s incremental borrowing rate is used. Right-of-use assets are measured at cost comprising the amount of the lease liability, adjusted for payments made or received before the commencement date, initial direct costs and restoration costs.

Payments associated with short-term leases and leases of low-value assets are recognized on a straight-line basis as an expense in profit or loss. Short-term leases are leases with a lease term of 12 months or less. Low-value assets primarily comprise IT equipment and small items of office furniture.

F-17

iii)    Depreciation

Depreciation is charged to the Consolidated Statement of Profit or Loss on a straight line basis over the shorter of the lease term and the estimated useful lives of each part of an item of property, plant and equipment once the item is brought into use. Land is not depreciated. The estimated useful lives are as follows:

•Buildings 40 years

•Plant and equipment 5 to 14 years

•Computer equipment 3 to 5 years

The assets’ residual values and useful lives are reviewed on a frequent basis.

3.9    Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average principle and includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Inventories that are acquired through business combinations are fair valued at the time of acquisition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of direct costs and overheads based on normal operating capacity. Provision is made for slow moving, obsolete and defective inventories.

3.10    Employee benefits

i)    Defined contribution plans

Obligations for contributions to defined contribution pension plans are recognized as an expense in the Consolidated Statement of Profit or Loss as incurred. Prepaid contributions are recognized as an asset to the extent that a cash refund or reduction in the future payments is available.

ii)    Defined benefit plans

The Company’s net obligation in respect of defined benefit pension plans and other post-employment benefits is calculated separately for each plan by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. That net obligation is discounted to determine its present value. The calculation is performed by a qualified actuary using the projected unit credit method.

The current service cost of the defined benefit plan, recognized in the Consolidated Statement of Profit or Loss in staff costs included within Operating profit/(loss), except where included in the cost of an asset, reflects the increase in the defined benefit obligation resulting from employee service in the current year, benefit changes, curtailments and settlements.

Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in Other Comprehensive Income in the period in which they arise.

The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the Consolidated Statement of Profit or Loss.

Past service cost is recognized immediately.

iii)    Share-based payment schemes

Employee benefits given through share-based payment schemes are discussed further in section 3.15 of this note.

F-18

3.11    Founder Preferred Shares

Nomad Foods issued Founder Preferred Shares to both TOMS Acquisition I LLC and Mariposa Acquisition II, LLC (collectively the “Founder Entities”) in connection with its initial public offering in April 2014. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Dividend Amount”). The instrument and its component parts were analyzed under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015, of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.

3.12    Provisions

Provisions are recognized when the Company has a legal or constructive present obligation as a result of a past event and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors’ best estimate of the expenditure required to settle the obligation at the financial year end date and are discounted to present value where the effect is material.

Where it is not possible to make a reliable estimate of the estimated financial effect of a provision, appropriate disclosure of the resulting contingent liability is made, but no provision is recognized.

3.13    Financial instruments

Financial assets and liabilities are recognized in the Company’s Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument.

i)    Trade receivables

Trade receivables are amounts due from customers for goods sold when control of the products has transferred, being when the products are delivered in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. The Company holds the trade receivables with the objective of collecting the contractual cash flows and so they are subsequently measured at amortized cost using the effective interest method, less any loss allowance. Since trade receivables are due within one year, this equates to initial carrying value less any loss allowance.

To assist in managing operating cash flow, we may enter into non-recourse factoring arrangements with certain receivables whereby we sell specific account receivables to one or more external financial institutions. The risks and rewards of ownership are considered to have been transferred at the point of sale. Up to the point of sale, these receivables are treated as held for sale and measured at fair value through Profit or Loss. Under the terms of the contractual arrangements, the Company may continue to collect the cash from the customer receivables sold, albeit acting solely as a collecting agent on behalf of the purchaser of receivables. Any cash received from customers which is due to be paid to the agent is presented as a financial liability in the Statement of Financial Position and as a financing activity within the Statement of Cash Flows. Factoring fees associated with the sale of factored receivables were minimal for all periods presented. See Note 18.

The Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables. Trade receivables are grouped by days past due. Expected loss rates are based on historical credit losses experienced in each market as well as forward looking information where this is significant. Trade receivables are written off when there is no reasonable expectation of recovery. Appropriate allowances for expected credit losses and estimated irrecoverable amounts are recognized in the Consolidated Statement of Profit or Loss.

F-19

Trade receivables are presented net of associated contract liabilities, referred to as 'trade terms' as discussed further in Note 3.14 and Note 4.

ii)    Cash and cash equivalents

Cash and cash equivalents comprise of cash balances and deposits that are readily convertible to a known amount of cash and are measured at amortized cost. Deposits held in money market funds are measured at fair value through Profit or Loss as the cash flows do not only represent principal and interest.

iii)    Loans and borrowings

a.    Valuation

Interest bearing borrowings are recognized initially at fair value less attributable transaction costs.

Subsequent to initial recognition, interest bearing loans and borrowings are stated at amortized cost with any difference between cost and redemption value being recognized in the Consolidated Statement of Profit or Loss over the expected period of the borrowings.

b.    Capitalization of transaction costs

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

iv)    Trade payables

Trade payables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method. Since trade payables are largely due within one year, this equates to initial carrying value.

v)    Derivative financial instruments and hedge accounting

Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge accounting relationship, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company has elected the cost of hedging approach for the fair value movement on currency basis spreads of all hedging relationships, whereby the movements will be recognized within equity, if material, to the extent that they relate to the hedged item. In cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition.

The fair value of all financial derivative instruments (including but not limited to forward foreign exchange contracts, currency swaps and cross currency interest rates swaps), is determined per market standard using forward foreign exchange and interest rates at the balance sheet date, with the resulting value discounted back to present value.

F-20

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company applies the hedge accounting requirements of IFRS 9 to all hedging relationships. IAS 39 was beforehand with the impact of the changes disclosed in Note 2 Basis of preparation.

a.    Cash flow hedges

Where a derivative financial instrument is designated as a hedge of the cash flow of a recognized asset or liability, (including a highly probable forecast transaction) the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve, within other reserves. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss.

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, if the result of a forecasted transaction is recognition of a non-financial asset (for example inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve (presented together as 'Other reserves') are included in the initial cost of the non-financial item upon its recognition. For all other hedged forecasted transactions, the amounts accumulated in the hedging reserve and cost of hedging reserve are reclassified to the Consolidated Statement of Profit or Loss in the same period, or periods, in which the hedged forecasted future cash flows affect the Consolidated Statement of Profit or Loss.

When a hedging instrument expires or is sold, exercised or otherwise terminated, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately.

When a hedging instrument is substantially modified, any fair value gain or loss is recognized immediately in the Consolidated Statement of Profit or Loss.

b.    Net investment hedges

Foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income to the extent that the hedge is effective, and are presented in the translation reserve within equity. 

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the change in fair value of the future price element of the hedging instrument (‘forward element’) is not included as part of the hedging relationships and is recognized in the Consolidated Statement of Profit or Loss immediately.

F-21

To the extent that any net investment hedge is entered into and the hedge is deemed effective, any foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal.

vi)    Short-term investments

The Company may invest surplus cash positions in short-term investments to manage liquidity and credit risk. Short‐term investments are held within managed investment funds and are measured at fair value with all changes in fair value are recognized immediately in the Consolidated Statement of Profit or Loss.

Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data.

3.14    Revenue from contracts with customers

The Company manufactures and sells a range of frozen foods to retail, wholesale and Food Service markets. Revenue is recognized when control of the products has transferred, being when the products are delivered to the customer in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. A provision for product return allowances, which is estimated based upon the Company’s historical performance and management’s experience, is recorded as a reduction of sales in the same period that the revenue is recognized. Revenue excludes sales taxes and intra-company sales.

Products are often sold with variable pricing arrangements, including payment discounts, trade promotions and slotting fees. Discounts given by the Company include rebates, price reductions and incentives to customers, promotional couponing and trade communication costs. Trade promotions consist of pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. Certain retailers require the payment of slotting fees to obtain space for the Company’s products on the retailers’ store shelves.

Where variable pricing arrangements are in place, revenue is only recognized to the extent that it is highly probable that the amount recognized is unlikely to be reversed. Accumulated experience is used to estimate and provide for the discounts. Revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. Accruals for expected pay-outs under these programs are collectively known as ‘trade terms’ and are included within trade and other receivables or within trade and other payables in the Consolidated Statement of Financial Position. No element of financing is deemed present as the sales are made in line with market practice and accruals are typically settled within twelve months of the sale.

3.15    Share based payments

The Nomad Foods Long-term Incentive Plan known as the (the "Management Share Awards"), which incorporates an annual Non-Executive Directors Restricted Stock Scheme, falls within the provisions of IFRS 2 “Share-based Payment” and awards under the Management Share Awards represent equity settled share based payments. A charge is taken to the Consolidated Statement of Profit or Loss for the difference between the fair value of the shares at grant date and the amount subscribed, spread over the vesting period.

Share based payment arrangements in which Nomad receives goods or services as consideration for its own equity instruments are accounted for as equity-settled share based payment transactions, regardless of how the equity instruments are obtained by Nomad.

F-22

The grant date fair value of share-based payment awards granted to any Director or employee is recognized as an expense, with a corresponding increase in equity, over the period that any Director or employee becomes unconditionally entitled to the awards.

The fair value of the awards granted is measured using a valuation model, taking into account the terms and conditions upon which the awards were granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.

See Note 8(b) for further information on the Company’s share-based payment arrangements and details of the valuation model used.

3.16    Interest income

Interest income is recognized in the Consolidated Statement of Profit or Loss on an accruals basis using the effective interest method.

3.17    Expenses & Exceptional items

i)    Borrowing costs

Unless capitalized as part of the cost of borrowing (see Note 3.13(iii)), borrowing costs are recognized in the Consolidated Statement of Profit or Loss in the period in which they are incurred.

ii)    Exceptional items

The separate reporting of exceptional items which are presented as exceptional within the relevant Consolidated Statement of Profit or Loss category, helps provide an indication of the Company’s underlying business performance. Exceptional items have been identified and presented by virtue of their size, nature or incidence. In determining whether an event or transaction is exceptional, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence. Exceptional items comprise restructuring costs, impairments or reversal of impairments of intangible assets, operational restructuring, integration and acquisition costs relating to new acquisitions, implementation of strategic opportunities and other significant items (see Note 7).

iii)    Research and development

Expenditure on research activities is recognized in the Consolidated Statement of Profit or Loss as an expense as incurred.

3.18    Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognized in the Consolidated Statement of Profit and Loss except to the extent that it relates to items recognized in Other Comprehensive Income, in which case it is recognized within the Statement of Other Comprehensive Income.

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the financial year end date, and any adjustment to tax payable in respect of previous years. Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on the best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals.

F-23

Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts used for taxation purposes on an undiscounted basis. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial year end date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized.

3.19    Segment reporting

The Chief Operating Decision Maker (“CODM”) has been determined to be the Chief Executive Officer as he is primarily responsible for the allocation of resources to the segments and the assessment of performance of the segments.

Nomad’s operations are organized into one operating unit, "Frozen", which comprises all the brands, as well as the factories, private label business units and certain corporate overheads. The CODM primarily uses “Adjusted EBITDA”, disclosed in Note 5, as the key measure of the segment’s results. Adjusted EBITDA is EBITDA adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

EBITDA, disclosed in Note 5, is defined as profit/(loss) for the period before taxation, net financing costs, depreciation and amortization.

3.20    Onerous contracts provisions

Where the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

3.21    IFRSs not yet adopted

At the date of authorization of these financial statements, except as disclosed in Note 2, there are no Standards and Interpretations relevant to the Company which are in issue but not yet effective.

4)     Critical accounting estimates and judgments

The preparation of financial statements in accordance with IFRS requires the use of judgment in applying the accounting policies and estimation that affect the reported amounts of assets and liabilities and results. Actual results could differ from those estimates and the financial statements will be impacted by key judgments taken.

Key Judgments

Judgments are made in the process of applying accounting policies. Those judgments which are considered key are listed below.

F-24

a)        Business Combinations

For business combinations that have a significant effect on the amounts reported in the consolidated financial statements. The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified, the useful economic life of assets and in selecting an appropriate valuation methodology. Furthermore, judgment is applied in allocating business combinations to operating segments, as well as allocating Goodwill to cash generating units. Please refer to Note 14 for details of business combinations in the period.

b)        Discounts and trade promotions

Management use judgment when considering when accruals for discounts and trade promotions can be released. Management makes the judgment based on the principle that accruals are reversed only to the extent that it is highly probable that a significant reversal will not occur.

c)        Uncertain tax positions

Management use judgment when determining whether it is appropriate to accrue for uncertain tax positions and for how long accruals for uncertain tax positions are retained. Management considers tax laws which are in place in making that assessment determining whether it is appropriate to release.

d)        Cash generating units

When performing goodwill impairment testing, management apply judgment to the allocation of goodwill to cash generating units. Management has determined goodwill is monitored at the operating segment level of “Frozen”. Please refer to Note 13 for further information.

e)        Operating segments

Management apply judgment in determining the Chief Operating Decision Maker (“CODM”), and the nature and extent of the financial information which is reviewed by the CODM. Management have considered how resources are allocated in determining the single reporting and operating segment of “Frozen”. Please refer to Note 5 for further information.

Significant estimates

Information about estimates and assumptions that have significant effects on the amounts reported in the consolidated financial statements are listed below. Management have taken into account the impact and potential future impact of COVID-19 on these estimates. We will continue to assess the impact of future developments in relation to COVID-19 as it relates to estimates, especially around the carrying value of goodwill, brands and other intangibles, as well as on property, plant and equipment. In particular, we will focus on the long-term impact on the food service customer relationship intangible assets.

a)        Discounts and trade promotions

Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has bespoke agreements that are governed by a combination of observable and unobservable performance conditions.

Trade promotions comprise of amounts paid to retailers for programs designed to promote Company products and include pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The estimated ultimate cost of the program is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends.

F-25

At each financial year end date, any discount or trade promotion incurred but not yet invoiced is estimated and accrued for. In certain cases, the estimate for discounts and trade promotions requires the use of forecast information for future trading periods and therefore a degree of estimation uncertainty exists. These estimates are sensitive to variances between actual results and forecasts. The estimate is based on accumulated experience.

The accruals are presented as ‘trade terms’ and offset against trade receivables due to the same customer, or as trade term payables where there is no receivable to be offset. The balance of the reduction in trade receivables for trade terms as of December 31, 2021 is disclosed in Note 18 and the balance classified as a trade term payable is disclosed in Note 22.

b)        Business combinations

The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable estimation in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following estimates and assumptions can materially affect our financial position and profit:

•The fair value and expected useful economic life of acquired intangible and tangible assets that are subject to depreciation or amortization in future periods.

•Future changes to the assumptions over forecast future profitability used in estimating the value of intangible assets and goodwill may result in additional expenses or income.

•Future changes to the assumptions used in estimating the value of uncertain tax positions may result in additional expenses or income.

Please refer to Note 14 for details of business combinations in the period.

c)        Carrying value of goodwill and brands

Determining whether goodwill and brands are impaired requires an estimation of the value in use of the cash generating unit to which goodwill and brands have been allocated. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. Future cash flows for the purposes of the value in use calculation are taken from approved budgets. Details of impairment reviews including disclosures covering sensitivities are provided in Note 13.

d)        Employee benefit obligation

The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each scheme has an actuarial valuation performed by a specialist third party and is dependent on a series of assumptions which are estimated by management. See Note 23 for details of these assumptions and a sensitivity analysis on material assumptions.

e)        Uncertain tax positions

Where tax exposures can be quantified, an accrual for uncertain tax positions is based on the Group's judgment of the most likely amount of the liability expected to be paid to the relevant tax authority; or, when there is a wide range of possible outcomes, a probability weighted average approach. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these accruals. The factors considered in estimating the accrual include the progress of discussions with the tax authorities, the complexity of respective tax legislation, valuations of assets for tax purposes and the level of documentary support for historical positions taken by previous owners. The accruals are made on the basis of a weighted average of potential outcomes.

F-26

f)        Fair value of derivative financial instruments.

Note 34 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations. These inputs may be readily observable, market corroborated, or generally unobservable inputs and are further discussed in Note 34.

5)    Segment reporting

Nomad has one reporting and operating segment, "Frozen", reflected in the segment presentation below for the periods presented. The CODM primarily uses “Adjusted EBITDA”, disclosed in Note 3.19, as the key measure of the segment’s results, which is considered non-IFRS financial information.

Segment Adjusted EBITDA

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Profit for the period		181.0	225.1	153.6
Taxation		55.7	70.4	56.7
Net financing costs		106.0	63.7	73.2
Depreciation and amortization		71.6	67.6	68.3
Acquisition purchase price adjustments		8.4	—	—
Exceptional items	7	45.3	20.6	54.5
Other add-backs		18.7	19.4	25.7
Adjusted EBITDA		486.7	466.8	432.0

Acquisition purchase price adjustments relate to the reversal of the non-cash increase applied to inventory acquired in business combinations to value it at fair value as opposed to cost.

Other add-backs include the elimination of share-based payment expense and related employer payroll expense of €5.8 million (2020: €12.1 million, 2019: €22.4 million) and elimination of non-operating M&A related costs, professional fees and transaction costs of €12.9 million (2020: €7.3 million, 2019: €3.3 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

No information on segment assets or liabilities is presented to the CODM.

Product information

Management considers the products it sells belong to one category, being "Frozen".

F-27

Geographical information

External revenue by geography

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
United Kingdom	758.3	747.3	712.5
Italy	417.9	426.3	394.1
Germany	396.3	393.2	329.6
France	188.6	203.8	176.6
Sweden	148.1	158.7	175.7
Austria	129.3	127.9	108.2
Norway	121.7	115.6	120.4
Spain	75.1	82.6	79.5
Rest of Europe	371.3	260.5	227.7
Total external revenue by geography	2,606.6	2,515.9	2,324.3

Non-current assets by geography

	December 31, 2021	December 31, 2020
	€m	€m
Germany	140.0	135.5
United Kingdom	139.6	132.1
Italy	64.8	68.5
Serbia	48.5	—
Croatia	38.5	—
Ireland	34.3	31.9
Norway	31.0	30.0
Sweden	29.8	28.5
Rest of Europe	72.3	52.7
Total non-current assets by geography	598.8	479.2

Non-current assets exclude deferred tax assets, goodwill and brands which are not bound to one geographical area.

6)    Operating profit

Operating profit is stated after charging:

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Staff costs	8	340.6	340.2	308.6
Depreciation of property, plant and equipment	12	63.4	59.8	59.7
Impairment of property, plant and equipment	12	—	—	0.1
Impairment of software and brands	13	1.7	—	—
Amortization of software and brands	13	8.2	7.8	8.6
Operating lease charges		6.1	3.0	4.5
Exchange losses/(gains)		27.0	(2.8)	(14.6)
Research & development expenditure		19.2	17.6	18.9
Inventories recognized as an expense within cost of goods sold		1,694.3	1,627.9	1,536.0

F-28

7)    Exceptional items

Exceptional items are made up as follows:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Supply chain reconfiguration (1)	—	(12.5)	(3.6)
Findus Group integration costs (2)	—	—	3.5
Fortenova Acquisition integration costs (3)	3.5	—	—
Findus Switzerland integration costs (4)	6.2	0.3	—
Brexit (5)	5.3	1.6	1.6
Business Transformation program (6)	18.8	2.3	—
Information Technology Transformation program (7)	4.2	—	—
Goodfella's Pizza & Aunt Bessie's integration costs (8)	—	4.0	12.5
Factory optimization (9)	4.9	10.0	5.7
Settlement of legacy matters (10)	(2.6)	(2.9)	(9.2)
Release of indemnification assets (11)	5.0	17.8	44.0
Total exceptional items	45.3	20.6	54.5

We do not consider these items to be indicative of our ongoing operating performance.

(1)Supply chain reconfiguration

Supply chain reconfiguration relates to activities associated with the closure of the Bjuv manufacturing facility in Sweden which ceased production in 2017. No income has been recognized in the year ended December 31, 2021 (2020: €12.5 million, 2019: €3.6 million).

In 2020, the Company signed an agreement to end its leasehold of a cold store in Sweden in 2021, which was originally due to expire in 2040. The cold store will continue to be used by the Company under a service contract once the lease has come to an end. The agreement resulted in a significant modification of a right-of-use asset and reduction in lease liabilities. The carrying value of the right-of-use asset had previously been impaired such that its value was significantly lower than that of the liabilities extinguished. Consequently, the Company recognized a gain from the transaction. As part of the transaction, the Company has become liable to fulfill certain severance arrangements in 2021 which have been provided for, the cost of which offsets a portion of the income from the modification of the lease.

In 2019, the income related to the sale of the agricultural land and the finalization of consideration received for the sale of the industrial property, which had completed in 2018.

(2)Findus Group integration costs

Following the acquisition of the Findus Group on November 2, 2015, the Company initiated a substantial integration project. Expenses presented primarily relate to the roll-out of the Nomad ERP system which completed in 2019.

(3)Fortenova Acquisition integration costs

As disclosed in Note 14, the Company completed the acquisition of the Fortenova Group’s Frozen Food Business Group on September 30, 2021, following which the Company is undertaking an integration project over the next three years. Integration expenses incurred relate to external consultancy costs, organizational structure alignment to Nomad design, systems configuration and roll-out of our controls environment to the acquired business.

F-29

(4)Findus Switzerland integration costs

As disclosed in Note 14, the Company completed the acquisition of Findus Switzerland on December 31, 2020, following which the Company commenced an integration project which is expected to complete in 2022. Integration expenses incurred and to be incurred in the future relate to external consultancy costs, organizational structure alignment to Nomad design and roll-out of the Nomad ERP system.

(5)Brexit

As part of the process of the United Kingdom exiting the European Union, commonly referred to as Brexit, the Company has incurred expenses to prepare for, and respond to, changes impacting our supply chain. Whilst an agreement with the EU was reached on December 24, 2020, border control processes remain in a period of transition. Expenses in 2021 relate to project costs and the write-off of system development costs no longer required due to changes in regulations and the Company's approach to handling Brexit-related logistic issues.

(6)Business transformation program

In 2020, the Company launched the first phase of a multi-year, enterprise-wide transformation and optimization program. Over the next few years, additional transformation phases will be implemented. The program aims to standardize, simplify and automate end-to-end business processes. This will enable key decision making and analytical capability, building a platform and organization to support future growth and provide better value for shareholders. Execution of the business transformation program will include the evaluation and implementation of a new ERP system.

Expenses in the year consist of restructuring and transformational project costs, including business technology transformation initiative costs and related professional fees.

(7)Information Technology Transformation program

In 2021, the Company launched a program to transform the Information Technology (“IT”) operating model, specifically to modernize the end-to-end technology estate to support current and future complex and evolving business needs driven by acquisitions and organic growth. Among the many changes being made, the program moves our operating model to a cloud-hosted solution, which better deploys new services to the business and end user, including application management, supporting a diverse workforce across multiple locations and languages, as well as deploying artificial Intelligence assisted tools. Other key components of the program include the Company’s cyber security services to adapt to rapidly changing threats and a change of IT service partners to enable one-off renovation and uplift of capabilities across the business.

(8)Goodfella's Pizza & Aunt Bessie's integration costs

Following the acquisition of the Goodfella’s pizza business in April 2018 and the Aunt Bessie's business in July 2018, the Company completed an integration project which finished in 2020.

F-30

(9)Factory optimization

In 2018, the Company initiated a three-year factory optimization program. The focus of the program is to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. The program is expected to provide a number of benefits, including an optimized supply chain infrastructure, benefits derived from the implementation of a standardized global manufacturing and planning processes, and an increased level of sustainable performance improvement. Due to delays in delivering the program across the Nomad manufacturing portfolio due to various government lockdowns and travel bans, the project has been extended for an additional year.

(10)Settlement of legacy matters

A net income of €2.6 million has been recognized associated with the release of acquired provisions relating to periods prior to acquisition by the Company. Net income of €2.9 million was recognized in the year ended December 31, 2020 associated with the release of acquired tax liabilities relating to periods prior to acquisition by the Company. Net income of €9.2 million was recognized in the year ended December 31, 2019. This includes an income of €2.7 million recognized on settlement of contingent consideration for the La Cocinera acquisition and net income of €0.7 million associated with settlements of tax audits.

(11)Release of indemnification assets

The charges for the release of indemnification assets relates to the partial release of shares held in escrow associated with the acquisition of the Findus Group in 2015, as discussed in Note 19.

Tax impact of exceptional items

The tax impact of the exceptional items amounts to a credit of €8.4 million in the year ended December 31, 2021 (year ended December 31, 2020: €3.5 million, year ended December 31, 2019: €3.1 million).

Cash flow impact of exceptional items

Included in the Consolidated Statements of Cash Flows for the year ended December 31, 2021 is €48.8 million (year ended December 31, 2020: €12.1 million, year ended December 31, 2019: €15.9 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items as well as the cash impact of the settlement of provisions brought forward from previous accounting periods.

8)    Payroll costs, share based payments and management incentive schemes

(a)Payroll costs

The average number of persons employed by the Company (excluding non-Executive Directors) is analyzed and set out below:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Production	3,310	3,043	3,308
Administration, distribution & sales	2,193	1,647	1,448
Total number of employees	5,503	4,690	4,756

The increase in the average number of employees in the table above for the year ended December 31, 2021 compared with the year ended December 31, 2020 is primarily due to the Fortenova Acquisition and Findus Switzerland acquisition as described in Note 14.

F-31

The table below discloses the Company’s aggregate payroll costs of these persons. Payroll costs exclude long term management incentive scheme and share based payment costs, but includes bonus costs.

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Wages and salaries	266.4	276.4	250.4
Social security costs	56.1	49.2	45.2
Other pension costs	18.1	14.6	13.0
Total payroll costs	340.6	340.2	308.6

(b)Share based payments

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares.

Non-Executive Director Restricted Share Awards

In accordance with the Board approved independent Non-Executive Director compensation guidelines, each independent Non-Executive Director is entitled to a grant of $100,000 of restricted shares annually on the date of the annual general meeting, valued at the closing market price for such shares on this date. The restricted shares vest on the earlier of twelve months from the date of grant or the date of the Company’s next annual meeting of shareholders.

The Non-Executive Directors restricted share awards granted on June 19, 2018, which consisted of 32,172 shares at a share price of $18.07, vested on June 14, 2019 and were issued at a share price of $20.74, resulting in a €0.1 million increase in the share based compensation reserve. Of the total 44,272 number of shares vesting, 12,100 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

The Non-Executive Directors restricted share awards granted on June 14, 2019, which consisted of 39,370 shares at a share price of $20.32. In July 2019, in conjunction with the resignation of one of our Non-Executive Directors, 2,460 shares from this grant were vested and issued. The remaining awards vested on June 17, 2020 and were issued at a share price of $21.78. Of the total 34,447 number of shares vesting, 8,656 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

The Non-Executive Directors restricted share awards granted on June 17, 2020, which consisted of 32,140 shares at a share price of $21.78, vested on June 30, 2021 and were issued at a share price of $30.14, resulting in a €0.2 million increase in the share based compensation reserve. Of the total 32,140 number of shares vesting, 7,734 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

On June 30, 2021, after the Company's annual general meeting of shareholders, the current Non-Executive Directors were granted 24,759 restricted share award at a share price of $28.27.

The total charge for Non-Executive Director grants within the Statement of Consolidated Profit or Loss for the year ended December 31, 2021 for stock compensation awards was €0.8 million (year ended December 31, 2020: €0.7 million; year ended December 31, 2019: €0.9 million).

F-32

Director and Senior Management Share Awards

As part of its long term incentive initiatives, the Company has outstanding awards over 2,016,855 ordinary shares granted to certain members of its management team (the “Management Share Awards”) as of the following four award dates:

	January 1, 2016 Award	January 1, 2017 Award	January 1, 2018 Award	January 1, 2019 Award	January 1, 2020 Award	January 1, 2021 Award	Total
Number of awards outstanding at January 1, 2021	1,041,953	819,873	446,575	159,561	710,438	—	3,178,400
New awards granted in the period	—	—	—	—	—	820,202	820,202
Awards vested and issued in the period	(1,041,953)	(819,873)	—	—	—	—	(1,861,826)
Forfeitures in the period	—	—	(14,785)	(6,866)	(65,345)	(32,925)	(119,921)
Number of awards outstanding at December 31, 2021	—	—	431,790	152,695	645,093	787,277	2,016,855

The 2018 award has vesting conditions based on cumulative EBITDA performance over four years and Company share price performance over two years to five years. During 2021, the Compensation Committee of the Board of Directors amended the non-market condition targets for this award due to recent acquisitions, which did not increase its incremental fair value. The share price and EBITDA performance conditions for the 2018 award are weighted 50% each per performance target.

•For the 2018 award, for the share price target, the initial two-year period was through to January 1, 2020 and the subsequent three-year period is through to January 1, 2023. For the four-year cumulative EBITDA Performance Condition, if satisfied, will vest on January 1, 2022.

For the 2019, 2020 and 2021 awards, those grants have vesting conditions based on cumulative EBITDA performance, cumulative Net Sales and Company share price performance over three years. During 2021, the Compensation Committee of the Board of Directors amended the non-market condition targets for these awards due to recent acquisitions, which did not increase their incremental fair value. In addition, the 2020 award had a holding period of one-year that has been removed from the vesting period. The 2021 award was issued late in 2021 with a performance period starting January 1, 2021.

In September 2019, 166,427 restricted share awards were granted as part of the 2019 Management Share Award. The performance period associated with the award began as of January 1, 2019. The 2019 awards have vesting conditions based on three-year cumulative EBITDA and net sales, and Company share price performance measures. One third of the total share award is assigned to each type of performance measure. All shares are subject to a holding period of an additional year and require that the participants to the scheme are still actively employed during the entire four year period, through January 1, 2023.

In January 2020, 761,979 restricted share awards were granted as part of the 2020 Management Share Award. The performance period associated with the award began on January 1, 2020. The Share awards will vest on the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and share price performance measures over a three-year period. The cumulative EBITDA and Cumulative Net Sales tranches of shares are equally weighted, being worth 37.5% of the total award each. The Company Share Price Tranche is worth 25% of the total award. All shares vest, subject to satisfaction of the award conditions, on January 1, 2023.

F-33

In late 2021, 820,202 restricted share awards were granted as part of the 2021 Management Share Award. The performance period associated with the award began on January 1, 2021. The Share awards will vest on the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and Company share price performance measures over a three-year period. The cumulative EBITDA and Cumulative Net Sales tranches of shares are equally weighted, being worth 37.5% of the total award each. The Share Price Tranche is worth 25% of the total award. All shares vest, subject to satisfaction of the award conditions, on January 1, 2024.

In January 2019, 85,315 restricted shares granted as part of the 2017 Management Share Awards vested based on share price performance, resulting in the issuance of 51,932 ordinary shares (net of 33,383 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In January 2020, 284,555 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $22.37), resulting in the issuance of 163,816 ordinary shares to participants in the LTIP (net of 120,739 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In February 2020, 1,626,006 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $19.53), resulting in the issuance of 928,042 ordinary shares to participants in the LTIP (net of 697,964 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In September 2020, 42,825 restricted shares granted as part of the 2018 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.30). Due to the timing of the vesting, the resulting issuance of 25,655 ordinary shares to participants in the LTIP (net of 17,170 ordinary shares held back from issue by the

Company as settlement towards personal tax liabilities arising on the vested ordinary shares) occurred in October 2020.

In January 2021, 1,041,953 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.42), resulting in the issuance of 587,633 ordinary shares to participants in the LTIP (net of 454,320 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In January 2021, 368,154 restricted shares granted as part of the 2017 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.42), resulting in the issuance of 217,228 ordinary shares to participants in the LTIP (net of 150,926 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In February 2021, 451,719 restricted shares granted as part of the 2017 Management Share Awards vested as a result of the satisfaction of the applicable EBITDA Performance Condition (based on a share price of $25.89 at time of vesting), resulting in the issuance of 271,451 ordinary shares to participants in the LTIP (net of 180,268 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

The stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year ended December 31, 2021 related to the director and senior management share awards is €4.3 million (year ended December 31, 2020: €8.3 million: year ended December 31, 2019: €14.0 million).

The Company calculates the cost of the Management Share Awards based upon their fair value using the Monte Carlo Model, which is considered to be the most appropriate methodology considering the restricted shares only vest once the market performance conditions have been satisfied.

The inputs and assumptions underlying the Monte Carlo models for all awards outstanding as of the valuation date are now as follows:

F-34

	January 1, 2018 award			January 1, 2019 award			January 1, 2020 award			January 1, 2021 award
Grant date price	$	16.72		$	20.15		$	22.37		$	25.42
Exercise price	$	—		$	—		$	—		$	—
Expected life of restricted share	1.50 - 4.00 years			4.00 years			3.00 years			3.00 years
Expected volatility of the share price	22.7		%	24.0		%	24.4		%	30.0		%
Dividend yield expected	—		%	—		%	—		%	—		%
Risk free rate	2.55		%	1.33		%	1.70		%	0.24		%
Employee exit rate	14.0		%	14.0		%	27.3		%	14.0		%
EBITDA Performance Target Condition	35.0		%	35.0		%	35.0		%	35.0		%

The expected volatility of the share price inputs above were estimated by referencing selected quoted companies which are considered to exhibit some degree of comparability with the Company, as the Company has only been listed for approximately six years.

Based on the latest assessments of fair value and the number of shares expected to vest, the total fair values in respect of the Restricted Shares are:

•2018 award - $1.6 million (€1.3 million)

•2019 award - $1.4 million (€1.2 million)

•2020 award - $4.8 million (€4.3 million)

•2021 award - $7.0 million (€5.8 million)

Initial Director Options

In 2014, certain Non-Executive Directors were granted options (“Initial Options”) to purchase a maximum of 125,000 Ordinary Shares at an exercise price of $11.50 per ordinary share. The awards were valued at issuance and expensed during the two years ended April 1, 2016.

Throughout 2019, former Non-Executive Directors exercised 56,250 of the 125,000 initial options granted to them for €0.6 million.

In May 2020, former and current Non-Executive Directors were issued an aggregate of 49,196 shares (net of shares withheld for the settlement of taxes), exercising all the remaining initial options outstanding for €0.6 million.

9)    Directors and Key Management compensation

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Short-term employee benefits	2.2	3.9	2.8
Share-based payment expense	2.4	3.5	7.6
Non-Executive Director fees	0.3	0.3	0.4
Total Directors' and executive officers' compensation	4.9	7.7	10.8

All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and executive Officers.

F-35

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Benefits are accruing to the following number of key management personnel under:
Defined contribution plans	2	2	2
Share based payment schemes	2	2	2

10)    Finance income and costs

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Interest income	0.1	0.7	2.5
Net foreign exchange gains on translation of financial assets and liabilities	—	4.0	—
Finance income	0.1	4.7	2.5
Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss (a)	(59.8)	(64.0)	(79.0)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity	1.6	5.9	21.8
Net impairment loss on short-term investments	(8.6)	—	—
Net pension interest costs	(1.7)	(2.7)	(3.8)
Amortization of borrowing costs	(2.0)	(2.0)	(2.0)
Net foreign exchange losses on translation of financial assets and liabilities	(4.0)	—	(3.9)
Net fair value losses on derivatives held at fair value through profit or loss (b)	(13.7)	(5.6)	(8.8)
Financing costs incurred in amendment of terms of debt (c)	(17.9)	—	—
Finance costs	(106.1)	(68.4)	(75.7)
Net finance costs	(106.0)	(63.7)	(73.2)

(a) Includes the unwinding of discounting on lease liabilities. 

(b) Net fair value losses on derivatives held at fair value through profit or loss includes a one-off non-cash charge of €7.8 million for changes to cross currency interest rate swaps as disclosed in Note 34.

(c) Charges of €17.9 million have been recognized as a consequence of the refinancing in June 2021, as disclosed in Note 34. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs.

11)    Taxation

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Current tax expense
Current tax on profits for the period		(117.5)	(44.8)	(66.4)
Adjustments in respect of prior periods		0.6	(7.6)	—
		(116.9)	(52.4)	(66.4)
Deferred tax benefit/(expense)
Origination and reversal of temporary differences		116.3	(1.2)	9.7
Impact of change in tax rates		(55.1)	(16.8)	—
	16	61.2	(18.0)	9.7
Total tax expense		(55.7)	(70.4)	(56.7)

F-36

Reconciliation of effective tax rate:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Profit before tax	236.7	295.5	210.3
Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%)	(45.0)	(56.1)	(39.9)
Difference in tax rates	22.7	(18.2)	(11.9)
Non tax deductible interest	0.1	(0.1)	0.6
Other income and expenses not taxable or deductible	2.5	(0.8)	(1.2)
Unrecognized tax assets	(1.5)	(6.3)	(0.9)
Provisions for uncertainties	(52.5)	35.5	(3.4)
Impact of change in tax rates	(55.1)	(16.8)	—
Change in tax base of assets due to step-up	72.5	—	—
Prior period adjustment	0.6	(7.6)	—
Total tax expense	(55.7)	(70.4)	(56.7)

Effective tax rates

The Company is resident in the United Kingdom for tax purposes. The effective tax rate for the year ended December 31, 2021 was 23.5% (year ended December 31, 2020: 23.8%). The change is principally caused by the release of uncertain tax positions in relation to exposures that are now time barred, offset in part by the impact of a change in tax rates on deferred tax assets and liabilities.

The Company operates in many different jurisdictions and in some of these, certain matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments appeals and refunds. The Company actively seeks to manage the associated risks by proactively engaging with tax authorities and applying for Advanced Pricing Agreements where appropriate. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision, including releases of provisions when those exposures become time-barred.

Notwithstanding this, management believes that the Company’s position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided. As of December 31, 2021, the current tax payable of €198.5m and deferred tax assets of €128.3m includes provisions for tax uncertainties of €163.4m. As of December 31, 2020, the current tax payable of €166.2m and deferred tax assets of €113.5m included provisions for tax uncertainties of €103.9m.

The UK government announced an increase in the standard rate of corporation tax from 19% for 2021 (2020: 19%) to 25% effective from April 1, 2023, substantively enacted on May 24, 2021. The increase gave rise to a substantial one-off deferred tax expense, which is offset in part by a deferred tax benefit from the implementation of certain arrangements benefiting from one-off government incentives and other tax incentives. The financial statements for the year ended December 31, 2020 were prepared using the substantively enacted rate of corporation tax of 19%.

F-37

The tax (benefit)/expense relating to components of other comprehensive income is as follows:

		Before tax	Tax charge	After tax
Year ended December 31, 2021	Note	€m	€m	€m
Remeasurement of post-employment benefit liabilities		(36.1)	10.2	(25.9)
Net investment hedge		(18.8)	—	(18.8)
Cash flow hedges		(22.6)	13.6	(9.0)
Other comprehensive (income)/loss		(77.5)	23.8	(53.7)
Current tax			—
Deferred tax	16		23.8
			23.8
		Before tax	Tax benefit	After tax
Year ended December 31, 2020	Note	€m	€m	€m
Remeasurement of post-employment benefit liabilities		27.8	(8.3)	19.5
Net investment hedge		10.1	—	10.1
Cash flow hedges		17.3	(6.0)	11.3
Other comprehensive loss/(income)		55.2	(14.3)	40.9
Current tax			—
Deferred tax	16		(14.3)
			(14.3)
		Before tax	Tax benefit	After tax
Year ended December 31, 2019		€m	€m	€m
Remeasurement of post-employment benefit liabilities		35.9	(6.7)	29.2
Net investment hedge		(6.0)	—	(6.0)
Cash flow hedges		27.3	(5.6)	21.7
Other comprehensive loss/(income)		57.2	(12.3)	44.9
Current tax			—
Deferred tax			(12.3)
			(12.3)

F-38

12)    Property, plant and equipment

	December 31, 2021	December 31, 2020
	€m	€m
Owned property, plant and equipment (i)	489.2	373.2
Right-of-use assets (ii)	60.2	49.0
Property, plant and equipment	549.4	422.2

(i)    Owned property, plant and equipment

	Land and buildings	Plant and equipment	Computer equipment	Total
	€m	€m	€m	€m
Cost
Balance at December 31, 2019	156.2	331.9	13.8	501.9
Acquisitions through business combinations	5.1	3.5	—	8.6
Additions	6.8	54.6	2.1	63.5
Disposals	(0.1)	(2.6)	(0.3)	(3.0)
Effect of movements in foreign exchange	(2.7)	(11.3)	(0.3)	(14.3)
Balance at December 31, 2020	165.3	376.1	15.3	556.7
Acquisitions through business combinations	30.5	45.0	0.5	76.0
Additions	14.8	62.8	3.5	81.1
Disposals	(0.1)	(5.9)	—	(6.0)
Effect of movements in foreign exchange	6.2	16.2	0.4	22.8
Balance at December 31, 2021	216.7	494.2	19.7	730.6
Accumulated depreciation and impairment
Balance at December 31, 2019	23.0	125.0	3.9	151.9
Depreciation	7.6	33.5	3.0	44.1
Disposals	—	(1.8)	(0.3)	(2.1)
Effect of movements in foreign exchange	(1.4)	(8.6)	(0.4)	(10.4)
Balance at December 31, 2020	29.2	148.1	6.2	183.5
Depreciation	8.4	35.4	3.0	46.8
Disposals	—	(4.8)	—	(4.8)
Effect of movements in foreign exchange	2.9	12.6	0.4	15.9
Balance at December 31, 2021	40.5	191.3	9.6	241.4
Net book value December 31, 2019	133.2	206.9	9.9	350.0
Net book value December 31, 2020	136.1	228.0	9.1	373.2
Balance at December 31, 2021	176.2	302.9	10.1	489.2

Assets under construction

Additions for the year ended December 31, 2021 include assets under construction of €40.5 million (year ended December 31, 2020: €24.5 million).

F-39

Security

Borrowings have been provided by a syndicate of third party lenders under the terms of the Senior Facilities Agreement, (the “Syndicate”). Together with the holders of the Senior Secured Notes (the "Bond issue"), the Syndicate has security over the assets of the "Guarantor Group". The "Guarantor Group" consists of those companies which individually have more than 5% of consolidated total assets or EBITDA (subject to, and as defined in the Senior Facilities Agreement) of the Company and in total comprise more than 80% of consolidated total assets or EBITDA at any testing date.

(ii)    Right-of-use assets

	December 31, 2021	December 31, 2020
	€m	€m
Net book value
Land and Buildings	44.8	38.5
Plant and equipment and motor vehicles	15.3	10.3
Computer equipment	0.1	0.2
Right-of-use assets	60.2	49.0

Additions to right-of-use assets during the year ended December 31, 2021 were €8.1 million. A further €19.0 million of additions were acquired through business combinations.

Lease liabilities are included within loans and borrowings in Note 21. Interest on lease liabilities is presented as a finance cost in Note 10. Payments of lease liabilities are included as a financing activity within the Statement of Cash Flows.

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Depreciation
Land and Buildings	10.9	10.6	10.7
Plant and equipment and motor vehicles	5.5	4.9	5.2
Computer equipment	0.2	0.2	0.2
Depreciation expense of right-of-use assets	16.6	15.7	16.1

F-40

13)    Goodwill and Intangibles

	Goodwill	Brands	Computer software	Customer relationships	Total
	€m	€m	€m	€m	€m
Cost
Balance at December 31, 2019	1,862.9	2,051.1	29.8	31.0	3,974.8
Acquisitions through business combinations (restated)	40.1	66.0	0.1	—	106.2
Additions	—	—	8.8	—	8.8
Effect of movements in foreign exchange	(0.5)	5.3	0.3	—	5.1
Balance at December 31, 2020 (restated)	1,902.5	2,122.4	39.0	31.0	4,094.9
Acquisitions through business combinations	192.6	296.5	1.1	4.3	494.5
Additions	—	—	5.8	—	5.8
Disposals	—	—	(2.5)	—	(2.5)
Effect of movements in foreign exchange	4.3	3.2	(0.5)	—	7.0
Balance at December 31, 2021	2,099.4	2,422.1	42.9	35.3	4,599.7

	Goodwill	Brands	Computer software	Customer relationships	Total
	€m	€m	€m	€m	€m
Accumulated amortization and impairment
Balance at December 31, 2019	—	4.4	15.2	9.2	28.8
Amortization	—	1.2	4.4	2.2	7.8
Effect of movements in foreign exchange	—	—	0.1	—	0.1
Balance at December 31, 2020	—	5.6	19.7	11.4	36.7
Amortization	—	1.2	4.6	2.4	8.2
Impairment	—	—	1.7	—	1.7
Disposals	—	—	(1.7)	—	(1.7)
Effect of movements in foreign exchange	—	—	(0.3)	—	(0.3)
Balance at December 31, 2021	—	6.8	24.0	13.8	44.6
Net book value December 31, 2019	1,862.9	2,046.7	14.6	21.8	3,946.0
Net book value December 31, 2020 (restated)	1,902.5	2,116.8	19.3	19.6	4,058.2
Net book value December 31, 2021	2,099.4	2,415.3	18.9	21.5	4,555.1

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

Amortization and impairment of €9.9 million (December 31, 2020: €7.8 million; December 31, 2019: €8.6 million) is included in ‘other operating expenses’ in the Consolidated Statement of Profit or Loss.

Goodwill is initially recognized based on the accounting policy for goodwill (see note 3.5) and is subsequently measured at cost less amounts provided for impairment.

The Company’s goodwill, brand and customer relationships values have been allocated to a level no larger than the identified operating segment. This represents the lowest level within the Group at which the goodwill is monitored for internal management purposes. As required by IAS 36 'Impairment of Assets', an annual review of the carrying amount of the goodwill and the indefinite life brands is carried out to identify whether there is any impairment to these carrying values. This is done by means of comparison of the carrying values to the value in use of the CGU. Value in use is calculated as the net present value of the projected risk-adjusted cash flows of each CGU.

F-41

Key assumptions

The values for the key assumptions relating to the annual review of the carrying amount of goodwill and indefinite life brands were arrived at by taking into consideration detailed historical information and comparison to external sources where appropriate, such as market rates for discount factors.

•Budgeted cash flows: the calculation of value in use has been based on the cash flow forecasts by management for 2022 to 2025. The trends in these forecasts have been extrapolated to produce a forecast cash flow for 2026. Beyond 2026 the same assumptions have been applied for future periods in the absence of longer term detailed forecasts. These plans have been prepared and approved by management, and incorporate past performance of the entities acquired in the period, historical growth rates and projections of developments in key markets.

•Revenue: projected revenues are built up with reference to markets and product platforms. They incorporate past performance, historical growth rates and projections of developments in key markets.

•Profit margins: projected margins reflect historical performance, adjusted to account for volatility, such as the impact of COVID-19.

•Capital expenditure forecast reflects expected expenditure requirements and includes an allowance for the replacement of leased right-of-use assets.

•Discount rate: a pre-tax discount rate of 6.4% (2020: 5.8%) was applied to the cash flows. This discount rate has been calculated using a capital asset pricing model using observable market data, including the share price of Nomad Foods Limited.

•Long-term growth rates: the growth rate used in the testing after the detailed forecasting period was 1.0% (2020: 1.0%). These rates do not reflect the long-term assumptions used by the Company for investment planning.

Sensitivity to changes in assumptions

Impairment was not required at either December 31, 2021, or December 31, 2020. In each case the valuations derived from the discounted cash flow model indicate a sufficient amount of headroom for which any reasonably possible change to key assumptions is unlikely to result in an impairment of the related goodwill.

14)    Acquisitions

(a)     Findus Switzerland

On December 31, 2020, the Company completed its acquisition of all of the share capital of Findus Switzerland for total cash consideration of €112.8 million, which produces and sells frozen food in Switzerland. The deal extends the geographical reach of this brand, complementing the existing business model.

Due to the timing of the acquisition, the valuation of the business had not been completed within the financial statements reported as at December 31, 2020, with the difference between the consideration paid and the book value of assets valued being provisionally allocated to goodwill. The Company has since completed its fair valuation exercise over the identifiable assets acquired as well as liabilities and contingent liabilities assumed, with any corresponding adjustment necessary being made to the value of goodwill recognized. Furthermore, following customary working capital adjustments, a final payment of €0.8 million has been made to the seller in 2021.

F-42

The final assessment of the assets and liabilities acquired are as follows:

	As reported December 31, 2020	Adjustments	As restated December 31, 2020
	€m	€m	€m
Assets:
Intangible assets	24.5	41.6	66.1
Property, plant and equipment, including Right-of-use assets	8.9	—	8.9
Current assets	0.2	—	0.2
Inventories	11.5	1.1	12.6
Total assets	45.1	42.7	87.8
Liabilities:
Current liabilities	0.3	—	0.3
Non-current liabilities	6.8	—	6.8
Deferred tax liabilities	1.6	6.4	8.0
Total liabilities	8.7	6.4	15.1
Total identifiable net assets acquired	36.4	36.3	72.7
Total purchase consideration	112.0	0.8	112.8
Total identifiable net assets acquired	(36.4)	(36.3)	(72.7)
Goodwill	75.6	(35.5)	40.1

Goodwill recognized on acquisition is €40.1 million. The goodwill recognized is attributable mainly to the growth prospects for the business expected organically and operational synergies.

Restatement of prior year comparatives

The acquisition accounting was completed in 2021. As IFRS 3 requires fair value adjustments to be recorded with effect from the date of acquisition, this requires the restatement of previously reported financial results. The impact on the Statement of Financial Position as at December 31, 2020 is shown below.

	As reported December 31, 2020	Adjustments	As restated December 31, 2020
	€m	€m	€m
Goodwill	1,938.0	(35.5)	1,902.5
Intangible assets	2,114.1	41.6	2,155.7
Inventories	343.2	1.1	344.3
Deferred tax liabilities	(420.7)	(6.4)	(427.1)
Trade and other payables - current	(646.4)	(0.8)	(647.2)
Other assets and liabilities, not affected by restatement	(1,202.1)	—	(1,202.1)
Net assets	2,126.1	—	2,126.1

F-43

(b)     Fortenova Acquisition

On September 30, 2021, the Company announced the completion of the acquisition of the Fortenova Group’s Frozen Food Business Group (FFBG) for total cash consideration of €640.1 million, subject to customary completion payment conditions. FFBG is a leading European frozen food portfolio operating in attractive markets new to Nomad, including Croatia, Serbia, Bosnia & Herzegovina, Hungary, Slovenia, Kosovo, North Macedonia and Montenegro. Its two anchor brands, Ledo and Frikom, have unparalleled consumer awareness and number one market share in many of these markets and offer a broad range of frozen food products including fish, fruits, vegetables, ready meals, pastry and ice cream.

The preliminary assessment of the values of assets and liabilities at the date acquisition and the consideration paid is as follows:

	As reported September 30, 2021
	€m
Assets:
Intangible assets	301.9
Property, plant and equipment, including Right-of-use assets	95.0
Trade and other receivables	71.7
Cash	43.6
Inventories	46.9
Deferred taxes	14.8
Total assets	573.9
Liabilities:
Current liabilities	62.1
Non-current liabilities	16.6
Deferred taxes	47.7
Total liabilities	126.4
Total identifiable net assets acquired	447.5
Total purchase consideration	640.1
Total identifiable net assets acquired	(447.5)
Goodwill	192.6

The preliminary goodwill recognized on acquisition is €192.6 million. The goodwill recognized is attributable mainly to the growth prospects for the business expected organically and operational synergies.

If new information obtained within one year of the date of acquisition about facts and circumstances that existed at the date of acquisition is identified, then the accounting for the acquisition will be revised.

(c)     Impact of acquisitions on financial statements

Acquisition related costs of €12.9 million (2020: €4.8 million) are recognized as an expense in other operating expenses.

If the Fortenova Acquisition had occurred on January 1, 2021, management estimates that the combined Company would have revenue of €2,851.7 million and profit before tax of €279.9 million for the year ended December 31, 2021.

F-44

(d)     Purchase consideration - cash outflow

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Outflow of cash for business combinations, net of cash acquired		€m	€m	€m
Cash consideration		640.9	113.0	—
Less cash acquired		(43.6)	(0.1)	—
Contingent consideration paid related to acquisitions	24	—	—	1.5
Net outflow of cash - investing activities		597.3	112.9	1.5

15)    Investments

The following are the Company's significant investments as of December 31, 2021.

	Activity	Country of incorporation	Class of shares held	Ownership as of December 31, 2020
Nomad Foods Europe Holdings Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Holdco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Finco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Midco Limited	Holding/ Finance	England	Ordinary	100%
Nomad Foods Bondco Plc	Finance	England	Ordinary	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	Ordinary	100%
Nomad Foods Europe Limited	Management	England	Ordinary	100%
Birds Eye Limited	Trading	England	Ordinary	100%
Nomad Foods Europe Finance Limited	Finance	England	Ordinary	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	Ordinary	100%
Iglo Holding GmbH	Holding	Germany	Ordinary	100%
Iglo Nederland B.V.	Trading	Netherlands	Ordinary	100%
Iglo Belgium S.A.	Trading	Belgium	Ordinary	100%
Iglo Portugal	Trading	Portugal	Ordinary	100%
Iglo Austria Holdings GmbH	Holding	Austria	Ordinary	100%
C.S.I. Compagnia Surgelati Italiana S.R.L	Trading	Italy	Ordinary	100%
Findus Sverige Holdings AB	Holding	Sweden	Ordinary	100%
Iglo GmbH	Trading	Germany	Ordinary	100%
Frozen Fish International GmbH	Trading	Germany	Ordinary	100%
Liberator Germany Newco GmbH	Property	Germany	Ordinary	100%
Iglo Austria GmbH	Trading	Austria	Ordinary	100%
Findus Sverige AB	Trading	Sweden	Ordinary	100%
Frionor Sverige AB	Holding	Sweden	Ordinary	100%
Findus Holdings France SAS	Holding	France	Ordinary	100%
Findus France SAS	Trading	France	Ordinary	100%
Findus Espana SLU	Trading	Spain	Ordinary	100%
Findus Danmark A/S	Trading	Denmark	Ordinary	100%
Findus Finland Oy	Trading	Finland	Ordinary	100%
Findus Norge AS	Trading	Norway	Ordinary	100%
Findus Norge Holding AS	Holding	Norway	Ordinary	100%

F-45

Toppfrys AB	Trading	Sweden	Ordinary	100%
Findus Switzerland AG	Trading	Switzerland	Ordinary	100%
LEDO plus d.o.o.	Trading	Croatia	Ordinary	100%
INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD	Trading	Serbia	Ordinary	100%
LEDO d.o.o. Čitluk	Trading	Bosnia & Herzegovina	Ordinary	100%
IRIDA d.o.o.	Trading	Croatia	Ordinary	100%
LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság	Trading	Hungary	Ordinary	100%
Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.)	Trading	Slovenia	Ordinary	100%
Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga “Ledo” d.o.o. Podgorica)	Trading	Montenegro	Ordinary	100%
Ledo Sh.p.k.	Trading	Kosovo	Ordinary	100%
FRIKOM BEOGRAD DOOEL Cucer Sandevo	Trading	North Macedonia	Ordinary	100%

16)    Deferred tax assets and liabilities

Recognized deferred tax assets and liabilities

Deferred tax assets and liabilities are attributable to the following:

	December 31, 2021			December 31, 2020 (restated)
	Assets	Liabilities	Total	Assets	Liabilities	Total
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	8.9	(34.4)	(25.5)	20.6	(27.3)	(6.7)
Intangible assets	33.8	(382.9)	(349.1)	0.9	(384.4)	(383.5)
Employee benefits	36.4	—	36.4	48.3	(0.3)	48.0
Tax value of loss carry forwards	40.4	—	40.4	24.6	—	24.6
Derivative financial instruments	1.7	(7.0)	(5.3)	9.3	(0.1)	9.2
Other	7.1	(13.3)	(6.2)	9.8	(15.0)	(5.2)
Tax assets/(liabilities)	128.3	(437.6)	(309.3)	113.5	(427.1)	(313.6)

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future taxable profits is probable.

Deferred tax assets that the Company has not recognized in the financial statements amount to €70.4 million (December 31, 2020: €72.7 million). These deferred tax assets had not been recognized as the likelihood of recovery is not probable.

The aggregate deferred tax relating to items that have been credited directly to equity is €23.8 million (December 31, 2020: debit of €14.3 million).

F-46

Movement in deferred tax during the year:

	Opening balance Jan 1, 2021 (restated)	Acquired in business combinations	Recognized  in Statement of Profit or Loss	Recognized in Other Comprehensive Income	Movement in foreign exchange	Closing balance Dec 31, 2021
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	(6.7)	(2.2)	(17.2)	—	0.6	(25.5)
Intangible assets	(383.5)	(30.1)	64.5	—	—	(349.1)
Employee benefits	48.0	—	(1.2)	(10.2)	(0.2)	36.4
Tax value of loss carry forwards	24.6	—	15.8	—	—	40.4
Derivative financial instruments	9.2	—	(0.3)	(13.6)	(0.6)	(5.3)
Other	(5.2)	(0.6)	(0.4)	—	—	(6.2)
Total deferred tax	(313.6)	(32.9)	61.2	(23.8)	(0.2)	(309.3)

	Opening balance Jan 1, 2020	Acquired in business combinations (restated)	Recognized  in Statement of Profit or Loss	Recognized in Other Comprehensive Income	Movement in foreign exchange	Closing balance Dec 31, 2020 (restated)
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	(6.3)	(1.3)	1.0	—	(0.1)	(6.7)
Intangible assets	(356.6)	(6.3)	(20.6)	—	—	(383.5)
Employee benefits	39.8	—	—	8.3	(0.1)	48.0
Tax value of loss carry forwards	20.7	—	3.9	—	—	24.6
Derivative financial instruments	2.9	—	0.3	6.0	—	9.2
Other	(2.3)	(0.4)	(2.6)	—	0.1	(5.2)
Total deferred tax	(301.8)	(8.0)	(18.0)	14.3	(0.1)	(313.6)

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

17)    Inventories

	December 31, 2021	December 31, 2020 (restated)
	€m	€m
Raw materials and consumables	95.8	80.5
Work in progress	64.9	46.5
Finished goods and goods for resale	249.9	217.3
Total inventories	410.6	344.3

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

As at December 31, 2021, €2.1 million was recognized as a basis adjustment transferred to the carrying value of inventory. This has been applied to the three inventory categories above.

During the year ended December 31, 2021, €8.3 million (year ended December 31, 2020: €8.5 million, year ended December 31, 2019: €9.0 million) was charged to the Consolidated Statement of Profit or Loss for the write down of inventories.

F-47

18)    Trade and other receivables

	December 31, 2021	December 31, 2020
Current assets	€m	€m
Trade receivables	182.8	141.2
Prepayments and accrued income	15.4	9.2
Other receivables	32.3	31.2
Tax receivable	4.1	3.4
Total current trade and other receivables	234.6	185.0
Non-current assets
Other receivables	8.9	1.1
Total non-current trade and other receivables	8.9	1.1
Total trade and other receivables	243.5	186.1

Trade receivables, prepayments and other receivables, except for those defined as non-current, are expected to be recovered in less than 12 months. Other receivables includes VAT receivable.

The aging of trade receivables is detailed below:

	Gross	Impaired	Net
December 31, 2021	€m	€m	€m
Not past due	343.8	(0.1)	343.7
Past due less than 1 month	19.9	(0.1)	19.8
Past due 1 to 3 months	5.2	(0.6)	4.6
Past due 3 to 6 months	2.4	(0.1)	2.3
Past due more than 6 months	5.0	(2.7)	2.3
Sub-total	376.3	(3.6)	372.7
Reduction in trade-terms			(189.9)
Total trade receivables			182.8
	Gross	Impaired	Net
December 31, 2020	€m	€m	€m
Not past due	308.6	(0.3)	308.3
Past due less than 1 month	20.5	(0.2)	20.3
Past due 1 to 3 months	4.0	(0.1)	3.9
Past due 3 to 6 months	1.1	(0.1)	1.0
Past due more than 6 months	11.9	(3.7)	8.2
Sub-total	346.1	(4.4)	341.7
Reduction in trade-terms			(200.5)
Total trade receivables			141.2

Reduction in trade-terms are described in Note 4(a). Trade receivables have been provided against based on expected credit losses on positions net of trade-terms, which fall into all aging categories.

The maximum exposure to credit risk at the reporting date is the fair value of each class of receivable. The Company does not hold any collateral as security.

Debts past due are not impaired where there are eligible trade terms deductions which can be offset against them.

For the periods covered in these financial statements, the Company has entered into facilities with third-party banks/credit providers in which the Company has sold qualifying trade debtors on a non-recourse basis. Under the terms of these agreements, the Company transferred substantially all the credit risks and control of the receivables. All factoring facilities have been cancelled during 2021. No trade receivables have been derecognized at the period end (December 31, 2020:€ nil).

F-48

Liabilities related to contracts with customers

The Company has recognized the following liabilities related to contracts with customers:

	December 31, 2021	December 31, 2020
	€m	€m
Trade terms liabilities reported within trade receivables	(189.9)	(200.5)
Trade terms liabilities reported within trade and other payables (Note 22)	(93.8)	(89.7)
Total trade terms liabilities	(283.7)	(290.2)

Significant changes to trade terms

No significant changes to trade terms occurred in the year ended December 31, 2021.

Revenue recognized in relation to trade terms

Trade terms relate to sales made with variable consideration and are an estimate as disclosed in Note 4(a). Revenue recognized in the year ended December 31, 2021 relating to performance obligations that were satisfied in the prior year was €18.9 million (2020: €18.0 million).

19)Indemnification assets

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Balance at January 1	15.4	35.4
Release of indemnified provision	(5.9)	(20.0)
Balance at December 31	9.5	15.4

As at December 31, 2021, €7.0 million (December 31, 2020: €12.0 million) of the indemnification assets relate to the acquisition of the Findus Group in 2015 for which 342,190 shares are held in escrow and are valued at $25.39 (€22.40) (December 31, 2020: 618,099 shares valued at $25.42 (€20.69)) each. The shares placed in escrow were released in stages over a four-year period beginning January 2019 with the final release in January 2022. During 2021, 275,909 shares were released from escrow. As a consequence the indemnification asset was reduced by €5.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2021.

In January 2022, the remaining 342,190 shares were released from escrow. As a consequence the indemnification asset will be reduced by €7.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2022.

As at December 31, 2021, €2.5 million (2020: €3.4 million) of the indemnification asset relates to the Goodfella’s Pizza acquisition for several contingent liabilities that arose prior to acquisition and were recognized in the balance sheet to the same extent as the asset. During 2021, €0.9 million was released against the liabilities.

F-49

20)Cash and cash equivalents

		December 31, 2021	December 31, 2020
	Note	€m	€m
Cash and cash equivalents		254.0	393.1
Restricted cash		0.2	0.1
Cash and cash equivalents		254.2	393.2
Bank overdraft	22	—	(10.7)
Cash and cash equivalents per Statement of Cash Flows		254.2	382.5

‘Cash and cash equivalents’ comprise cash balances and deposits. Restricted cash comprises money that is primarily reserved for a specific purpose and therefore not available for immediate or general business use. Bank overdrafts that are repayable on demand and form an integral part of the Company's cash management are included as a component of cash and cash equivalents for the purposes of the Statement of Cash Flows.

21)Loans and borrowings

The repayment profile of the syndicated and other loans held by the Company is as follows:

	December 31, 2021	December 31, 2020
	€m	€m
Current liabilities
Syndicated loans	8.5	7.8
Lease liabilities	22.6	16.7
Less deferred borrowing costs to be amortized within 1 year	(2.0)	(2.0)
Total due in less than one year	29.1	22.5
Non-current liabilities
Syndicated loans	1,347.4	1,287.5
2024 fixed rate senior secured notes	—	400.0
2028 fixed rate senior secured notes	800.0	—
Lease liabilities	58.3	53.7
Less deferred borrowing costs to be amortized in 2-5 years	(5.7)	(4.9)
Less deferred borrowing costs to be amortized in more than 5 years	(1.7)	—
Total due after more than one year	2,198.3	1,736.3
Total borrowings	2,227.4	1,758.8

Syndicated loans includes the Senior U.S. Dollar debt of $916.4 million (€808.6 million) (the “Senior USD Loan”) and the Senior EUR debt of €553.2 million (the "Senior EUR Loan"), repayable in May 2024 and May 2028 respectively. The Senior USD Loan includes an annual amortization repayment, equivalent to 1.0% of the original issuance value or $9.6 million (€8.5 million) in May each year until maturity. The Senior EUR Loan is repayable only upon maturity. As required under the Senior Facilities Agreement, the Company is also required to undertake an annual excess cash flow calculation whereby additional principal could be repaid.

On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028. In addition, on July 9, 2021 the Company announced that Nomad Foods Bondco Plc completed a further private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75 (together the “Notes”).

Interest on the Notes accrue from June 24, 2021 (being the original date of issuance) and are payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. Eligible transaction costs on the new Notes of €4.0 million were capitalized and will be amortized over the life of the debt.

F-50

On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due June 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of €3.8 million were capitalized and will be amortized over the life of the debt.

Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was also replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum that may be adjusted subject to a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions.

Charges of €17.9 million have been recognized as a consequence of the refinancing activities in 2021. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs.

As at December 31, 2021 €2.8 million (December 31, 2020: €16.1 million) has been utilized for issuance of letters of credit and bank guarantees.

Guarantees and secured assets

The Senior Facility Agreement that governs the Company’s Senior debt, establishes security over the assets of the “Guarantor Group”. The Guarantor Group consists of those companies that individually have more than 5% of consolidated total assets or EBITDA (subject to the terms of the Senior Facilities Agreement) of the Company and in total comprise more than 80% of consolidated total assets or EBITDA at any testing date.

The Senior Facilities Agreement includes an excess cash flow calculation whereupon an amount of principal shall be repaid based upon terms including cash generated during the year and leverage. In 2021 the amount repaid was nil relating to the calculation performed at the end of 2020. Based on the calculation performed for December 31, 2021, there will be no excess cash flow repayment in 2022.

In connection with its pension scheme, Findus Sverige AB, a 100% owned subsidiary, is required to obtain credit insurance with PRI Pensionsgaranti (“PRI”), a credit insurance company that provides insurance annually against the risk of a sponsoring company’s insolvency. In connection with such credit insurance, as at December 31, 2021 Findus Sverige AB has granted floating charges over certain assets in favor of PRI in an amount of SEK 300 million (€29.3 million) (December 31, 2020: €29.8 million) and Nomad Foods Limited has issued a parent guarantee to PRI which will not exceed SEK 640 million (€62.4 million) (December 31, 2020: SEK 450 million (€44.7 million)).

F-51

22)Trade and other payables

	December 31, 2021	December 31, 2020 (restated)
Current liabilities	€m	€m
Trade payables	413.2	363.7
Accruals and deferred income	120.4	134.5
Trade terms payable	93.8	89.7
Social security and other taxes	24.6	24.1
Other payables	20.3	21.2
Financial payables	19.7	3.3
Bank overdrafts	—	10.7
Total current trade and other payables	692.0	647.2
Non-current liabilities
Accruals and deferred income	1.8	2.2
Total non-current trade and other payables	1.8	2.2
Total trade and other payables	693.8	649.4

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

The Company has implemented a Supply Chain Financing (“SCF”) program for its suppliers. The principal purpose of these arrangements is to provide the supplier with the option to access liquidity earlier through the sale of its receivables due from the Company to a bank or other financial institution prior to their due date. Management has determined that the Company’s payables to these suppliers have neither been extinguished nor have the liabilities been significantly modified by these arrangements. The value of amounts payable, invoice due dates and other terms and conditions applicable, from the Company’s perspective, remain unaltered, with only the ultimate payee being changed. At December 31, 2021, there was no material usage of the programs (December 31, 2020: nil). The cash outflows in respect of these arrangements will be recognized within operating cash flows.

23)Employee benefits

The Company operates defined benefit plans as well as defined contribution plans.

i.Defined contribution plans

The total expense relating to defined contribution plans for the year ended December 31, 2021 was €10.2 million (year ended December 31, 2020: €8.3 million, year ended December 31, 2019: €9.0 million)

ii.Defined benefit plans

The Company operates partially funded defined benefit pension plans in Germany and Austria, an unfunded defined benefit pension plan in Sweden and defined benefit indemnity arrangements in Italy and Austria. In addition, pension benefits in Switzerland are met via a contract with a collective foundation that offers a fully insured solution to provide a contribution-based cash balance retirement plan, which is classified as a defined benefit plan. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy, long term service awards are in operation and various other countries provide other employee benefits.

F-52

	December 31, 2021	December 31, 2020
	€m	€m
Net employee benefit obligations-Germany	149.3	181.2
Net employee benefit obligations-Sweden	70.3	74.1
Net employee benefit obligations-Austria	5.5	5.6
Net employee benefit obligations-Switzerland	5.8	6.6
Net employee benefit obligations-Italy	4.6	4.7
Net employee benefit obligations-total of other countries	8.7	4.0
Total net employee benefit obligations	244.2	276.2

The net obligation of €8.7 million (December 31, 2020: €4.0 million) in respect of other countries is the aggregate of a number of different types of minor schemes, each one not being considered individually material.

The amount included in the Statement of Financial Position arising from the Company’s obligations in respect of its defined benefit retirement plans and other post-employment benefits is as follows:

	Defined benefit retirement plans	Post-employment medical benefits and other benefits	Total
December 31, 2021	€m	€m	€m
Present value of unfunded employee benefit obligations	77.5	11.1	88.6
Present value of funded employee benefit obligations	264.0	—	264.0
Subtotal present value of employee benefit obligations	341.5	11.1	352.6
Fair value of plan assets	(108.4)	—	(108.4)
Recognized liability for net employee benefit obligations	233.1	11.1	244.2

	Defined benefit retirement plans	Post-employment medical benefits and other benefits	Total
December 31, 2020	€m	€m	€m
Present value of unfunded employee benefit obligations	79.6	9.0	88.6
Present value of funded employee benefit obligations	285.5	—	285.5
Subtotal present value of employee benefit obligations	365.1	9.0	374.1
Fair value of plan assets	(97.9)	—	(97.9)
Recognized liability for net employee benefit obligations	267.2	9.0	276.2

F-53

Reconciliation from the opening balances to the closing balances for the net employee benefit obligation and its components, including the amounts recognized in the Consolidated Statement of Profit or Loss and the Consolidated Statement of Comprehensive Income:

	Present value of defined benefit obligation		Fair value of plan assets		Net defined benefit obligation
	2021	2020	2021	2020	2021	2020
	€m	€m	€m	€m	€m	€m
Balance at January 1	374.1	323.9	(97.9)	(86.4)	276.2	237.5
Included in the Consolidated Statement of Profit or Loss
Current service cost	7.9	6.6	—	—	7.9	6.6
Interest cost (income)	2.2	3.7	(0.5)	(1.0)	1.7	2.7
	10.1	10.3	(0.5)	(1.0)	9.6	9.3
Included in the Consolidated Statement of Comprehensive Income
Actuarial (gain) loss arising from:
–demographic assumptions	(1.5)	—	—	—	(1.5)	—
–financial assumptions	(26.8)	29.1	—	—	(26.8)	29.1
–experience adjustment	1.8	(0.8)	—	—	1.8	(0.8)
Return on plan assets, excluding interest income	—	—	(9.6)	(0.4)	(9.6)	(0.4)
Exchange adjustments	(0.3)	2.8	(0.6)	—	(0.9)	2.8
	(26.8)	31.1	(10.2)	(0.4)	(37.0)	30.7
Other
Acquired through business combinations	3.5	18.4	—	(11.8)	3.5	6.6
Contributions by employer	—	—	(1.2)	(0.5)	(1.2)	(0.5)
Contributions by members	0.8	0.4	(0.8)	(0.5)	—	(0.1)
Benefits paid	(9.1)	(10.0)	2.2	2.7	(6.9)	(7.3)
	(4.8)	8.8	0.2	(10.1)	(4.6)	(1.3)
Balance at December 31	352.6	374.1	(108.4)	(97.9)	244.2	276.2

Current service cost is allocated between cost of sales and other operating expenses. Interest on net employee benefit obligation is disclosed in net financing costs.

The cumulative amount of actuarial losses recognized is as follows:

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income	40.5	77.5

The fair value of plan assets, all at quoted prices are as follows:

	December 31, 2021	December 31, 2020
	€m	€m
Equities	32.7	24.5
Debt instruments	42.7	44.1
Property	20.3	17.1
Other	12.7	12.2
Total	108.4	97.9

F-54

The following are the principal actuarial assumptions at the reporting date for the defined benefit retirement plans in Germany, Sweden, Austria, Switzerland and Italy. The remaining employee benefit plans are not considered to be material, individually and in aggregate, and therefore we do not provide disclosure of the individual actuarial assumptions for those plans:

	Defined benefit retirement plans
December 31, 2021	Germany		Sweden		Austria		Switzerland		Italy
Discount rate	1.10	%	1.80	%	0.90	%	0.10	%	0.35	%
Inflation rate	2.00	%	2.20	%	2.00	%	1.00	%	1.50	%
Rate of increase in salaries	2.80	%	3.20	%	2.00	%	1.50	%	2.63	%
Rate of increase for pensions in payment	1%-2%		2.20	%	—		—		—

	Defined benefit retirement plans
December 31, 2020	Germany		Sweden		Austria		Switzerland		Italy
Discount rate	0.55	%	1.05	%	1.00	%	0.15	%	0.33	%
Inflation rate	2.00	%	1.50	%	2.00	%	0.20	%	1.00	%
Rate of increase in salaries	2.80	%	2.50	%	2.00	%	0%-2.50%		2.63	%
Rate of increase for pensions in payment	1%-2%		1.50	%	—		—		—

In valuing the liabilities of the pension fund at December 31, 2021 and December 31, 2020, mortality assumptions have been made as indicated below. The assumptions relating to longevity underlying the pension liabilities at the financial year end date are based on standard actuarial mortality tables and include an allowance for future improvements in longevity. The assumptions are based on the following mortality tables:

•Germany: Richttafeln 2018 G

•Sweden: DUS 14

•Austria: AVÖ 2018 - P

•Switzerland: BVG 2020 GT (2020: BVG 2015 GT)

•Italy: RG48

These references are to the specific standard rates of mortality that are published and widely used in each country for the use of actuarial assessment of pension liabilities and take account of local current and future average life expectancy.

December 31, 2021 (years)	Germany	Sweden	Austria	Switzerland	Italy
Retiring at the end of the year:
Male	21	22	23	22	21
Female	24	24	26	24	22

December 31, 2020 (years)	Germany	Sweden	Austria	Switzerland	Italy
Retiring at the end of the year:
Male	21	22	23	21	21
Female	24	24	26	24	22

F-55

The history of experience adjustments from inception of the Company for the employee benefit plans is as follows:

	December 31, 2021	December 31, 2020	December 31, 2019
	€m	€m	€m
Present value of defined benefit obligations	341.5	365.1	314.9
Fair value of plan assets	(108.4)	(97.9)	(86.4)
Recognized liability in the scheme	233.1	267.2	228.5
Experience losses/(gains) on plan liabilities	1.8	(0.8)	0.2
Experience gains on plan assets	(9.6)	(0.4)	(5.1)

Net defined benefit obligation - sensitivity analysis

The effect of a 1 percentage point movement in the most significant assumptions for the year ended December 31, 2021 is as follows:

	Increase	Decrease
	€m	€m
Discount rate	(54.6)	71.9
Inflation rate	47.4	(38.7)
Rate of increase in salaries	15.2	(11.5)
Rate of increase for pensions in payment	47.6	(37.0)

There are no deficit elimination plans for any of the defined benefit plans. Expected contributions and payments to post-employment benefit plans for the period ending December 31, 2021 are €6.7 million. The weighted average duration of the defined benefit obligations is 18.9 years.

F-56

24)Provisions

	Restructuring	Onerous/ unfavorable contracts	Provisions related to other taxes	Other	Total
	€m	€m	€m	€m	€m
Balance at December 31, 2019	7.4	1.2	6.9	31.3	46.8
Additional provision in the period	15.6	—	0.1	13.4	29.1
Release of provision	—	(0.7)	(0.4)	(6.0)	(7.1)
Utilization of provision	(10.4)	(0.5)	—	(5.9)	(16.8)
Foreign exchange	0.3	—	—	(0.5)	(0.2)
Balance at December 31, 2020	12.9	—	6.6	32.3	51.8
Acquired through business combinations	—	—	0.3	3.8	4.1
Additional provision in the period	2.6	—	1.0	2.5	6.1
Release of provision	(0.1)	—	—	(4.0)	(4.1)
Utilization of provision	(9.8)	—	—	(6.9)	(16.7)
Foreign exchange	—	—	—	1.0	1.0
Balance at December 31, 2021	5.6	—	7.9	28.7	42.2
Analysis of total provisions:				December 31, 2021	December 31, 2020
Current				39.3	45.7
Non-current				2.9	6.1
Total				42.2	51.8

Restructuring

The €5.6 million (2020: €12.9 million) provision relates to committed plans for certain restructuring activities of exceptional nature which are due to be completed within the next 12 months.

The amounts have been provided based on the latest information available on the likely remaining expenditure required to complete the committed plans. An additional provision of €2.6 million has been made and €9.8 million has been utilized in the year ended December 31, 2021.

Provisions relating to other taxes

The €7.9 million (2020: €6.6 million) provision relates to other, non-income taxes due to tax authorities after tax investigations within certain operating subsidiaries within the Nomad Group.

Other

Other provisions include €3.9 million (December 31, 2020: €4.4 million) of contingent liabilities acquired as part of the Goodfella’s Pizza acquisition that are indemnified by the Seller’s insurance policies, €4.3 million (December 31, 2020: €4.7 million) of obligations in Italy, €4.6 million (December 31, 2020: €6.1 million) for asset retirement obligations, €1.3 million (December 31, 2020: €1.9 million) of pre-acquisition related liabilities related to the acquisition date liabilities of Aunt Bessie's Limited, €2.4 million (December 31, 2020: €6.6 million) of provisions in the period relate to employer taxes on the Long-term Incentive Plan (see Note 8) which would become payable on the issuance of shares, and other obligations from previous accounting periods.

F-57

25)Share capital, Capital reserve and Founder Preferred Shares Dividend reserve

Share capital and capital reserve

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Authorized:
Unlimited number of Ordinary Shares with nil nominal value issued at $10.00 per share	n/a	n/a
Unlimited number of Founder Preferred Shares with nil nominal value issued at $10.00 per share	n/a	n/a
Issued and fully paid:
173,559,173 (December 31, 2020: 172,180,897) Ordinary Shares with nil nominal value	1,639.6	1,636.9
1,500,000 (December 31, 2020: 1,500,000) Founder Preferred Shares with nil nominal value	10.6	10.6
Total share capital and capital reserve	1,650.2	1,647.5
Listing and share transaction costs	(27.1)	(27.0)
Total net share capital and capital reserve	1,623.1	1,620.5

Ordinary Shares

	Issued and Repurchased Ordinary shares  (in millions)
Balance at December 31, 2019	194.5
Shares issued in the year	7.6
Shares repurchased in the year	(29.9)
Balance at December 31, 2020	172.2
Shares issued in the year	5.0
Shares repurchased in the year	(3.6)
Balance at December 31, 2021	173.6

Note 8(b) sets out the Non-Executive Director, Initial Director Options and Director and Senior Management Restricted share awards.

Note 27 sets out the Founder Preferred Share Dividends issued as ordinary shares in all years presented.

On March 13, 2020, the Company announced a share repurchase program to purchase up to an aggregate of $300.0 million of the Company’s ordinary shares. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. After the announcement, the Company entered into a series of open-market repurchases. During 2020, 11,913,682 ordinary shares at an average price of $21.04, for aggregate gross costs of $250.9 million (€217.4 million) had been repurchased and canceled. Directly attributed transaction costs of €0.2 million were incurred. During 2021, a further 507,396 ordinary shares were repurchased and cancelled at an average price of $25.29 for aggregate gross costs of $12.8 million (€10.5 million) under this authorization.

In August 2020, the Company announced the repurchase of up to $500.0 million of shares, to be executed by way of a Dutch auction. On September 15, 2020, a total of 18,061,952 shares at a clearing price of $25.50 per share amounting to the purchase price of $460.6 million (€389.3 million) was paid to the prevailing shareholders with all shares canceled as of the same date. Directly attributed transaction costs of €1.9 million were incurred.

F-58

On August 5, 2021, the Company announced a new share repurchase program to purchase up to an aggregate of $500.0 million of the Company’s ordinary shares, to be executed in the period to August 2024. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions, at the Company's discretion, as permitted by securities laws and other legal requirements. Pursuant to the program, as at December 31, 2021, 3,090,082 ordinary shares had been repurchased and canceled at an average price of $24.50, for aggregate gross costs of $75.8 million (€67.1 million). Directly attributed transaction costs of €0.1 million were incurred.

Listing and share transaction costs

As at December 31, 2021, cumulative listing and share transaction costs, which includes the total cost of admission and share issuance expenses, as well as costs associated with share repurchases were €27.1 million and are disclosed as a deduction directly against the capital reserve.

	€m
At December 31, 2019	24.9
Share transaction costs	2.1
At December 31, 2020	27.0
Share transaction costs	0.1
At December 31, 2021	27.1

Obligation to purchase shares

As part of the August 5, 2021 authorized share repurchase program, the Company entered into share purchases at agreed prices, totaling 135,621 shares in late 2021 which had not been settled and were therefore not owned by Nomad until early 2022. As a result, the Company recorded €3.0 million within accounts payable to recognize the liability for those shares, with a corresponding other receivable to reflect the value of the shares to be received upon settlement.

Founder Preferred Shares Annual Dividend Amount

Each of the Founder Entities holds 750,000 shares for a total of 1,500,000 Founder Preferred Shares which were issued at $10.00 per share. The Founder Preferred Shares are intended to incentivize the Founders to achieve Nomad’s objectives. In addition to providing long term capital, the Founder Preferred Shares are structured to provide a dividend based on the future appreciation of the market value of the ordinary shares thus aligning the interests of the Founders with those of the holders of ordinary shares on a long term basis. The Founder Preferred Shares are also intended to encourage the Founders to grow Nomad to maximize value for holders of ordinary shares. There are no Founder Preferred Shares held in Treasury. Founder Preferred Shares confer upon the holder the following:

1.the right to one vote per Founder Preferred Share on all matters to be voted on by shareholders generally and to vote together with the holders of ordinary shares;

2.commencing on January 1, 2015 and for each financial year thereafter:

a.once the average price per ordinary share for the Dividend Determination Period, i.e. the last ten consecutive trading days of a year is at least $11.50 (which condition has been satisfied for the year ended December 31, 2015), the right to receive a Founder Preferred Shares Annual Dividend Amount (as more fully described below), payable in Ordinary Shares or cash, at the Company’s sole option; and

b.the right to receive dividends and other distributions as may be declared from time to time by the Company’s board of directors with respect to the Ordinary Shares (such dividends to be distributed among the holders of Founder Preferred Shares, as if for such purpose the Founder Preferred Shares had been converted into Ordinary Shares immediately prior to such distribution) plus an amount equal to 20% of the dividend which would be

F-59

distributable on such number of Ordinary Shares equal to the Preferred Share Dividend Equivalent (as defined below); and

3.in addition to amounts payable pursuant to clause 2 above, the right, together with the holders of Ordinary Shares, to receive such portion of all amounts available for distribution and from time to time distributed by way of dividend or otherwise at such time as determined by the Directors; and

4.the right to an equal share (with the holders of Ordinary Shares on a share for share basis) in the distribution of the surplus assets of Nomad on its liquidation as are attributable to the Founder Preferred Shares; and

5.the ability to convert into Ordinary Shares on a 1-for-1 basis (mandatorily upon a Change of Control or the seventh full financial year after an acquisition)

See Note 27 for further information on the Founder Preferred Shares Dividends issued.

26)    Share-based compensation reserve

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

	Share based compensation reserve
	€m
Balance as of January 1, 2021	8.3
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	4.3
Shares issued upon vesting of awards	(0.7)
Reclassification of awards for settlement of tax liabilities	(5.8)
Balance as of December 31, 2021	6.9

27)Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding.

F-60

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020.

On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021.

As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2021	245.5
Settlement of dividend through share issue	(79.5)
Balance as of December 31, 2021	166.0

F-61

28)Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

	Year ended December 31,
	2021	2020	2019
	€m	€m	€m
Balance as of January 1	84.7	94.8	88.8
Adjustment on adoption of hedge accounting under IFRS 9	1.6	—	—
Restated balance as of January 1	86.3	94.8	88.8
Foreign currency translation adjustments	31.7	(23.6)	19.2
Net deferred (losses)/gains on net investment hedges (1)	(12.9)	13.5	(13.2)
Total presented in Other Comprehensive Income	18.8	(10.1)	6.0
Balance as of December 31	105.1	84.7	94.8

(1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments.

The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments.

29)    Other reserves

Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33.

The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year.

F-62

	Cross currency interest rate swaps	Forward currency contracts	Total Cash flow hedge reserve	Cost of Hedging reserve	Total Other reserves
	€m	€m	€m	€m	€m
Balance as of January 1, 2019	0.9	7.6	8.5	—	8.5
Change in fair value of hedging instrument recognized in OCI for the year	28.1	3.8	31.9	—	31.9
Reclassified to cost of goods sold	—	(21.8)	(21.8)	—	(21.8)
Reclassified from OCI to finance costs	(37.4)	—	(37.4)	—	(37.4)
Deferred tax	1.6	4.0	5.6	—	5.6
Balance as of December 31, 2019	(6.8)	(6.4)	(13.2)	—	(13.2)
Change in fair value of hedging instrument recognized in OCI for the year	(63.7)	(20.0)	(83.7)	—	(83.7)
Reclassified to cost of goods sold	—	0.2	0.2	—	0.2
Reclassified from OCI to finance costs	66.2	—	66.2	—	66.2
Deferred tax	(0.2)	6.2	6.0	—	6.0
Balance as of December 31, 2020	(4.5)	(20.0)	(24.5)	—	(24.5)
Reallocation for IFRS 9 changes to policy (start of the year)	2.8	—	2.8	(4.4)	(1.6)
Transferred to the carrying value of inventory	—	27.6	27.6	—	27.6
Change in fair value of hedging instrument recognized in OCI for the year	73.3	9.3	82.6	2.4	85.0
Reclassified from OCI to finance costs	(64.1)	—	(64.1)	1.7	(62.4)
Deferred tax	(2.4)	(11.1)	(13.5)	(0.1)	(13.6)
Balance as of December 31, 2021	5.1	5.8	10.9	(0.4)	10.5

30)Earnings per share

Basic earnings per share

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Profit for the period attributable to equity owners of the parent (€m)	181.0	225.2	154.0
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	194,019,070	192,004,803
Basic earnings per share (€’s)	1.02	1.16	0.80

For the year ended December 31, 2021, basic earnings per share is calculated by dividing the profit attributable to the shareholders of the Company of €181.0 million (year ended December 31, 2020: €225.2 million, year ended December 31, 2019: €154.0 million) by the weighted average number of Ordinary Shares of 176,570,770 (December 31, 2020: 192,519,070, year ended December 31, 2019: 190,504,803) and Founder Preferred Shares of 1,500,000 (December 31, 2020: 1,500,000, year ended December 31, 2019: 1,500,000).

Diluted earnings per share

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Profit for the period attributable to equity owners of the parent (€m)	181.0	225.2	154.0
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	197,894,106	198,425,877
Diluted earnings per share (€’s)	1.02	1.14	0.78

For the year ended December 31, 2021, the number of shares in the diluted earnings per share calculation include nil shares for the dilutive impact of the Ordinary shares to settle the Founder Preferred Shares Annual Dividend for the year ended December 31, 2021, as no shares were due to be issued. Refer to Notes 27 and 38 for further details.

F-63

31)Reconciliation of liabilities arising from financing activities

The table below details changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Company's consolidated statements of cash flows from financing activities.

	Cash / non-cash	Total loans and borrowings (Note 21)	Financial payables (Note 22)	Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	Derivatives: (Net) Fair value of cross currency interest rate swaps
		€m	€m	€m	€m
Opening balance January 1, 2021		1,758.8	3.3	0.2	72.3
Cash inflow (1)	Cash	800.0	—	0.3	1.4
Cash outflow (2)	Cash	(436.0)	(38.1)	—	(2.3)
Interest accretion (3)	Cash	2.2	57.6	—	—
Acquired through business combinations	Non-cash	19.6	—	—	—
Exchange movement	Non-cash	64.1	(0.2)	—	—
Fair value changes	Non-cash	—	—	(0.1)	(44.0)
Other non-cash adjustments	Non-cash	18.7	(2.9)	—	(6.8)
Closing balance December 31, 2021		2,227.4	19.7	0.4	20.6

	Cash / non-cash	Total loans and borrowings (Note 21)	Financial payables (Note 22)	Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	Derivatives: (Net) Fair value of cross currency interest rate swaps
		€m	€m	€m	€m
Opening balance January 1, 2020		1,875.3	4.1	(0.2)	15.3
Cash inflow (1)	Cash	—	—	—	6.8
Cash outflow (2)	Cash	(32.0)	(57.0)	(2.2)	(3.9)
Interest accretion (3)	Cash	5.2	58.8	—	—
Acquired through business combinations	Non-cash	0.4	—	—	—
Exchange movement	Non-cash	(71.7)	0.9	—	—
Fair value changes	Non-cash	—	—	2.6	54.1
Other non-cash adjustments	Non-cash	(18.4)	(3.5)	—	—
Closing balance December 31, 2020		1,758.8	3.3	0.2	72.3

(1) Cash inflows from cross currency interest rate swaps are part of effective cash flow hedging relationships and are

presented within interest paid within the Consolidated Statements of Cash Flows.

(2) Cash outflows from cross currency interest rate swaps are not part of a cash flow hedge and are presented within

proceeds on settlement of derivatives within the Consolidated Statements of Cash Flows.

(3) Interest accretion includes interest on lease liabilities.

F-64

32)Cash flows from operating activities

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Cash flows from operating activities
Profit for the period		181.0	225.1	153.6
Adjustments for:
Exceptional items	7	45.3	20.6	54.5
Non-cash fair value purchase price adjustment of inventory	5	8.4	—	—
Share based payments expense		5.1	9.0	14.9
Depreciation and amortization		71.6	67.6	68.3
Loss on disposal and impairment of property, plant and equipment		0.7	0.9	0.6
Net finance costs	10	106.0	63.7	73.2
Taxation	11	55.7	70.4	56.7
Operating cash flow before changes in working capital, provisions and exceptional items		473.8	457.3	421.8
(Increase)/decrease in inventories		(23.8)	(12.7)	23.5
Decrease/(increase) in trade and other receivables		24.1	(1.8)	(34.4)
(Decrease)/increase in trade and other payables		(25.0)	107.2	(40.6)
Increase in employee benefit and other provisions		1.2	2.0	6.6
Cash generated from operations before tax and exceptional items		450.3	552.0	376.9

33)Financial risk management

Overall risk management policy

The Company’s activities expose it to a variety of financial risks, including currency risk, interest rate risk, credit risk and liquidity risk.

The Company’s overall risk management program focuses on minimizing potential adverse effects on the Company’s financial performance. Where appropriate, the Company uses derivative financial instruments to hedge certain risk exposures.

Risk management is led by senior management and executed according to Company policy. All hedging activity is carried out by a central treasury department that evaluates and hedges financial risks according to forecasts provided by the Company’s operating units.

Derivatives and hedging

Derivatives are used for economic hedging purposes and not as speculative investments. Where derivatives do not meet hedge accounting criteria, they are classified as 'fair value through profit or loss' for accounting purposes and are accounted for at fair value through profit or loss. They are presented as current assets or liabilities to the extent they are expected to be settled within 12 months after the end of the reporting period. The Company's derivative financial instruments are disclosed within Note 34.

Hedge accounting is applied to remove the accounting mismatch between the hedging instrument and the hedged item. The effective portion of the change in the fair value of the hedging instrument is accounted for in the translation reserve or cash flow hedge reserve through Other Comprehensive Income and will be recognized in profit or loss in the same period as the hedged item. Movements in the Company's translation reserve and cash flow hedging reserve are presented in Notes 28 and 29 respectively. The Company's accounting policy for hedge accounting is disclosed within Note 3.

F-65

On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior USD Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction was considered to be a substantial modification of the hedging instruments, so is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that were previously used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss of €6.8 million, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 10. The cash flow hedge reserve related to the previous hedge relationship will be released on a straight line basis until May 2022.

As at December 31, 2021, the Company has $916.4 million of U.S. Dollar LIBOR floating rate debt. The Company uses cross currency interest rate swaps to convert this into €827.8 million of debt with a fixed rate of interest and designated as a cash flow hedge.

In creating cash flow hedges over U.S. Dollar debt, the Company enters into cross currency hedging arrangements with matching critical terms as the hedged item, such as reference rate, reset dates, payment dates, and notional amount. As part of the extension of the cross currency interest rate swaps on July 29, 2021 the Company entered into off market derivatives with an embedded financing component. Amortization of the embedded financing component shall lead to some ineffectiveness in the hedging relationship.

There was no material ineffectiveness during 2021 in relation to the cross currency interest rate swaps.

The effects of the cash flow hedging instruments on the Company's financial position and performance are as follows:

All amounts stated in €m, unless otherwise stated	December 31, 2021	December 31, 2020
USD - cross currency interest rate swaps
Carrying amount of liability	(20.6)	(89.5)
Notional amount (USD)	$916.4	$926.0
Maturity date	5/15/2024	5/15/2022
Change in fair value of outstanding hedging instruments since January 1	68.9	(71.0)
(Gain)/loss in value of hedged item used to determine effectiveness	(69.6)	71.0
Weighted average hedged rate for the year	1.11	1.11

The effects of the net investment hedging instruments on the Company's financial position and performance are as follows:

All amounts stated in €m, unless otherwise stated	December 31, 2021	December 31, 2020
UK cross-currency interest rate swaps hedge
Carrying amount of cross-currency interest rate swaps	—	14.3
Notional amount (GBP)	—	£220.2
Maturity date	7/29/2021	5/15/2022
Change in fair value of cross-currency interest rate swaps as a result of foreign currency movements since January 1	(12.9)	13.5
Loss/(gain) in value of hedged item used to determine hedge effectiveness	12.9	(13.5)
Weighted average hedged rate for the year	1.19	1.19

The impact of the net investment hedge is taken directly to equity via the foreign currency translation reserve. The amount taken to this reserve that arose on the translation of the notional component of cross currency interest rate swaps was a loss of €12.9 million (2020: €13.5 million gain).

F-66

In determining hedge effectiveness for a net investment hedge, the economic relationship between hedging instrument and balance sheet exposure should be established including the notional amount and currency of the underlying investment. Hedge ineffectiveness may arise due to the value of the hedged item being less than the notional value of the hedging instrument. There was no material ineffectiveness in the net investment hedge in either 2021 or 2020. The ineffective amount taken through the Consolidated Statements of Profit or Loss in 2021 amounted to €nil (2020: €nil).

The Company's policy is to reduce its risk of foreign exchange movements on material operating cash flows in currencies other than the operating entity's functional currency using forward foreign exchange contracts designated as cash flow hedges. These forecast cash flows represent the hedged item and is subject to management assessment.

In order to qualify as a cash flow hedge, the hedging instrument must meet the requirements of IFRS 9, including alignment of the critical terms between the hedging instrument and hedged item. The group designates the forward component of forward contracts as the hedging instrument.

Hedge ineffectiveness may arise if timing of the forecast transaction changes from what was originally estimated, if credit dominates the relationship between hedged item of hedging instrument. There was no material ineffectiveness during 2021 in relation to the forward foreign exchange contracts.

The effects of the foreign currency hedging instruments on the Company's financial position and performance are as follows:

As at December 31, 2021	EUR/USD	GBP/USD	GBP/EUR	SEK/EUR	SEK/USD	Other Currencies
	€m	€m	€m	€m	€m	€m
Derivative financial instruments - forward currency contracts
Carrying amount of (liability)/asset	17.5	1.2	(6.7)	0.5	0.1	0.3
Notional amount	343.6	58.4	244.7	70.4	4.5	96.4
Fair value (gains)/losses of outstanding hedging instruments since January 1	(26.3)	(0.5)	12.0	(0.9)	13.5	0.6
Weighted average hedge rate for the year	1.20	1.38	1.15	0.10	0.11	—

As at December 31, 2020	EUR/USD	GBP/USD	GBP/EUR	SEK/EUR	SEK/USD	Other Currencies
	€m	€m	€m	€m	€m	€m
Derivative financial instruments - forward currency contracts
Carrying amount of asset/(liability)	(21.9)	(3.7)	1.4	(4.0)	(2.6)	(0.5)
Notional amount	249.0	53.5	159.0	77.3	14.1	16.8
Fair value (gains)/losses of outstanding hedging instruments since January 1	(20.6)	(2.0)	8.5	(4.2)	(2.2)	0.8
Weighted average hedge rate for the year	1.13	1.28	1.12	0.09	0.10	0.21

Gains/losses in the year from foreign exchange swap contracts used for liquidity purposes designated as fair value through the Consolidated Statements of Profit or Loss amounted to a €0.6 million gain (2020: €2.4 million loss, 2019: €4.8 million gain).

Losses in the year from cross currency interest rate swap contracts designated as fair value through the Consolidated Statement of Profit or Loss amounted to a €14.3 million loss (2020: €3.2 million loss, 2019: €13.6 million loss).

F-67

Market risk (including foreign exchange and interest rate risk)

In managing market risks, the Company aims to minimize the impact of short term fluctuations on the Company’s earnings. Over the longer term, permanent changes in both foreign exchange rates and interest rates will have an impact on consolidated earnings. 

Currency risk Foreign currency risk on assets and liabilities in currencies other than functional currency

Foreign Exchange

translation risk    The Company is exposed to foreign exchange translation risk arising from the translation of assets and liabilities denominated in currencies other than the Euro. Key areas of foreign currency exposure include non-Euro debt and investments in subsidiaries not held in Euro. Company policy is to mitigate the potential foreign exchange translation risk by converting where appropriate, borrowings into Euro. This has been achieved on the Senior USD Loan through the use of cross currency interest rate swaps designated as a cash flow hedge. The Company also hedged translation exposure on consolidation of GBP net assets through the use of cross currency interest rate swaps designated as a net investment hedge. The net investment hedge was discontinued when CCIRS contracts that were used as a net investment hedge of the Company’s investments in Pound Sterling were extinguished.

Mitigation & Impact on

Statement of Financial    Foreign exchange translation risk resulting from the translation of non-Euro

Position    Denominated borrowings into Euros, to the extent that they are hedged will be mitigated by the translation of the underlying cross currency interest rate hedging arrangements.

Currency risk Foreign currency risk on purchases

The Company is exposed to foreign exchange risk where a business unit has material operating cash flows in a currency other than the functional currency of that entity.

The most significant exposures for the Company are the purchase of raw materials, stock and services purchased in U.S. Dollars and Euros.

Mitigation & Impact on    The Company’s policy is to reduce this risk by using foreign exchange forward contracts

Statement of Financial    that are designated as cash flow hedges.

Position / Equity    

    As at December 31, 2021, the fair value of USD forward contracts entered into to hedge the future purchase of U.S. Dollars in EUR, GBP and SEK functional currency entities is an asset of €18.8 million (2020: €28.3 million liability). All forecast transactions are still expected to occur. As at December 31, 2021, 95.1% (2020: 87.9%) of forecast future U.S. Dollar payments to the end of 2022 were hedged through the use of forward contracts and existing cash. All forward contracts have been designated as cash flow hedges and have a maturity within the next 12 months.

The fair value of the Euro forward contracts with reference to non-Euro functional currencies as at December 31, 2021, is a liability of €5.9 million (2020: €3.1 million). As at December 31, 2021, 77.2% (2020: 84.9%) of forecast future net Euro payments to the end of 2022 were hedged through the use of forward contracts and existing cash. All forward contracts have been designated as cash flow hedges and have a maturity within the next 12 months.

Sensitivity analysis    During 2021, the Euro weakened by 7.3% against Pound Sterling (2020: strengthened by 5.2%, 2019: weakened by 5.3%), weakened by 7.8% against the U.S. Dollar (2020: strengthened by 9.6%, 2019: weakened by 2.0%) and strengthened by 1.8% against the Swedish Krona (2020: weakened by 3.8%, 2019: strengthened by 2.2%).

The table below illustrates the hypothetical sensitivity of the Company’s reported profit and closing equity to a 1% movement in the EUR/GBP, EUR/USD and EUR/SEK exchange rates at the reporting date, assuming all other variables remain unchanged. This analysis is for illustrative purposes only, as in practice the foreign exchange rates rarely change in isolation. Figures are presented post-tax.

F-68

The analysis assumes that exchange rate fluctuations on foreign exchange derivatives that form part of an effective cash flow hedge relationship affect the cash flow hedge reserve in equity. For foreign exchange derivatives which are not designated hedges, movements in exchange rates impact the Income Statement.

Positive figures represent an increase in profit or equity.

	Profit or loss		Equity
	2021	2020	2021	2020
	€m	€m	€m	€m
1% increase in the value of the Euro against Pound Sterling	—	0.7	1.5	2.8
1% increase in the value of the Euro against U.S. Dollar	—	—	(2.0)	(1.4)
1% increase in the value of the Euro against Swedish Krona	(0.4)	(0.4)	0.4	0.5

A 1% decrease in the value of the Euro against the currencies identified in the table above would result in a equal and opposite movement to the values disclosed in the table above. This analysis is for illustrative purposes.

On an annualized 2021 basis, and assuming all other factors remain constant, for each 1% movement in value of the Euro against Pound Sterling, the impact to the Company profit or loss before tax would be approximately €3.3 million (2020: €3.0 million), excluding the impact of any forward contracts.

On an annualized 2021 basis, and assuming all other factors remain constant, for each 1% movement in value of the Euro against the U.S. Dollar, the impact to the Company profit or loss before tax would be approximately €3.0 million (2020: €3.0 million), excluding the impact of any forward contracts.

On an annualized 2021 basis, and assuming all other factors remain constant, for each 1% movement in value of the Euro against Swedish Krona, the impact to the Company profit or loss before tax would be approximately €1.0 million (2020: €1.1 million), excluding the impact of any forward contracts.

We do not expect purchase levels to be materially different in the coming year.

Interest rate risk

Description    The Company is exposed to changes in interest rates to the extent that it enters into floating rate borrowings, including the senior loans.

Mitigation & Impact on

Equity / Income The Company’s policy on interest rate risk is to mitigate the Company’s exposure to fluctuations

Statement    in interest rates.

    As a result of decisions taken by national regulators, GBP LIBOR and certain USD LIBOR time periods were phased out at the end of Dec 2021 and replaced by alternative reference indexes (SONIA and SOFR). Our expectation is that both debt agreements and hedging contracts will be aligned to the new benchmarks as they become known, and as such it is highly probable that the existing hedging relationships can be continued. It is expected that the transition to the new benchmarks, to the extent not already reflected in the current financing facilities, will occur during the refinance of the USD Term Loan.

There are no current plans to phase out EURIBOR. If EURIBOR ceases to exist, we will need to renegotiate our Senior Facilities Agreement with our lenders and associated cross currency interest rate swaps.

F-69

Sensitivity analysis    During 2021, three month EURIBOR rates remained below zero (2020: no change). Within the Euro denominated senior loans, there is a EURIBOR floor of 0%.

If interest rates were to move by 1%, this would have a correspondingly decrease or increase in the Company’s profit/(loss) before tax by approximately €2.6 million (2020: €5.6 million), subject to the EURIBOR floor of 0%.

Credit risk

Description    Credit risk arises on cash and cash equivalents, derivative financial instruments with banks and financial institutions, any short term investments, as well as on credit exposures to customers. See Note 18 for analysis of the trade receivables balance and Note 20 for analysis of the cash and cash equivalents balance. The maximum exposure to credit risk at the end of the reporting period is the carrying amount of each class of financial assets.

Mitigation    The Company limits counterparty exposures by monitoring each counterparty carefully and where possible, sets credit limits according to approved treasury policy. The Company limits its exposure to individual financial institutions by diversification of exposure across a range of financial institutions.

The credit quality of customers is assessed taking into account their financial position, past experience and other factors. Credit limits are set for customers and regularly monitored to mitigate ongoing payment risk.

Liquidity risk

Description    The Company is exposed to the risk that it is unable to meet its commitments as they fall due. The Company has financial conditions, including financial covenants as part of the Senior debt arrangements which it must comply with in order to maintain its current level of borrowings. There have been no breaches of the covenants throughout the year.

Mitigation    The Company ensures that it has sufficient cash and available funding through regular cash flow and covenant forecasting. The Company uses liquidity swaps to manage timing of cash flows in non-functional currencies. These swaps are accounted for as FVTPL. In addition, the Company has access to a revolving credit facility of €175.0 million, expiring in June 2026. This is available for general corporate purposes. Currently €2.8 million is utilized for letters of credit, overdrafts, customs bonds and bank guarantees.

Capital risk management

The objective of the Company when considering total capital is to protect the value of capital investments and to generate returns on shareholder funds. Total capital is defined as including Loans and Borrowings and equity, including derivatives used for the purpose of hedging currency and interest exposure on Loans and Borrowings, but excluding the cash flow hedging reserve.

In support of its objectives, the Company may undertake actions to adjust its capital structure accordingly. Actions may include, but not limited to, raising or prepayment of Borrowings together with related derivative instruments, issuance of additional share capital, payment of dividends or share repurchase programs.

Maturity analysis

The USD senior loan includes the annual requirement to repay 1% of the original issued notional of $9.6 million (€8.7 million) (2020: €8.7 million) In addition, the Senior Facilities Agreement also includes an excess cash flow calculation whereupon an amount of principal shall be repaid based upon terms including cash generated and leverage. Based upon the calculation as at December 31, 2021, no excess cash flow will be repayable in 2022 (2020: nil repayable in 2021).

The tables below show a maturity analysis of contractual undiscounted cash flows prepared using forward interest rates where applicable, showing items at the earliest date on which the Company could be required to pay the liability:

F-70

2021	2022	2023	2024	2025	2026	Over 5 years	Total
	€m	€m	€m	€m	€m	€m	€m
Borrowings-principal	8.5	8.5	791.7	—	—	1,353.2	2,161.9
Borrowings-interest	57.5	63.5	50.4	34.0	34.1	67.0	306.5
Forward contracts Sell	805.3	—	—	—	—	—	805.3
Forward contracts Buy	(818.0)	—	—	—	—	—	(818.0)
Cross Currency Interest Rate Swaps Pay	25.0	24.9	818.5	—	—	—	868.4
Cross Currency Interest Rate Swaps Receive	(30.8)	(38.0)	(808.0)	—	—	—	(876.8)
Lease Liabilities	23.1	18.2	11.2	7.3	5.6	25.2	90.6
Trade and other payables excluding non-financial liabilities	647.1	—	—	—	—	—	647.1
Total	717.7	77.1	863.8	41.3	39.7	1,445.4	3,185.0

2020	2021	2022	2023	2024	2025	Over 5 years	Total
	€m	€m	€m	€m	€m	€m	€m
Borrowings-principal	7.8	7.8	7.8	1,683.1	—	—	1,706.5
Borrowings-interest	46.6	46.8	47.2	20.4	—	—	161.0
Forward contracts Sell	677.3	—	—	—	—	—	677.3
Forward contracts Buy	(647.5)	—	—	—	—	—	(647.5)
Cross Currency Interest Rate Swaps Pay	38.5	1,135.9	—	—	—	—	1,174.4
Cross Currency Interest Rate Swaps Receive	(34.6)	(1,059.0)	—	—	—	—	(1,093.6)
Lease Liabilities	17.2	13.6	9.9	6.2	5.2	28.1	80.2
Trade and other payables excluding non-financial liabilities	601.1	—	—	—	—	—	601.1
Total	706.4	145.1	64.9	1,709.7	5.2	28.1	2,659.4

34)Financial instruments

Categories of financial instruments

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2021	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	201.6	—	—	—	—	201.6
Derivative financial instruments	—	—	0.5	19.7	—	20.2
Cash and cash equivalents	254.2	—	—	—	—	254.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(647.1)	(647.1)
Derivative financial instruments	—	—	(0.1)	(28.0)	—	(28.1)
Loans and borrowings (1)	—	—	—	—	(2,236.8)	(2,236.8)
Total	455.8	—	0.4	(8.3)	(2,883.9)	(2,436.0)

(1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21.

F-71

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2020	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	141.2	—	—	—	—	141.2
Derivative financial instruments	—	—	2.9	19.8	—	22.7
Cash and cash equivalents	393.2	—	—	—	—	393.2
Short - term investments	—	25.0	—	—	—	25.0
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(601.1)	(601.1)
Derivative financial instruments	—	—	(0.2)	(124.8)	—	(125.0)
Loans and borrowings (2)	—	—	—	—	(1,765.7)	(1,765.7)
Total	534.4	25.0	2.7	(105.0)	(2,366.8)	(1,909.7)

(2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21.

Fair values

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values.

Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange.

Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. 

Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for non binding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed.

While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company.

F-72

(i)Derivative financial instruments

Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’.

(ii)Trade and other payables/receivables

The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash.

(iii)Cash and cash equivalents

The carrying value of cash and cash equivalents is deemed to equal fair value.

(iv)Short-term investments

Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. The Company has classified these as level 2 instruments as defined in IFRS 13 “Fair value measurement”.

(v)Interest bearing loans and liabilities

The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities.

On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028 (the “Notes”). Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Notes, eligible transaction costs of approximately €4.0 million were capitalized and will be amortized over the life of the debt.

On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75.

On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of approximately €3.8 million were capitalized and will be amortized over the life of the debt.

Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum and that includes a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions.

The Company continues to have outstanding senior USD loans as at December 31, 2021 of $916.4 million (€808.6 million) (the “Senior USD Loan”). The Senior USD Loan is repayable in May 2024. The Senior USD Loan requires a repayment of $9.6 million (€8.5 million) in May each year until maturity equivalent to 1.0% of the original issued notional.

F-73

Furthermore as part of the senior loan structure, the Company is additionally required to undertake an annual excess cash flow calculation whereby additional principal could be paid.

The Company uses cross currency interest rate swaps (“CCIRS”) to convert its $916.4 million of floating rate Senior USD Loans into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge.

On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior Secured USD Term Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction is considered to be a substantial modification of the hedging instruments, so is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that have previously been used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 10. The cash flow hedge reserve related to the previous hedge relationship will be released on a straight line basis until May 2022.

The senior loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries.

	Fair value		Carrying value
	December 31, 2021	December 31, 2020	December 31, 2021	December 31, 2020
	€m	€m	€m	€m
Senior EUR/USD loans	1,360.8	1,300.4	1,355.8	1,295.1
Other external debt	0.1	0.2	0.1	0.2
2024 fixed rate senior secured notes	—	405.8	—	400.0
2028 fixed rate senior secured notes	802.6	—	800.0	—
Less deferred borrowing costs	—	—	(9.4)	(6.9)
	2,163.5	1,706.4	2,146.5	1,688.4

Derivatives

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Cross Currency Interest Rate Swaps	—	17.2
Forward foreign exchange contracts	20.2	5.5
Total assets	20.2	22.7
Cross Currency Interest Rate Swaps	(20.6)	(89.5)
Forward foreign exchange contracts	(7.3)	(35.5)
Total liabilities	(27.9)	(125.0)
Total	(7.7)	(102.3)

Offsetting of derivatives

Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default.

F-74

The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements.

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2021	€m	€m	€m
Derivatives - assets	20.2	(10.8)	9.4
Derivatives - liabilities	(27.9)	10.8	(17.1)

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2020	€m	€m	€m
Derivatives - assets	22.7	(22.7)	—
Derivatives - liabilities	(125.0)	22.7	(102.3)

35)Commitments

Future aggregate minimum contractual payments under non-cancellable service agreements and lease rentals for short-lived and low-value assets are payable as follows:

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Less than one year	2.2	1.9
Between one and three years	4.1	3.5
Between three and five years	2.2	2.0
More than five years	0.2	0.1
Total	8.7	7.5

These agreements may be subject to contractual annual increases linked to inflation indices. The payments shown above exclude the impact of these contractual increases which cannot be reliably estimated.

36)Capital commitments

Capital expenditure contracted for at the end of the reporting period but not yet incurred is as follows:

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Property, plant and equipment	21.3	13.6
Intangible assets	1.7	3.4
Total	23.0	17.0

37)        Related parties

Founder Preferred Shares

Nomad has issued Founder Preferred Shares to its Founder Entities. 

The conditions of the Founder Preferred Shares Annual Dividend Amount in 2018, 2019 and 2020 were met and further details relating to these dividends is set out in Note 27.

F-75

Advisory Services Agreements

On June 15, 2015, the Company entered into an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of Mr. Franklin, and TOMS Capital LLC, an affiliate of Mr. Gottesman. Pursuant to the terms of the Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC provide high-level strategic advice and guidance to the Company. Under the terms of the Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC are entitled to receive an aggregate annual fee equal to $2.0 million, payable in quarterly installments. This agreement expires on June 1st annually and will be automatically renewed for successive one-year terms unless any party notifies the other parties in writing of its intention not to renew the agreement no later than 90 days prior to the expiration of the term. The agreement may only be terminated by the Company upon a vote of a majority of its directors. In the event that the agreement is terminated by the Company, the effective date of the termination will be 6 months following the expiration of the initial term or a renewal term, as the case may be.

On January 1, 2022, the Company entered into an Amended and Restated Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of Sir Martin, and TOMS Capital LLC, an affiliate of Mr. Gottesman. Pursuant to the terms of the Amended and Restated Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC provide high-level strategic advice and guidance to the Company. Under the terms of the Amended and Restated Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC are entitled to receive an aggregate annual fee equal to $4.0 million, payable in quarterly installments. This agreement expires on January 1st annually and will be automatically renewed for successive one-year terms unless any party notifies the other parties in writing of its intention not to renew the agreement no later than 90 days prior to the expiration of the term. The agreement may only be terminated by the Company upon a vote of a majority of its directors. In the event that the agreement is terminated by the Company, the effective date of the termination will be 6 months following the expiration of the initial term or a renewal term, as the case may be.

Total fees and expenses of €0.8 million and €0.8 million were incurred by Mariposa Capital, LLC and TOMS Capital LLC respectively in the course of their duties and were reimbursed in the year ending December 31, 2021 (year ended December 31, 2020: €1.0 million and €0.9 million respectively).

During 2020, the Company entered into an agreement with a working capital solutions specialist to facilitate a program that provides our suppliers with the ability to receive advance payments from a third party credit institution as part of our ordinary course of business payables, in exchange for a discounted invoice amount. The working capital solutions specialist is owned in part by affiliates of JRJ Group (of which one of our non-executive directors, Mr. Isaacs, is a founding partner) and TOMS Capital LLC (of which Mr. Gottesman is the founder and managing partner). Amounts paid by the Company to the working capital solutions specialist related to setup during 2020 were less than €0.1 million and are not considered to be material to either party. Ongoing fees associated with this service are received by the working capital solutions specialist directly from our suppliers utilizing the service.

Directors and Key Management

All significant management decision making authority is vested within the Board of Directors and the Executive Team, therefore key management are considered to be the Directors and Executive Officers. Their remuneration has been disclosed in Note 9.

In May 2020, former and current Non-Executive Directors were issued shares, exercising all the remaining initial options outstanding as detailed in Note 25.

Non-executive Directors continue to receive fees for their services as board members and to certain committees and are settled through payroll. Director fees are payable quarterly in arrears. Total Non-executive Director fees and expenses for the year ending December 31, 2021 was €0.4 million (year ended December 31, 2020: €0.3 million).

Non-Executive Directors are also eligible to an annual restricted stock grant issued under the LTIP which will vest on the earlier to occur of the date of the Company’s annual meeting of shareholders or thirteen months from the date of grant. Details of the annual restricted stock grants under the LTIP can be found in Note 8(b).

As part of its long term incentive initiatives, the Company has 2,016,855 restricted shares outstanding to the management team (the “Management Share Awards”). The Directors and Executive Officers have all been awarded shares. The associated performance metrics and valuation method is detailed in Note 8(b).

F-76

38)    Significant events after the Statement of Financial Position date

From January 1, 2022 to March 2, 2022, the Company has repurchased and canceled an additional 1,160,547 ordinary shares in open market transactions for $30.5 million (€26.9 million) under its previously announced share repurchase program authorized by Nomad’s Board of Directors in August 2021.

F-77

Item 19.    Exhibits

The following exhibits are filed as part of this annual report:

EXHIBIT INDEX

		Incorporation by Reference
Exhibit  No.	Exhibit Description	Form	Exhibit  No.	Period Covered or Date of Filing	Filed with this Annual Report
1.1	Amended and Restated Memorandum and Articles of Association.	6-K (001-37669)	99.1	1/14/2016
2.1	Registration Rights Agreement dated as of June 1, 2015 among Nomad Holdings Limited, Birds Eye Iglo Limited Partnership Inc, Mariposa Acquisition II, LLC, TOMS Acquisition I LLC, TOMS Capital Investments LLC and funds managed by Pershing Square.	F-1 (333-208181)	4.1	11/24/2015
2.2	Indenture dated as of May 3, 2017 among Nomad Foods Bondco PLC, Nomad Foods Limited, Deutsche Trustee Company Limited, Deutsche Bank AG, London Branch, Deutsche Bank Luxembourg S.A., and Credit Suisse AG, London Branch and the Subsidiary Guarantors named therein.	6-K (001-37669)	99.3	5/3/2017
2.3	Description of Securities.				X
4.1	Share Sale and Purchase Agreement, dated as of October 29, 2015, among Liongem Sweden 1 AB, Iglo Foods Group Limited and Nomad Foods Limited	F-1 (333-208181)	2.2	11/24/2015
4.2	Intercreditor Agreement, originally dated as of July 3, 2014, as amended and restated from time to time including, pursuant to the 2017 Amendment and Restatement Agreement among Nomad Foods Limited, Credit Suisse AG, London Branch, Deutsche Bank Company Limited and certain entities named therein.	6-K (001-37669)	99.2	5/3/2017
4.3	Amendment and Restatement Agreement, dated June 15, 2018, relating to Senior Facilities Agreement, originally dated July 3, 2014, as amended and restated from time to time, including pursuant to Amendment and Restatement Agreement dated December 20, 2017 for Nomad Foods Limited with Credit Suisse AG, London Branch.	20-F (001-37669)	4.3	2/27/2020
4.4	Nomad Foods Limited Amended and Restated Long-Term 2015 Incentive Plan.	20-F (001-37669)	4.4	2/27/2020
4.5	Nomad Foods Limited Long Term 2015 Incentive Plan Restricted Share Unit Agreement.	20-F (001-37669)	4.5	2/27/2020
4.6	Service Agreement between the Company and Stéfan Descheemaeker.	F-1 (333-208181)	10.3	11/24/2015
4.6A	Amended and Restated Service Agreement between the Company and Stéfan Descheemaeker, dated May 1, 2020.	6-K (001-37669)	99.1	5/5/2020
4.7	Service Agreement, dated as of February 15, 2018, between the Company and Samy Zekhout.	20-F (001-37669)	4.7	3/22/2018
4.8	Advisory Services Agreement, dated as of June 15, 2015, among Nomad Foods Limited, Mariposa Capital, LLC and TOMS Capital LLC.	F-1 (333-208181)	10.5	11/24/2015
4.8A	Amended and Restated Advisory Services Agreement, dated as of January 1, 2022, among Nomad Foods Limited, Mariposa Capital, LLC and TOMS Capital LLC.				X

F-78

		Incorporation by Reference
Exhibit  No.	Exhibit Description	Form	Exhibit  No.	Period Covered or Date of Filing	Filed with this Annual Report
8.1	List of Significant Subsidiaries.				X
12.1	Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.				X
12.2	Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.				X
13.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
13.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
15.1	Consent of PricewaterhouseCoopers LLP				X
101.INS	XBRL Instance Document				X
101.SCH	XBRL Taxonomy Extension Schema Document				X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document				X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document				X
101.LAB	XBRL Taxonomy Extension Label Linkbase Document				X
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document				X

F-79

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on Form 20-F on its behalf.

Date:    March 3, 2022

NOMAD FOODS LIMITED

By: /s/ Samy Zekhout                                                 

Name: Samy Zekhout

Title:    Chief Financial Officer

F-80

EX-2.3

NOMAD FOODS LIMITED

DESCRIPTION OF SECURITIES

As of December 31, 2021, Nomad Foods Limited had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended – its ordinary shares of no par value (the “Ordinary Shares”). References herein to “we,” “us,” “our” and “Company” refer to Nomad Foods Limited.

The following description of our securities is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Amended and Restated Memorandum and Articles of Association, which we refer to as our Memorandum and Articles, which are incorporated by reference as an exhibit to the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission of which this Exhibit is a part. We encourage you to read our Memorandum and Articles and the applicable provisions of British Virgin Islands law for additional information.

General

Our Memorandum and Articles authorize the issuance of an unlimited number of shares of no par value, which may be Ordinary Shares or founder preferred shares (the “Founder Preferred Shares”). As of December 31, 2021, 173,559,173 Ordinary Shares and 1,500,000 Founder Preferred Shares were issued and outstanding. Our Ordinary Shares are listed on the New York Stock Exchange under the trading symbol “NOMD”.

Ordinary Shares

The following summarizes the rights of holders of our Ordinary Shares:

Voting Rights

Each holder of our Ordinary Shares is entitled to one vote per Ordinary Share on all matters to be voted on by shareholders generally and to vote together with the holders of Founder Preferred Shares. The affirmative vote of a majority of the votes of the shares entitled to vote which either were present at a meeting and were voted, or consented in writing, is required to approve action on a matter.

Dividends

Subject to the rights of the holders of the Founder Preferred Shares, the holders of our Ordinary Shares are entitled to share ratably in dividends and other distributions as may be declared from time to time by our board of directors out of funds legally available for that purpose, if any.

Dissolution; Liquidation

Subject to the BVI Business Companies Act, 2004 (as amended) (the “BVI Act”), upon our liquidation, dissolution or winding up, the holders of our Ordinary Shares, along with holders of our Founder Preferred Shares, will be entitled to the distribution of the remaining assets pro rata to the number of fully paid up shares held by each holder relative to the total number of issued and fully paid up Ordinary Shares as if the fully paid up Founder Preferred Shares had been converted into Ordinary Shares immediately prior to the winding up.

Transfer

Subject to the BVI Act and the terms of the Memorandum and Articles, any shareholder may transfer all or any portion of his, her or its Ordinary Shares.

Variation of Rights

As permitted by British Virgin Islands law and our Memorandum and Articles, we may vary the rights attached to any class, including our Ordinary Shares, with the written consent of at least 50% of the holders of each class of shares affected or by a resolution passed by at least 50% of the votes cast by eligible holders of the issued shares of the affected class at a separate meeting of the holders of that class.

Other Matters

Our Ordinary Shares carry no preemptive rights and are not redeemable (other than by agreement between the Company and the relevant shareholder) or entitled to the benefits of any sinking fund or liable for further capital calls. There are no limitations on the rights to own securities, including the rights of non-resident or foreign shareholders to hold or exercise voting rights on the securities imposed by British Virgin Islands law or by the Memorandum and Articles.

Founder Preferred Shares

Defined Terms

In the following summary of the material provisions of our Founder Preferred Shares and our Memorandum and Articles, the following words have the following meanings:

Acquisition means the Company’s acquisition of Iglo Foods Holdings Limited and its consolidated subsidiaries on June 1, 2015;

Admission means the initial admission of the Ordinary Shares to the standard listing segment of the Official List maintained by the UKLA and to trading on the London Stock Exchange’s main market for listed securities, which occurred on April 15, 2014;

Annual Dividend Amount means: A x B where:

A = an amount equal to 20% of the increase (if any) in the value of an Ordinary Share. Such increase shall be calculated as being the difference between (i) the Dividend Price for that Dividend Year and (ii) (a) if no Annual Dividend Amount has previously been paid, a price of US$10.00 per Ordinary Share, or (b) if an Annual Dividend Amount has previously been paid, the highest Dividend Price for any prior Dividend Year, provided that in each case such amount is subject to such adjustment either as the directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the Ordinary Shares in issue after the date of Admission or otherwise as determined in accordance with Article 5.4 of our Memorandum and Articles; and B = the Preferred Share Dividend Equivalent;

Average Price means for any security, as of any date (or relevant period, as applicable): (i) in respect of Ordinary Shares or any other security, the volume weighted average price for such security on the London Stock Exchange as reported by Bloomberg through its “Volume at Price” functions; (ii) if the London Stock Exchange is not the principal securities exchange or trading market for that security, the volume weighted average price ofthat security on the principal securities exchange or trading market on which that security is listed or traded as reported by Bloomberg through its “Volume at Price” functions; (iii) if the foregoing do not apply, the last closing trade price of that security in the over-the-counter market on the electronic bulletin board for that security as reported by Bloomberg; or (iv) if no last closing trade price is reported for that security by Bloomberg, the last closing ask price of that security as reported by Bloomberg. If the Average Price cannot be calculated for that security on that date on any of the foregoing bases, the Average Price of that security on such date shall be the fair market value as mutually determined by the Company and the holders of the majority of outstanding Founder Preferred Shares (acting reasonably);

Bloomberg means Bloomberg Financial Markets;

Change of Controlmeans the acquisition of Control of the Company by any person or party (or by any group of persons or parties who are acting in concert);

Control means (a) the power (whether by way of ownership of shares, proxy, contract, agency or otherwise) to: (i) cast, or control the casting of, more than 50 (fifty) per cent. of the maximum number of votes that might be cast at a meeting of Members; or (ii) appoint or remove all, or the majority, of the directors or other equivalent officers of the Company; or (iii) give directions with respect to the operating and financial policies of the Company with which the directors or other equivalent officers of the Company are obliged to comply; and/or (b) the holding beneficially of

more than 50 (fifty) per cent. of the issued shares of the Company (excluding any issued shares that carry no right to participate beyond a specified amount in a distribution of either profits or capital);

Dividend Determination Period means the last ten consecutive Trading Days of a Dividend Year;

Dividend Price means the Average Price per Ordinary Share for the Dividend Determination Period in the relevant Dividend Year;

Dividend Year means the period commencing on the date of Admission and ending on the last day of the Company’s first financial year, and thereafter each financial year of the Company;

London Stock Exchangemeans the London Stock Exchange plc;

paid up in relation to shares means fully paid or credited as fully paid, but excludes partly paid shares;

Payment Date means a day no later than ten Trading Days after the last day of the relevant Dividend Year, except in respect of any Annual Dividend Amount becoming due on the Trading Day immediately prior to the date of commencement of the Company’s liquidation, in which case the Payment Date shall be such Trading Day, and except in respect of any Annual Dividend Amount becoming due on account of an automatic conversion immediately upon a Change of Control pursuant to Article 5.1(a) of the Memorandum and Articles, in which case the Payment Date shall be the Trading Day immediately after such event;

Preferred Share Dividend Equivalentmeans 140,220,619 Ordinary Shares, being such number of Ordinary Shares outstanding immediately following the Acquisition but excluding any Ordinary Shares issued to shareholders or other beneficial owners of a company or business acquired pursuant to or in connection with the Acquisition (which total number is subject to such adjustment either as the directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the Ordinary Shares in issue after the date of admission to the LSE or otherwise as determined in accordance with Article 5.4 of the Memorandum and Articles relating to the treatment of stock splits, stock dividends and similar events); and

Trading Day means any day on which the New York Stock Exchange (or such other applicable securities exchange or quotation system) is open for business and on which the Ordinary Shares may be dealt in (other than a day on which the New York Stock Exchange (or such other applicable securities exchange or quotation system) is scheduled to or does close prior to its regular weekday closing time).

The following summarizes the rights of holders of our Founder Preferred Shares:

Voting Rights

Each holder of our Founder Preferred Shares is entitled to one vote per Founder Preferred Share on all matters to be voted on by shareholders generally and to vote together with the holders of Ordinary Shares. The affirmative vote of a majority of the votes of the shares entitled to vote which either were present at a meeting and were voted, or consented in writing, is required to approve action on a matter.

Dividends

Commencing on January 1, 2015 and for each financial year thereafter:

a.once the average price per Ordinary Share for the Dividend Determination Period, i.e. the last ten consecutive trading days of a year is at least $11.50 (which condition was satisfied for the year ended December 31, 2015), holders of our Founder Preferred Shares have the right to receive a Founder Preferred Shares Annual Dividend Amount, payable in Ordinary Shares or cash, at the Company’s sole option; and

a.holders of our Founder Preferred Shares have the right to receive dividends and other distributions as may be declared from time to time by the Company’s board of directors with respect to the Ordinary Shares (such dividends to be distributed among the holders of Founder Preferred Shares, as if for such purpose the Founder Preferred Shares had been converted into Ordinary Shares immediately prior to such distribution)

plus an amount equal to 20% of the dividend which would be distributable on such number of Ordinary Shares equal to the Preferred Share Dividend Equivalent; and

In addition to amounts payable above, holders of Founder Preferred Shares have the right, together with the holders of Ordinary Shares, to receive such portion of all amounts available for distribution and from time to time distributed by way of dividend or otherwise at such time as determined by the directors.

Liquidation

Holders of our Founder Preferred Shares have the right to an equal share (with the holders of Ordinary Shares on a share for share basis) in the distribution of the surplus assets of the Company on its liquidation as are attributable to the Founder Preferred Shares.

Conversion

Founder Preferred Shares are convertible, at the option of the holders, into Ordinary Shares on a 1-for-1 basis (mandatorily upon a Change of Control or the seventh full financial year after an acquisition).

Transfer Agent

The transfer agent for our Ordinary Shares and Preferred Shares is Computershare.

Indemnification Matters

Our Memorandum and Articles provide that we may indemnify any person who is or was a director or who is or was, at our request, serving as a director of, or in any other capacity is or was acting for, another entity, against all expenses, including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings. A person may be indemnified only if he or she acted honestly and in good faith with a view to our best interests and, in the case of criminal proceedings,

had no reasonable cause to believe that his or her conduct was unlawful. The decision of our board of directors as to whether the director or officer acted honestly and in good faith with a view to our best interests and as to whether the director or officer had no reasonable cause to believe that his or her conduct was unlawful, is in the absence of fraud sufficient for the purpose of indemnification, unless a question of law is involved. The termination of any proceedings by any judgment, order, settlement, conviction or the entry of no plea does not, by itself, create a presumption that a director or officer did not act honestly and in good faith and with a view to our best interests or that the director or officer had reasonable cause to believe that his or her conduct was unlawful.

In addition, we have agreed with our directors, subject to the BVI Act, to indemnify them against a number of liabilities and expenses incurred by such persons in connection with claims made by reason of their being such a director or officer.

We may purchase and maintain insurance in relation to any of our directors or officers against any liability asserted against the directors or officers and incurred by the directors or officers in that capacity, whether or not we have or would have had the power to indemnify the directors or officers against the liability as provided in our Memorandum and Articles.

Disclosure Requirements

Our Memorandum and Articles provide that we may, by notice in writing, require any person to whom we know or have reasonable cause to believe to have been interested in our shares at any time during the three years preceding such notice, to confirm whether or not that is the case and to give such further information as may be required by our Memorandum and Articles. If a shareholder is in default of supplying us with the information required within the prescribed period, our directors, in their absolute discretion, may serve a direction notice on the shareholder which may direct that, in respect of the shares in which default has occurred, the shareholder shall not be entitled to attend or vote in meetings of shareholders. Additionally, if the shares in which the default has occurred represent at least 0.25% of the number of the class concerned, the direction notice may direct that dividends on such shares be retained by the Company and that no transfer of the shares shall be registered until the default is rectified.

Comparison of Shareholder Rights Described Herein

We are incorporated under, and are governed by, the laws of the British Virgin Islands. The following discussion summarizes with respect to the matters described herein the material differences between the rights of holders of our Ordinary Shares and the rights of common shareholders of a typical corporation incorporated under the laws of the State of Delaware.

Amendment of Governing Documents

Under Delaware corporate law, with very limited exceptions, a vote of the shareholders of a corporation is required to amend the certificate of incorporation. In addition, Delaware corporate law provides that shareholders have the right to amend the corporation’s bylaws, but the certificate of incorporation may also confer such right on the directors of the corporation.

Sale of Assets

Under Delaware corporate law, a vote of the shareholders is required to approve a sale, lease or exchange of property and assets of a corporation (including property and assets of its qualifying subsidiaries) only when all or substantially all of the corporation’s property and assets are being sold other than to a qualifying subsidiary of the corporation. Under British Virgin Islands law generally, shareholder approval is required when more than 50% of a company’s total assets by value are being disposed of or sold to any person if not made in the usual or regular course of the business carried out by the company. Under our Memorandum and Articles, this requirement of British Virgin Islands law has been disapplied and accordingly no shareholder approval is required in relation to such a disposal or sale.

Redemption of Shares

Under Delaware corporate law, by provision of the certificate of incorporation, any class or series of stock may be made subject to redemption by the corporation at its option, at the option of the holders of that stock or upon the happening of a specified event, provided that after such redemption shares of a class or series of stock with full voting power remain outstanding. The class or series of stock may, by provision of the certificate of incorporation, be made redeemable for cash, property or rights, as specified in the certificate of incorporation or in the resolution of the board of directors providing for the issue of the stock pursuant to the power expressly vested in the board of directors by the certificate of incorporation. Under Delaware corporate law, shares also may be repurchased with the consent of both the corporation and the holder, except that shares may not be repurchased for more than the price at which such shares may then be redeemed at the option of the corporation. Both the redemption and repurchase of shares of a Delaware corporation are subject to certain solvency limitations established by Delaware corporate law and Delaware common law. As permitted by British Virgin Islands law and our Memorandum and Articles, shares may be repurchased, redeemed or otherwise acquired by us. However, the consent of the shareholder whose shares are to be repurchased, redeemed or otherwise acquired must be obtained, except as specified in the terms of the applicable class or series of shares.

Squeeze-Out Merger

Under the Delaware General Corporation Law § 253, in a process known as a “short form” merger, a corporation that owns at least 90% of the outstanding shares of each class of voting stock of another corporation and where at least one of the corporations is a Delaware corporation and the laws of the jurisdiction of the other corporation don’t prohibit such action, may either merge the other corporation into itself or merge itself into the other corporation by executing, acknowledging and filing with the Delaware Secretary of State a certificate of ownership and merger setting forth a copy of the resolution of its board of directors authorizing such merger. If the parent corporation is a Delaware corporation that is not the surviving corporation, the merger also must be approved by a majority of the outstanding stock of the parent corporation entitled to vote thereon and the resolution must include provision for the pro rata issuance of stock of the surviving corporation to the holders of the stock of the parent corporation on surrender of any certificate therefor. If the parent corporation does not own all of the stock of the subsidiary corporation immediately prior to the merger, the minority shareholders of the subsidiary corporation party to the merger have appraisal rights as set forth in § 262 of the Delaware General Corporation Law.

Under the BVI Act, subject to any limitations in a company’s memorandum and articles of association, members holding 90% of the votes of the outstanding shares entitled to vote, and members holding 90% of the votes of the outstanding shares of each class of shares entitled to vote, may give a written instruction to the company directing the company to redeem the shares held by the remaining members. In our Memorandum and Articles, we have opted out of the BVI Act’s squeeze out provisions.

Variation of Rights of Shares

Under Delaware corporate law, a corporation may vary the rights of a class of stock with the approval of a majority of the outstanding shares entitled to vote thereon, and, in certain circumstances, including if such variation would change the rights of such class so as to affect them adversely, with the approval of a majority of the outstanding shares of such class, voting separately as a single class.

As permitted by British Virgin Islands law and our Memorandum and Articles, we may vary the rights attached to any class with the written consent of at least 50% of the holders of each class of shares affected or by a resolution passed by at least 50% of the votes cast by eligible holders of the issued shares of the affected class at a separate meeting of the holders of that class.

Election of Directors

Under Delaware corporate law generally, unless otherwise specified in the certificate of incorporation or bylaws of a corporation, directors are elected by a plurality of the votes of the shares entitled to vote on the election of directors and vacancies and newly created directorships resulting from an increase in the number of directors may be filled by a majority of the directors then in office (although less than a quorum) or by the sole remaining director. Subject to the BVI Act and pursuant to our Memorandum and Articles, directors shall be appointed at any time, and from time to time, by our directors, without the approval of shareholders, either to fill a vacancy or as an alternate or additional director. The shareholders may, by a majority vote, appoint any person as a director. In addition, for so long as an initial holder of Founder Preferred Shares holds 20% or more of the Founder Preferred Shares in issue, such holder is entitled to nominate, and the directors are required to appoint, a person as director. If such holder notifies the Company to remove any director nominated by him or her, the other directors shall remove such director, and the holder will have the right to nominate a director to fill the resulting vacancy. In the event an initial holder ceases to be a holder of Founder Preferred Shares or holds less than 20% of the Founder Preferred Shares in issue, such initial holder will no longer be entitled to nominate a person as a director, and the holders of a majority of the Founder Preferred Shares in issue will be entitled to exercise that initial holder’s former rights to appoint a director instead.

Mergers

Under Delaware corporate law, one or more constituent corporations may merge into and become part of another constituent corporation in a process known as a merger. In order to be properly adopted, the agreement of merger must be adopted by the board of directors of each constituent Delaware corporation by a resolution or unanimous consent in lieu of a meeting. In addition, the agreement of merger generally must be approved at a meeting of shareholders of each constituent Delaware corporation by a majority of the outstanding stock of such corporation entitled to vote, unless the certificate of incorporation provides for a supermajority vote.

Under the BVI Act, two or more companies may merge or consolidate in accordance with the statutory provisions. In order to merge or consolidate, the directors of each constituent company must approve a written plan of merger or consolidation, which must be authorized by a resolution of shareholders. One or more companies may also merge or consolidate with one or more companies incorporated under the laws of jurisdictions outside the British Virgin Islands if the merger or consolidation is permitted by the laws of the jurisdictions in which the companies incorporated outside the British Virgin Islands are incorporated. In respect of such a merger or consolidation, a British Virgin Islands company is required to comply with the provisions of the BVI Act, and a company incorporated outside the British Virgin Islands is required to comply with the laws of its jurisdiction of incorporation.

Shareholders not otherwise entitled to vote on the merger or consolidation may still acquire the right to vote if the plan of merger or consolidation contains any provision that, if proposed as an amendment to the memorandum and

articles of association, would entitle them to vote as a class or series on the proposed amendment. In any event, all shareholders must be given a copy of the plan of merger or consolidation irrespective of whether they are entitled to vote at the meeting or consent to the written resolution to approve the plan of merger or consolidation.

Cumulative Voting

Under Delaware corporate law, cumulative voting for elections of directors is not permitted unless the company’s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder’s voting power with respect to electing such director. There are no prohibitions on cumulative voting under the laws of the British Virgin Islands, but our Memorandum and Articles do not provide for cumulative voting.

EX-4.8A

AMENDED AND RESTATED
ADVISORY SERVICES AGREEMENT

This AMENDED AND RESTATED ADVISORY SERVICES AGREEMENT (this “Agreement”), effective as of January 1, 2022 (the “Effective Date”), is entered into by and between Nomad Foods Limited (the “Company”), Mariposa Capital, LLC, a Delaware limited liability company (“Mariposa”) and TOMS Capital LLC (“TOMS” and together with Mariposa, “Advisors”).

WHEREAS, the Company and the Advisors are currently party to an existing Advisory Services Agreement dated June 1, 2015 (the “Existing Agreement”) and now desire to amend and restate the Existing Agreement to modify certain of the terms and conditions set forth therein, on the terms and subject to the conditions set forth in this Agreement on the basis that the workload of the Advisors is materially greater than originally envisioned, particularly in the fields of M&A and other corporate activities including capital allocation and financing activities.

WHEREAS, the Company desires to receive from Advisors, and Advisors desire to provide to the Company, the Services (as defined below) pursuant to the terms and conditions set forth in this Agreement; and

WHEREAS, the compensation arrangements set forth in this Agreement are designed to compensate Advisors for providing such Services to the Company.

NOW, THEREFORE, in consideration of the mutual agreements hereinafter set forth, the parties hereto agree as follows:

1.Agreement; Term.

(a)The Company hereby retains Advisors to perform, and Advisors agree to render to the Company and its direct and indirect subsidiaries (“Subsidiaries”), on the terms herein set forth, the following services (collectively, the “Services”):

(i)corporate development and advisory services;

(ii)advisory services with respect to mergers and acquisitions;

(iii)investor relations services;

(iv)strategic planning advisory services;

(v)capital expenditure allocation advisory services;

(vi)strategic treasury advisory services (including without limitation advice regarding financings, equity offerings, global cash planning and other related services); and

(vii)such other services relating to the Company and its Subsidiaries as may from time to time be mutually agreed to among the parties.

(b)It is expressly understood and agreed that Advisors shall devote only so much time, and shall consult with and advise the officers and directors of the Company only to such extent and, at such times and places, as may be mutually convenient to the Company and Advisors. Each Advisor shall be free to provide similar services to such other business

enterprises or activities as such Advisor may deem fit without any limitation or restriction whatsoever.

(c)The initial term of this Agreement shall commence as of the Effective Date and shall terminate on the first anniversary of the Effective Date (the “Initial Term”). The Initial Term shall be automatically renewed for successive one-year terms (each, a “Renewal Term”) unless either party notifies the other party in writing of its intention not to renew the Agreement no later than 90 days prior to the expiration of the Initial Term or a Renewal Term, as the case may be. This Agreement may only be terminated by the Company upon a vote of a majority of the Company’s directors. In the event that this Agreement is terminated by the Company, the effective date of the termination shall be six months following the expiration of the Initial Term or a Renewal Term, as the case may be.

2.Compensation and Expenses.

(a)For the Services to be rendered by Advisors hereunder, Advisors shall receive an annual fee (the “Management Fee”) equal to $4,000,000 to be split equally among the Advisors. The Company shall pay the Management Fee in quarterly installments, in advance, equal to $1,000,000.

(b)The Company shall reimburse each Advisor for the cost of all reasonable out-of-pocket fees and expenses incurred by such Advisor and its respective affiliates in the performance of the Services hereunder and all matters related thereto. The aforementioned expenses will be payable by the Company to such Advisor or its respective designee promptly following presentation by such Advisor of invoices for such expenses.

3.Relationship of the Parties. Each Advisor is providing the Services hereunder as an independent contractor. Nothing in this Agreement shall be deemed to constitute any parties hereto as joint venturers, alter egos, partners or participants in an unincorporated business or other separate entity, nor in any manner create any employer-employee or principal-agent relationship between the Company and/or any of its Subsidiaries on the one hand, and any Advisor or any of such Advisor’s members, advisors, officers or employees on the other hand (notwithstanding the fact that the Company and an Advisor may have in common any officers, directors, stockholders, members, managers, employees, or other personnel).

4.Directors and Officers. Nothing in this Agreement shall be construed to relieve the directors or officers of the Company and its Subsidiaries from the performance of their respective duties or limit the exercise of their powers in accordance with the Company’s and its Subsidiaries’ charter, bylaws, operating agreement, other constituent documents, applicable law, or otherwise. The activities of the Company and its Subsidiaries shall at all times be subject to the control and direction of their respective directors and officers. The Company and its Subsidiaries reserve the right to make all decisions with regard to any matter upon which any Advisor has rendered its advice and consultation. The Company, its Subsidiaries and Advisors expressly acknowledge and agree that Advisors are being engaged by the Company and its Subsidiaries to provide the Services to the Company and its Subsidiaries, for which Advisors will be compensated pursuant to the terms of this Agreement. Advisors shall not, and shall have no authority to, control the Company or its Subsidiaries or the Company’s or its Subsidiaries’ day-to-day operations, whether through the performance of Advisors’ duties hereunder or otherwise. Moreover, although the Company and/or its Subsidiaries may grant to any Advisor authority to sign, review or approve the Company’s and/or its Subsidiaries’ checks, payments, expenditures, transfers and/or conveyances, any such grant of authority shall be made by the Company or its

2

Subsidiaries, as applicable, and accepted by each Advisor with the express understanding and limitation that such Advisor shall possess and exercise such authority solely in its capacity as a provider of the Services pursuant to the terms of this Agreement, and in no other capacity, and that no inference shall be drawn therefrom as to any ability of any Advisor to control the Company or its Subsidiaries or the Company’s or its Subsidiaries’ day-to-day operations or any liability or responsibility therefor. The Company’s and its Subsidiaries’ directors, officers and employees shall retain all responsibility for the Company, its Subsidiaries and their operations as and to the extent required by the Company’s and its Subsidiaries’ charter, bylaws, operating agreement, other constituent documents, and applicable law.

5.Limitation of Liability. Neither Advisors nor any of their respective affiliates, nor any of their respective members, managers, partners, directors, officers, employees, agents and/or controlling persons, nor any successor by operation of law (including by merger) of any such person, nor any entity that acquires all or substantially all of the assets of any such person in a single transaction or series of related transactions (all of the foregoing, collectively, the “Advisor Indemnitees”) shall be liable to the Company or any of its Subsidiaries or affiliates or any of the security holders or creditors of the Company or any of its affiliates for (i) any damage, loss, liability, deficiency, diminution in value, action, suit, claim, proceeding, investigation, audit, demand, assessment, fine, judgment, cost or other expense (including, without limitation, legal fees and expenses) (collectively “Liabilities”) directly or indirectly (whether direct or indirect, in contract or tort or otherwise) arising out of, related to, caused by, based upon or in connection with the performance of the Services contemplated by this Agreement unless such Liability shall be proven to result directly and primarily from the willful misconduct of such person or (ii) any Outside Activities (as defined below). Advisors make no representations or warranties, express or implied, in respect of the Services provided by any Advisor Indemnitee. In no event will any Advisor Indemnitee be liable to the Company (x) for any special, indirect, punitive, incidental or consequential damages, including, without limitation, loss of profits or savings or lost business, whether or not such damages are foreseeable or such Advisor Indemnitee has been advised of the possibility of such damages or (y) in respect of any Liabilities relating to any third party claims (whether based in contract, tort or otherwise), except as set forth in Section 6 below. Under no circumstances will the aggregate of any and all Liabilities of Advisor Indemnitees exceed, in the aggregate, the fees actually paid to Advisors hereunder.

6.Indemnification. The Company and its Subsidiaries shall jointly and severally reimburse, defend, indemnify and hold Advisor Indemnitees, and each of them, harmless from and against any Liabilities arising out of, related to, caused by, based upon or in connection with (a) any act or omission of, or on behalf of, the Company, any of its Subsidiaries, Advisors or any of Advisor Indemnitees, except to the extent proven to result directly and primarily from the willful misconduct of the person seeking indemnification, or (b) any act or omission made at the direction of the Company or any of its Subsidiaries (collectively, “Claims”). The Company and its Subsidiaries and affiliates shall jointly and severally defend at their own cost and expense any and all suits or actions (just or unjust) which may be brought against the Company, its Subsidiaries or any of their affiliates, or any Advisor Indemnitee or in which any Advisor Indemnitee may be impleaded with others upon any Claims, or upon any matter, directly or indirectly arising out of, related to, caused by, based upon or in connection with this Agreement or the performance (or failure of performance) hereof by any Advisor Indemnitee.

7.Notices. All notices, requests, demands or other communications permitted or required to be given hereunder shall be given or made in writing and shall be (i) delivered personally (including delivery by commercial courier), (ii) sent by registered or certified airmail, postage prepaid, or (iii) sent by electronic mail, addressed to the party to whom they are directed

3

at the following addresses, or at such other address as ay be designated by notice from such party hereunder:

To the Company:

Nomad Foods Limited

No. 1 New Square

Bedfont Lakes Business Park

Feltham, Middlesex

TW14 8HA

Attention: Neil Fletcher

Email: Neil.Fletcher@nomadfoods.com

To Mariposa:

Mariposa Capital, LLC

500 South Pointe Drive

Suite 240

Miami Beach, Florida 33139
Attention: Desiree DeStefano

Email: ddestefano@marcapllc.com

To TOMS:

TOMS Capital LLC

450 West 15th Street

13th Floor

New York, NY 10014

Attention: Alex San Miguel

Email: Alex@tomscapital.com

Any notice, request, demand or other communication permitted or required to be given hereunder shall be deemed conclusively to have been given: (a) on the first business day following the day timely deposited with a nationally recognized overnight delivery service with an order for next-day delivery, with the cost of delivery prepaid for the account of the sender; (b) on the fifth business day following the day duly sent by certified or registered United States mail, postage prepaid and return receipt requested; or (c) if delivered by other means, when actually received by the addressee on a business day (or on the next business day if received after the close of normal business hours or on any non-business day).

8.Assignment; Successors and Assigns. This Agreement and the rights, duties and obligations of the Company and its Subsidiaries hereunder may not be assigned or delegated by the Company or its Subsidiaries without the prior written consent of Advisors. This Agreement and the rights, duties and obligations of Advisors hereunder may not be assigned or delegated by Advisors, other than to an affiliate of an Advisor, without the prior written consent of the Company (which consent shall not be unreasonably withheld, delayed or conditioned). All covenants, promises and agreements by or on behalf of the parties contained in this Agreement

4

shall be binding upon and shall inure to the benefit of the parties hereto and their respective heirs, legal representatives, successors and assigns.

9.Amendments. No amendment, supplement or waiver of any provision of this Agreement shall be effective unless the same shall be in writing and signed by Advisors and the Company (in the case of an amendment or supplement) or by the waiving party (in the case of a waiver); provided, however, that the allocation of the Management Fee may be amended upon delivery of a joint written instruction from the Advisors to the Company.

10.Applicable Law; WAIVER OF JURY TRIAL. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of New York, without giving effect to principles of conflicts of law or choice of law that would compel the application of the substantive laws of any other jurisdiction. EACH PARTY HERETO HEREBY WAIVES, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, TRIAL BY JURY IN ANY LITIGATION IN ANY COURT WITH RESPECT TO, IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, OR THE VALIDITY, PROTECTION, INTERPRETATION, COLLECTION OR ENFORCEMENT THEREOF.

11.Section Headings. The headings of each section are contained herein for convenience of reference only and shall not affect in any way the meaning or interpretation of this Agreement.

12.Entire Agreement. This Agreement sets forth the entire agreement of the parties hereto with regard to the subject matter hereof and supersedes and replaces all prior agreements (including the Existing Agreement), understandings and representations, oral or written, with regard to such matters.

13.Severability. If any provision of this Agreement or application thereof under any circumstances is adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other provision or application of this Agreement which can be given effect without the invalid or unenforceable provision or application and shall not invalidate or render unenforceable such provision or application in any other jurisdiction. If any provision is held void, invalid or unenforceable with respect to particular circumstances, it shall nevertheless remain in full force and effect in all other circumstances.

14.Counterparts. This Agreement may be executed in counterparts, each of which shall be an original, and both of which together shall constitute one and the same document. Any counterpart may be executed by PDF or facsimile signature and such PDF or facsimile signature shall be deemed an original.

15.Further Assurances. Each party hereto agrees to use all reasonable efforts to obtain all consents and approvals, and to do all other things, necessary for the transactions contemplated by this Agreement. The parties agree to take such further action and to deliver or cause to be delivered any additional agreements or instruments as any of them may reasonably request for the purpose of carrying out this Agreement and the agreements and transactions contemplated hereby.

16.Attorneys’ Fees. If any action at law or in equity is necessary or desirable to enforce or interpret the terms of this Agreement, to protect the rights obtained hereunder, or where any provision hereof is validly asserted as a defense, then each Advisor shall be entitled to recover from the Company its reasonable attorneys’ fees incurred in connection therewith,

5

including attorneys’ fees on appeal, and all costs and disbursements, in addition to any other available relief or remedy to which it may be entitled.

17.Outside Activities. The Company hereby acknowledges and agrees that one or more of Advisor Indemnitees have had, and from time to time may have, outside activities or interests that conflict or may conflict with the best interests of the Company, its Subsidiaries or any of their affiliates (collectively, “Outside Activities”), including (without limitation) investment opportunities or investments in, ownership of, or participation in entities that are or could be complementary to, or competitive with, the Company, its Subsidiaries or any of their affiliates. The Company hereby consents to all such Outside Activities, and no Advisor Indemnitee shall be liable to the Company, its Subsidiaries or any of their affiliates for breach of any duty (contractual or otherwise), including without limitation any fiduciary duties, by reason of any such activities or of such person’s participation therein. In the event that any Advisor Indemnitee acquires knowledge of a potential transaction or matter that may be a corporate opportunity for both the Company, its Subsidiaries or any of their affiliates, on the one hand, and any Advisor Indemnitee, on the other hand, or any other person, no Advisor Indemnitee shall have any duty (contractual or otherwise), including without limitation any fiduciary duties, to communicate, present or offer such corporate opportunity to the Company, its Subsidiaries or any of their affiliates and, notwithstanding any provision of this Agreement to the contrary, shall not be liable to the Company, its Subsidiaries or any of their affiliates for breach of any duty (contractual or otherwise), including without limitation any fiduciary duties, by reason of the fact that any Advisor Indemnitee directly or indirectly pursues or acquires such opportunity for itself, directs such opportunity to another person, or does not present or communicate such opportunity to the Company, its Subsidiaries or any of their affiliates, even though such corporate opportunity may be of a character that, if presented to the Company, its Subsidiaries or any of their affiliates, could be taken by the Company, its Subsidiaries or any of their affiliates, as applicable. The Company hereby renounces any interest, right, or expectancy in any such opportunity not offered to it by Advisor Indemnitees to the fullest extent permitted by law. For the avoidance of doubt, the provisions of this Section 17 shall not limit in any respect the provisions of Section 4 of this Agreement.

18.Construction. The construction of this Agreement shall not take into consideration the party who drafted or whose representative drafted any portion of this Agreement, and no canon of construction shall be applied that resolves ambiguities against the drafter of a document.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

6

IN WITNESS WHEREOF, the parties have executed this Amended and Restated Advisory Services Agreement as of the date first above written.

COMPANY:

NOMAD FOODS LIMITED

By: /s/ Samy Zekhout    

Name: Samy Zekhout

Title: Chief Financial Officer

ADVISORS:

MARIPOSA CAPITAL, LLC

By: /s/ Desiree DeStefano    

Name: Desiree DeStefano

Title: CFO

TOMS CAPITAL, LLC

By: /s/ Alex San Miguel    

Name: Alex San Miguel

Title: Partner

ACTIVE 62215196v3

EX-8.1

Exhibit 8.1

SIGNIFICANT SUBSIDIARIES OF NOMAD FOODS LIMITED

Name	Activity	Country of   incorporation	Ownership as  of December 31, 2020
Nomad Foods Europe Holdings Limited	Holding	England	100%
Nomad Foods Europe Holdco Limited	Holding	England	100%
Nomad Foods Europe Finco Limited	Holding	England	100%
Nomad Foods Europe Midco Limited	Holding/Finance	England	100%
Nomad Foods Bondco Plc	Finance	England	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	100%
Nomad Foods Europe Limited	Management	England	100%
Birds Eye Limited	Trading	England	100%
Nomad Foods Europe Finance Limited	Finance	England	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	100%
Iglo Holding GmbH	Holding	Germany	100%
Iglo Nederland B.V.	Trading	Netherlands	100%
Iglo Belgium S.A.	Trading	Belgium	100%
Iglo Portugal	Trading	Portugal	100%
Iglo Austria Holdings GmbH	Holding	Austria	100%
C.S.I. Compagnia Surgelati Italiana S.R.L	Trading	Italy	100%
Findus Sverige Holdings AB	Holding	Sweden	100%
Iglo GmbH	Trading	Germany	100%
Frozen Fish International GmbH	Trading	Germany	100%
Liberator Germany Newco GmbH	Property	Germany	100%
Iglo Austria GmbH	Trading	Austria	100%
Findus Sverige AB	Trading	Sweden	100%
Frionor Sverige AB	Holding	Sweden	100%
Findus Holdings France SAS	Holding	France	100%
Findus France SAS	Trading	France	100%
Findus España SLU	Trading	Spain	100%
Findus Danmark A/S	Trading	Denmark	100%
Findus Finland Oy	Trading	Finland	100%
Findus Norge AS	Trading	Norway	100%
Findus Norge Holding AS	Holding	Norway	100%
Toppfrys AB	Trading	Sweden	100%
Findus Switzerland AG	Trading	Switzerland	100%
LEDO plus d.o.o.	Trading	Croatia	100%
INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD	Trading	Serbia	100%
LEDO d.o.o Čitluk	Trading	Bosnia & Herzegovina	100%
IRIDA d.o.o.	Trading	Croatia	100%
LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság	Trading	Hungary	100%
Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.)	Trading	Slovenia	100%

Exhibit 8.1

Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga "Ledo" d.o.o. Podgorica)	Trading	Montenegro	100%
Ledo Sh.p.k.	Trading	Kosovo	100%
FRIKOM BEOGRAD DOOEL Cucer Sandevo	Trading	North Macedonia	100%

EX-12.1

Exhibit 12.1

CERTIFICATION

I, Stéfan Descheemaeker, certify that:

1.    I have reviewed this annual report on Form 20-F of Nomad Foods Limited;

 2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4.    The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 5.    The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date:  March 3, 2022

/s/ Stéfan Descheemaeker

Stéfan Descheemaeker

Chief Executive Officer

EX-12.2

Exhibit 12.2

CERTIFICATION

I, Samy Zekhout, certify that:

1.    I have reviewed this annual report on Form 20-F of Nomad Foods Limited;

 2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4.    The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 5.    The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date:  March 3, 2022

/s/ Samy Zekhout

Samy Zekhout

Chief Financial Officer

EX-13.1

Exhibit 13.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this annual report on Form 20-F of Nomad Foods Limited (the “Company”) for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stéfan Descheemaeker, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(i)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

(ii)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  March 3, 2022

/s/ Stéfan Descheemaeker

Stéfan Descheemaeker

Chief Executive Officer

(Principal Executive Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of this Report.

EX-13.2

Exhibit 13.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this annual report on Form 20-F of Nomad Foods Limited (the “Company”) for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Samy Zekhout, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(i)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

(ii)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  March 3, 2022

/s/ Samy Zekhout

Samy Zekhout

Chief Financial Officer

(Principal Financial Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of this Report.

EX-15.1

Exhibit 15.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (Nos. 333-217044 and 333-225402) and Form S-8 (No. 333-211095) of Nomad Foods Limited of our report dated March 3, 2022 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.

/s/ PricewaterhouseCoopers LLP

London, United Kingdom

March 3, 2022

XML

Cover	12 Months Ended
	Dec. 31, 2021 shares
Document and Entities Information [Line Items]
Document Type	20-F
Document Registration Statement	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-37669
Entity Registrant Name	Nomad Foods Limited
Entity Incorporation, State or Country Code	D8
Entity Address, Address Line One	No. 1 New Square
Entity Address, Address Line Two	Bedfont Lakes Business Park
Entity Address, City or Town	Feltham
Entity Address, Postal Zip Code	TW14 8HA
Entity Address, Country	GB
Title of 12(b) Security	Ordinary Shares, no par value
Trading Symbol	NOMD
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding	173,559,173
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Accounting Standard	International Financial Reporting Standards
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Central Index Key	0001651717
Entity Shell Company	false
Business Contact
Document and Entities Information [Line Items]
Entity Address, Address Line One	No. 1 New Square
Entity Address, Address Line Two	Bedfont Lakes Business Park
Entity Address, City or Town	Feltham
Entity Address, Postal Zip Code	TW14 8HA
Contact Personnel Name	Samy Zekhout
City Area Code	+(44)
Local Phone Number	208 918 3200
Contact Personnel Fax Number	+(44) 208 918 3491
Preference shares [member]
Document and Entities Information [Line Items]
Entity Common Stock, Shares Outstanding	1,500,000

XML

Audit Information	12 Months Ended
	Dec. 31, 2021
Auditor [Line Items]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	London, United Kingdom
Auditor Firm ID	876

XML

Consolidated Statements of Financial Position - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Non-current assets
Goodwill	€ 2,099.4	€ 1,902.5
Intangibles	2,455.7	2,155.7
Property, plant and equipment	549.4	422.2
Other non-current assets	8.9	1.1
Derivative financial instruments	0.0	17.2
Deferred tax assets	128.3	113.5
Total non-current assets	5,241.7	4,612.2
Current assets
Cash and cash equivalents	254.2	393.2
Inventories	410.6	344.3
Trade and other receivables	234.6	185.0
Indemnification assets	9.5	15.4
Short-term deposits, not classified as cash equivalents	0.0	25.0
Derivative financial instruments	20.2	5.5
Total current assets	929.1	968.4
Assets	6,170.8	5,580.6
Current liabilities
Trade and other payables	692.0	647.2
Current tax payable	198.5	166.2
Provisions	39.3	45.7
Loans and borrowings	29.1	22.5
Derivative financial instruments	7.3	35.5
Total current liabilities	966.2	917.1
Non-current liabilities
Loans and borrowings	2,198.3	1,736.3
Employee benefits	244.2	276.2
Other non-current liabilities	1.8	2.2
Provisions	2.9	6.1
Derivative financial instruments	20.8	89.5
Deferred tax liabilities	437.6	427.1
Total non-current liabilities	2,905.6	2,537.4
Total liabilities	3,871.8	3,454.5
Net assets	2,299.0	2,126.1
Equity
Share capital and capital reserve	1,623.1	1,620.5
Share-based compensation reserve	6.9	8.3
Founder Preferred Shares Dividend Reserve	166.0	245.5
Translation reserve	105.1	84.7
Other reserves	10.5	(24.5)
Retained earnings	387.4	191.6
Equity	€ 2,299.0	€ 2,126.1

XML

Consolidated Statements of Profit or Loss - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Profit or loss [abstract]
Revenue	€ 2,606.6	€ 2,515.9	€ 2,324.3
Cost of sales	(1,862.3)	(1,753.4)	(1,626.4)
Gross profit	744.3	762.5	697.9
Other operating expenses	(356.3)	(382.7)	(359.9)
Exceptional items	(45.3)	(20.6)	(54.5)
Operating profit	342.7	359.2	283.5
Finance income	0.1	4.7	2.5
Finance costs	(106.1)	(68.4)	(75.7)
Net finance costs	(106.0)	(63.7)	(73.2)
Profit before tax	236.7	295.5	210.3
Taxation	(55.7)	(70.4)	(56.7)
Profit for the period	181.0	225.2	154.0
Profit (loss), attributable to non-controlling interests	0.0	(0.1)	(0.4)
Profit (loss)	€ 181.0	€ 225.1	€ 153.6
Earnings per share:
Basic earnings per share (in euros per share)	€ 1.02	€ 1.16	€ 0.80
Diluted earnings per share (in euros per share)	€ 1.02	€ 1.14	€ 0.78

XML

Consolidated Statements of Comprehensive Income - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of comprehensive income [abstract]
Profit (loss)	€ 181.0	€ 225.1	€ 153.6
Other comprehensive income/(loss):
Actuarial gains/(losses) on defined benefit pension plans	36.1	(27.8)	(35.9)
Taxation (charge)/credit on remeasurement of defined benefit pension plans	(10.2)	8.3	6.7
Items not reclassified to the Consolidated Statement of Profit or Loss	25.9	(19.5)	(29.2)
Gain/(loss) on investment in foreign subsidiary, net of hedge		(10.1)	6.0
Effective portion of changes in fair value of cash flow hedges	22.6	(17.3)	(27.3)
Taxation (charge)/credit relating to components of other comprehensive income	(13.6)	6.0	5.6
Items that may be subsequently reclassified to the Consolidated Statement of Profit or Loss	27.8	(21.4)	(15.7)
Other comprehensive income/(loss) for the period, net of tax	53.7	(40.9)	(44.9)
Comprehensive income	234.7	184.2	108.7
Total comprehensive income for the period	234.7	184.3	109.1
Comprehensive income, attributable to non-controlling interests	€ 0.0	€ (0.1)	€ (0.4)

XML

Consolidated Statements of Changes in Equity - EUR (€) € in Millions	Total	Share capital and capital reserve	Share based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Other reserves*	Accumulated deficit reserve	Equity attributable to owners of parent [member]	Non-controlling interests [member]
Equity | Increase (decrease) due to changes in accounting policy required by IFRSs	€ 31.3				€ 0.0		€ 31.3	€ 31.3
Equity	2,059.1	€ 1,748.5	€ 9.4	€ 372.6	88.8	€ 8.5	(167.9)	2,059.9	€ (0.8)
Equity (restated)	2,090.4	1,748.5	9.4	372.6	88.8	8.5	(136.6)	2,091.2	(0.8)
Profit (loss)	153.6						154.0	154.0	(0.4)
Other comprehensive income/(loss) for the year	(44.9)				6.0	(21.7)	(29.2)	(44.9)
Comprehensive income	108.7				6.0	(21.7)	124.8	109.1	(0.4)
Dividends recognised as distributions to owners		2.5		(2.5)
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity	(0.8)	0.0	(0.8)					(0.8)
Issue of equity	354.2	355.5	(1.3)					354.2
Increase (decrease) from listing and share transaction costs, equity	(11.1)	(11.1)						(11.1)
Share based payment charge	14.9		14.9					14.9
Reclassification of awards for settlement of tax liabilities	0.4		0.4					0.4
Increase (decrease) through transactions with owners, equity	357.6	346.9	13.2	(2.5)				357.6	0.0
Equity | Increase (decrease) due to changes in accounting policy required by IFRSs					0.0
Equity	2,556.7	2,095.4	22.6	370.1	94.8	(13.2)	(11.8)	2,557.9	(1.2)
Equity (restated)					94.8
Profit (loss)	225.1						225.2	225.2	(0.1)
Other comprehensive income/(loss) for the year	(40.9)				(10.1)	(11.3)	(19.5)	(40.9)
Comprehensive income	184.2				(10.1)	(11.3)	205.7	184.3	(0.1)
Dividends recognised as distributions to owners		124.6		(124.6)
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity	0.0	0.7	(0.7)					0.0
Issue of equity	0.5	8.4	(7.9)					0.5
Repurchase of ordinary shares (in shares)	(608.6)	(608.6)						(608.6)
Share based payment charge	9.0		9.0					9.0
Reclassification of awards for settlement of tax liabilities	(14.7)		(14.7)					(14.7)
Increase/(decrease) through non-controlling interests extinguished on acquisition of subsidiary	(1.0)						(2.3)	(2.3)	1.3
Increase (decrease) through transactions with owners, equity	(614.8)	(474.9)	(14.3)	(124.6)			(2.3)	(616.1)	1.3
Equity | Increase (decrease) due to changes in accounting policy required by IFRSs					1.6	(1.6)
Equity	2,126.1	1,620.5	8.3	245.5	84.7	(24.5)	191.6	€ 2,126.1	€ 0.0
Equity (restated)	2,126.1	1,620.5	8.3	245.5	86.3	(26.1)	191.6
Profit (loss)	181.0						181.0
Other comprehensive income/(loss) for the year	53.7				18.8	9.0	25.9
Comprehensive income	234.7				18.8	9.0	206.9
Deferred hedging gains transferred to the carrying value of inventory	27.6					27.6
Dividends recognised as distributions to owners		79.5		(79.5)
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity		0.6	(0.6)
Issue of equity	0.0	0.1	(0.1)
Repurchase of ordinary shares (in shares)	(77.6)	(77.6)
Share based payment charge	5.1		5.1
Reclassification of awards for settlement of tax liabilities	(16.9)		(5.8)				(11.1)
Increase (decrease) through transactions with owners, equity	(89.4)	2.6	(1.4)	(79.5)			(11.1)
Equity	€ 2,299.0	€ 1,623.1	€ 6.9	€ 166.0	€ 105.1	€ 10.5	€ 387.4

XML

Consolidated Statements of Cash Flows - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of cash flows [abstract]
Cash generated from operations before tax and exceptional items	€ 450.3	€ 552.0	€ 376.9
Cash flows relating to exceptional items	(48.8)	(12.1)	(15.9)
Tax paid	(95.2)	(82.9)	(45.6)
Net cash flows from operating activities	306.3	457.0	315.4
Cash flows from investing activities
Business combinations, net of cash acquired	(597.3)	(112.9)	(1.5)
Purchase of property, plant and equipment and intangibles	(79.2)	(58.7)	(47.3)
Purchase of investments	0.0	(25.0)	(25.0)
Redemption of investments	16.5	25.2	0.0
Net cash used in investing activities	(660.0)	(171.4)	(73.8)
Cash flows from financing activities
Proceeds from issuance of Ordinary Shares	0.0	0.6	354.1
Share issuance costs	0.0	0.0	(11.1)
Repurchase of ordinary shares	(77.6)	(608.6)	0.0
Income taxes paid (refund), classified as financing activities	(22.6)	(19.2)	0.0
Proceeds from new loans and notes	800.0	0.0	2.0
Repayment of loan principal	(408.7)	(11.7)	(22.2)
Payments of lease liabilities, classified as financing activities	(19.4)	(20.3)	(21.8)
Payment of financing fees	(18.7)	0.0	0.0
Interest paid	(36.7)	(50.2)	(48.4)
Interest received	0.1	0.7	2.4
Other financing cash flows	(2.0)	(6.1)	(3.6)
Net cash provided by/(used in) financing activities	214.4	(714.8)	251.4
Net (decrease)/increase in cash and cash equivalents	(139.3)	(429.2)	493.0
Cash and cash equivalents at beginning of period	393.2	824.8	327.6
Effect of exchange rate fluctuations	11.0	(13.1)	4.2
Cash and cash equivalents at end of period	254.2	393.2	824.8
Cash and cash equivalents if different from statement of financial position	€ 254.2	€ 382.5	€ 824.8

XML

General information

12 Months Ended

Dec. 31, 2021

General Information About Financial Statements [Abstract]

General information

General information

Nomad Foods Limited (the “Company” or “Nomad”) was incorporated in the British Virgin Islands on April 1, 2014. The address of Nomad’s registered office is Ritter House, Wickhams Cay II, Road Town, Tortola, VG1110 British Virgin. The Company is domiciled for tax in the United Kingdom.

Nomad Foods Limited (NYSE: NOMD) is Europe's leading frozen foods company. Nomad Foods Limited's (the “Company” or “Nomad”) portfolio of iconic brands, which includes Birds Eye, Findus, iglo, Ledo and Frikom, have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.

XML

Basis of preparation

12 Months Ended

Dec. 31, 2021

Basis Of Presentation [Abstract]

Basis of preparation

Basis of preparation

The consolidated financial statements of Nomad and its subsidiaries (the “Company” or “Nomad”) have been prepared in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board. These consolidated financial statements are also in accordance with International Financial Reporting Standards as adopted by the European Union.

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as current economic conditions in light of the COVID-19 pandemic. Actual results could differ from these estimates. In preparing cash flow forecasts, management consider severe but plausible downside scenarios taking into consideration the Company's key risks, including the impacts of the COVID-19 pandemic. Having considered these risks in their assessment, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these financial statements.

Adoption of new accounting standards - IFRS 9 'Financial Instruments'

IFRS 9 ‘Financial Instruments’ was issued in July 2014 and replaced IAS 39 ‘Financial Instruments: Recognition and Measurement.’ The Company had previously elected to continue hedge accounting under IAS 39 as was allowed by the standard. On January 1, 2021, the Company adopted hedge accounting under IFRS 9, as the hedge accounting requirements have been simplified and are more closely aligned to the Company's risk management strategy. Under IFRS 9 all existing hedging relationships qualified as continuing hedging relationships.

The Company applied IFRS 9 hedge accounting prospectively, "except for application of the cost of hedging approach". The Company has elected the cost of hedging approach for the fair value movement of all hedging instruments, whereby the movements will be recognized within equity, to the extent that they relate to the hedged item. As permitted by the standard, adjustments required as a result of adopting the cost of hedging approach, have been made to the opening Consolidated Statement of Changes in Equity. As such, prior year comparatives have not been restated. A summary of adjustments arising from application of IFRS 9 for hedge accounting as of January 1, 2021 are as follows:

	Opening Balance January 1, 2021 (IAS 39) €m	Impact of change in policy €m	Opening Balance January 1, 2021 (IFRS 9) €m
Cash flow hedge reserve	(24.5)	2.8	(21.7)
Cost of hedging reserve	—	(4.4)	(4.4)
Other reserves	(24.5)	(1.6)	(26.1)
Translation reserve	84.7	1.6	86.3

The Company's policy is to reduce its risk of foreign exchange movements on forecasted transactions (such as purchases of raw materials) in currencies other than the operating entity's functional currency using forward foreign exchange contracts designated as cash flow hedges. Under IFRS 9, in cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow

hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The Company has elected to apply this accounting policy prospectively and therefore as at January 1, 2021 any existing hedges of non-financial items (such as inventory) that were already recognized in the Consolidated Statement of Financial Position, did not result in an opening balance transfer out of equity to the non-financial item as a result of the transition to IFRS 9. For the year ended December 31, 2021, €27.6 million was recognized as deferred hedging gains transferred to the carrying value of inventory. This is not a reclassification adjustment and will not be recognized in the Consolidated Statement of Other Comprehensive Income for the period.

Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 – Interest Rate Benchmark Reform (Phase 2)

In August 2020, the IASB issued Interest Rate Benchmark Reform (Phase 2), which amends other IFRS standards. The amendments provide temporary reliefs which address the financial reporting effects when an interbank offered rate (IBOR) is replaced with an alternative nearly risk-free interest rate (RFR). The amendments in this final phase relate to practical expedient for particular changes in contractual cash flows, relief from specific hedge accounting requirements and certain disclosure requirement.

On June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing revolving credit facility of €80.0 million and replace it with a new €175.0 million facility, paying interest rate applicable to the respective drawn down currency. Per the restated Senior Facilities Agreement, the Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately if there is a drawdown on the facility. The Secured Overnight Financing Rate (“SOFR”) will replace USD LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR, when existing benchmark rates are replaced and borrowings are requested under the Facility.

Equally, on June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. There is currently no indication of the timing of the phase-out of EURIBOR. The Company continues to assess changes in underlying markets and expects to be able to refinance its Senior EUR Loan once replacement reference rates become confirmed.

The existing senior USD loan of $916.4 million (the "Senior USD Loan") paying interest at a rate per annum equal to LIBOR (subject to a zero floor) plus 2.25% per annum has not been refinanced during 2021. The Company uses cross currency interest rate swaps to convert cash flows payable under the Senior USD Loan into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. The USD LIBOR phase out is expected to be completed by June 2023, and therefore in due course the Company will need to renegotiate the terms of our Senior Facilities Agreement with our lenders and amend the terms of linked interest rate hedging arrangements. Such an amendment is expected to be able to be achieved without material financial impact on the Company.

The Amendments are effective for annual periods beginning on or after January 1, 2021. Phase 2 amendments will require the Company to account for a change in the basis for determining the cash flows of a financial asset or a financial liability measured at amortized cost, by updating the effective interest rates as required by IBOR reform. Management continues to assess implications as a result of these amendments on the wider business. These amendments had no impact on the financial statements of the Company for the year ended December 31, 2021. The Company intends to use the practical expedients in future periods as they become applicable.

Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS

Amendments to IAS 12 - Deferred Tax related to Assets and Liabilities arising from a Single Transaction

In May 2021, the International Accounting Standards Board issued targeted amendments to IAS 12, Income Taxes. The amendments are effective for annual periods beginning on or after January 1, 2023, although earlier application is permitted. With a view to reducing diversity in reporting, the amendments will clarify that companies are required to recognize deferred taxes on transactions where both assets and liabilities are recognized, such as with leases and asset retirement (decommissioning) obligations. Based upon our current facts and circumstances, we do not expect our financial performance or disclosure to be materially affected by the application of the amended standard.

Other

The consolidated financial statements and notes are presented in the reporting currency of millions of Euros. All financial information has been rounded to the nearest €0.1 million, except where otherwise indicated.

The consolidated financial statements were approved for issuance by the Board of Directors of Nomad Foods Limited on March 2, 2022. The Directors have, at the time of approving the financial statements, a reasonable expectation that Nomad has adequate resources to continue in operational existence for the foreseeable future given the cash funds available and the current forecast cash outflows. Thus, Nomad continues to adopt the going concern basis of accounting in preparing the financial statements.

XML

Accounting policies

12 Months Ended

Dec. 31, 2021

Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]

Accounting policies

Accounting policies

The accounting policies set out below have, unless otherwise stated, been applied consistently. Judgments made by the Directors in the application of these accounting policies that have a significant effect on the financial statements and key sources of estimation uncertainty are discussed in Note 4.

3.1    Measurement convention

The financial statements are prepared on the historical cost basis with the exception of derivative financial instruments, business combinations, share based payments, and founder preferred shares which are stated at fair value.

3.2    Business combination

The Company uses the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred and the equity interest issued by the Company. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred.

Non-controlling interests arise from business combinations in which the Company acquires less than a 100 per cent interest. Non-controlling interests are initially measured at either fair value or at the non-controlling interest’s proportionate share of the fair value of the acquiree’s identifiable net assets. Nomad determines on a transaction by transaction basis which measurement method is used.

The excess of the consideration transferred, the amount of any non-controlling interests in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree over the fair value of the identifiable net assets is recorded as goodwill.

Where selling shareholders have contractually agreed to indemnify Nomad Foods Limited for contingent liabilities, an indemnification asset is recognized equivalent to the fair value of the liability recognized by Nomad. The indemnification asset is deducted from consideration transferred for the business combination. The indemnification asset value will subsequently be revised where revisions are made to the value of the liability or where there are doubts over the ability to recover losses from the selling shareholders.

3.3    Basis of consolidation

The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions, and any unrealized income and expenses arising from intra-group transactions are eliminated. Accounting policies are applied consistently across the Company.

Subsidiaries are all entities (including structured entities) over which Nomad has control; directly or indirectly. The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases.

Where the Company owns less than a 100 per cent interest in a subsidiary, a non-controlling interest is recognized. The carrying amount of non-controlling interests is increased or decreased by the non-controlling interest’s share of subsequent changes in equity and payments to the non-controlling interest. Total comprehensive income is attributed to the non-controlling interests even if this results in the non-controlling interests having a negative balance.

3.4    Foreign currency

i)    Foreign currency transactions

Transactions in foreign currencies (currencies other than the functional currency of the transacting entity) are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the foreign exchange rate ruling the financial year end. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are generally recognized in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges, qualifying net investment hedges or are attributable to part of a net investment in a foreign operation.

Non-monetary assets and liabilities in a foreign currency are translated into the functional currency to establish historical cost, using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated at foreign exchange rates ruling at the date the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss.

The revenues and expenses of foreign operations are translated at an average rate for the period (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transaction).

ii)    Assets and liabilities of foreign operations

For the purposes of presenting consolidated financial statements, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated at foreign exchange rates ruling at the financial year ended December 31, 2021 of £1:€1.19 (December 31, 2020: £1:€1.11). The revenues and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rates ruling at the dates of the transactions. The average rate used for year ended December 31, 2021 is £1:€1.16 (year ended December 31, 2020: £1:€1.13, year ended December 31, 2019: £1:€1.14).

Foreign exchange gains and losses that relate to these assets and liabilities are presented in the Consolidated Statement of Profit or Loss within ‘finance income or costs’, except where hedge accounting applies.

iii)    Net investment in foreign operations

Exchange differences arising from the translation of foreign operations and of any related qualifying hedges are taken directly to the translation reserve within equity. They are realized through the Consolidated Statement of Profit or Loss upon disposal of the related foreign operation.

3.5    Goodwill

Goodwill represents amounts arising on acquisition of subsidiaries. Goodwill is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired.

Goodwill is stated at cost less any accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

Goodwill is not monitored below the operating segment. Goodwill is not amortized but is tested annually for impairment. 

3.6    Other intangible assets

Intangible assets acquired separately are recorded at cost and those acquired as part of a business combination are recorded at fair value as at the date of acquisition.

i)    Computer software

Capitalized software costs include the cost of acquired computer software licenses and costs that are directly associated with the design, construction and testing of such software where this relates to a major business system. Costs associated with identifying, sourcing, evaluating or maintaining computer software are recognized as an expense within other operating expenses as incurred.

The assets are stated at cost less accumulated amortization and impairment losses. Software costs are amortized by equal monthly installments over their estimated useful economic life of five to ten years once the software is capable of being brought into use.

ii)    Brands

Our largest brands, including Birds Eye, Iglo, Findus, Ledo and Frikom are considered to have indefinite lives. This is based on the market position of the brands, the significant levels of investment in advertising and promoting the brands, and the fact that they have been established for at least 20 years. Therefore these brands are not amortized, but instead held at historical cost less provision for any impairment.

Brands that are deemed to not have an indefinite life are being amortized by equal monthly installments within other operating expenses over the course of their remaining useful economic life.

iii)    Customer relationships

Long standing Food Service customer relationships have been identified as intangible assets as part of business combinations. These are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over their expected lives. The most significant of these assets were acquired as part of the Findus Acquisition in 2015 and are being amortized over 14 years.

3.7    Impairment of non-current assets

The carrying amounts of the Company’s non-current assets are reviewed annually to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated. Impairment losses are recognized in the Consolidated Statement of Profit or Loss in the period in which they arise. For goodwill and assets that have an indefinite useful life an impairment review is performed at least annually.

Assets that are subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the net carrying amount may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount.

i)    Calculation of recoverable amount

Recoverable amount is the greater of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows of the business are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

ii)    Allocation of impairment losses

Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating units, then to reduce the carrying amount of the other assets in the unit on a pro rata basis. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

iii)    Reversals of impairment

An impairment loss in respect of goodwill is not reversed. In respect of other assets, an impairment loss is reversed when there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

3.8    Property, plant and equipment

i)    Owned assets

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use.

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

ii)    Leased assets

The Company leases various properties, equipment and cars. The Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

Where a contract contains both lease and non-lease components, the Group has elected to account for the contract as a single lease.

Leases are recognized as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the group. Each lease payment is allocated between the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The right-of-use asset is classified within property, plant and equipment and is depreciated over the shorter of the asset's useful life or the lease term on a straight-line basis.

Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities are presented within loans and borrowings and include the net present value of expected lease payments, including those from extension options if the Company reasonably expects to exercise them. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be determined, otherwise the Company’s incremental borrowing rate is used. Right-of-use assets are measured at cost comprising the amount of the lease liability, adjusted for payments made or received before the commencement date, initial direct costs and restoration costs.

Payments associated with short-term leases and leases of low-value assets are recognized on a straight-line basis as an expense in profit or loss. Short-term leases are leases with a lease term of 12 months or less. Low-value assets primarily comprise IT equipment and small items of office furniture.

iii)    Depreciation

Depreciation is charged to the Consolidated Statement of Profit or Loss on a straight line basis over the shorter of the lease term and the estimated useful lives of each part of an item of property, plant and equipment once the item is brought into use. Land is not depreciated. The estimated useful lives are as follows:

•Buildings 40 years

•Plant and equipment 5 to 14 years

•Computer equipment 3 to 5 years

The assets’ residual values and useful lives are reviewed on a frequent basis.

3.9    Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average principle and includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Inventories that are acquired through business combinations are fair valued at the time of acquisition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of direct costs and overheads based on normal operating capacity. Provision is made for slow moving, obsolete and defective inventories.

3.10    Employee benefits

i)    Defined contribution plans

Obligations for contributions to defined contribution pension plans are recognized as an expense in the Consolidated Statement of Profit or Loss as incurred. Prepaid contributions are recognized as an asset to the extent that a cash refund or reduction in the future payments is available.

ii)    Defined benefit plans

The Company’s net obligation in respect of defined benefit pension plans and other post-employment benefits is calculated separately for each plan by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. That net obligation is discounted to determine its present value. The calculation is performed by a qualified actuary using the projected unit credit method.

The current service cost of the defined benefit plan, recognized in the Consolidated Statement of Profit or Loss in staff costs included within Operating profit/(loss), except where included in the cost of an asset, reflects the increase in the defined benefit obligation resulting from employee service in the current year, benefit changes, curtailments and settlements.

Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in Other Comprehensive Income in the period in which they arise.

The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the Consolidated Statement of Profit or Loss.

Past service cost is recognized immediately.

iii)    Share-based payment schemes

Employee benefits given through share-based payment schemes are discussed further in section 3.15 of this note.

3.11    Founder Preferred Shares

Nomad Foods issued Founder Preferred Shares to both TOMS Acquisition I LLC and Mariposa Acquisition II, LLC (collectively the “Founder Entities”) in connection with its initial public offering in April 2014. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Dividend Amount”). The instrument and its component parts were analyzed under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015, of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.

3.12    Provisions

Provisions are recognized when the Company has a legal or constructive present obligation as a result of a past event and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors’ best estimate of the expenditure required to settle the obligation at the financial year end date and are discounted to present value where the effect is material.

Where it is not possible to make a reliable estimate of the estimated financial effect of a provision, appropriate disclosure of the resulting contingent liability is made, but no provision is recognized.

3.13    Financial instruments

Financial assets and liabilities are recognized in the Company’s Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument.

i)    Trade receivables

Trade receivables are amounts due from customers for goods sold when control of the products has transferred, being when the products are delivered in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. The Company holds the trade receivables with the objective of collecting the contractual cash flows and so they are subsequently measured at amortized cost using the effective interest method, less any loss allowance. Since trade receivables are due within one year, this equates to initial carrying value less any loss allowance.

To assist in managing operating cash flow, we may enter into non-recourse factoring arrangements with certain receivables whereby we sell specific account receivables to one or more external financial institutions. The risks and rewards of ownership are considered to have been transferred at the point of sale. Up to the point of sale, these receivables are treated as held for sale and measured at fair value through Profit or Loss. Under the terms of the contractual arrangements, the Company may continue to collect the cash from the customer receivables sold, albeit acting solely as a collecting agent on behalf of the purchaser of receivables. Any cash received from customers which is due to be paid to the agent is presented as a financial liability in the Statement of Financial Position and as a financing activity within the Statement of Cash Flows. Factoring fees associated with the sale of factored receivables were minimal for all periods presented. See Note 18.

The Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables. Trade receivables are grouped by days past due. Expected loss rates are based on historical credit losses experienced in each market as well as forward looking information where this is significant. Trade receivables are written off when there is no reasonable expectation of recovery. Appropriate allowances for expected credit losses and estimated irrecoverable amounts are recognized in the Consolidated Statement of Profit or Loss.

Trade receivables are presented net of associated contract liabilities, referred to as 'trade terms' as discussed further in Note 3.14 and Note 4.

ii)    Cash and cash equivalents

Cash and cash equivalents comprise of cash balances and deposits that are readily convertible to a known amount of cash and are measured at amortized cost. Deposits held in money market funds are measured at fair value through Profit or Loss as the cash flows do not only represent principal and interest.

iii)    Loans and borrowings

a.    Valuation

Interest bearing borrowings are recognized initially at fair value less attributable transaction costs.

Subsequent to initial recognition, interest bearing loans and borrowings are stated at amortized cost with any difference between cost and redemption value being recognized in the Consolidated Statement of Profit or Loss over the expected period of the borrowings.

b.    Capitalization of transaction costs

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

iv)    Trade payables

Trade payables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method. Since trade payables are largely due within one year, this equates to initial carrying value.

v)    Derivative financial instruments and hedge accounting

Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge accounting relationship, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company has elected the cost of hedging approach for the fair value movement on currency basis spreads of all hedging relationships, whereby the movements will be recognized within equity, if material, to the extent that they relate to the hedged item. In cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition.

The fair value of all financial derivative instruments (including but not limited to forward foreign exchange contracts, currency swaps and cross currency interest rates swaps), is determined per market standard using forward foreign exchange and interest rates at the balance sheet date, with the resulting value discounted back to present value.

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company applies the hedge accounting requirements of IFRS 9 to all hedging relationships. IAS 39 was beforehand with the impact of the changes disclosed in Note 2 Basis of preparation.

a.    Cash flow hedges

Where a derivative financial instrument is designated as a hedge of the cash flow of a recognized asset or liability, (including a highly probable forecast transaction) the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve, within other reserves. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss.

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, if the result of a forecasted transaction is recognition of a non-financial asset (for example inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve (presented together as 'Other reserves') are included in the initial cost of the non-financial item upon its recognition. For all other hedged forecasted transactions, the amounts accumulated in the hedging reserve and cost of hedging reserve are reclassified to the Consolidated Statement of Profit or Loss in the same period, or periods, in which the hedged forecasted future cash flows affect the Consolidated Statement of Profit or Loss.

When a hedging instrument expires or is sold, exercised or otherwise terminated, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately.

When a hedging instrument is substantially modified, any fair value gain or loss is recognized immediately in the Consolidated Statement of Profit or Loss.

b.    Net investment hedges

Foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income to the extent that the hedge is effective, and are presented in the translation reserve within equity. 

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the change in fair value of the future price element of the hedging instrument (‘forward element’) is not included as part of the hedging relationships and is recognized in the Consolidated Statement of Profit or Loss immediately.

To the extent that any net investment hedge is entered into and the hedge is deemed effective, any foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal.

vi)    Short-term investments

The Company may invest surplus cash positions in short-term investments to manage liquidity and credit risk. Short‐term investments are held within managed investment funds and are measured at fair value with all changes in fair value are recognized immediately in the Consolidated Statement of Profit or Loss.

Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data.

3.14    Revenue from contracts with customers

The Company manufactures and sells a range of frozen foods to retail, wholesale and Food Service markets. Revenue is recognized when control of the products has transferred, being when the products are delivered to the customer in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. A provision for product return allowances, which is estimated based upon the Company’s historical performance and management’s experience, is recorded as a reduction of sales in the same period that the revenue is recognized. Revenue excludes sales taxes and intra-company sales.

Products are often sold with variable pricing arrangements, including payment discounts, trade promotions and slotting fees. Discounts given by the Company include rebates, price reductions and incentives to customers, promotional couponing and trade communication costs. Trade promotions consist of pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. Certain retailers require the payment of slotting fees to obtain space for the Company’s products on the retailers’ store shelves.

Where variable pricing arrangements are in place, revenue is only recognized to the extent that it is highly probable that the amount recognized is unlikely to be reversed. Accumulated experience is used to estimate and provide for the discounts. Revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. Accruals for expected pay-outs under these programs are collectively known as ‘trade terms’ and are included within trade and other receivables or within trade and other payables in the Consolidated Statement of Financial Position. No element of financing is deemed present as the sales are made in line with market practice and accruals are typically settled within twelve months of the sale.

3.15    Share based payments

The Nomad Foods Long-term Incentive Plan known as the (the "Management Share Awards"), which incorporates an annual Non-Executive Directors Restricted Stock Scheme, falls within the provisions of IFRS 2 “Share-based Payment” and awards under the Management Share Awards represent equity settled share based payments. A charge is taken to the Consolidated Statement of Profit or Loss for the difference between the fair value of the shares at grant date and the amount subscribed, spread over the vesting period.

Share based payment arrangements in which Nomad receives goods or services as consideration for its own equity instruments are accounted for as equity-settled share based payment transactions, regardless of how the equity instruments are obtained by Nomad.

The grant date fair value of share-based payment awards granted to any Director or employee is recognized as an expense, with a corresponding increase in equity, over the period that any Director or employee becomes unconditionally entitled to the awards.

The fair value of the awards granted is measured using a valuation model, taking into account the terms and conditions upon which the awards were granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.

See Note 8(b) for further information on the Company’s share-based payment arrangements and details of the valuation model used.

3.16    Interest income

Interest income is recognized in the Consolidated Statement of Profit or Loss on an accruals basis using the effective interest method.

3.17    Expenses & Exceptional items

i)    Borrowing costs

Unless capitalized as part of the cost of borrowing (see Note 3.13(iii)), borrowing costs are recognized in the Consolidated Statement of Profit or Loss in the period in which they are incurred.

ii)    Exceptional items

The separate reporting of exceptional items which are presented as exceptional within the relevant Consolidated Statement of Profit or Loss category, helps provide an indication of the Company’s underlying business performance. Exceptional items have been identified and presented by virtue of their size, nature or incidence. In determining whether an event or transaction is exceptional, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence. Exceptional items comprise restructuring costs, impairments or reversal of impairments of intangible assets, operational restructuring, integration and acquisition costs relating to new acquisitions, implementation of strategic opportunities and other significant items (see Note 7).

iii)    Research and development

Expenditure on research activities is recognized in the Consolidated Statement of Profit or Loss as an expense as incurred.

3.18    Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognized in the Consolidated Statement of Profit and Loss except to the extent that it relates to items recognized in Other Comprehensive Income, in which case it is recognized within the Statement of Other Comprehensive Income.

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the financial year end date, and any adjustment to tax payable in respect of previous years. Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on the best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals.

Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts used for taxation purposes on an undiscounted basis. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial year end date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized.

3.19    Segment reporting

The Chief Operating Decision Maker (“CODM”) has been determined to be the Chief Executive Officer as he is primarily responsible for the allocation of resources to the segments and the assessment of performance of the segments.

Nomad’s operations are organized into one operating unit, "Frozen", which comprises all the brands, as well as the factories, private label business units and certain corporate overheads. The CODM primarily uses “Adjusted EBITDA”, disclosed in Note 5, as the key measure of the segment’s results. Adjusted EBITDA is EBITDA adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

EBITDA, disclosed in Note 5, is defined as profit/(loss) for the period before taxation, net financing costs, depreciation and amortization.

3.20    Onerous contracts provisions

Where the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

3.21    IFRSs not yet adopted

At the date of authorization of these financial statements, except as disclosed in Note 2, there are no Standards and Interpretations relevant to the Company which are in issue but not yet effective.

XML

Critical accounting estimates and judgments

12 Months Ended

Dec. 31, 2021

Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]

Critical accounting estimates and judgments

Critical accounting estimates and judgments

The preparation of financial statements in accordance with IFRS requires the use of judgment in applying the accounting policies and estimation that affect the reported amounts of assets and liabilities and results. Actual results could differ from those estimates and the financial statements will be impacted by key judgments taken.

Key Judgments

Judgments are made in the process of applying accounting policies. Those judgments which are considered key are listed below.

a)        Business Combinations

For business combinations that have a significant effect on the amounts reported in the consolidated financial statements. The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified, the useful economic life of assets and in selecting an appropriate valuation methodology. Furthermore, judgment is applied in allocating business combinations to operating segments, as well as allocating Goodwill to cash generating units. Please refer to Note 14 for details of business combinations in the period.

b)        Discounts and trade promotions

Management use judgment when considering when accruals for discounts and trade promotions can be released. Management makes the judgment based on the principle that accruals are reversed only to the extent that it is highly probable that a significant reversal will not occur.

c)        Uncertain tax positions

Management use judgment when determining whether it is appropriate to accrue for uncertain tax positions and for how long accruals for uncertain tax positions are retained. Management considers tax laws which are in place in making that assessment determining whether it is appropriate to release.

d)        Cash generating units

When performing goodwill impairment testing, management apply judgment to the allocation of goodwill to cash generating units. Management has determined goodwill is monitored at the operating segment level of “Frozen”. Please refer to Note 13 for further information.

e)        Operating segments

Management apply judgment in determining the Chief Operating Decision Maker (“CODM”), and the nature and extent of the financial information which is reviewed by the CODM. Management have considered how resources are allocated in determining the single reporting and operating segment of “Frozen”. Please refer to Note 5 for further information.

Significant estimates

Information about estimates and assumptions that have significant effects on the amounts reported in the consolidated financial statements are listed below. Management have taken into account the impact and potential future impact of COVID-19 on these estimates. We will continue to assess the impact of future developments in relation to COVID-19 as it relates to estimates, especially around the carrying value of goodwill, brands and other intangibles, as well as on property, plant and equipment. In particular, we will focus on the long-term impact on the food service customer relationship intangible assets.

a)        Discounts and trade promotions

Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has bespoke agreements that are governed by a combination of observable and unobservable performance conditions.

Trade promotions comprise of amounts paid to retailers for programs designed to promote Company products and include pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The estimated ultimate cost of the program is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends.

At each financial year end date, any discount or trade promotion incurred but not yet invoiced is estimated and accrued for. In certain cases, the estimate for discounts and trade promotions requires the use of forecast information for future trading periods and therefore a degree of estimation uncertainty exists. These estimates are sensitive to variances between actual results and forecasts. The estimate is based on accumulated experience.

The accruals are presented as ‘trade terms’ and offset against trade receivables due to the same customer, or as trade term payables where there is no receivable to be offset. The balance of the reduction in trade receivables for trade terms as of December 31, 2021 is disclosed in Note 18 and the balance classified as a trade term payable is disclosed in Note 22.

b)        Business combinations

The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable estimation in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following estimates and assumptions can materially affect our financial position and profit:

•The fair value and expected useful economic life of acquired intangible and tangible assets that are subject to depreciation or amortization in future periods.

•Future changes to the assumptions over forecast future profitability used in estimating the value of intangible assets and goodwill may result in additional expenses or income.

•Future changes to the assumptions used in estimating the value of uncertain tax positions may result in additional expenses or income.

Please refer to Note 14 for details of business combinations in the period.

c)        Carrying value of goodwill and brands

Determining whether goodwill and brands are impaired requires an estimation of the value in use of the cash generating unit to which goodwill and brands have been allocated. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. Future cash flows for the purposes of the value in use calculation are taken from approved budgets. Details of impairment reviews including disclosures covering sensitivities are provided in Note 13.

d)        Employee benefit obligation

The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each scheme has an actuarial valuation performed by a specialist third party and is dependent on a series of assumptions which are estimated by management. See Note 23 for details of these assumptions and a sensitivity analysis on material assumptions.

e)        Uncertain tax positions

Where tax exposures can be quantified, an accrual for uncertain tax positions is based on the Group's judgment of the most likely amount of the liability expected to be paid to the relevant tax authority; or, when there is a wide range of possible outcomes, a probability weighted average approach. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these accruals. The factors considered in estimating the accrual include the progress of discussions with the tax authorities, the complexity of respective tax legislation, valuations of assets for tax purposes and the level of documentary support for historical positions taken by previous owners. The accruals are made on the basis of a weighted average of potential outcomes.

f)        Fair value of derivative financial instruments.

Note 34 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations. These inputs may be readily observable, market corroborated, or generally unobservable inputs and are further discussed in Note 34.

XML

Segment reporting

12 Months Ended

Dec. 31, 2021

Operating Segments [Abstract]

Segment reporting

Segment reporting

Nomad has one reporting and operating segment, "Frozen", reflected in the segment presentation below for the periods presented. The CODM primarily uses “Adjusted EBITDA”, disclosed in Note 3.19, as the key measure of the segment’s results, which is considered non-IFRS financial information.

Segment Adjusted EBITDA

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Profit for the period		181.0	225.1	153.6
Taxation		55.7	70.4	56.7
Net financing costs		106.0	63.7	73.2
Depreciation and amortization		71.6	67.6	68.3
Acquisition purchase price adjustments		8.4	—	—
Exceptional items	7	45.3	20.6	54.5
Other add-backs		18.7	19.4	25.7
Adjusted EBITDA		486.7	466.8	432.0

Acquisition purchase price adjustments relate to the reversal of the non-cash increase applied to inventory acquired in business combinations to value it at fair value as opposed to cost.

Other add-backs include the elimination of share-based payment expense and related employer payroll expense of €5.8 million (2020: €12.1 million, 2019: €22.4 million) and elimination of non-operating M&A related costs, professional fees and transaction costs of €12.9 million (2020: €7.3 million, 2019: €3.3 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

No information on segment assets or liabilities is presented to the CODM.

Product information

Management considers the products it sells belong to one category, being "Frozen".

Geographical information

External revenue by geography

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
United Kingdom	758.3	747.3	712.5
Italy	417.9	426.3	394.1
Germany	396.3	393.2	329.6
France	188.6	203.8	176.6
Sweden	148.1	158.7	175.7
Austria	129.3	127.9	108.2
Norway	121.7	115.6	120.4
Spain	75.1	82.6	79.5
Rest of Europe	371.3	260.5	227.7
Total external revenue by geography	2,606.6	2,515.9	2,324.3

Non-current assets by geography

	December 31, 2021	December 31, 2020
	€m	€m
Germany	140.0	135.5
United Kingdom	139.6	132.1
Italy	64.8	68.5
Serbia	48.5	—
Croatia	38.5	—
Ireland	34.3	31.9
Norway	31.0	30.0
Sweden	29.8	28.5
Rest of Europe	72.3	52.7
Total non-current assets by geography	598.8	479.2

Non-current assets exclude deferred tax assets, goodwill and brands which are not bound to one geographical area

XML

Operating profit/(loss)

12 Months Ended

Dec. 31, 2021

Analysis of income and expense [abstract]

Operating profit/(loss)

Operating profit

Operating profit is stated after charging:

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Staff costs	8	340.6	340.2	308.6
Depreciation of property, plant and equipment	12	63.4	59.8	59.7
Impairment of property, plant and equipment	12	—	—	0.1
Impairment of software and brands	13	1.7	—	—
Amortization of software and brands	13	8.2	7.8	8.6
Operating lease charges		6.1	3.0	4.5
Exchange losses/(gains)		27.0	(2.8)	(14.6)
Research & development expenditure		19.2	17.6	18.9
Inventories recognized as an expense within cost of goods sold		1,694.3	1,627.9	1,536.0

XML

Exceptional items

12 Months Ended

Dec. 31, 2021

Analysis of income and expense [abstract]

Exceptional items

Exceptional items

Exceptional items are made up as follows:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Supply chain reconfiguration (1)	—	(12.5)	(3.6)
Findus Group integration costs (2)	—	—	3.5
Fortenova Acquisition integration costs (3)	3.5	—	—
Findus Switzerland integration costs (4)	6.2	0.3	—
Brexit (5)	5.3	1.6	1.6
Business Transformation program (6)	18.8	2.3	—
Information Technology Transformation program (7)	4.2	—	—
Goodfella's Pizza & Aunt Bessie's integration costs (8)	—	4.0	12.5
Factory optimization (9)	4.9	10.0	5.7
Settlement of legacy matters (10)	(2.6)	(2.9)	(9.2)
Release of indemnification assets (11)	5.0	17.8	44.0
Total exceptional items	45.3	20.6	54.5

We do not consider these items to be indicative of our ongoing operating performance.

(1)Supply chain reconfiguration

Supply chain reconfiguration relates to activities associated with the closure of the Bjuv manufacturing facility in Sweden which ceased production in 2017. No income has been recognized in the year ended December 31, 2021 (2020: €12.5 million, 2019: €3.6 million).

In 2020, the Company signed an agreement to end its leasehold of a cold store in Sweden in 2021, which was originally due to expire in 2040. The cold store will continue to be used by the Company under a service contract once the lease has come to an end. The agreement resulted in a significant modification of a right-of-use asset and reduction in lease liabilities. The carrying value of the right-of-use asset had previously been impaired such that its value was significantly lower than that of the liabilities extinguished. Consequently, the Company recognized a gain from the transaction. As part of the transaction, the Company has become liable to fulfill certain severance arrangements in 2021 which have been provided for, the cost of which offsets a portion of the income from the modification of the lease.

In 2019, the income related to the sale of the agricultural land and the finalization of consideration received for the sale of the industrial property, which had completed in 2018.

(2)Findus Group integration costs

Following the acquisition of the Findus Group on November 2, 2015, the Company initiated a substantial integration project. Expenses presented primarily relate to the roll-out of the Nomad ERP system which completed in 2019.

(3)Fortenova Acquisition integration costs

As disclosed in Note 14, the Company completed the acquisition of the Fortenova Group’s Frozen Food Business Group on September 30, 2021, following which the Company is undertaking an integration project over the next three years. Integration expenses incurred relate to external consultancy costs, organizational structure alignment to Nomad design, systems configuration and roll-out of our controls environment to the acquired business.

(4)Findus Switzerland integration costs

As disclosed in Note 14, the Company completed the acquisition of Findus Switzerland on December 31, 2020, following which the Company commenced an integration project which is expected to complete in 2022. Integration expenses incurred and to be incurred in the future relate to external consultancy costs, organizational structure alignment to Nomad design and roll-out of the Nomad ERP system.

(5)Brexit

As part of the process of the United Kingdom exiting the European Union, commonly referred to as Brexit, the Company has incurred expenses to prepare for, and respond to, changes impacting our supply chain. Whilst an agreement with the EU was reached on December 24, 2020, border control processes remain in a period of transition. Expenses in 2021 relate to project costs and the write-off of system development costs no longer required due to changes in regulations and the Company's approach to handling Brexit-related logistic issues.

(6)Business transformation program

In 2020, the Company launched the first phase of a multi-year, enterprise-wide transformation and optimization program. Over the next few years, additional transformation phases will be implemented. The program aims to standardize, simplify and automate end-to-end business processes. This will enable key decision making and analytical capability, building a platform and organization to support future growth and provide better value for shareholders. Execution of the business transformation program will include the evaluation and implementation of a new ERP system.

Expenses in the year consist of restructuring and transformational project costs, including business technology transformation initiative costs and related professional fees.

(7)Information Technology Transformation program

In 2021, the Company launched a program to transform the Information Technology (“IT”) operating model, specifically to modernize the end-to-end technology estate to support current and future complex and evolving business needs driven by acquisitions and organic growth. Among the many changes being made, the program moves our operating model to a cloud-hosted solution, which better deploys new services to the business and end user, including application management, supporting a diverse workforce across multiple locations and languages, as well as deploying artificial Intelligence assisted tools. Other key components of the program include the Company’s cyber security services to adapt to rapidly changing threats and a change of IT service partners to enable one-off renovation and uplift of capabilities across the business.

(8)Goodfella's Pizza & Aunt Bessie's integration costs

Following the acquisition of the Goodfella’s pizza business in April 2018 and the Aunt Bessie's business in July 2018, the Company completed an integration project which finished in 2020.

(9)Factory optimization

In 2018, the Company initiated a three-year factory optimization program. The focus of the program is to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. The program is expected to provide a number of benefits, including an optimized supply chain infrastructure, benefits derived from the implementation of a standardized global manufacturing and planning processes, and an increased level of sustainable performance improvement. Due to delays in delivering the program across the Nomad manufacturing portfolio due to various government lockdowns and travel bans, the project has been extended for an additional year.

(10)Settlement of legacy matters

A net income of €2.6 million has been recognized associated with the release of acquired provisions relating to periods prior to acquisition by the Company. Net income of €2.9 million was recognized in the year ended December 31, 2020 associated with the release of acquired tax liabilities relating to periods prior to acquisition by the Company. Net income of €9.2 million was recognized in the year ended December 31, 2019. This includes an income of €2.7 million recognized on settlement of contingent consideration for the La Cocinera acquisition and net income of €0.7 million associated with settlements of tax audits.

(11)Release of indemnification assets

The charges for the release of indemnification assets relates to the partial release of shares held in escrow associated with the acquisition of the Findus Group in 2015, as discussed in Note 19.

Tax impact of exceptional items

The tax impact of the exceptional items amounts to a credit of €8.4 million in the year ended December 31, 2021 (year ended December 31, 2020: €3.5 million, year ended December 31, 2019: €3.1 million).

Cash flow impact of exceptional items

Included in the Consolidated Statements of Cash Flows for the year ended December 31, 2021 is €48.8 million (year ended December 31, 2020: €12.1 million, year ended December 31, 2019: €15.9 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items as well as the cash impact of the settlement of provisions brought forward from previous accounting periods.

XML

Payroll costs, share based payments and management incentive schemes

12 Months Ended

Dec. 31, 2021

Employee Benefits And Share-Based Payments [Abstract]

Payroll costs, share based payments and management incentive schemes

Payroll costs, share based payments and management incentive schemes

(a)Payroll costs

The average number of persons employed by the Company (excluding non-Executive Directors) is analyzed and set out below:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Production	3,310	3,043	3,308
Administration, distribution & sales	2,193	1,647	1,448
Total number of employees	5,503	4,690	4,756

The increase in the average number of employees in the table above for the year ended December 31, 2021 compared with the year ended December 31, 2020 is primarily due to the Fortenova Acquisition and Findus Switzerland acquisition as described in Note 14.

The table below discloses the Company’s aggregate payroll costs of these persons. Payroll costs exclude long term management incentive scheme and share based payment costs, but includes bonus costs.

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Wages and salaries	266.4	276.4	250.4
Social security costs	56.1	49.2	45.2
Other pension costs	18.1	14.6	13.0
Total payroll costs	340.6	340.2	308.6

(b)Share based payments

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares.

Non-Executive Director Restricted Share Awards

In accordance with the Board approved independent Non-Executive Director compensation guidelines, each independent Non-Executive Director is entitled to a grant of $100,000 of restricted shares annually on the date of the annual general meeting, valued at the closing market price for such shares on this date. The restricted shares vest on the earlier of twelve months from the date of grant or the date of the Company’s next annual meeting of shareholders.

The Non-Executive Directors restricted share awards granted on June 19, 2018, which consisted of 32,172 shares at a share price of $18.07, vested on June 14, 2019 and were issued at a share price of $20.74, resulting in a €0.1 million increase in the share based compensation reserve. Of the total 44,272 number of shares vesting, 12,100 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

The Non-Executive Directors restricted share awards granted on June 14, 2019, which consisted of 39,370 shares at a share price of $20.32. In July 2019, in conjunction with the resignation of one of our Non-Executive Directors, 2,460 shares from this grant were vested and issued. The remaining awards vested on June 17, 2020 and were issued at a share price of $21.78. Of the total 34,447 number of shares vesting, 8,656 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

The Non-Executive Directors restricted share awards granted on June 17, 2020, which consisted of 32,140 shares at a share price of $21.78, vested on June 30, 2021 and were issued at a share price of $30.14, resulting in a €0.2 million increase in the share based compensation reserve. Of the total 32,140 number of shares vesting, 7,734 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

On June 30, 2021, after the Company's annual general meeting of shareholders, the current Non-Executive Directors were granted 24,759 restricted share award at a share price of $28.27.

The total charge for Non-Executive Director grants within the Statement of Consolidated Profit or Loss for the year ended December 31, 2021 for stock compensation awards was €0.8 million (year ended December 31, 2020: €0.7 million; year ended December 31, 2019: €0.9 million).

Director and Senior Management Share Awards

As part of its long term incentive initiatives, the Company has outstanding awards over 2,016,855 ordinary shares granted to certain members of its management team (the “Management Share Awards”) as of the following four award dates:

	January 1, 2016 Award	January 1, 2017 Award	January 1, 2018 Award	January 1, 2019 Award	January 1, 2020 Award	January 1, 2021 Award	Total
Number of awards outstanding at January 1, 2021	1,041,953	819,873	446,575	159,561	710,438	—	3,178,400
New awards granted in the period	—	—	—	—	—	820,202	820,202
Awards vested and issued in the period	(1,041,953)	(819,873)	—	—	—	—	(1,861,826)
Forfeitures in the period	—	—	(14,785)	(6,866)	(65,345)	(32,925)	(119,921)
Number of awards outstanding at December 31, 2021	—	—	431,790	152,695	645,093	787,277	2,016,855

The 2018 award has vesting conditions based on cumulative EBITDA performance over four years and Company share price performance over two years to five years. During 2021, the Compensation Committee of the Board of Directors amended the non-market condition targets for this award due to recent acquisitions, which did not increase its incremental fair value. The share price and EBITDA performance conditions for the 2018 award are weighted 50% each per performance target.

•For the 2018 award, for the share price target, the initial two-year period was through to January 1, 2020 and the subsequent three-year period is through to January 1, 2023. For the four-year cumulative EBITDA Performance Condition, if satisfied, will vest on January 1, 2022.

For the 2019, 2020 and 2021 awards, those grants have vesting conditions based on cumulative EBITDA performance, cumulative Net Sales and Company share price performance over three years. During 2021, the Compensation Committee of the Board of Directors amended the non-market condition targets for these awards due to recent acquisitions, which did not increase their incremental fair value. In addition, the 2020 award had a holding period of one-year that has been removed from the vesting period. The 2021 award was issued late in 2021 with a performance period starting January 1, 2021.

In September 2019, 166,427 restricted share awards were granted as part of the 2019 Management Share Award. The performance period associated with the award began as of January 1, 2019. The 2019 awards have vesting conditions based on three-year cumulative EBITDA and net sales, and Company share price performance measures. One third of the total share award is assigned to each type of performance measure. All shares are subject to a holding period of an additional year and require that the participants to the scheme are still actively employed during the entire four year period, through January 1, 2023.

In January 2020, 761,979 restricted share awards were granted as part of the 2020 Management Share Award. The performance period associated with the award began on January 1, 2020. The Share awards will vest on the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and share price performance measures over a three-year period. The cumulative EBITDA and Cumulative Net Sales tranches of shares are equally weighted, being worth 37.5% of the total award each. The Company Share Price Tranche is worth 25% of the total award. All shares vest, subject to satisfaction of the award conditions, on January 1, 2023.

In late 2021, 820,202 restricted share awards were granted as part of the 2021 Management Share Award. The performance period associated with the award began on January 1, 2021. The Share awards will vest on the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and Company share price performance measures over a three-year period. The cumulative EBITDA and Cumulative Net Sales tranches of shares are equally weighted, being worth 37.5% of the total award each. The Share Price Tranche is worth 25% of the total award. All shares vest, subject to satisfaction of the award conditions, on January 1, 2024.

In January 2019, 85,315 restricted shares granted as part of the 2017 Management Share Awards vested based on share price performance, resulting in the issuance of 51,932 ordinary shares (net of 33,383 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In January 2020, 284,555 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $22.37), resulting in the issuance of 163,816 ordinary shares to participants in the LTIP (net of 120,739 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In February 2020, 1,626,006 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $19.53), resulting in the issuance of 928,042 ordinary shares to participants in the LTIP (net of 697,964 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In September 2020, 42,825 restricted shares granted as part of the 2018 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.30). Due to the timing of the vesting, the resulting issuance of 25,655 ordinary shares to participants in the LTIP (net of 17,170 ordinary shares held back from issue by the

Company as settlement towards personal tax liabilities arising on the vested ordinary shares) occurred in October 2020.

In January 2021, 1,041,953 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.42), resulting in the issuance of 587,633 ordinary shares to participants in the LTIP (net of 454,320 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In January 2021, 368,154 restricted shares granted as part of the 2017 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.42), resulting in the issuance of 217,228 ordinary shares to participants in the LTIP (net of 150,926 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In February 2021, 451,719 restricted shares granted as part of the 2017 Management Share Awards vested as a result of the satisfaction of the applicable EBITDA Performance Condition (based on a share price of $25.89 at time of vesting), resulting in the issuance of 271,451 ordinary shares to participants in the LTIP (net of 180,268 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

The stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year ended December 31, 2021 related to the director and senior management share awards is €4.3 million (year ended December 31, 2020: €8.3 million: year ended December 31, 2019: €14.0 million).

The Company calculates the cost of the Management Share Awards based upon their fair value using the Monte Carlo Model, which is considered to be the most appropriate methodology considering the restricted shares only vest once the market performance conditions have been satisfied.

The inputs and assumptions underlying the Monte Carlo models for all awards outstanding as of the valuation date are now as follows:

	January 1, 2018 award			January 1, 2019 award			January 1, 2020 award			January 1, 2021 award
Grant date price	$	16.72		$	20.15		$	22.37		$	25.42
Exercise price	$	—		$	—		$	—		$	—
Expected life of restricted share	1.50 - 4.00 years			4.00 years			3.00 years			3.00 years
Expected volatility of the share price	22.7		%	24.0		%	24.4		%	30.0		%
Dividend yield expected	—		%	—		%	—		%	—		%
Risk free rate	2.55		%	1.33		%	1.70		%	0.24		%
Employee exit rate	14.0		%	14.0		%	27.3		%	14.0		%
EBITDA Performance Target Condition	35.0		%	35.0		%	35.0		%	35.0		%

The expected volatility of the share price inputs above were estimated by referencing selected quoted companies which are considered to exhibit some degree of comparability with the Company, as the Company has only been listed for approximately six years.

Based on the latest assessments of fair value and the number of shares expected to vest, the total fair values in respect of the Restricted Shares are:

•2018 award - $1.6 million (€1.3 million)

•2019 award - $1.4 million (€1.2 million)

•2020 award - $4.8 million (€4.3 million)

•2021 award - $7.0 million (€5.8 million)

Initial Director Options

In 2014, certain Non-Executive Directors were granted options (“Initial Options”) to purchase a maximum of 125,000 Ordinary Shares at an exercise price of $11.50 per ordinary share. The awards were valued at issuance and expensed during the two years ended April 1, 2016.

Throughout 2019, former Non-Executive Directors exercised 56,250 of the 125,000 initial options granted to them for €0.6 million.

In May 2020, former and current Non-Executive Directors were issued an aggregate of 49,196 shares (net of shares withheld for the settlement of taxes), exercising all the remaining initial options outstanding for €0.6 million.

XML

Directors and Key Management compensation

12 Months Ended

Dec. 31, 2021

Related Party [Abstract]

Disclosure of information about key management personnel [text block]

Directors and Key Management compensation

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Short-term employee benefits	2.2	3.9	2.8
Share-based payment expense	2.4	3.5	7.6
Non-Executive Director fees	0.3	0.3	0.4
Total Directors' and executive officers' compensation	4.9	7.7	10.8

All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and executive Officers.

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Benefits are accruing to the following number of key management personnel under:
Defined contribution plans	2	2	2
Share based payment schemes	2	2	2

XML

Finance income and costs

12 Months Ended

Dec. 31, 2021

Analysis of income and expense [abstract]

Finance income and costs

Finance income and costs

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Interest income	0.1	0.7	2.5
Net foreign exchange gains on translation of financial assets and liabilities	—	4.0	—
Finance income	0.1	4.7	2.5
Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss (a)	(59.8)	(64.0)	(79.0)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity	1.6	5.9	21.8
Net impairment loss on short-term investments	(8.6)	—	—
Net pension interest costs	(1.7)	(2.7)	(3.8)
Amortization of borrowing costs	(2.0)	(2.0)	(2.0)
Net foreign exchange losses on translation of financial assets and liabilities	(4.0)	—	(3.9)
Net fair value losses on derivatives held at fair value through profit or loss (b)	(13.7)	(5.6)	(8.8)
Financing costs incurred in amendment of terms of debt (c)	(17.9)	—	—
Finance costs	(106.1)	(68.4)	(75.7)
Net finance costs	(106.0)	(63.7)	(73.2)

(a) Includes the unwinding of discounting on lease liabilities. 

(b) Net fair value losses on derivatives held at fair value through profit or loss includes a one-off non-cash charge of €7.8 million for changes to cross currency interest rate swaps as disclosed in Note 34.

(c) Charges of €17.9 million have been recognized as a consequence of the refinancing in June 2021, as disclosed in Note 34. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs.

XML

Taxation

12 Months Ended

Dec. 31, 2021

Income Taxes [Abstract]

Taxation

Taxation

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Current tax expense
Current tax on profits for the period		(117.5)	(44.8)	(66.4)
Adjustments in respect of prior periods		0.6	(7.6)	—
		(116.9)	(52.4)	(66.4)
Deferred tax benefit/(expense)
Origination and reversal of temporary differences		116.3	(1.2)	9.7
Impact of change in tax rates		(55.1)	(16.8)	—
	16	61.2	(18.0)	9.7
Total tax expense		(55.7)	(70.4)	(56.7)

Reconciliation of effective tax rate:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Profit before tax	236.7	295.5	210.3
Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%)	(45.0)	(56.1)	(39.9)
Difference in tax rates	22.7	(18.2)	(11.9)
Non tax deductible interest	0.1	(0.1)	0.6
Other income and expenses not taxable or deductible	2.5	(0.8)	(1.2)
Unrecognized tax assets	(1.5)	(6.3)	(0.9)
Provisions for uncertainties	(52.5)	35.5	(3.4)
Impact of change in tax rates	(55.1)	(16.8)	—
Change in tax base of assets due to step-up	72.5	—	—
Prior period adjustment	0.6	(7.6)	—
Total tax expense	(55.7)	(70.4)	(56.7)

Effective tax rates

The Company is resident in the United Kingdom for tax purposes. The effective tax rate for the year ended December 31, 2021 was 23.5% (year ended December 31, 2020: 23.8%). The change is principally caused by the release of uncertain tax positions in relation to exposures that are now time barred, offset in part by the impact of a change in tax rates on deferred tax assets and liabilities.

The Company operates in many different jurisdictions and in some of these, certain matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments appeals and refunds. The Company actively seeks to manage the associated risks by proactively engaging with tax authorities and applying for Advanced Pricing Agreements where appropriate. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision, including releases of provisions when those exposures become time-barred.

Notwithstanding this, management believes that the Company’s position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided. As of December 31, 2021, the current tax payable of €198.5m and deferred tax assets of €128.3m includes provisions for tax uncertainties of €163.4m. As of December 31, 2020, the current tax payable of €166.2m and deferred tax assets of €113.5m included provisions for tax uncertainties of €103.9m.

The UK government announced an increase in the standard rate of corporation tax from 19% for 2021 (2020: 19%) to 25% effective from April 1, 2023, substantively enacted on May 24, 2021. The increase gave rise to a substantial one-off deferred tax expense, which is offset in part by a deferred tax benefit from the implementation of certain arrangements benefiting from one-off government incentives and other tax incentives. The financial statements for the year ended December 31, 2020 were prepared using the substantively enacted rate of corporation tax of 19%.

The tax (benefit)/expense relating to components of other comprehensive income is as follows:

		Before tax	Tax charge	After tax
Year ended December 31, 2021	Note	€m	€m	€m
Remeasurement of post-employment benefit liabilities		(36.1)	10.2	(25.9)
Net investment hedge		(18.8)	—	(18.8)
Cash flow hedges		(22.6)	13.6	(9.0)
Other comprehensive (income)/loss		(77.5)	23.8	(53.7)
Current tax			—
Deferred tax	16		23.8
			23.8
		Before tax	Tax benefit	After tax
Year ended December 31, 2020	Note	€m	€m	€m
Remeasurement of post-employment benefit liabilities		27.8	(8.3)	19.5
Net investment hedge		10.1	—	10.1
Cash flow hedges		17.3	(6.0)	11.3
Other comprehensive loss/(income)		55.2	(14.3)	40.9
Current tax			—
Deferred tax	16		(14.3)
			(14.3)
		Before tax	Tax benefit	After tax
Year ended December 31, 2019		€m	€m	€m
Remeasurement of post-employment benefit liabilities		35.9	(6.7)	29.2
Net investment hedge		(6.0)	—	(6.0)
Cash flow hedges		27.3	(5.6)	21.7
Other comprehensive loss/(income)		57.2	(12.3)	44.9
Current tax			—
Deferred tax			(12.3)
			(12.3)

Deferred tax assets and liabilities

Recognized deferred tax assets and liabilities

Deferred tax assets and liabilities are attributable to the following:

	December 31, 2021			December 31, 2020 (restated)
	Assets	Liabilities	Total	Assets	Liabilities	Total
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	8.9	(34.4)	(25.5)	20.6	(27.3)	(6.7)
Intangible assets	33.8	(382.9)	(349.1)	0.9	(384.4)	(383.5)
Employee benefits	36.4	—	36.4	48.3	(0.3)	48.0
Tax value of loss carry forwards	40.4	—	40.4	24.6	—	24.6
Derivative financial instruments	1.7	(7.0)	(5.3)	9.3	(0.1)	9.2
Other	7.1	(13.3)	(6.2)	9.8	(15.0)	(5.2)
Tax assets/(liabilities)	128.3	(437.6)	(309.3)	113.5	(427.1)	(313.6)

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future taxable profits is probable.

Deferred tax assets that the Company has not recognized in the financial statements amount to €70.4 million (December 31, 2020: €72.7 million). These deferred tax assets had not been recognized as the likelihood of recovery is not probable.

The aggregate deferred tax relating to items that have been credited directly to equity is €23.8 million (December 31, 2020: debit of €14.3 million).

Movement in deferred tax during the year:

	Opening balance Jan 1, 2021 (restated)	Acquired in business combinations	Recognized  in Statement of Profit or Loss	Recognized in Other Comprehensive Income	Movement in foreign exchange	Closing balance Dec 31, 2021
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	(6.7)	(2.2)	(17.2)	—	0.6	(25.5)
Intangible assets	(383.5)	(30.1)	64.5	—	—	(349.1)
Employee benefits	48.0	—	(1.2)	(10.2)	(0.2)	36.4
Tax value of loss carry forwards	24.6	—	15.8	—	—	40.4
Derivative financial instruments	9.2	—	(0.3)	(13.6)	(0.6)	(5.3)
Other	(5.2)	(0.6)	(0.4)	—	—	(6.2)
Total deferred tax	(313.6)	(32.9)	61.2	(23.8)	(0.2)	(309.3)

	Opening balance Jan 1, 2020	Acquired in business combinations (restated)	Recognized  in Statement of Profit or Loss	Recognized in Other Comprehensive Income	Movement in foreign exchange	Closing balance Dec 31, 2020 (restated)
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	(6.3)	(1.3)	1.0	—	(0.1)	(6.7)
Intangible assets	(356.6)	(6.3)	(20.6)	—	—	(383.5)
Employee benefits	39.8	—	—	8.3	(0.1)	48.0
Tax value of loss carry forwards	20.7	—	3.9	—	—	24.6
Derivative financial instruments	2.9	—	0.3	6.0	—	9.2
Other	(2.3)	(0.4)	(2.6)	—	0.1	(5.2)
Total deferred tax	(301.8)	(8.0)	(18.0)	14.3	(0.1)	(313.6)

XML

Goodwill and Intangibles

12 Months Ended

Dec. 31, 2021

Intangible assets and goodwill [abstract]

Goodwill and Intangibles

Goodwill and Intangibles

	Goodwill	Brands	Computer software	Customer relationships	Total
	€m	€m	€m	€m	€m
Cost
Balance at December 31, 2019	1,862.9	2,051.1	29.8	31.0	3,974.8
Acquisitions through business combinations (restated)	40.1	66.0	0.1	—	106.2
Additions	—	—	8.8	—	8.8
Effect of movements in foreign exchange	(0.5)	5.3	0.3	—	5.1
Balance at December 31, 2020 (restated)	1,902.5	2,122.4	39.0	31.0	4,094.9
Acquisitions through business combinations	192.6	296.5	1.1	4.3	494.5
Additions	—	—	5.8	—	5.8
Disposals	—	—	(2.5)	—	(2.5)
Effect of movements in foreign exchange	4.3	3.2	(0.5)	—	7.0
Balance at December 31, 2021	2,099.4	2,422.1	42.9	35.3	4,599.7

	Goodwill	Brands	Computer software	Customer relationships	Total
	€m	€m	€m	€m	€m
Accumulated amortization and impairment
Balance at December 31, 2019	—	4.4	15.2	9.2	28.8
Amortization	—	1.2	4.4	2.2	7.8
Effect of movements in foreign exchange	—	—	0.1	—	0.1
Balance at December 31, 2020	—	5.6	19.7	11.4	36.7
Amortization	—	1.2	4.6	2.4	8.2
Impairment	—	—	1.7	—	1.7
Disposals	—	—	(1.7)	—	(1.7)
Effect of movements in foreign exchange	—	—	(0.3)	—	(0.3)
Balance at December 31, 2021	—	6.8	24.0	13.8	44.6
Net book value December 31, 2019	1,862.9	2,046.7	14.6	21.8	3,946.0
Net book value December 31, 2020 (restated)	1,902.5	2,116.8	19.3	19.6	4,058.2
Net book value December 31, 2021	2,099.4	2,415.3	18.9	21.5	4,555.1

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

Amortization and impairment of €9.9 million (December 31, 2020: €7.8 million; December 31, 2019: €8.6 million) is included in ‘other operating expenses’ in the Consolidated Statement of Profit or Loss.

Goodwill is initially recognized based on the accounting policy for goodwill (see note 3.5) and is subsequently measured at cost less amounts provided for impairment.

The Company’s goodwill, brand and customer relationships values have been allocated to a level no larger than the identified operating segment. This represents the lowest level within the Group at which the goodwill is monitored for internal management purposes. As required by IAS 36 'Impairment of Assets', an annual review of the carrying amount of the goodwill and the indefinite life brands is carried out to identify whether there is any impairment to these carrying values. This is done by means of comparison of the carrying values to the value in use of the CGU. Value in use is calculated as the net present value of the projected risk-adjusted cash flows of each CGU.

Key assumptions

The values for the key assumptions relating to the annual review of the carrying amount of goodwill and indefinite life brands were arrived at by taking into consideration detailed historical information and comparison to external sources where appropriate, such as market rates for discount factors.

•Budgeted cash flows: the calculation of value in use has been based on the cash flow forecasts by management for 2022 to 2025. The trends in these forecasts have been extrapolated to produce a forecast cash flow for 2026. Beyond 2026 the same assumptions have been applied for future periods in the absence of longer term detailed forecasts. These plans have been prepared and approved by management, and incorporate past performance of the entities acquired in the period, historical growth rates and projections of developments in key markets.

•Revenue: projected revenues are built up with reference to markets and product platforms. They incorporate past performance, historical growth rates and projections of developments in key markets.

•Profit margins: projected margins reflect historical performance, adjusted to account for volatility, such as the impact of COVID-19.

•Capital expenditure forecast reflects expected expenditure requirements and includes an allowance for the replacement of leased right-of-use assets.

•Discount rate: a pre-tax discount rate of 6.4% (2020: 5.8%) was applied to the cash flows. This discount rate has been calculated using a capital asset pricing model using observable market data, including the share price of Nomad Foods Limited.

•Long-term growth rates: the growth rate used in the testing after the detailed forecasting period was 1.0% (2020: 1.0%). These rates do not reflect the long-term assumptions used by the Company for investment planning.

Sensitivity to changes in assumptions

Impairment was not required at either December 31, 2021, or December 31, 2020. In each case the valuations derived from the discounted cash flow model indicate a sufficient amount of headroom for which any reasonably possible change to key assumptions is unlikely to result in an impairment of the related goodwill.

XML

Acquisitions

12 Months Ended

Dec. 31, 2021

Business Combinations1 [Abstract]

Acquisitions

Indemnification assets

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Balance at January 1	15.4	35.4
Release of indemnified provision	(5.9)	(20.0)
Balance at December 31	9.5	15.4

As at December 31, 2021, €7.0 million (December 31, 2020: €12.0 million) of the indemnification assets relate to the acquisition of the Findus Group in 2015 for which 342,190 shares are held in escrow and are valued at $25.39 (€22.40) (December 31, 2020: 618,099 shares valued at $25.42 (€20.69)) each. The shares placed in escrow were released in stages over a four-year period beginning January 2019 with the final release in January 2022. During 2021, 275,909 shares were released from escrow. As a consequence the indemnification asset was reduced by €5.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2021.

In January 2022, the remaining 342,190 shares were released from escrow. As a consequence the indemnification asset will be reduced by €7.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2022.

As at December 31, 2021, €2.5 million (2020: €3.4 million) of the indemnification asset relates to the Goodfella’s Pizza acquisition for several contingent liabilities that arose prior to acquisition and were recognized in the balance sheet to the same extent as the asset. During 2021, €0.9 million was released against the liabilities.

XML

Investments

12 Months Ended

Dec. 31, 2021

Interests in Other Entities [Abstract]

Investments

Investments

The following are the Company's significant investments as of December 31, 2021.

	Activity	Country of incorporation	Class of shares held	Ownership as of December 31, 2020
Nomad Foods Europe Holdings Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Holdco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Finco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Midco Limited	Holding/ Finance	England	Ordinary	100%
Nomad Foods Bondco Plc	Finance	England	Ordinary	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	Ordinary	100%
Nomad Foods Europe Limited	Management	England	Ordinary	100%
Birds Eye Limited	Trading	England	Ordinary	100%
Nomad Foods Europe Finance Limited	Finance	England	Ordinary	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	Ordinary	100%
Iglo Holding GmbH	Holding	Germany	Ordinary	100%
Iglo Nederland B.V.	Trading	Netherlands	Ordinary	100%
Iglo Belgium S.A.	Trading	Belgium	Ordinary	100%
Iglo Portugal	Trading	Portugal	Ordinary	100%
Iglo Austria Holdings GmbH	Holding	Austria	Ordinary	100%
C.S.I. Compagnia Surgelati Italiana S.R.L	Trading	Italy	Ordinary	100%
Findus Sverige Holdings AB	Holding	Sweden	Ordinary	100%
Iglo GmbH	Trading	Germany	Ordinary	100%
Frozen Fish International GmbH	Trading	Germany	Ordinary	100%
Liberator Germany Newco GmbH	Property	Germany	Ordinary	100%
Iglo Austria GmbH	Trading	Austria	Ordinary	100%
Findus Sverige AB	Trading	Sweden	Ordinary	100%
Frionor Sverige AB	Holding	Sweden	Ordinary	100%
Findus Holdings France SAS	Holding	France	Ordinary	100%
Findus France SAS	Trading	France	Ordinary	100%
Findus Espana SLU	Trading	Spain	Ordinary	100%
Findus Danmark A/S	Trading	Denmark	Ordinary	100%
Findus Finland Oy	Trading	Finland	Ordinary	100%
Findus Norge AS	Trading	Norway	Ordinary	100%
Findus Norge Holding AS	Holding	Norway	Ordinary	100%

Toppfrys AB	Trading	Sweden	Ordinary	100%
Findus Switzerland AG	Trading	Switzerland	Ordinary	100%
LEDO plus d.o.o.	Trading	Croatia	Ordinary	100%
INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD	Trading	Serbia	Ordinary	100%
LEDO d.o.o. Čitluk	Trading	Bosnia & Herzegovina	Ordinary	100%
IRIDA d.o.o.	Trading	Croatia	Ordinary	100%
LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság	Trading	Hungary	Ordinary	100%
Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.)	Trading	Slovenia	Ordinary	100%
Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga “Ledo” d.o.o. Podgorica)	Trading	Montenegro	Ordinary	100%
Ledo Sh.p.k.	Trading	Kosovo	Ordinary	100%
FRIKOM BEOGRAD DOOEL Cucer Sandevo	Trading	North Macedonia	Ordinary	100%

XML

Deferred tax assets and liabilities

12 Months Ended

Dec. 31, 2021

Disclosure of income tax [Abstract]

Deferred tax assets and liabilities

Taxation

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Current tax expense
Current tax on profits for the period		(117.5)	(44.8)	(66.4)
Adjustments in respect of prior periods		0.6	(7.6)	—
		(116.9)	(52.4)	(66.4)
Deferred tax benefit/(expense)
Origination and reversal of temporary differences		116.3	(1.2)	9.7
Impact of change in tax rates		(55.1)	(16.8)	—
	16	61.2	(18.0)	9.7
Total tax expense		(55.7)	(70.4)	(56.7)

Reconciliation of effective tax rate:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Profit before tax	236.7	295.5	210.3
Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%)	(45.0)	(56.1)	(39.9)
Difference in tax rates	22.7	(18.2)	(11.9)
Non tax deductible interest	0.1	(0.1)	0.6
Other income and expenses not taxable or deductible	2.5	(0.8)	(1.2)
Unrecognized tax assets	(1.5)	(6.3)	(0.9)
Provisions for uncertainties	(52.5)	35.5	(3.4)
Impact of change in tax rates	(55.1)	(16.8)	—
Change in tax base of assets due to step-up	72.5	—	—
Prior period adjustment	0.6	(7.6)	—
Total tax expense	(55.7)	(70.4)	(56.7)

Effective tax rates

The Company is resident in the United Kingdom for tax purposes. The effective tax rate for the year ended December 31, 2021 was 23.5% (year ended December 31, 2020: 23.8%). The change is principally caused by the release of uncertain tax positions in relation to exposures that are now time barred, offset in part by the impact of a change in tax rates on deferred tax assets and liabilities.

The Company operates in many different jurisdictions and in some of these, certain matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments appeals and refunds. The Company actively seeks to manage the associated risks by proactively engaging with tax authorities and applying for Advanced Pricing Agreements where appropriate. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision, including releases of provisions when those exposures become time-barred.

Notwithstanding this, management believes that the Company’s position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided. As of December 31, 2021, the current tax payable of €198.5m and deferred tax assets of €128.3m includes provisions for tax uncertainties of €163.4m. As of December 31, 2020, the current tax payable of €166.2m and deferred tax assets of €113.5m included provisions for tax uncertainties of €103.9m.

The UK government announced an increase in the standard rate of corporation tax from 19% for 2021 (2020: 19%) to 25% effective from April 1, 2023, substantively enacted on May 24, 2021. The increase gave rise to a substantial one-off deferred tax expense, which is offset in part by a deferred tax benefit from the implementation of certain arrangements benefiting from one-off government incentives and other tax incentives. The financial statements for the year ended December 31, 2020 were prepared using the substantively enacted rate of corporation tax of 19%.

The tax (benefit)/expense relating to components of other comprehensive income is as follows:

		Before tax	Tax charge	After tax
Year ended December 31, 2021	Note	€m	€m	€m
Remeasurement of post-employment benefit liabilities		(36.1)	10.2	(25.9)
Net investment hedge		(18.8)	—	(18.8)
Cash flow hedges		(22.6)	13.6	(9.0)
Other comprehensive (income)/loss		(77.5)	23.8	(53.7)
Current tax			—
Deferred tax	16		23.8
			23.8
		Before tax	Tax benefit	After tax
Year ended December 31, 2020	Note	€m	€m	€m
Remeasurement of post-employment benefit liabilities		27.8	(8.3)	19.5
Net investment hedge		10.1	—	10.1
Cash flow hedges		17.3	(6.0)	11.3
Other comprehensive loss/(income)		55.2	(14.3)	40.9
Current tax			—
Deferred tax	16		(14.3)
			(14.3)
		Before tax	Tax benefit	After tax
Year ended December 31, 2019		€m	€m	€m
Remeasurement of post-employment benefit liabilities		35.9	(6.7)	29.2
Net investment hedge		(6.0)	—	(6.0)
Cash flow hedges		27.3	(5.6)	21.7
Other comprehensive loss/(income)		57.2	(12.3)	44.9
Current tax			—
Deferred tax			(12.3)
			(12.3)

Deferred tax assets and liabilities

Recognized deferred tax assets and liabilities

Deferred tax assets and liabilities are attributable to the following:

	December 31, 2021			December 31, 2020 (restated)
	Assets	Liabilities	Total	Assets	Liabilities	Total
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	8.9	(34.4)	(25.5)	20.6	(27.3)	(6.7)
Intangible assets	33.8	(382.9)	(349.1)	0.9	(384.4)	(383.5)
Employee benefits	36.4	—	36.4	48.3	(0.3)	48.0
Tax value of loss carry forwards	40.4	—	40.4	24.6	—	24.6
Derivative financial instruments	1.7	(7.0)	(5.3)	9.3	(0.1)	9.2
Other	7.1	(13.3)	(6.2)	9.8	(15.0)	(5.2)
Tax assets/(liabilities)	128.3	(437.6)	(309.3)	113.5	(427.1)	(313.6)

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future taxable profits is probable.

Deferred tax assets that the Company has not recognized in the financial statements amount to €70.4 million (December 31, 2020: €72.7 million). These deferred tax assets had not been recognized as the likelihood of recovery is not probable.

The aggregate deferred tax relating to items that have been credited directly to equity is €23.8 million (December 31, 2020: debit of €14.3 million).

Movement in deferred tax during the year:

	Opening balance Jan 1, 2021 (restated)	Acquired in business combinations	Recognized  in Statement of Profit or Loss	Recognized in Other Comprehensive Income	Movement in foreign exchange	Closing balance Dec 31, 2021
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	(6.7)	(2.2)	(17.2)	—	0.6	(25.5)
Intangible assets	(383.5)	(30.1)	64.5	—	—	(349.1)
Employee benefits	48.0	—	(1.2)	(10.2)	(0.2)	36.4
Tax value of loss carry forwards	24.6	—	15.8	—	—	40.4
Derivative financial instruments	9.2	—	(0.3)	(13.6)	(0.6)	(5.3)
Other	(5.2)	(0.6)	(0.4)	—	—	(6.2)
Total deferred tax	(313.6)	(32.9)	61.2	(23.8)	(0.2)	(309.3)

	Opening balance Jan 1, 2020	Acquired in business combinations (restated)	Recognized  in Statement of Profit or Loss	Recognized in Other Comprehensive Income	Movement in foreign exchange	Closing balance Dec 31, 2020 (restated)
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	(6.3)	(1.3)	1.0	—	(0.1)	(6.7)
Intangible assets	(356.6)	(6.3)	(20.6)	—	—	(383.5)
Employee benefits	39.8	—	—	8.3	(0.1)	48.0
Tax value of loss carry forwards	20.7	—	3.9	—	—	24.6
Derivative financial instruments	2.9	—	0.3	6.0	—	9.2
Other	(2.3)	(0.4)	(2.6)	—	0.1	(5.2)
Total deferred tax	(301.8)	(8.0)	(18.0)	14.3	(0.1)	(313.6)

XML

Inventories

12 Months Ended

Dec. 31, 2021

Inventories [Abstract]

Inventories

17)    Inventories

	December 31, 2021	December 31, 2020 (restated)
	€m	€m
Raw materials and consumables	95.8	80.5
Work in progress	64.9	46.5
Finished goods and goods for resale	249.9	217.3
Total inventories	410.6	344.3

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

As at December 31, 2021, €2.1 million was recognized as a basis adjustment transferred to the carrying value of inventory. This has been applied to the three inventory categories above.

During the year ended December 31, 2021, €8.3 million (year ended December 31, 2020: €8.5 million, year ended December 31, 2019: €9.0 million) was charged to the Consolidated Statement of Profit or Loss for the write down of inventories.

XML

Trade and other receivables

12 Months Ended

Dec. 31, 2021

Subclassifications of assets, liabilities and equities [abstract]

Trade and other receivables

Trade and other receivables

	December 31, 2021	December 31, 2020
Current assets	€m	€m
Trade receivables	182.8	141.2
Prepayments and accrued income	15.4	9.2
Other receivables	32.3	31.2
Tax receivable	4.1	3.4
Total current trade and other receivables	234.6	185.0
Non-current assets
Other receivables	8.9	1.1
Total non-current trade and other receivables	8.9	1.1
Total trade and other receivables	243.5	186.1

Trade receivables, prepayments and other receivables, except for those defined as non-current, are expected to be recovered in less than 12 months. Other receivables includes VAT receivable.

The aging of trade receivables is detailed below:

	Gross	Impaired	Net
December 31, 2021	€m	€m	€m
Not past due	343.8	(0.1)	343.7
Past due less than 1 month	19.9	(0.1)	19.8
Past due 1 to 3 months	5.2	(0.6)	4.6
Past due 3 to 6 months	2.4	(0.1)	2.3
Past due more than 6 months	5.0	(2.7)	2.3
Sub-total	376.3	(3.6)	372.7
Reduction in trade-terms			(189.9)
Total trade receivables			182.8
	Gross	Impaired	Net
December 31, 2020	€m	€m	€m
Not past due	308.6	(0.3)	308.3
Past due less than 1 month	20.5	(0.2)	20.3
Past due 1 to 3 months	4.0	(0.1)	3.9
Past due 3 to 6 months	1.1	(0.1)	1.0
Past due more than 6 months	11.9	(3.7)	8.2
Sub-total	346.1	(4.4)	341.7
Reduction in trade-terms			(200.5)
Total trade receivables			141.2

Reduction in trade-terms are described in Note 4(a). Trade receivables have been provided against based on expected credit losses on positions net of trade-terms, which fall into all aging categories.

The maximum exposure to credit risk at the reporting date is the fair value of each class of receivable. The Company does not hold any collateral as security.

Debts past due are not impaired where there are eligible trade terms deductions which can be offset against them.

For the periods covered in these financial statements, the Company has entered into facilities with third-party banks/credit providers in which the Company has sold qualifying trade debtors on a non-recourse basis. Under the terms of these agreements, the Company transferred substantially all the credit risks and control of the receivables. All factoring facilities have been cancelled during 2021. No trade receivables have been derecognized at the period end (December 31, 2020:€ nil).

Liabilities related to contracts with customers

The Company has recognized the following liabilities related to contracts with customers:

	December 31, 2021	December 31, 2020
	€m	€m
Trade terms liabilities reported within trade receivables	(189.9)	(200.5)
Trade terms liabilities reported within trade and other payables (Note 22)	(93.8)	(89.7)
Total trade terms liabilities	(283.7)	(290.2)

Significant changes to trade terms

No significant changes to trade terms occurred in the year ended December 31, 2021.

Revenue recognized in relation to trade terms

Trade terms relate to sales made with variable consideration and are an estimate as disclosed in Note 4(a). Revenue recognized in the year ended December 31, 2021 relating to performance obligations that were satisfied in the prior year was €18.9 million (2020: €18.0 million).

XML

Indemnification assets

12 Months Ended

Dec. 31, 2021

Business Combinations1 [Abstract]

Indemnification assets

Indemnification assets

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Balance at January 1	15.4	35.4
Release of indemnified provision	(5.9)	(20.0)
Balance at December 31	9.5	15.4

As at December 31, 2021, €7.0 million (December 31, 2020: €12.0 million) of the indemnification assets relate to the acquisition of the Findus Group in 2015 for which 342,190 shares are held in escrow and are valued at $25.39 (€22.40) (December 31, 2020: 618,099 shares valued at $25.42 (€20.69)) each. The shares placed in escrow were released in stages over a four-year period beginning January 2019 with the final release in January 2022. During 2021, 275,909 shares were released from escrow. As a consequence the indemnification asset was reduced by €5.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2021.

In January 2022, the remaining 342,190 shares were released from escrow. As a consequence the indemnification asset will be reduced by €7.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2022.

As at December 31, 2021, €2.5 million (2020: €3.4 million) of the indemnification asset relates to the Goodfella’s Pizza acquisition for several contingent liabilities that arose prior to acquisition and were recognized in the balance sheet to the same extent as the asset. During 2021, €0.9 million was released against the liabilities.

XML

Cash and cash equivalents

12 Months Ended

Dec. 31, 2021

Subclassifications of assets, liabilities and equities [abstract]

Cash and cash equivalents

Cash and cash equivalents

		December 31, 2021	December 31, 2020
	Note	€m	€m
Cash and cash equivalents		254.0	393.1
Restricted cash		0.2	0.1
Cash and cash equivalents		254.2	393.2
Bank overdraft	22	—	(10.7)
Cash and cash equivalents per Statement of Cash Flows		254.2	382.5

‘Cash and cash equivalents’ comprise cash balances and deposits. Restricted cash comprises money that is primarily reserved for a specific purpose and therefore not available for immediate or general business use. Bank overdrafts that are repayable on demand and form an integral part of the Company's cash management are included as a component of cash and cash equivalents for the purposes of the Statement of Cash Flows.

XML

Loans and borrowings

12 Months Ended

Dec. 31, 2021

Financial Instruments [Abstract]

Loans and borrowings

Loans and borrowings

The repayment profile of the syndicated and other loans held by the Company is as follows:

	December 31, 2021	December 31, 2020
	€m	€m
Current liabilities
Syndicated loans	8.5	7.8
Lease liabilities	22.6	16.7
Less deferred borrowing costs to be amortized within 1 year	(2.0)	(2.0)
Total due in less than one year	29.1	22.5
Non-current liabilities
Syndicated loans	1,347.4	1,287.5
2024 fixed rate senior secured notes	—	400.0
2028 fixed rate senior secured notes	800.0	—
Lease liabilities	58.3	53.7
Less deferred borrowing costs to be amortized in 2-5 years	(5.7)	(4.9)
Less deferred borrowing costs to be amortized in more than 5 years	(1.7)	—
Total due after more than one year	2,198.3	1,736.3
Total borrowings	2,227.4	1,758.8

Syndicated loans includes the Senior U.S. Dollar debt of $916.4 million (€808.6 million) (the “Senior USD Loan”) and the Senior EUR debt of €553.2 million (the "Senior EUR Loan"), repayable in May 2024 and May 2028 respectively. The Senior USD Loan includes an annual amortization repayment, equivalent to 1.0% of the original issuance value or $9.6 million (€8.5 million) in May each year until maturity. The Senior EUR Loan is repayable only upon maturity. As required under the Senior Facilities Agreement, the Company is also required to undertake an annual excess cash flow calculation whereby additional principal could be repaid.

On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028. In addition, on July 9, 2021 the Company announced that Nomad Foods Bondco Plc completed a further private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75 (together the “Notes”).

Interest on the Notes accrue from June 24, 2021 (being the original date of issuance) and are payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. Eligible transaction costs on the new Notes of €4.0 million were capitalized and will be amortized over the life of the debt.

On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due June 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of €3.8 million were capitalized and will be amortized over the life of the debt.

Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was also replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum that may be adjusted subject to a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions.

Charges of €17.9 million have been recognized as a consequence of the refinancing activities in 2021. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs.

As at December 31, 2021 €2.8 million (December 31, 2020: €16.1 million) has been utilized for issuance of letters of credit and bank guarantees.

Guarantees and secured assets

The Senior Facility Agreement that governs the Company’s Senior debt, establishes security over the assets of the “Guarantor Group”. The Guarantor Group consists of those companies that individually have more than 5% of consolidated total assets or EBITDA (subject to the terms of the Senior Facilities Agreement) of the Company and in total comprise more than 80% of consolidated total assets or EBITDA at any testing date.

The Senior Facilities Agreement includes an excess cash flow calculation whereupon an amount of principal shall be repaid based upon terms including cash generated during the year and leverage. In 2021 the amount repaid was nil relating to the calculation performed at the end of 2020. Based on the calculation performed for December 31, 2021, there will be no excess cash flow repayment in 2022.

In connection with its pension scheme, Findus Sverige AB, a 100% owned subsidiary, is required to obtain credit insurance with PRI Pensionsgaranti (“PRI”), a credit insurance company that provides insurance annually against the risk of a sponsoring company’s insolvency. In connection with such credit insurance, as at December 31, 2021 Findus Sverige AB has granted floating charges over certain assets in favor of PRI in an amount of SEK 300 million (€29.3 million) (December 31, 2020: €29.8 million) and Nomad Foods Limited has issued a parent guarantee to PRI which will not exceed SEK 640 million (€62.4 million) (December 31, 2020: SEK 450 million (€44.7 million))

XML

Trade and other payables

12 Months Ended

Dec. 31, 2021

Subclassifications of assets, liabilities and equities [abstract]

Trade and other payables

Trade and other payables

	December 31, 2021	December 31, 2020 (restated)
Current liabilities	€m	€m
Trade payables	413.2	363.7
Accruals and deferred income	120.4	134.5
Trade terms payable	93.8	89.7
Social security and other taxes	24.6	24.1
Other payables	20.3	21.2
Financial payables	19.7	3.3
Bank overdrafts	—	10.7
Total current trade and other payables	692.0	647.2
Non-current liabilities
Accruals and deferred income	1.8	2.2
Total non-current trade and other payables	1.8	2.2
Total trade and other payables	693.8	649.4

As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition.

The Company has implemented a Supply Chain Financing (“SCF”) program for its suppliers. The principal purpose of these arrangements is to provide the supplier with the option to access liquidity earlier through the sale of its receivables due from the Company to a bank or other financial institution prior to their due date. Management has determined that the Company’s payables to these suppliers have neither been extinguished nor have the liabilities been significantly modified by these arrangements. The value of amounts payable, invoice due dates and other terms and conditions applicable, from the Company’s perspective, remain unaltered, with only the ultimate payee being changed. At December 31, 2021, there was no material usage of the programs (December 31, 2020: nil). The cash outflows in respect of these arrangements will be recognized within operating cash flows.

XML

Employee benefits

12 Months Ended

Dec. 31, 2021

Employee Benefits [Abstract]

Employee benefits

Employee benefits

The Company operates defined benefit plans as well as defined contribution plans.

i.Defined contribution plans

The total expense relating to defined contribution plans for the year ended December 31, 2021 was €10.2 million (year ended December 31, 2020: €8.3 million, year ended December 31, 2019: €9.0 million)

ii.Defined benefit plans

The Company operates partially funded defined benefit pension plans in Germany and Austria, an unfunded defined benefit pension plan in Sweden and defined benefit indemnity arrangements in Italy and Austria. In addition, pension benefits in Switzerland are met via a contract with a collective foundation that offers a fully insured solution to provide a contribution-based cash balance retirement plan, which is classified as a defined benefit plan. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy, long term service awards are in operation and various other countries provide other employee benefits.

	December 31, 2021	December 31, 2020
	€m	€m
Net employee benefit obligations-Germany	149.3	181.2
Net employee benefit obligations-Sweden	70.3	74.1
Net employee benefit obligations-Austria	5.5	5.6
Net employee benefit obligations-Switzerland	5.8	6.6
Net employee benefit obligations-Italy	4.6	4.7
Net employee benefit obligations-total of other countries	8.7	4.0
Total net employee benefit obligations	244.2	276.2

The net obligation of €8.7 million (December 31, 2020: €4.0 million) in respect of other countries is the aggregate of a number of different types of minor schemes, each one not being considered individually material.

The amount included in the Statement of Financial Position arising from the Company’s obligations in respect of its defined benefit retirement plans and other post-employment benefits is as follows:

	Defined benefit retirement plans	Post-employment medical benefits and other benefits	Total
December 31, 2021	€m	€m	€m
Present value of unfunded employee benefit obligations	77.5	11.1	88.6
Present value of funded employee benefit obligations	264.0	—	264.0
Subtotal present value of employee benefit obligations	341.5	11.1	352.6
Fair value of plan assets	(108.4)	—	(108.4)
Recognized liability for net employee benefit obligations	233.1	11.1	244.2

	Defined benefit retirement plans	Post-employment medical benefits and other benefits	Total
December 31, 2020	€m	€m	€m
Present value of unfunded employee benefit obligations	79.6	9.0	88.6
Present value of funded employee benefit obligations	285.5	—	285.5
Subtotal present value of employee benefit obligations	365.1	9.0	374.1
Fair value of plan assets	(97.9)	—	(97.9)
Recognized liability for net employee benefit obligations	267.2	9.0	276.2

Reconciliation from the opening balances to the closing balances for the net employee benefit obligation and its components, including the amounts recognized in the Consolidated Statement of Profit or Loss and the Consolidated Statement of Comprehensive Income:

	Present value of defined benefit obligation		Fair value of plan assets		Net defined benefit obligation
	2021	2020	2021	2020	2021	2020
	€m	€m	€m	€m	€m	€m
Balance at January 1	374.1	323.9	(97.9)	(86.4)	276.2	237.5
Included in the Consolidated Statement of Profit or Loss
Current service cost	7.9	6.6	—	—	7.9	6.6
Interest cost (income)	2.2	3.7	(0.5)	(1.0)	1.7	2.7
	10.1	10.3	(0.5)	(1.0)	9.6	9.3
Included in the Consolidated Statement of Comprehensive Income
Actuarial (gain) loss arising from:
–demographic assumptions	(1.5)	—	—	—	(1.5)	—
–financial assumptions	(26.8)	29.1	—	—	(26.8)	29.1
–experience adjustment	1.8	(0.8)	—	—	1.8	(0.8)
Return on plan assets, excluding interest income	—	—	(9.6)	(0.4)	(9.6)	(0.4)
Exchange adjustments	(0.3)	2.8	(0.6)	—	(0.9)	2.8
	(26.8)	31.1	(10.2)	(0.4)	(37.0)	30.7
Other
Acquired through business combinations	3.5	18.4	—	(11.8)	3.5	6.6
Contributions by employer	—	—	(1.2)	(0.5)	(1.2)	(0.5)
Contributions by members	0.8	0.4	(0.8)	(0.5)	—	(0.1)
Benefits paid	(9.1)	(10.0)	2.2	2.7	(6.9)	(7.3)
	(4.8)	8.8	0.2	(10.1)	(4.6)	(1.3)
Balance at December 31	352.6	374.1	(108.4)	(97.9)	244.2	276.2

Current service cost is allocated between cost of sales and other operating expenses. Interest on net employee benefit obligation is disclosed in net financing costs.

The cumulative amount of actuarial losses recognized is as follows:

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income	40.5	77.5

The fair value of plan assets, all at quoted prices are as follows:

	December 31, 2021	December 31, 2020
	€m	€m
Equities	32.7	24.5
Debt instruments	42.7	44.1
Property	20.3	17.1
Other	12.7	12.2
Total	108.4	97.9

The following are the principal actuarial assumptions at the reporting date for the defined benefit retirement plans in Germany, Sweden, Austria, Switzerland and Italy. The remaining employee benefit plans are not considered to be material, individually and in aggregate, and therefore we do not provide disclosure of the individual actuarial assumptions for those plans:

	Defined benefit retirement plans
December 31, 2021	Germany		Sweden		Austria		Switzerland		Italy
Discount rate	1.10	%	1.80	%	0.90	%	0.10	%	0.35	%
Inflation rate	2.00	%	2.20	%	2.00	%	1.00	%	1.50	%
Rate of increase in salaries	2.80	%	3.20	%	2.00	%	1.50	%	2.63	%
Rate of increase for pensions in payment	1%-2%		2.20	%	—		—		—

	Defined benefit retirement plans
December 31, 2020	Germany		Sweden		Austria		Switzerland		Italy
Discount rate	0.55	%	1.05	%	1.00	%	0.15	%	0.33	%
Inflation rate	2.00	%	1.50	%	2.00	%	0.20	%	1.00	%
Rate of increase in salaries	2.80	%	2.50	%	2.00	%	0%-2.50%		2.63	%
Rate of increase for pensions in payment	1%-2%		1.50	%	—		—		—

In valuing the liabilities of the pension fund at December 31, 2021 and December 31, 2020, mortality assumptions have been made as indicated below. The assumptions relating to longevity underlying the pension liabilities at the financial year end date are based on standard actuarial mortality tables and include an allowance for future improvements in longevity. The assumptions are based on the following mortality tables:

•Germany: Richttafeln 2018 G

•Sweden: DUS 14

•Austria: AVÖ 2018 - P

•Switzerland: BVG 2020 GT (2020: BVG 2015 GT)

•Italy: RG48

These references are to the specific standard rates of mortality that are published and widely used in each country for the use of actuarial assessment of pension liabilities and take account of local current and future average life expectancy.

December 31, 2021 (years)	Germany	Sweden	Austria	Switzerland	Italy
Retiring at the end of the year:
Male	21	22	23	22	21
Female	24	24	26	24	22

December 31, 2020 (years)	Germany	Sweden	Austria	Switzerland	Italy
Retiring at the end of the year:
Male	21	22	23	21	21
Female	24	24	26	24	22

The history of experience adjustments from inception of the Company for the employee benefit plans is as follows:

	December 31, 2021	December 31, 2020	December 31, 2019
	€m	€m	€m
Present value of defined benefit obligations	341.5	365.1	314.9
Fair value of plan assets	(108.4)	(97.9)	(86.4)
Recognized liability in the scheme	233.1	267.2	228.5
Experience losses/(gains) on plan liabilities	1.8	(0.8)	0.2
Experience gains on plan assets	(9.6)	(0.4)	(5.1)

Net defined benefit obligation - sensitivity analysis

The effect of a 1 percentage point movement in the most significant assumptions for the year ended December 31, 2021 is as follows:

	Increase	Decrease
	€m	€m
Discount rate	(54.6)	71.9
Inflation rate	47.4	(38.7)
Rate of increase in salaries	15.2	(11.5)
Rate of increase for pensions in payment	47.6	(37.0)

There are no deficit elimination plans for any of the defined benefit plans. Expected contributions and payments to post-employment benefit plans for the period ending December 31, 2021 are €6.7 million. The weighted average duration of the defined benefit obligations is 18.9 years.

XML

Provisions

12 Months Ended

Dec. 31, 2021

Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]

Provisions

Provisions

	Restructuring	Onerous/ unfavorable contracts	Provisions related to other taxes	Other	Total
	€m	€m	€m	€m	€m
Balance at December 31, 2019	7.4	1.2	6.9	31.3	46.8
Additional provision in the period	15.6	—	0.1	13.4	29.1
Release of provision	—	(0.7)	(0.4)	(6.0)	(7.1)
Utilization of provision	(10.4)	(0.5)	—	(5.9)	(16.8)
Foreign exchange	0.3	—	—	(0.5)	(0.2)
Balance at December 31, 2020	12.9	—	6.6	32.3	51.8
Acquired through business combinations	—	—	0.3	3.8	4.1
Additional provision in the period	2.6	—	1.0	2.5	6.1
Release of provision	(0.1)	—	—	(4.0)	(4.1)
Utilization of provision	(9.8)	—	—	(6.9)	(16.7)
Foreign exchange	—	—	—	1.0	1.0
Balance at December 31, 2021	5.6	—	7.9	28.7	42.2
Analysis of total provisions:				December 31, 2021	December 31, 2020
Current				39.3	45.7
Non-current				2.9	6.1
Total				42.2	51.8

Restructuring

The €5.6 million (2020: €12.9 million) provision relates to committed plans for certain restructuring activities of exceptional nature which are due to be completed within the next 12 months.

The amounts have been provided based on the latest information available on the likely remaining expenditure required to complete the committed plans. An additional provision of €2.6 million has been made and €9.8 million has been utilized in the year ended December 31, 2021.

Provisions relating to other taxes

The €7.9 million (2020: €6.6 million) provision relates to other, non-income taxes due to tax authorities after tax investigations within certain operating subsidiaries within the Nomad Group.

Other

Other provisions include €3.9 million (December 31, 2020: €4.4 million) of contingent liabilities acquired as part of the Goodfella’s Pizza acquisition that are indemnified by the Seller’s insurance policies, €4.3 million (December 31, 2020: €4.7 million) of obligations in Italy, €4.6 million (December 31, 2020: €6.1 million) for asset retirement obligations, €1.3 million (December 31, 2020: €1.9 million) of pre-acquisition related liabilities related to the acquisition date liabilities of Aunt Bessie's Limited, €2.4 million (December 31, 2020: €6.6 million) of provisions in the period relate to employer taxes on the Long-term Incentive Plan (see Note 8) which would become payable on the issuance of shares, and other obligations from previous accounting periods.

XML

Share capital and reserves

12 Months Ended

Dec. 31, 2021

Share Capital, Reserves and Other Equity Interest [Abstract]

Share capital and reserves

Share capital, Capital reserve and Founder Preferred Shares Dividend reserve

Share capital and capital reserve

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Authorized:
Unlimited number of Ordinary Shares with nil nominal value issued at $10.00 per share	n/a	n/a
Unlimited number of Founder Preferred Shares with nil nominal value issued at $10.00 per share	n/a	n/a
Issued and fully paid:
173,559,173 (December 31, 2020: 172,180,897) Ordinary Shares with nil nominal value	1,639.6	1,636.9
1,500,000 (December 31, 2020: 1,500,000) Founder Preferred Shares with nil nominal value	10.6	10.6
Total share capital and capital reserve	1,650.2	1,647.5
Listing and share transaction costs	(27.1)	(27.0)
Total net share capital and capital reserve	1,623.1	1,620.5

Ordinary Shares

	Issued and Repurchased Ordinary shares  (in millions)
Balance at December 31, 2019	194.5
Shares issued in the year	7.6
Shares repurchased in the year	(29.9)
Balance at December 31, 2020	172.2
Shares issued in the year	5.0
Shares repurchased in the year	(3.6)
Balance at December 31, 2021	173.6

Note 8(b) sets out the Non-Executive Director, Initial Director Options and Director and Senior Management Restricted share awards.

Note 27 sets out the Founder Preferred Share Dividends issued as ordinary shares in all years presented.

On March 13, 2020, the Company announced a share repurchase program to purchase up to an aggregate of $300.0 million of the Company’s ordinary shares. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. After the announcement, the Company entered into a series of open-market repurchases. During 2020, 11,913,682 ordinary shares at an average price of $21.04, for aggregate gross costs of $250.9 million (€217.4 million) had been repurchased and canceled. Directly attributed transaction costs of €0.2 million were incurred. During 2021, a further 507,396 ordinary shares were repurchased and cancelled at an average price of $25.29 for aggregate gross costs of $12.8 million (€10.5 million) under this authorization.

In August 2020, the Company announced the repurchase of up to $500.0 million of shares, to be executed by way of a Dutch auction. On September 15, 2020, a total of 18,061,952 shares at a clearing price of $25.50 per share amounting to the purchase price of $460.6 million (€389.3 million) was paid to the prevailing shareholders with all shares canceled as of the same date. Directly attributed transaction costs of €1.9 million were incurred.

On August 5, 2021, the Company announced a new share repurchase program to purchase up to an aggregate of $500.0 million of the Company’s ordinary shares, to be executed in the period to August 2024. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions, at the Company's discretion, as permitted by securities laws and other legal requirements. Pursuant to the program, as at December 31, 2021, 3,090,082 ordinary shares had been repurchased and canceled at an average price of $24.50, for aggregate gross costs of $75.8 million (€67.1 million). Directly attributed transaction costs of €0.1 million were incurred.

Listing and share transaction costs

As at December 31, 2021, cumulative listing and share transaction costs, which includes the total cost of admission and share issuance expenses, as well as costs associated with share repurchases were €27.1 million and are disclosed as a deduction directly against the capital reserve.

	€m
At December 31, 2019	24.9
Share transaction costs	2.1
At December 31, 2020	27.0
Share transaction costs	0.1
At December 31, 2021	27.1

Obligation to purchase shares

As part of the August 5, 2021 authorized share repurchase program, the Company entered into share purchases at agreed prices, totaling 135,621 shares in late 2021 which had not been settled and were therefore not owned by Nomad until early 2022. As a result, the Company recorded €3.0 million within accounts payable to recognize the liability for those shares, with a corresponding other receivable to reflect the value of the shares to be received upon settlement.

Founder Preferred Shares Annual Dividend Amount

Each of the Founder Entities holds 750,000 shares for a total of 1,500,000 Founder Preferred Shares which were issued at $10.00 per share. The Founder Preferred Shares are intended to incentivize the Founders to achieve Nomad’s objectives. In addition to providing long term capital, the Founder Preferred Shares are structured to provide a dividend based on the future appreciation of the market value of the ordinary shares thus aligning the interests of the Founders with those of the holders of ordinary shares on a long term basis. The Founder Preferred Shares are also intended to encourage the Founders to grow Nomad to maximize value for holders of ordinary shares. There are no Founder Preferred Shares held in Treasury. Founder Preferred Shares confer upon the holder the following:

1.the right to one vote per Founder Preferred Share on all matters to be voted on by shareholders generally and to vote together with the holders of ordinary shares;

2.commencing on January 1, 2015 and for each financial year thereafter:

a.once the average price per ordinary share for the Dividend Determination Period, i.e. the last ten consecutive trading days of a year is at least $11.50 (which condition has been satisfied for the year ended December 31, 2015), the right to receive a Founder Preferred Shares Annual Dividend Amount (as more fully described below), payable in Ordinary Shares or cash, at the Company’s sole option; and

b.the right to receive dividends and other distributions as may be declared from time to time by the Company’s board of directors with respect to the Ordinary Shares (such dividends to be distributed among the holders of Founder Preferred Shares, as if for such purpose the Founder Preferred Shares had been converted into Ordinary Shares immediately prior to such distribution) plus an amount equal to 20% of the dividend which would be

distributable on such number of Ordinary Shares equal to the Preferred Share Dividend Equivalent (as defined below); and

3.in addition to amounts payable pursuant to clause 2 above, the right, together with the holders of Ordinary Shares, to receive such portion of all amounts available for distribution and from time to time distributed by way of dividend or otherwise at such time as determined by the Directors; and

4.the right to an equal share (with the holders of Ordinary Shares on a share for share basis) in the distribution of the surplus assets of Nomad on its liquidation as are attributable to the Founder Preferred Shares; and

5.the ability to convert into Ordinary Shares on a 1-for-1 basis (mandatorily upon a Change of Control or the seventh full financial year after an acquisition)

See Note 27 for further information on the Founder Preferred Shares Dividends issued.

XML

Share-based compensation reserve

12 Months Ended

Dec. 31, 2021

Share Capital, Reserves and Other Equity Interest [Abstract]

Share-based compensation reserve

Share-based compensation reserve

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

	Share based compensation reserve
	€m
Balance as of January 1, 2021	8.3
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	4.3
Shares issued upon vesting of awards	(0.7)
Reclassification of awards for settlement of tax liabilities	(5.8)
Balance as of December 31, 2021	6.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020.

On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021.

As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2021	245.5
Settlement of dividend through share issue	(79.5)
Balance as of December 31, 2021	166.0

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

	Year ended December 31,
	2021	2020	2019
	€m	€m	€m
Balance as of January 1	84.7	94.8	88.8
Adjustment on adoption of hedge accounting under IFRS 9	1.6	—	—
Restated balance as of January 1	86.3	94.8	88.8
Foreign currency translation adjustments	31.7	(23.6)	19.2
Net deferred (losses)/gains on net investment hedges (1)	(12.9)	13.5	(13.2)
Total presented in Other Comprehensive Income	18.8	(10.1)	6.0
Balance as of December 31	105.1	84.7	94.8

(1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments.

The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments.

reserves

Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33.

The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year.

	Cross currency interest rate swaps	Forward currency contracts	Total Cash flow hedge reserve	Cost of Hedging reserve	Total Other reserves
	€m	€m	€m	€m	€m
Balance as of January 1, 2019	0.9	7.6	8.5	—	8.5
Change in fair value of hedging instrument recognized in OCI for the year	28.1	3.8	31.9	—	31.9
Reclassified to cost of goods sold	—	(21.8)	(21.8)	—	(21.8)
Reclassified from OCI to finance costs	(37.4)	—	(37.4)	—	(37.4)
Deferred tax	1.6	4.0	5.6	—	5.6
Balance as of December 31, 2019	(6.8)	(6.4)	(13.2)	—	(13.2)
Change in fair value of hedging instrument recognized in OCI for the year	(63.7)	(20.0)	(83.7)	—	(83.7)
Reclassified to cost of goods sold	—	0.2	0.2	—	0.2
Reclassified from OCI to finance costs	66.2	—	66.2	—	66.2
Deferred tax	(0.2)	6.2	6.0	—	6.0
Balance as of December 31, 2020	(4.5)	(20.0)	(24.5)	—	(24.5)
Reallocation for IFRS 9 changes to policy (start of the year)	2.8	—	2.8	(4.4)	(1.6)
Transferred to the carrying value of inventory	—	27.6	27.6	—	27.6
Change in fair value of hedging instrument recognized in OCI for the year	73.3	9.3	82.6	2.4	85.0
Reclassified from OCI to finance costs	(64.1)	—	(64.1)	1.7	(62.4)
Deferred tax	(2.4)	(11.1)	(13.5)	(0.1)	(13.6)
Balance as of December 31, 2021	5.1	5.8	10.9	(0.4)	10.5

XML

Founder Preferred Shares Dividend Reserve

12 Months Ended

Dec. 31, 2021

Share Capital, Reserves and Other Equity Interest [Abstract]

Founder Preferred Shares Dividend reserve

Share-based compensation reserve

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

	Share based compensation reserve
	€m
Balance as of January 1, 2021	8.3
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	4.3
Shares issued upon vesting of awards	(0.7)
Reclassification of awards for settlement of tax liabilities	(5.8)
Balance as of December 31, 2021	6.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020.

On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021.

As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2021	245.5
Settlement of dividend through share issue	(79.5)
Balance as of December 31, 2021	166.0

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

	Year ended December 31,
	2021	2020	2019
	€m	€m	€m
Balance as of January 1	84.7	94.8	88.8
Adjustment on adoption of hedge accounting under IFRS 9	1.6	—	—
Restated balance as of January 1	86.3	94.8	88.8
Foreign currency translation adjustments	31.7	(23.6)	19.2
Net deferred (losses)/gains on net investment hedges (1)	(12.9)	13.5	(13.2)
Total presented in Other Comprehensive Income	18.8	(10.1)	6.0
Balance as of December 31	105.1	84.7	94.8

(1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments.

The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments.

reserves

Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33.

The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year.

	Cross currency interest rate swaps	Forward currency contracts	Total Cash flow hedge reserve	Cost of Hedging reserve	Total Other reserves
	€m	€m	€m	€m	€m
Balance as of January 1, 2019	0.9	7.6	8.5	—	8.5
Change in fair value of hedging instrument recognized in OCI for the year	28.1	3.8	31.9	—	31.9
Reclassified to cost of goods sold	—	(21.8)	(21.8)	—	(21.8)
Reclassified from OCI to finance costs	(37.4)	—	(37.4)	—	(37.4)
Deferred tax	1.6	4.0	5.6	—	5.6
Balance as of December 31, 2019	(6.8)	(6.4)	(13.2)	—	(13.2)
Change in fair value of hedging instrument recognized in OCI for the year	(63.7)	(20.0)	(83.7)	—	(83.7)
Reclassified to cost of goods sold	—	0.2	0.2	—	0.2
Reclassified from OCI to finance costs	66.2	—	66.2	—	66.2
Deferred tax	(0.2)	6.2	6.0	—	6.0
Balance as of December 31, 2020	(4.5)	(20.0)	(24.5)	—	(24.5)
Reallocation for IFRS 9 changes to policy (start of the year)	2.8	—	2.8	(4.4)	(1.6)
Transferred to the carrying value of inventory	—	27.6	27.6	—	27.6
Change in fair value of hedging instrument recognized in OCI for the year	73.3	9.3	82.6	2.4	85.0
Reclassified from OCI to finance costs	(64.1)	—	(64.1)	1.7	(62.4)
Deferred tax	(2.4)	(11.1)	(13.5)	(0.1)	(13.6)
Balance as of December 31, 2021	5.1	5.8	10.9	(0.4)	10.5

XML

Translation reserve Translation reserve (Notes)

12 Months Ended

Dec. 31, 2021

Disclosure of share capital, reserves and other equity interest [Abstract]

Share-based compensation reserve

Share-based compensation reserve

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

	Share based compensation reserve
	€m
Balance as of January 1, 2021	8.3
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	4.3
Shares issued upon vesting of awards	(0.7)
Reclassification of awards for settlement of tax liabilities	(5.8)
Balance as of December 31, 2021	6.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020.

On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021.

As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2021	245.5
Settlement of dividend through share issue	(79.5)
Balance as of December 31, 2021	166.0

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

	Year ended December 31,
	2021	2020	2019
	€m	€m	€m
Balance as of January 1	84.7	94.8	88.8
Adjustment on adoption of hedge accounting under IFRS 9	1.6	—	—
Restated balance as of January 1	86.3	94.8	88.8
Foreign currency translation adjustments	31.7	(23.6)	19.2
Net deferred (losses)/gains on net investment hedges (1)	(12.9)	13.5	(13.2)
Total presented in Other Comprehensive Income	18.8	(10.1)	6.0
Balance as of December 31	105.1	84.7	94.8

(1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments.

The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments.

reserves

Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33.

The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year.

	Cross currency interest rate swaps	Forward currency contracts	Total Cash flow hedge reserve	Cost of Hedging reserve	Total Other reserves
	€m	€m	€m	€m	€m
Balance as of January 1, 2019	0.9	7.6	8.5	—	8.5
Change in fair value of hedging instrument recognized in OCI for the year	28.1	3.8	31.9	—	31.9
Reclassified to cost of goods sold	—	(21.8)	(21.8)	—	(21.8)
Reclassified from OCI to finance costs	(37.4)	—	(37.4)	—	(37.4)
Deferred tax	1.6	4.0	5.6	—	5.6
Balance as of December 31, 2019	(6.8)	(6.4)	(13.2)	—	(13.2)
Change in fair value of hedging instrument recognized in OCI for the year	(63.7)	(20.0)	(83.7)	—	(83.7)
Reclassified to cost of goods sold	—	0.2	0.2	—	0.2
Reclassified from OCI to finance costs	66.2	—	66.2	—	66.2
Deferred tax	(0.2)	6.2	6.0	—	6.0
Balance as of December 31, 2020	(4.5)	(20.0)	(24.5)	—	(24.5)
Reallocation for IFRS 9 changes to policy (start of the year)	2.8	—	2.8	(4.4)	(1.6)
Transferred to the carrying value of inventory	—	27.6	27.6	—	27.6
Change in fair value of hedging instrument recognized in OCI for the year	73.3	9.3	82.6	2.4	85.0
Reclassified from OCI to finance costs	(64.1)	—	(64.1)	1.7	(62.4)
Deferred tax	(2.4)	(11.1)	(13.5)	(0.1)	(13.6)
Balance as of December 31, 2021	5.1	5.8	10.9	(0.4)	10.5

XML

Cash flow hedging reserve

12 Months Ended

Dec. 31, 2021

Share Capital, Reserves and Other Equity Interest [Abstract]

Cash flow hedging reserve

Share-based compensation reserve

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

	Share based compensation reserve
	€m
Balance as of January 1, 2021	8.3
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	4.3
Shares issued upon vesting of awards	(0.7)
Reclassification of awards for settlement of tax liabilities	(5.8)
Balance as of December 31, 2021	6.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020.

On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021.

As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2021	245.5
Settlement of dividend through share issue	(79.5)
Balance as of December 31, 2021	166.0

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

	Year ended December 31,
	2021	2020	2019
	€m	€m	€m
Balance as of January 1	84.7	94.8	88.8
Adjustment on adoption of hedge accounting under IFRS 9	1.6	—	—
Restated balance as of January 1	86.3	94.8	88.8
Foreign currency translation adjustments	31.7	(23.6)	19.2
Net deferred (losses)/gains on net investment hedges (1)	(12.9)	13.5	(13.2)
Total presented in Other Comprehensive Income	18.8	(10.1)	6.0
Balance as of December 31	105.1	84.7	94.8

(1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments.

The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments.

reserves

Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33.

The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year.

	Cross currency interest rate swaps	Forward currency contracts	Total Cash flow hedge reserve	Cost of Hedging reserve	Total Other reserves
	€m	€m	€m	€m	€m
Balance as of January 1, 2019	0.9	7.6	8.5	—	8.5
Change in fair value of hedging instrument recognized in OCI for the year	28.1	3.8	31.9	—	31.9
Reclassified to cost of goods sold	—	(21.8)	(21.8)	—	(21.8)
Reclassified from OCI to finance costs	(37.4)	—	(37.4)	—	(37.4)
Deferred tax	1.6	4.0	5.6	—	5.6
Balance as of December 31, 2019	(6.8)	(6.4)	(13.2)	—	(13.2)
Change in fair value of hedging instrument recognized in OCI for the year	(63.7)	(20.0)	(83.7)	—	(83.7)
Reclassified to cost of goods sold	—	0.2	0.2	—	0.2
Reclassified from OCI to finance costs	66.2	—	66.2	—	66.2
Deferred tax	(0.2)	6.2	6.0	—	6.0
Balance as of December 31, 2020	(4.5)	(20.0)	(24.5)	—	(24.5)
Reallocation for IFRS 9 changes to policy (start of the year)	2.8	—	2.8	(4.4)	(1.6)
Transferred to the carrying value of inventory	—	27.6	27.6	—	27.6
Change in fair value of hedging instrument recognized in OCI for the year	73.3	9.3	82.6	2.4	85.0
Reclassified from OCI to finance costs	(64.1)	—	(64.1)	1.7	(62.4)
Deferred tax	(2.4)	(11.1)	(13.5)	(0.1)	(13.6)
Balance as of December 31, 2021	5.1	5.8	10.9	(0.4)	10.5

XML

Earnings/(loss) per share

12 Months Ended

Dec. 31, 2021

Earnings per share [abstract]

Earnings/(loss) per share

Earnings per share

Basic earnings per share

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Profit for the period attributable to equity owners of the parent (€m)	181.0	225.2	154.0
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	194,019,070	192,004,803
Basic earnings per share (€’s)	1.02	1.16	0.80

For the year ended December 31, 2021, basic earnings per share is calculated by dividing the profit attributable to the shareholders of the Company of €181.0 million (year ended December 31, 2020: €225.2 million, year ended December 31, 2019: €154.0 million) by the weighted average number of Ordinary Shares of 176,570,770 (December 31, 2020: 192,519,070, year ended December 31, 2019: 190,504,803) and Founder Preferred Shares of 1,500,000 (December 31, 2020: 1,500,000, year ended December 31, 2019: 1,500,000).

Diluted earnings per share

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Profit for the period attributable to equity owners of the parent (€m)	181.0	225.2	154.0
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	197,894,106	198,425,877
Diluted earnings per share (€’s)	1.02	1.14	0.78

For the year ended December 31, 2021, the number of shares in the diluted earnings per share calculation include nil shares for the dilutive impact of the Ordinary shares to settle the Founder Preferred Shares Annual Dividend for the year ended December 31, 2021, as no shares were due to be issued. Refer to Notes 27 and 38 for further details.

XML

Reconciliation of liabilities arising from financing activities

12 Months Ended

Dec. 31, 2021

Disclosure of reconciliation of liabilities arising from financing activities [abstract]

Reconciliation of liabilities arising from financing activities

Reconciliation of liabilities arising from financing activities

The table below details changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Company's consolidated statements of cash flows from financing activities.

	Cash / non-cash	Total loans and borrowings (Note 21)	Financial payables (Note 22)	Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	Derivatives: (Net) Fair value of cross currency interest rate swaps
		€m	€m	€m	€m
Opening balance January 1, 2021		1,758.8	3.3	0.2	72.3
Cash inflow (1)	Cash	800.0	—	0.3	1.4
Cash outflow (2)	Cash	(436.0)	(38.1)	—	(2.3)
Interest accretion (3)	Cash	2.2	57.6	—	—
Acquired through business combinations	Non-cash	19.6	—	—	—
Exchange movement	Non-cash	64.1	(0.2)	—	—
Fair value changes	Non-cash	—	—	(0.1)	(44.0)
Other non-cash adjustments	Non-cash	18.7	(2.9)	—	(6.8)
Closing balance December 31, 2021		2,227.4	19.7	0.4	20.6

	Cash / non-cash	Total loans and borrowings (Note 21)	Financial payables (Note 22)	Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	Derivatives: (Net) Fair value of cross currency interest rate swaps
		€m	€m	€m	€m
Opening balance January 1, 2020		1,875.3	4.1	(0.2)	15.3
Cash inflow (1)	Cash	—	—	—	6.8
Cash outflow (2)	Cash	(32.0)	(57.0)	(2.2)	(3.9)
Interest accretion (3)	Cash	5.2	58.8	—	—
Acquired through business combinations	Non-cash	0.4	—	—	—
Exchange movement	Non-cash	(71.7)	0.9	—	—
Fair value changes	Non-cash	—	—	2.6	54.1
Other non-cash adjustments	Non-cash	(18.4)	(3.5)	—	—
Closing balance December 31, 2020		1,758.8	3.3	0.2	72.3

(1) Cash inflows from cross currency interest rate swaps are part of effective cash flow hedging relationships and are

presented within interest paid within the Consolidated Statements of Cash Flows.

(2) Cash outflows from cross currency interest rate swaps are not part of a cash flow hedge and are presented within

proceeds on settlement of derivatives within the Consolidated Statements of Cash Flows.

XML

Cash flows from operating activities

12 Months Ended

Dec. 31, 2021

Cash Flow Statement [Abstract]

Cash flows from operating activities

Cash flows from operating activities

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Cash flows from operating activities
Profit for the period		181.0	225.1	153.6
Adjustments for:
Exceptional items	7	45.3	20.6	54.5
Non-cash fair value purchase price adjustment of inventory	5	8.4	—	—
Share based payments expense		5.1	9.0	14.9
Depreciation and amortization		71.6	67.6	68.3
Loss on disposal and impairment of property, plant and equipment		0.7	0.9	0.6
Net finance costs	10	106.0	63.7	73.2
Taxation	11	55.7	70.4	56.7
Operating cash flow before changes in working capital, provisions and exceptional items		473.8	457.3	421.8
(Increase)/decrease in inventories		(23.8)	(12.7)	23.5
Decrease/(increase) in trade and other receivables		24.1	(1.8)	(34.4)
(Decrease)/increase in trade and other payables		(25.0)	107.2	(40.6)
Increase in employee benefit and other provisions		1.2	2.0	6.6
Cash generated from operations before tax and exceptional items		450.3	552.0	376.9

XML

Financial instruments

12 Months Ended

Dec. 31, 2021

Financial Instruments [Abstract]

Financial instruments

The effects of the cash flow hedging instruments on the Company's financial position and performance are as follows:

All amounts stated in €m, unless otherwise stated	December 31, 2021	December 31, 2020
USD - cross currency interest rate swaps
Carrying amount of liability	(20.6)	(89.5)
Notional amount (USD)	$916.4	$926.0
Maturity date	5/15/2024	5/15/2022
Change in fair value of outstanding hedging instruments since January 1	68.9	(71.0)
(Gain)/loss in value of hedged item used to determine effectiveness	(69.6)	71.0
Weighted average hedged rate for the year	1.11	1.11

The effects of the net investment hedging instruments on the Company's financial position and performance are as follows:

All amounts stated in €m, unless otherwise stated	December 31, 2021	December 31, 2020
UK cross-currency interest rate swaps hedge
Carrying amount of cross-currency interest rate swaps	—	14.3
Notional amount (GBP)	—	£220.2
Maturity date	7/29/2021	5/15/2022
Change in fair value of cross-currency interest rate swaps as a result of foreign currency movements since January 1	(12.9)	13.5
Loss/(gain) in value of hedged item used to determine hedge effectiveness	12.9	(13.5)
Weighted average hedged rate for the year	1.19	1.19

position and performance are as follows:

As at December 31, 2021	EUR/USD	GBP/USD	GBP/EUR	SEK/EUR	SEK/USD	Other Currencies
	€m	€m	€m	€m	€m	€m
Derivative financial instruments - forward currency contracts
Carrying amount of (liability)/asset	17.5	1.2	(6.7)	0.5	0.1	0.3
Notional amount	343.6	58.4	244.7	70.4	4.5	96.4
Fair value (gains)/losses of outstanding hedging instruments since January 1	(26.3)	(0.5)	12.0	(0.9)	13.5	0.6
Weighted average hedge rate for the year	1.20	1.38	1.15	0.10	0.11	—

As at December 31, 2020	EUR/USD	GBP/USD	GBP/EUR	SEK/EUR	SEK/USD	Other Currencies
	€m	€m	€m	€m	€m	€m
Derivative financial instruments - forward currency contracts
Carrying amount of asset/(liability)	(21.9)	(3.7)	1.4	(4.0)	(2.6)	(0.5)
Notional amount	249.0	53.5	159.0	77.3	14.1	16.8
Fair value (gains)/losses of outstanding hedging instruments since January 1	(20.6)	(2.0)	8.5	(4.2)	(2.2)	0.8
Weighted average hedge rate for the year	1.13	1.28	1.12	0.09	0.10	0.21

Financial instruments

Categories of financial instruments

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2021	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	201.6	—	—	—	—	201.6
Derivative financial instruments	—	—	0.5	19.7	—	20.2
Cash and cash equivalents	254.2	—	—	—	—	254.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(647.1)	(647.1)
Derivative financial instruments	—	—	(0.1)	(28.0)	—	(28.1)
Loans and borrowings (1)	—	—	—	—	(2,236.8)	(2,236.8)
Total	455.8	—	0.4	(8.3)	(2,883.9)	(2,436.0)

(1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2020	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	141.2	—	—	—	—	141.2
Derivative financial instruments	—	—	2.9	19.8	—	22.7
Cash and cash equivalents	393.2	—	—	—	—	393.2
Short - term investments	—	25.0	—	—	—	25.0
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(601.1)	(601.1)
Derivative financial instruments	—	—	(0.2)	(124.8)	—	(125.0)
Loans and borrowings (2)	—	—	—	—	(1,765.7)	(1,765.7)
Total	534.4	25.0	2.7	(105.0)	(2,366.8)	(1,909.7)

(2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21.

Fair values

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values.

Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange.

Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. 

Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for non binding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed.

While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company.

(i)Derivative financial instruments

Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’.

(ii)Trade and other payables/receivables

The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash.

(iii)Cash and cash equivalents

The carrying value of cash and cash equivalents is deemed to equal fair value.

(iv)Short-term investments

Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. The Company has classified these as level 2 instruments as defined in IFRS 13 “Fair value measurement”.

(v)Interest bearing loans and liabilities

The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities.

On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028 (the “Notes”). Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Notes, eligible transaction costs of approximately €4.0 million were capitalized and will be amortized over the life of the debt.

On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75.

On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of approximately €3.8 million were capitalized and will be amortized over the life of the debt.

Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum and that includes a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions.

The Company continues to have outstanding senior USD loans as at December 31, 2021 of $916.4 million (€808.6 million) (the “Senior USD Loan”). The Senior USD Loan is repayable in May 2024. The Senior USD Loan requires a repayment of $9.6 million (€8.5 million) in May each year until maturity equivalent to 1.0% of the original issued notional.

Furthermore as part of the senior loan structure, the Company is additionally required to undertake an annual excess cash flow calculation whereby additional principal could be paid.

The Company uses cross currency interest rate swaps (“CCIRS”) to convert its $916.4 million of floating rate Senior USD Loans into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge.

On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior Secured USD Term Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction is considered to be a substantial modification of the hedging instruments, so is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that have previously been used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 10. The cash flow hedge reserve related to the previous hedge relationship will be released on a straight line basis until May 2022.

The senior loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries.

	Fair value		Carrying value
	December 31, 2021	December 31, 2020	December 31, 2021	December 31, 2020
	€m	€m	€m	€m
Senior EUR/USD loans	1,360.8	1,300.4	1,355.8	1,295.1
Other external debt	0.1	0.2	0.1	0.2
2024 fixed rate senior secured notes	—	405.8	—	400.0
2028 fixed rate senior secured notes	802.6	—	800.0	—
Less deferred borrowing costs	—	—	(9.4)	(6.9)
	2,163.5	1,706.4	2,146.5	1,688.4

Derivatives

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Cross Currency Interest Rate Swaps	—	17.2
Forward foreign exchange contracts	20.2	5.5
Total assets	20.2	22.7
Cross Currency Interest Rate Swaps	(20.6)	(89.5)
Forward foreign exchange contracts	(7.3)	(35.5)
Total liabilities	(27.9)	(125.0)
Total	(7.7)	(102.3)

Offsetting of derivatives

Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default.

The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements.

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2021	€m	€m	€m
Derivatives - assets	20.2	(10.8)	9.4
Derivatives - liabilities	(27.9)	10.8	(17.1)

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2020	€m	€m	€m
Derivatives - assets	22.7	(22.7)	—
Derivatives - liabilities	(125.0)	22.7	(102.3)

XML

Commitments

12 Months Ended

Dec. 31, 2021

Leases1 [Abstract]

Commitments

Commitments

Future aggregate minimum contractual payments under non-cancellable service agreements and lease rentals for short-lived and low-value assets are payable as follows:

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Less than one year	2.2	1.9
Between one and three years	4.1	3.5
Between three and five years	2.2	2.0
More than five years	0.2	0.1
Total	8.7	7.5

These agreements may be subject to contractual annual increases linked to inflation indices. The payments shown above exclude the impact of these contractual increases which cannot be reliably estimated.

XML

Capital commitments

12 Months Ended

Dec. 31, 2021

Additional information [abstract]

Capital commitments

Capital commitments

Capital expenditure contracted for at the end of the reporting period but not yet incurred is as follows:

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Property, plant and equipment	21.3	13.6
Intangible assets	1.7	3.4
Total	23.0	17.0

XML

Related parties

12 Months Ended

Dec. 31, 2021

Related Party [Abstract]

Related parties

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Short-term employee benefits	2.2	3.9	2.8
Share-based payment expense	2.4	3.5	7.6
Non-Executive Director fees	0.3	0.3	0.4
Total Directors' and executive officers' compensation	4.9	7.7	10.8

XML

Significant events after the Statement of Financial Position date	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2015
Events After Reporting Period [Abstract]
Preference shares, dividend payment terms, weighted average share price, minimum term required		10 days
Significant events after the Statement of Financial Position date	Significant events after the Statement of Financial Position date

XML

Basis of preparation Summary of adjustments arising form application of IFRS 9 (Policies)

12 Months Ended

Dec. 31, 2021

Disclosure of notes and other explanatory information [Abstract]

IFRS 9 'Financial Instruments'

Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS

Amendments to IAS 12 - Deferred Tax related to Assets and Liabilities arising from a Single Transaction

In May 2021, the International Accounting Standards Board issued targeted amendments to IAS 12, Income Taxes. The amendments are effective for annual periods beginning on or after January 1, 2023, although earlier application is permitted. With a view to reducing diversity in reporting, the amendments will clarify that companies are required to recognize deferred taxes on transactions where both assets and liabilities are recognized, such as with leases and asset retirement (decommissioning) obligations. Based upon our current facts and circumstances, we do not expect our financial performance or disclosure to be materially affected by the application of the amended standard.

IFRSs not yet adoptedAt the date of authorization of these financial statements, except as disclosed in Note 2, there are no Standards and Interpretations relevant to the Company which are in issue but not yet effective.

Amended standards early adopted

Adoption of new accounting standards - IFRS 9 'Financial Instruments'

IFRS 9 ‘Financial Instruments’ was issued in July 2014 and replaced IAS 39 ‘Financial Instruments: Recognition and Measurement.’ The Company had previously elected to continue hedge accounting under IAS 39 as was allowed by the standard. On January 1, 2021, the Company adopted hedge accounting under IFRS 9, as the hedge accounting requirements have been simplified and are more closely aligned to the Company's risk management strategy. Under IFRS 9 all existing hedging relationships qualified as continuing hedging relationships.

The Company applied IFRS 9 hedge accounting prospectively, "except for application of the cost of hedging approach". The Company has elected the cost of hedging approach for the fair value movement of all hedging instruments, whereby the movements will be recognized within equity, to the extent that they relate to the hedged item. As permitted by the standard, adjustments required as a result of adopting the cost of hedging approach, have been made to the opening Consolidated Statement of Changes in Equity. As such, prior year comparatives have not been restated. A summary of adjustments arising from application of IFRS 9 for hedge accounting as of January 1, 2021 are as follows:

	Opening Balance January 1, 2021 (IAS 39) €m	Impact of change in policy €m	Opening Balance January 1, 2021 (IFRS 9) €m
Cash flow hedge reserve	(24.5)	2.8	(21.7)
Cost of hedging reserve	—	(4.4)	(4.4)
Other reserves	(24.5)	(1.6)	(26.1)
Translation reserve	84.7	1.6	86.3

The Company's policy is to reduce its risk of foreign exchange movements on forecasted transactions (such as purchases of raw materials) in currencies other than the operating entity's functional currency using forward foreign exchange contracts designated as cash flow hedges. Under IFRS 9, in cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow

hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The Company has elected to apply this accounting policy prospectively and therefore as at January 1, 2021 any existing hedges of non-financial items (such as inventory) that were already recognized in the Consolidated Statement of Financial Position, did not result in an opening balance transfer out of equity to the non-financial item as a result of the transition to IFRS 9. For the year ended December 31, 2021, €27.6 million was recognized as deferred hedging gains transferred to the carrying value of inventory. This is not a reclassification adjustment and will not be recognized in the Consolidated Statement of Other Comprehensive Income for the period.

Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 – Interest Rate Benchmark Reform (Phase 2)

In August 2020, the IASB issued Interest Rate Benchmark Reform (Phase 2), which amends other IFRS standards. The amendments provide temporary reliefs which address the financial reporting effects when an interbank offered rate (IBOR) is replaced with an alternative nearly risk-free interest rate (RFR). The amendments in this final phase relate to practical expedient for particular changes in contractual cash flows, relief from specific hedge accounting requirements and certain disclosure requirement.

On June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing revolving credit facility of €80.0 million and replace it with a new €175.0 million facility, paying interest rate applicable to the respective drawn down currency. Per the restated Senior Facilities Agreement, the Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately if there is a drawdown on the facility. The Secured Overnight Financing Rate (“SOFR”) will replace USD LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR, when existing benchmark rates are replaced and borrowings are requested under the Facility.

Equally, on June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. There is currently no indication of the timing of the phase-out of EURIBOR. The Company continues to assess changes in underlying markets and expects to be able to refinance its Senior EUR Loan once replacement reference rates become confirmed.

The existing senior USD loan of $916.4 million (the "Senior USD Loan") paying interest at a rate per annum equal to LIBOR (subject to a zero floor) plus 2.25% per annum has not been refinanced during 2021. The Company uses cross currency interest rate swaps to convert cash flows payable under the Senior USD Loan into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. The USD LIBOR phase out is expected to be completed by June 2023, and therefore in due course the Company will need to renegotiate the terms of our Senior Facilities Agreement with our lenders and amend the terms of linked interest rate hedging arrangements. Such an amendment is expected to be able to be achieved without material financial impact on the Company.

The Amendments are effective for annual periods beginning on or after January 1, 2021. Phase 2 amendments will require the Company to account for a change in the basis for determining the cash flows of a financial asset or a financial liability measured at amortized cost, by updating the effective interest rates as required by IBOR reform. Management continues to assess implications as a result of these amendments on the wider business. These amendments had no impact on the financial statements of the Company for the year ended December 31, 2021. The Company intends to use the practical expedients in future periods as they become applicable.

XML

Accounting policies (Policies)

12 Months Ended

Dec. 31, 2021

Disclosure of types of insurance contracts [line items]

Measurement convention

Measurement conventionThe financial statements are prepared on the historical cost basis with the exception of derivative financial instruments, business combinations, share based payments, and founder preferred shares which are stated at fair value.

Business combination

Business combination

The Company uses the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred and the equity interest issued by the Company. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred.

Non-controlling interests arise from business combinations in which the Company acquires less than a 100 per cent interest. Non-controlling interests are initially measured at either fair value or at the non-controlling interest’s proportionate share of the fair value of the acquiree’s identifiable net assets. Nomad determines on a transaction by transaction basis which measurement method is used.

The excess of the consideration transferred, the amount of any non-controlling interests in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree over the fair value of the identifiable net assets is recorded as goodwill.

Where selling shareholders have contractually agreed to indemnify Nomad Foods Limited for contingent liabilities, an indemnification asset is recognized equivalent to the fair value of the liability recognized by Nomad. The indemnification asset is deducted from consideration transferred for the business combination. The indemnification asset value will subsequently be revised where revisions are made to the value of the liability or where there are doubts over the ability to recover losses from the selling shareholders.

Basis of consolidation

Basis of consolidation

The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions, and any unrealized income and expenses arising from intra-group transactions are eliminated. Accounting policies are applied consistently across the Company.

Subsidiaries are all entities (including structured entities) over which Nomad has control; directly or indirectly. The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases.

Where the Company owns less than a 100 per cent interest in a subsidiary, a non-controlling interest is recognized. The carrying amount of non-controlling interests is increased or decreased by the non-controlling interest’s share of subsequent changes in equity and payments to the non-controlling interest. Total comprehensive income is attributed to the non-controlling interests even if this results in the non-controlling interests having a negative balance.

Foreign currency

Foreign currency

i)    Foreign currency transactions

Transactions in foreign currencies (currencies other than the functional currency of the transacting entity) are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the foreign exchange rate ruling the financial year end. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are generally recognized in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges, qualifying net investment hedges or are attributable to part of a net investment in a foreign operation.

Non-monetary assets and liabilities in a foreign currency are translated into the functional currency to establish historical cost, using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated at foreign exchange rates ruling at the date the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss.

The revenues and expenses of foreign operations are translated at an average rate for the period (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transaction).

ii)    Assets and liabilities of foreign operations

For the purposes of presenting consolidated financial statements, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated at foreign exchange rates ruling at the financial year ended December 31, 2021 of £1:€1.19 (December 31, 2020: £1:€1.11). The revenues and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rates ruling at the dates of the transactions. The average rate used for year ended December 31, 2021 is £1:€1.16 (year ended December 31, 2020: £1:€1.13, year ended December 31, 2019: £1:€1.14).

Foreign exchange gains and losses that relate to these assets and liabilities are presented in the Consolidated Statement of Profit or Loss within ‘finance income or costs’, except where hedge accounting applies.

iii)    Net investment in foreign operations

Exchange differences arising from the translation of foreign operations and of any related qualifying hedges are taken directly to the translation reserve within equity. They are realized through the Consolidated Statement of Profit or Loss upon disposal of the related foreign operation.

Goodwill

Goodwill

Goodwill represents amounts arising on acquisition of subsidiaries. Goodwill is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired.

Goodwill is stated at cost less any accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

Goodwill is not monitored below the operating segment. Goodwill is not amortized but is tested annually for impairment.

Other intangible assets

Other intangible assets

Intangible assets acquired separately are recorded at cost and those acquired as part of a business combination are recorded at fair value as at the date of acquisition.

i)    Computer software

Capitalized software costs include the cost of acquired computer software licenses and costs that are directly associated with the design, construction and testing of such software where this relates to a major business system. Costs associated with identifying, sourcing, evaluating or maintaining computer software are recognized as an expense within other operating expenses as incurred.

The assets are stated at cost less accumulated amortization and impairment losses. Software costs are amortized by equal monthly installments over their estimated useful economic life of five to ten years once the software is capable of being brought into use.

ii)    Brands

Our largest brands, including Birds Eye, Iglo, Findus, Ledo and Frikom are considered to have indefinite lives. This is based on the market position of the brands, the significant levels of investment in advertising and promoting the brands, and the fact that they have been established for at least 20 years. Therefore these brands are not amortized, but instead held at historical cost less provision for any impairment.

Brands that are deemed to not have an indefinite life are being amortized by equal monthly installments within other operating expenses over the course of their remaining useful economic life.

iii)    Customer relationships

Long standing Food Service customer relationships have been identified as intangible assets as part of business combinations. These are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over their expected lives. The most significant of these assets were acquired as part of the Findus Acquisition in 2015 and are being amortized over 14 years.

Impairment of non-current assets

Impairment of non-current assets

The carrying amounts of the Company’s non-current assets are reviewed annually to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated. Impairment losses are recognized in the Consolidated Statement of Profit or Loss in the period in which they arise. For goodwill and assets that have an indefinite useful life an impairment review is performed at least annually.

Assets that are subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the net carrying amount may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount.

i)    Calculation of recoverable amount

Recoverable amount is the greater of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows of the business are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

ii)    Allocation of impairment losses

Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating units, then to reduce the carrying amount of the other assets in the unit on a pro rata basis. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

iii)    Reversals of impairment

An impairment loss in respect of goodwill is not reversed. In respect of other assets, an impairment loss is reversed when there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

Property, plant and equipment

Property, plant and equipment

i)    Owned assets

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use.

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

ii)    Leased assets

The Company leases various properties, equipment and cars. The Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

Where a contract contains both lease and non-lease components, the Group has elected to account for the contract as a single lease.

Leases are recognized as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the group. Each lease payment is allocated between the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The right-of-use asset is classified within property, plant and equipment and is depreciated over the shorter of the asset's useful life or the lease term on a straight-line basis.

Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities are presented within loans and borrowings and include the net present value of expected lease payments, including those from extension options if the Company reasonably expects to exercise them. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be determined, otherwise the Company’s incremental borrowing rate is used. Right-of-use assets are measured at cost comprising the amount of the lease liability, adjusted for payments made or received before the commencement date, initial direct costs and restoration costs.

Payments associated with short-term leases and leases of low-value assets are recognized on a straight-line basis as an expense in profit or loss. Short-term leases are leases with a lease term of 12 months or less. Low-value assets primarily comprise IT equipment and small items of office furniture.

iii)    Depreciation

Depreciation is charged to the Consolidated Statement of Profit or Loss on a straight line basis over the shorter of the lease term and the estimated useful lives of each part of an item of property, plant and equipment once the item is brought into use. Land is not depreciated. The estimated useful lives are as follows:

•Buildings 40 years

•Plant and equipment 5 to 14 years

•Computer equipment 3 to 5 years

The assets’ residual values and useful lives are reviewed on a frequent basis.

Inventories

InventoriesInventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average principle and includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Inventories that are acquired through business combinations are fair valued at the time of acquisition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of direct costs and overheads based on normal operating capacity. Provision is made for slow moving, obsolete and defective inventories.

Employee benefits

Employee benefits

i)    Defined contribution plans

Obligations for contributions to defined contribution pension plans are recognized as an expense in the Consolidated Statement of Profit or Loss as incurred. Prepaid contributions are recognized as an asset to the extent that a cash refund or reduction in the future payments is available.

ii)    Defined benefit plans

The Company’s net obligation in respect of defined benefit pension plans and other post-employment benefits is calculated separately for each plan by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. That net obligation is discounted to determine its present value. The calculation is performed by a qualified actuary using the projected unit credit method.

The current service cost of the defined benefit plan, recognized in the Consolidated Statement of Profit or Loss in staff costs included within Operating profit/(loss), except where included in the cost of an asset, reflects the increase in the defined benefit obligation resulting from employee service in the current year, benefit changes, curtailments and settlements.

Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in Other Comprehensive Income in the period in which they arise.

The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the Consolidated Statement of Profit or Loss.

Past service cost is recognized immediately.

iii)    Share-based payment schemes

Employee benefits given through share-based payment schemes are discussed further in section 3.15 of this note.

Founder Preferred Shares

Founder Preferred Shares

Nomad Foods issued Founder Preferred Shares to both TOMS Acquisition I LLC and Mariposa Acquisition II, LLC (collectively the “Founder Entities”) in connection with its initial public offering in April 2014. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Dividend Amount”). The instrument and its component parts were analyzed under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015, of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.

Provisions/Onerous contracts provisions

ProvisionsProvisions are recognized when the Company has a legal or constructive present obligation as a result of a past event and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors’ best estimate of the expenditure required to settle the obligation at the financial year end date and are discounted to present value where the effect is material.Where it is not possible to make a reliable estimate of the estimated financial effect of a provision, appropriate disclosure of the resulting contingent liability is made, but no provision is recognized.

Financial instruments

Financial instruments

Financial assets and liabilities are recognized in the Company’s Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument.

i)    Trade receivables

Trade receivables are amounts due from customers for goods sold when control of the products has transferred, being when the products are delivered in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. The Company holds the trade receivables with the objective of collecting the contractual cash flows and so they are subsequently measured at amortized cost using the effective interest method, less any loss allowance. Since trade receivables are due within one year, this equates to initial carrying value less any loss allowance.

To assist in managing operating cash flow, we may enter into non-recourse factoring arrangements with certain receivables whereby we sell specific account receivables to one or more external financial institutions. The risks and rewards of ownership are considered to have been transferred at the point of sale. Up to the point of sale, these receivables are treated as held for sale and measured at fair value through Profit or Loss. Under the terms of the contractual arrangements, the Company may continue to collect the cash from the customer receivables sold, albeit acting solely as a collecting agent on behalf of the purchaser of receivables. Any cash received from customers which is due to be paid to the agent is presented as a financial liability in the Statement of Financial Position and as a financing activity within the Statement of Cash Flows. Factoring fees associated with the sale of factored receivables were minimal for all periods presented. See Note 18.

The Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables. Trade receivables are grouped by days past due. Expected loss rates are based on historical credit losses experienced in each market as well as forward looking information where this is significant. Trade receivables are written off when there is no reasonable expectation of recovery. Appropriate allowances for expected credit losses and estimated irrecoverable amounts are recognized in the Consolidated Statement of Profit or Loss.

Trade receivables are presented net of associated contract liabilities, referred to as 'trade terms' as discussed further in Note 3.14 and Note 4.

ii)    Cash and cash equivalents

Cash and cash equivalents comprise of cash balances and deposits that are readily convertible to a known amount of cash and are measured at amortized cost. Deposits held in money market funds are measured at fair value through Profit or Loss as the cash flows do not only represent principal and interest.

iii)    Loans and borrowings

a.    Valuation

Interest bearing borrowings are recognized initially at fair value less attributable transaction costs.

Subsequent to initial recognition, interest bearing loans and borrowings are stated at amortized cost with any difference between cost and redemption value being recognized in the Consolidated Statement of Profit or Loss over the expected period of the borrowings.

b.    Capitalization of transaction costs

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

iv)    Trade payables

Trade payables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method. Since trade payables are largely due within one year, this equates to initial carrying value.

v)    Derivative financial instruments and hedge accounting

Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge accounting relationship, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company has elected the cost of hedging approach for the fair value movement on currency basis spreads of all hedging relationships, whereby the movements will be recognized within equity, if material, to the extent that they relate to the hedged item. In cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition.

The fair value of all financial derivative instruments (including but not limited to forward foreign exchange contracts, currency swaps and cross currency interest rates swaps), is determined per market standard using forward foreign exchange and interest rates at the balance sheet date, with the resulting value discounted back to present value.

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company applies the hedge accounting requirements of IFRS 9 to all hedging relationships. IAS 39 was beforehand with the impact of the changes disclosed in Note 2 Basis of preparation.

a.    Cash flow hedges

Where a derivative financial instrument is designated as a hedge of the cash flow of a recognized asset or liability, (including a highly probable forecast transaction) the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve, within other reserves. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss.

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, if the result of a forecasted transaction is recognition of a non-financial asset (for example inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve (presented together as 'Other reserves') are included in the initial cost of the non-financial item upon its recognition. For all other hedged forecasted transactions, the amounts accumulated in the hedging reserve and cost of hedging reserve are reclassified to the Consolidated Statement of Profit or Loss in the same period, or periods, in which the hedged forecasted future cash flows affect the Consolidated Statement of Profit or Loss.

When a hedging instrument expires or is sold, exercised or otherwise terminated, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately.

When a hedging instrument is substantially modified, any fair value gain or loss is recognized immediately in the Consolidated Statement of Profit or Loss.

b.    Net investment hedges

Foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income to the extent that the hedge is effective, and are presented in the translation reserve within equity. 

Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the change in fair value of the future price element of the hedging instrument (‘forward element’) is not included as part of the hedging relationships and is recognized in the Consolidated Statement of Profit or Loss immediately.

To the extent that any net investment hedge is entered into and the hedge is deemed effective, any foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal.

vi)    Short-term investments

The Company may invest surplus cash positions in short-term investments to manage liquidity and credit risk. Short‐term investments are held within managed investment funds and are measured at fair value with all changes in fair value are recognized immediately in the Consolidated Statement of Profit or Loss.

Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data.

Revenue

Revenue from contracts with customers

The Company manufactures and sells a range of frozen foods to retail, wholesale and Food Service markets. Revenue is recognized when control of the products has transferred, being when the products are delivered to the customer in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. A provision for product return allowances, which is estimated based upon the Company’s historical performance and management’s experience, is recorded as a reduction of sales in the same period that the revenue is recognized. Revenue excludes sales taxes and intra-company sales.

Products are often sold with variable pricing arrangements, including payment discounts, trade promotions and slotting fees. Discounts given by the Company include rebates, price reductions and incentives to customers, promotional couponing and trade communication costs. Trade promotions consist of pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. Certain retailers require the payment of slotting fees to obtain space for the Company’s products on the retailers’ store shelves.

Where variable pricing arrangements are in place, revenue is only recognized to the extent that it is highly probable that the amount recognized is unlikely to be reversed. Accumulated experience is used to estimate and provide for the discounts. Revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. Accruals for expected pay-outs under these programs are collectively known as ‘trade terms’ and are included within trade and other receivables or within trade and other payables in the Consolidated Statement of Financial Position. No element of financing is deemed present as the sales are made in line with market practice and accruals are typically settled within twelve months of the sale.

Share based payments

Share based payments

The Nomad Foods Long-term Incentive Plan known as the (the "Management Share Awards"), which incorporates an annual Non-Executive Directors Restricted Stock Scheme, falls within the provisions of IFRS 2 “Share-based Payment” and awards under the Management Share Awards represent equity settled share based payments. A charge is taken to the Consolidated Statement of Profit or Loss for the difference between the fair value of the shares at grant date and the amount subscribed, spread over the vesting period.

Share based payment arrangements in which Nomad receives goods or services as consideration for its own equity instruments are accounted for as equity-settled share based payment transactions, regardless of how the equity instruments are obtained by Nomad.

The grant date fair value of share-based payment awards granted to any Director or employee is recognized as an expense, with a corresponding increase in equity, over the period that any Director or employee becomes unconditionally entitled to the awards.

The fair value of the awards granted is measured using a valuation model, taking into account the terms and conditions upon which the awards were granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.

See Note 8(b) for further information on the Company’s share-based payment arrangements and details of the valuation model used.

Interest income

Interest incomeInterest income is recognized in the Consolidated Statement of Profit or Loss on an accruals basis using the effective interest method.

Expenses

Expenses & Exceptional items

i)    Borrowing costs

Unless capitalized as part of the cost of borrowing (see Note 3.13(iii)), borrowing costs are recognized in the Consolidated Statement of Profit or Loss in the period in which they are incurred.

ii)    Exceptional items

The separate reporting of exceptional items which are presented as exceptional within the relevant Consolidated Statement of Profit or Loss category, helps provide an indication of the Company’s underlying business performance. Exceptional items have been identified and presented by virtue of their size, nature or incidence. In determining whether an event or transaction is exceptional, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence. Exceptional items comprise restructuring costs, impairments or reversal of impairments of intangible assets, operational restructuring, integration and acquisition costs relating to new acquisitions, implementation of strategic opportunities and other significant items (see Note 7).

iii)    Research and development

Expenditure on research activities is recognized in the Consolidated Statement of Profit or Loss as an expense as incurred.

Taxation

Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognized in the Consolidated Statement of Profit and Loss except to the extent that it relates to items recognized in Other Comprehensive Income, in which case it is recognized within the Statement of Other Comprehensive Income.

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the financial year end date, and any adjustment to tax payable in respect of previous years. Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on the best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals.

Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts used for taxation purposes on an undiscounted basis. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial year end date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized.

Segment reporting

Segment reporting

The Chief Operating Decision Maker (“CODM”) has been determined to be the Chief Executive Officer as he is primarily responsible for the allocation of resources to the segments and the assessment of performance of the segments.

Nomad’s operations are organized into one operating unit, "Frozen", which comprises all the brands, as well as the factories, private label business units and certain corporate overheads. The CODM primarily uses “Adjusted EBITDA”, disclosed in Note 5, as the key measure of the segment’s results. Adjusted EBITDA is EBITDA adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

EBITDA, disclosed in Note 5, is defined as profit/(loss) for the period before taxation, net financing costs, depreciation and amortization.

IFRSs not yet adopted

Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS

Amendments to IAS 12 - Deferred Tax related to Assets and Liabilities arising from a Single Transaction

In May 2021, the International Accounting Standards Board issued targeted amendments to IAS 12, Income Taxes. The amendments are effective for annual periods beginning on or after January 1, 2023, although earlier application is permitted. With a view to reducing diversity in reporting, the amendments will clarify that companies are required to recognize deferred taxes on transactions where both assets and liabilities are recognized, such as with leases and asset retirement (decommissioning) obligations. Based upon our current facts and circumstances, we do not expect our financial performance or disclosure to be materially affected by the application of the amended standard.

IFRSs not yet adoptedAt the date of authorization of these financial statements, except as disclosed in Note 2, there are no Standards and Interpretations relevant to the Company which are in issue but not yet effective.

Onerous/ unfavorable contracts

Disclosure of types of insurance contracts [line items]

Provisions/Onerous contracts provisions

Onerous contracts provisionsWhere the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

XML

Segment reporting (Tables)

12 Months Ended

Dec. 31, 2021

Operating Segments [Abstract]

Segment As Adjusted EBITDA

Segment Adjusted EBITDA

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Profit for the period		181.0	225.1	153.6
Taxation		55.7	70.4	56.7
Net financing costs		106.0	63.7	73.2
Depreciation and amortization		71.6	67.6	68.3
Acquisition purchase price adjustments		8.4	—	—
Exceptional items	7	45.3	20.6	54.5
Other add-backs		18.7	19.4	25.7
Adjusted EBITDA		486.7	466.8	432.0

External Revenue and Non-current Assets by Geography

External revenue by geography

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
United Kingdom	758.3	747.3	712.5
Italy	417.9	426.3	394.1
Germany	396.3	393.2	329.6
France	188.6	203.8	176.6
Sweden	148.1	158.7	175.7
Austria	129.3	127.9	108.2
Norway	121.7	115.6	120.4
Spain	75.1	82.6	79.5
Rest of Europe	371.3	260.5	227.7
Total external revenue by geography	2,606.6	2,515.9	2,324.3

Non-current assets by geography

	December 31, 2021	December 31, 2020
	€m	€m
Germany	140.0	135.5
United Kingdom	139.6	132.1
Italy	64.8	68.5
Serbia	48.5	—
Croatia	38.5	—
Ireland	34.3	31.9
Norway	31.0	30.0
Sweden	29.8	28.5
Rest of Europe	72.3	52.7
Total non-current assets by geography	598.8	479.2

XML

Operating profit/(loss) (Tables)

12 Months Ended

Dec. 31, 2021

Analysis of income and expense [abstract]

Disclosure of Detailed Information About Profit (Loss) from Operating Activities

Operating profit is stated after charging:

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Staff costs	8	340.6	340.2	308.6
Depreciation of property, plant and equipment	12	63.4	59.8	59.7
Impairment of property, plant and equipment	12	—	—	0.1
Impairment of software and brands	13	1.7	—	—
Amortization of software and brands	13	8.2	7.8	8.6
Operating lease charges		6.1	3.0	4.5
Exchange losses/(gains)		27.0	(2.8)	(14.6)
Research & development expenditure		19.2	17.6	18.9
Inventories recognized as an expense within cost of goods sold		1,694.3	1,627.9	1,536.0

XML

Exceptional items (Tables)

12 Months Ended

Dec. 31, 2021

Analysis of income and expense [abstract]

Schedule of Exceptional Items

Exceptional items are made up as follows:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Supply chain reconfiguration (1)	—	(12.5)	(3.6)
Findus Group integration costs (2)	—	—	3.5
Fortenova Acquisition integration costs (3)	3.5	—	—
Findus Switzerland integration costs (4)	6.2	0.3	—
Brexit (5)	5.3	1.6	1.6
Business Transformation program (6)	18.8	2.3	—
Information Technology Transformation program (7)	4.2	—	—
Goodfella's Pizza & Aunt Bessie's integration costs (8)	—	4.0	12.5
Factory optimization (9)	4.9	10.0	5.7
Settlement of legacy matters (10)	(2.6)	(2.9)	(9.2)
Release of indemnification assets (11)	5.0	17.8	44.0
Total exceptional items	45.3	20.6	54.5

XML

Payroll costs, share based payments and management incentive schemes (Tables)

12 Months Ended

Dec. 31, 2021

Employee Benefits And Share-Based Payments [Abstract]

Disclosure of Employee Information

The average number of persons employed by the Company (excluding non-Executive Directors) is analyzed and set out below:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Production	3,310	3,043	3,308
Administration, distribution & sales	2,193	1,647	1,448
Total number of employees	5,503	4,690	4,756

Disclosure of Employee Benefit Expense

The table below discloses the Company’s aggregate payroll costs of these persons. Payroll costs exclude long term management incentive scheme and share based payment costs, but includes bonus costs.

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Wages and salaries	266.4	276.4	250.4
Social security costs	56.1	49.2	45.2
Other pension costs	18.1	14.6	13.0
Total payroll costs	340.6	340.2	308.6

Disclosure of number and weighted average exercise prices of share options

management team (the “Management Share Awards”) as of the following four award dates:

	January 1, 2016 Award	January 1, 2017 Award	January 1, 2018 Award	January 1, 2019 Award	January 1, 2020 Award	January 1, 2021 Award	Total
Number of awards outstanding at January 1, 2021	1,041,953	819,873	446,575	159,561	710,438	—	3,178,400
New awards granted in the period	—	—	—	—	—	820,202	820,202
Awards vested and issued in the period	(1,041,953)	(819,873)	—	—	—	—	(1,861,826)
Forfeitures in the period	—	—	(14,785)	(6,866)	(65,345)	(32,925)	(119,921)
Number of awards outstanding at December 31, 2021	—	—	431,790	152,695	645,093	787,277	2,016,855

Inputs and assumptions underlying the Monte Carlo Model

	January 1, 2018 award			January 1, 2019 award			January 1, 2020 award			January 1, 2021 award
Grant date price	$	16.72		$	20.15		$	22.37		$	25.42
Exercise price	$	—		$	—		$	—		$	—
Expected life of restricted share	1.50 - 4.00 years			4.00 years			3.00 years			3.00 years
Expected volatility of the share price	22.7		%	24.0		%	24.4		%	30.0		%
Dividend yield expected	—		%	—		%	—		%	—		%
Risk free rate	2.55		%	1.33		%	1.70		%	0.24		%
Employee exit rate	14.0		%	14.0		%	27.3		%	14.0		%
EBITDA Performance Target Condition	35.0		%	35.0		%	35.0		%	35.0		%

XML

Directors and Key Management compensation (Tables)

12 Months Ended

Dec. 31, 2021

Related Party [Abstract]

Disclosure of transactions between related parties [text block]

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Benefits are accruing to the following number of key management personnel under:
Defined contribution plans	2	2	2
Share based payment schemes	2	2	2

Disclosure of information about key management personnel [text block]

Directors and Key Management compensation

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Short-term employee benefits	2.2	3.9	2.8
Share-based payment expense	2.4	3.5	7.6
Non-Executive Director fees	0.3	0.3	0.4
Total Directors' and executive officers' compensation	4.9	7.7	10.8

All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and executive Officers.

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Benefits are accruing to the following number of key management personnel under:
Defined contribution plans	2	2	2
Share based payment schemes	2	2	2

XML

Finance income and costs (Tables)

12 Months Ended

Dec. 31, 2021

Analysis of income and expense [abstract]

Schedule of Finance income and costs

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Interest income	0.1	0.7	2.5
Net foreign exchange gains on translation of financial assets and liabilities	—	4.0	—
Finance income	0.1	4.7	2.5
Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss (a)	(59.8)	(64.0)	(79.0)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity	1.6	5.9	21.8
Net impairment loss on short-term investments	(8.6)	—	—
Net pension interest costs	(1.7)	(2.7)	(3.8)
Amortization of borrowing costs	(2.0)	(2.0)	(2.0)
Net foreign exchange losses on translation of financial assets and liabilities	(4.0)	—	(3.9)
Net fair value losses on derivatives held at fair value through profit or loss (b)	(13.7)	(5.6)	(8.8)
Financing costs incurred in amendment of terms of debt (c)	(17.9)	—	—
Finance costs	(106.1)	(68.4)	(75.7)
Net finance costs	(106.0)	(63.7)	(73.2)

(a) Includes the unwinding of discounting on lease liabilities. 

(b) Net fair value losses on derivatives held at fair value through profit or loss includes a one-off non-cash charge of €7.8 million for changes to cross currency interest rate swaps as disclosed in Note 34.

(c) Charges of €17.9 million have been recognized as a consequence of the refinancing in June 2021, as disclosed in Note 34. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs.

XML

Taxation (Tables)

12 Months Ended

Dec. 31, 2021

Income Taxes [Abstract]

Components Of Tax Expense (Benefit)

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Current tax expense
Current tax on profits for the period		(117.5)	(44.8)	(66.4)
Adjustments in respect of prior periods		0.6	(7.6)	—
		(116.9)	(52.4)	(66.4)
Deferred tax benefit/(expense)
Origination and reversal of temporary differences		116.3	(1.2)	9.7
Impact of change in tax rates		(55.1)	(16.8)	—
	16	61.2	(18.0)	9.7
Total tax expense		(55.7)	(70.4)	(56.7)

Reconciliation Of Effective Tax Rate

Reconciliation of effective tax rate:

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Profit before tax	236.7	295.5	210.3
Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%)	(45.0)	(56.1)	(39.9)
Difference in tax rates	22.7	(18.2)	(11.9)
Non tax deductible interest	0.1	(0.1)	0.6
Other income and expenses not taxable or deductible	2.5	(0.8)	(1.2)
Unrecognized tax assets	(1.5)	(6.3)	(0.9)
Provisions for uncertainties	(52.5)	35.5	(3.4)
Impact of change in tax rates	(55.1)	(16.8)	—
Change in tax base of assets due to step-up	72.5	—	—
Prior period adjustment	0.6	(7.6)	—
Total tax expense	(55.7)	(70.4)	(56.7)

Income Tax Relating to Components Of Other Comprehensive Income

The tax (benefit)/expense relating to components of other comprehensive income is as follows:

		Before tax	Tax charge	After tax
Year ended December 31, 2021	Note	€m	€m	€m
Remeasurement of post-employment benefit liabilities		(36.1)	10.2	(25.9)
Net investment hedge		(18.8)	—	(18.8)
Cash flow hedges		(22.6)	13.6	(9.0)
Other comprehensive (income)/loss		(77.5)	23.8	(53.7)
Current tax			—
Deferred tax	16		23.8
			23.8
		Before tax	Tax benefit	After tax
Year ended December 31, 2020	Note	€m	€m	€m
Remeasurement of post-employment benefit liabilities		27.8	(8.3)	19.5
Net investment hedge		10.1	—	10.1
Cash flow hedges		17.3	(6.0)	11.3
Other comprehensive loss/(income)		55.2	(14.3)	40.9
Current tax			—
Deferred tax	16		(14.3)
			(14.3)
		Before tax	Tax benefit	After tax
Year ended December 31, 2019		€m	€m	€m
Remeasurement of post-employment benefit liabilities		35.9	(6.7)	29.2
Net investment hedge		(6.0)	—	(6.0)
Cash flow hedges		27.3	(5.6)	21.7
Other comprehensive loss/(income)		57.2	(12.3)	44.9
Current tax			—
Deferred tax			(12.3)
			(12.3)

XML

Property, plant and equipment Disclosure NBV of Tangible Assets and Right of use Assets (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure of detailed information about property, plant and equipment [abstract]

Disclosure NBV Tangible and Right of use Assets [Table Text Block]

12)    Property, plant and equipment

	December 31, 2021	December 31, 2020
	€m	€m
Owned property, plant and equipment (i)	489.2	373.2
Right-of-use assets (ii)	60.2	49.0
Property, plant and equipment	549.4	422.2

Disclosure of detailed information about property, plant and equipment [text block]

	Land and buildings	Plant and equipment	Computer equipment	Total
	€m	€m	€m	€m
Cost
Balance at December 31, 2019	156.2	331.9	13.8	501.9
Acquisitions through business combinations	5.1	3.5	—	8.6
Additions	6.8	54.6	2.1	63.5
Disposals	(0.1)	(2.6)	(0.3)	(3.0)
Effect of movements in foreign exchange	(2.7)	(11.3)	(0.3)	(14.3)
Balance at December 31, 2020	165.3	376.1	15.3	556.7
Acquisitions through business combinations	30.5	45.0	0.5	76.0
Additions	14.8	62.8	3.5	81.1
Disposals	(0.1)	(5.9)	—	(6.0)
Effect of movements in foreign exchange	6.2	16.2	0.4	22.8
Balance at December 31, 2021	216.7	494.2	19.7	730.6
Accumulated depreciation and impairment
Balance at December 31, 2019	23.0	125.0	3.9	151.9
Depreciation	7.6	33.5	3.0	44.1
Disposals	—	(1.8)	(0.3)	(2.1)
Effect of movements in foreign exchange	(1.4)	(8.6)	(0.4)	(10.4)
Balance at December 31, 2020	29.2	148.1	6.2	183.5
Depreciation	8.4	35.4	3.0	46.8
Disposals	—	(4.8)	—	(4.8)
Effect of movements in foreign exchange	2.9	12.6	0.4	15.9
Balance at December 31, 2021	40.5	191.3	9.6	241.4
Net book value December 31, 2019	133.2	206.9	9.9	350.0
Net book value December 31, 2020	136.1	228.0	9.1	373.2
Balance at December 31, 2021	176.2	302.9	10.1	489.2

Asset Class of RIght of use Assets [Table Text Block]

(ii)    Right-of-use assets

	December 31, 2021	December 31, 2020
	€m	€m
Net book value
Land and Buildings	44.8	38.5
Plant and equipment and motor vehicles	15.3	10.3
Computer equipment	0.1	0.2
Right-of-use assets	60.2	49.0

Additions to right-of-use assets during the year ended December 31, 2021 were €8.1 million. A further €19.0 million of additions were acquired through business combinations.

Lease liabilities are included within loans and borrowings in Note 21. Interest on lease liabilities is presented as a finance cost in Note 10. Payments of lease liabilities are included as a financing activity within the Statement of Cash Flows.

Disclosure of depreciation and amortisation expense [text block]

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	€m	€m	€m
Depreciation
Land and Buildings	10.9	10.6	10.7
Plant and equipment and motor vehicles	5.5	4.9	5.2
Computer equipment	0.2	0.2	0.2
Depreciation expense of right-of-use assets	16.6	15.7	16.1

XML

Goodwill and Intangibles (Tables)

12 Months Ended

Dec. 31, 2021

Intangible assets and goodwill [abstract]

Disclosure of reconciliation of changes in intangible assets and goodwill

	Goodwill	Brands	Computer software	Customer relationships	Total
	€m	€m	€m	€m	€m
Cost
Balance at December 31, 2019	1,862.9	2,051.1	29.8	31.0	3,974.8
Acquisitions through business combinations (restated)	40.1	66.0	0.1	—	106.2
Additions	—	—	8.8	—	8.8
Effect of movements in foreign exchange	(0.5)	5.3	0.3	—	5.1
Balance at December 31, 2020 (restated)	1,902.5	2,122.4	39.0	31.0	4,094.9
Acquisitions through business combinations	192.6	296.5	1.1	4.3	494.5
Additions	—	—	5.8	—	5.8
Disposals	—	—	(2.5)	—	(2.5)
Effect of movements in foreign exchange	4.3	3.2	(0.5)	—	7.0
Balance at December 31, 2021	2,099.4	2,422.1	42.9	35.3	4,599.7

	Goodwill	Brands	Computer software	Customer relationships	Total
	€m	€m	€m	€m	€m
Accumulated amortization and impairment
Balance at December 31, 2019	—	4.4	15.2	9.2	28.8
Amortization	—	1.2	4.4	2.2	7.8
Effect of movements in foreign exchange	—	—	0.1	—	0.1
Balance at December 31, 2020	—	5.6	19.7	11.4	36.7
Amortization	—	1.2	4.6	2.4	8.2
Impairment	—	—	1.7	—	1.7
Disposals	—	—	(1.7)	—	(1.7)
Effect of movements in foreign exchange	—	—	(0.3)	—	(0.3)
Balance at December 31, 2021	—	6.8	24.0	13.8	44.6
Net book value December 31, 2019	1,862.9	2,046.7	14.6	21.8	3,946.0
Net book value December 31, 2020 (restated)	1,902.5	2,116.8	19.3	19.6	4,058.2
Net book value December 31, 2021	2,099.4	2,415.3	18.9	21.5	4,555.1

XML

Acquisitions (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure of detailed information about business combination [abstract]

Acquisitions

The final assessment of the assets and liabilities acquired are as follows:

	As reported December 31, 2020	Adjustments	As restated December 31, 2020
	€m	€m	€m
Assets:
Intangible assets	24.5	41.6	66.1
Property, plant and equipment, including Right-of-use assets	8.9	—	8.9
Current assets	0.2	—	0.2
Inventories	11.5	1.1	12.6
Total assets	45.1	42.7	87.8
Liabilities:
Current liabilities	0.3	—	0.3
Non-current liabilities	6.8	—	6.8
Deferred tax liabilities	1.6	6.4	8.0
Total liabilities	8.7	6.4	15.1
Total identifiable net assets acquired	36.4	36.3	72.7
Total purchase consideration	112.0	0.8	112.8
Total identifiable net assets acquired	(36.4)	(36.3)	(72.7)
Goodwill	75.6	(35.5)	40.1

Purchase consideration - cash outflow

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Outflow of cash for business combinations, net of cash acquired		€m	€m	€m
Cash consideration		640.9	113.0	—
Less cash acquired		(43.6)	(0.1)	—
Contingent consideration paid related to acquisitions	24	—	—	1.5
Net outflow of cash - investing activities		597.3	112.9	1.5

Indemnification assets

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Balance at January 1	15.4	35.4
Release of indemnified provision	(5.9)	(20.0)
Balance at December 31	9.5	15.4

XML

Investments (Tables)

12 Months Ended

Dec. 31, 2021

Interests in Other Entities [Abstract]

Disclosure of Significant Investments

The following are the Company's significant investments as of December 31, 2021.

	Activity	Country of incorporation	Class of shares held	Ownership as of December 31, 2020
Nomad Foods Europe Holdings Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Holdco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Finco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Midco Limited	Holding/ Finance	England	Ordinary	100%
Nomad Foods Bondco Plc	Finance	England	Ordinary	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	Ordinary	100%
Nomad Foods Europe Limited	Management	England	Ordinary	100%
Birds Eye Limited	Trading	England	Ordinary	100%
Nomad Foods Europe Finance Limited	Finance	England	Ordinary	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	Ordinary	100%
Iglo Holding GmbH	Holding	Germany	Ordinary	100%
Iglo Nederland B.V.	Trading	Netherlands	Ordinary	100%
Iglo Belgium S.A.	Trading	Belgium	Ordinary	100%
Iglo Portugal	Trading	Portugal	Ordinary	100%
Iglo Austria Holdings GmbH	Holding	Austria	Ordinary	100%
C.S.I. Compagnia Surgelati Italiana S.R.L	Trading	Italy	Ordinary	100%
Findus Sverige Holdings AB	Holding	Sweden	Ordinary	100%
Iglo GmbH	Trading	Germany	Ordinary	100%
Frozen Fish International GmbH	Trading	Germany	Ordinary	100%
Liberator Germany Newco GmbH	Property	Germany	Ordinary	100%
Iglo Austria GmbH	Trading	Austria	Ordinary	100%
Findus Sverige AB	Trading	Sweden	Ordinary	100%
Frionor Sverige AB	Holding	Sweden	Ordinary	100%
Findus Holdings France SAS	Holding	France	Ordinary	100%
Findus France SAS	Trading	France	Ordinary	100%
Findus Espana SLU	Trading	Spain	Ordinary	100%
Findus Danmark A/S	Trading	Denmark	Ordinary	100%
Findus Finland Oy	Trading	Finland	Ordinary	100%
Findus Norge AS	Trading	Norway	Ordinary	100%
Findus Norge Holding AS	Holding	Norway	Ordinary	100%

Toppfrys AB	Trading	Sweden	Ordinary	100%
Findus Switzerland AG	Trading	Switzerland	Ordinary	100%
LEDO plus d.o.o.	Trading	Croatia	Ordinary	100%
INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD	Trading	Serbia	Ordinary	100%
LEDO d.o.o. Čitluk	Trading	Bosnia & Herzegovina	Ordinary	100%
IRIDA d.o.o.	Trading	Croatia	Ordinary	100%
LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság	Trading	Hungary	Ordinary	100%
Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.)	Trading	Slovenia	Ordinary	100%
Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga “Ledo” d.o.o. Podgorica)	Trading	Montenegro	Ordinary	100%
Ledo Sh.p.k.	Trading	Kosovo	Ordinary	100%
FRIKOM BEOGRAD DOOEL Cucer Sandevo	Trading	North Macedonia	Ordinary	100%

XML

Deferred tax assets and liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure of income tax [Abstract]

Schedule of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities are attributable to the following:

	December 31, 2021			December 31, 2020 (restated)
	Assets	Liabilities	Total	Assets	Liabilities	Total
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	8.9	(34.4)	(25.5)	20.6	(27.3)	(6.7)
Intangible assets	33.8	(382.9)	(349.1)	0.9	(384.4)	(383.5)
Employee benefits	36.4	—	36.4	48.3	(0.3)	48.0
Tax value of loss carry forwards	40.4	—	40.4	24.6	—	24.6
Derivative financial instruments	1.7	(7.0)	(5.3)	9.3	(0.1)	9.2
Other	7.1	(13.3)	(6.2)	9.8	(15.0)	(5.2)
Tax assets/(liabilities)	128.3	(437.6)	(309.3)	113.5	(427.1)	(313.6)

Movement in deferred tax during the year:

	Opening balance Jan 1, 2021 (restated)	Acquired in business combinations	Recognized  in Statement of Profit or Loss	Recognized in Other Comprehensive Income	Movement in foreign exchange	Closing balance Dec 31, 2021
	€m	€m	€m	€m	€m	€m
Property, plant and equipment	(6.7)	(2.2)	(17.2)	—	0.6	(25.5)
Intangible assets	(383.5)	(30.1)	64.5	—	—	(349.1)
Employee benefits	48.0	—	(1.2)	(10.2)	(0.2)	36.4
Tax value of loss carry forwards	24.6	—	15.8	—	—	40.4
Derivative financial instruments	9.2	—	(0.3)	(13.6)	(0.6)	(5.3)
Other	(5.2)	(0.6)	(0.4)	—	—	(6.2)
Total deferred tax	(313.6)	(32.9)	61.2	(23.8)	(0.2)	(309.3)

XML

Inventories (Tables)

12 Months Ended

Dec. 31, 2021

Inventories [Abstract]

Schedule of inventories

	December 31, 2021	December 31, 2020 (restated)
	€m	€m
Raw materials and consumables	95.8	80.5
Work in progress	64.9	46.5
Finished goods and goods for resale	249.9	217.3
Total inventories	410.6	344.3

XML

Trade and other receivables (Tables)

12 Months Ended

Dec. 31, 2021

Subclassifications of assets, liabilities and equities [abstract]

Disclosure of trade terms

Liabilities related to contracts with customers The Company has recognized the following liabilities related to contracts with customers:December 31, 2021December 31, 2020€m€mTrade terms liabilities reported within trade receivables(189.9)(200.5)Trade terms liabilities reported within trade and other payables (Note 22)(93.8)(89.7)Total trade terms liabilities(283.7)(290.2)Significant changes to trade termsNo significant changes to trade terms occurred in the year ended December 31, 2021.Revenue recognized in relation to trade termsTrade terms relate to sales made with variable consideration and are an estimate as disclosed in Note 4(a). Revenue recognized in the year ended December 31, 2021 relating to performance obligations that were satisfied in the prior year was €18.9 million (2020: €18.0 million).

Schedule of Trade and Other Receivables

	December 31, 2021	December 31, 2020
Current assets	€m	€m
Trade receivables	182.8	141.2
Prepayments and accrued income	15.4	9.2
Other receivables	32.3	31.2
Tax receivable	4.1	3.4
Total current trade and other receivables	234.6	185.0
Non-current assets
Other receivables	8.9	1.1
Total non-current trade and other receivables	8.9	1.1
Total trade and other receivables	243.5	186.1

Disclosure of Aging Trade Receivables

The aging of trade receivables is detailed below:

	Gross	Impaired	Net
December 31, 2021	€m	€m	€m
Not past due	343.8	(0.1)	343.7
Past due less than 1 month	19.9	(0.1)	19.8
Past due 1 to 3 months	5.2	(0.6)	4.6
Past due 3 to 6 months	2.4	(0.1)	2.3
Past due more than 6 months	5.0	(2.7)	2.3
Sub-total	376.3	(3.6)	372.7
Reduction in trade-terms			(189.9)
Total trade receivables			182.8
	Gross	Impaired	Net
December 31, 2020	€m	€m	€m
Not past due	308.6	(0.3)	308.3
Past due less than 1 month	20.5	(0.2)	20.3
Past due 1 to 3 months	4.0	(0.1)	3.9
Past due 3 to 6 months	1.1	(0.1)	1.0
Past due more than 6 months	11.9	(3.7)	8.2
Sub-total	346.1	(4.4)	341.7
Reduction in trade-terms			(200.5)
Total trade receivables			141.2

XML

Indemnification assets (Tables)

12 Months Ended

Dec. 31, 2021

Business Combinations1 [Abstract]

Disclosure of detailed information about business combination

The final assessment of the assets and liabilities acquired are as follows:

	As reported December 31, 2020	Adjustments	As restated December 31, 2020
	€m	€m	€m
Assets:
Intangible assets	24.5	41.6	66.1
Property, plant and equipment, including Right-of-use assets	8.9	—	8.9
Current assets	0.2	—	0.2
Inventories	11.5	1.1	12.6
Total assets	45.1	42.7	87.8
Liabilities:
Current liabilities	0.3	—	0.3
Non-current liabilities	6.8	—	6.8
Deferred tax liabilities	1.6	6.4	8.0
Total liabilities	8.7	6.4	15.1
Total identifiable net assets acquired	36.4	36.3	72.7
Total purchase consideration	112.0	0.8	112.8
Total identifiable net assets acquired	(36.4)	(36.3)	(72.7)
Goodwill	75.6	(35.5)	40.1

Purchase consideration - cash outflow

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Outflow of cash for business combinations, net of cash acquired		€m	€m	€m
Cash consideration		640.9	113.0	—
Less cash acquired		(43.6)	(0.1)	—
Contingent consideration paid related to acquisitions	24	—	—	1.5
Net outflow of cash - investing activities		597.3	112.9	1.5

Indemnification assets

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Balance at January 1	15.4	35.4
Release of indemnified provision	(5.9)	(20.0)
Balance at December 31	9.5	15.4

XML

Cash and cash equivalents (Tables)

12 Months Ended

Dec. 31, 2021

Subclassifications of assets, liabilities and equities [abstract]

Schedule of Cash and Cash Equivalents per Statement of Cash Flows

		December 31, 2021	December 31, 2020
	Note	€m	€m
Cash and cash equivalents		254.0	393.1
Restricted cash		0.2	0.1
Cash and cash equivalents		254.2	393.2
Bank overdraft	22	—	(10.7)
Cash and cash equivalents per Statement of Cash Flows		254.2	382.5

XML

Loans and borrowings (Tables)

12 Months Ended

Dec. 31, 2021

Financial Instruments [Abstract]

Repayment Profile and Individual Loan Details

The repayment profile of the syndicated and other loans held by the Company is as follows:

	December 31, 2021	December 31, 2020
	€m	€m
Current liabilities
Syndicated loans	8.5	7.8
Lease liabilities	22.6	16.7
Less deferred borrowing costs to be amortized within 1 year	(2.0)	(2.0)
Total due in less than one year	29.1	22.5
Non-current liabilities
Syndicated loans	1,347.4	1,287.5
2024 fixed rate senior secured notes	—	400.0
2028 fixed rate senior secured notes	800.0	—
Lease liabilities	58.3	53.7
Less deferred borrowing costs to be amortized in 2-5 years	(5.7)	(4.9)
Less deferred borrowing costs to be amortized in more than 5 years	(1.7)	—
Total due after more than one year	2,198.3	1,736.3
Total borrowings	2,227.4	1,758.8

XML

Trade and other payables (Tables)

12 Months Ended

Dec. 31, 2021

Subclassifications of assets, liabilities and equities [abstract]

Disclosure of Detailed Information About Trade and Other Payables

	December 31, 2021	December 31, 2020 (restated)
Current liabilities	€m	€m
Trade payables	413.2	363.7
Accruals and deferred income	120.4	134.5
Trade terms payable	93.8	89.7
Social security and other taxes	24.6	24.1
Other payables	20.3	21.2
Financial payables	19.7	3.3
Bank overdrafts	—	10.7
Total current trade and other payables	692.0	647.2
Non-current liabilities
Accruals and deferred income	1.8	2.2
Total non-current trade and other payables	1.8	2.2
Total trade and other payables	693.8	649.4

XML

Employee benefits (Tables)

12 Months Ended

Dec. 31, 2021

Employee Benefits [Abstract]

Schedule Of Net Defined Benefit Liability (Asset)

	December 31, 2021	December 31, 2020
	€m	€m
Net employee benefit obligations-Germany	149.3	181.2
Net employee benefit obligations-Sweden	70.3	74.1
Net employee benefit obligations-Austria	5.5	5.6
Net employee benefit obligations-Switzerland	5.8	6.6
Net employee benefit obligations-Italy	4.6	4.7
Net employee benefit obligations-total of other countries	8.7	4.0
Total net employee benefit obligations	244.2	276.2

The history of experience adjustments from inception of the Company for the employee benefit plans is as follows:

	December 31, 2021	December 31, 2020	December 31, 2019
	€m	€m	€m
Present value of defined benefit obligations	341.5	365.1	314.9
Fair value of plan assets	(108.4)	(97.9)	(86.4)
Recognized liability in the scheme	233.1	267.2	228.5
Experience losses/(gains) on plan liabilities	1.8	(0.8)	0.2
Experience gains on plan assets	(9.6)	(0.4)	(5.1)

Schedule of Net Employee Benefit Obligations And Components

Reconciliation from the opening balances to the closing balances for the net employee benefit obligation and its components, including the amounts recognized in the Consolidated Statement of Profit or Loss and the Consolidated Statement of Comprehensive Income:

	Present value of defined benefit obligation		Fair value of plan assets		Net defined benefit obligation
	2021	2020	2021	2020	2021	2020
	€m	€m	€m	€m	€m	€m
Balance at January 1	374.1	323.9	(97.9)	(86.4)	276.2	237.5
Included in the Consolidated Statement of Profit or Loss
Current service cost	7.9	6.6	—	—	7.9	6.6
Interest cost (income)	2.2	3.7	(0.5)	(1.0)	1.7	2.7
	10.1	10.3	(0.5)	(1.0)	9.6	9.3
Included in the Consolidated Statement of Comprehensive Income
Actuarial (gain) loss arising from:
–demographic assumptions	(1.5)	—	—	—	(1.5)	—
–financial assumptions	(26.8)	29.1	—	—	(26.8)	29.1
–experience adjustment	1.8	(0.8)	—	—	1.8	(0.8)
Return on plan assets, excluding interest income	—	—	(9.6)	(0.4)	(9.6)	(0.4)
Exchange adjustments	(0.3)	2.8	(0.6)	—	(0.9)	2.8
	(26.8)	31.1	(10.2)	(0.4)	(37.0)	30.7
Other
Acquired through business combinations	3.5	18.4	—	(11.8)	3.5	6.6
Contributions by employer	—	—	(1.2)	(0.5)	(1.2)	(0.5)
Contributions by members	0.8	0.4	(0.8)	(0.5)	—	(0.1)
Benefits paid	(9.1)	(10.0)	2.2	2.7	(6.9)	(7.3)
	(4.8)	8.8	0.2	(10.1)	(4.6)	(1.3)
Balance at December 31	352.6	374.1	(108.4)	(97.9)	244.2	276.2

Schedule Of Cumulative Actuarial Losses Recognized

The cumulative amount of actuarial losses recognized is as follows:

	Year ended December 31, 2021	Year ended December 31, 2020
	€m	€m
Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income	40.5	77.5

Schedule Of Plan Assets At Fair Value

The fair value of plan assets, all at quoted prices are as follows:

	December 31, 2021	December 31, 2020
	€m	€m
Equities	32.7	24.5
Debt instruments	42.7	44.1
Property	20.3	17.1
Other	12.7	12.2
Total	108.4	97.9

Defined Benefit Plan Principal Actuarial Assumptions

The following are the principal actuarial assumptions at the reporting date for the defined benefit retirement plans in Germany, Sweden, Austria, Switzerland and Italy. The remaining employee benefit plans are not considered to be material, individually and in aggregate, and therefore we do not provide disclosure of the individual actuarial assumptions for those plans:

	Defined benefit retirement plans
December 31, 2021	Germany		Sweden		Austria		Switzerland		Italy
Discount rate	1.10	%	1.80	%	0.90	%	0.10	%	0.35	%
Inflation rate	2.00	%	2.20	%	2.00	%	1.00	%	1.50	%
Rate of increase in salaries	2.80	%	3.20	%	2.00	%	1.50	%	2.63	%
Rate of increase for pensions in payment	1%-2%		2.20	%	—		—		—

	Defined benefit retirement plans
December 31, 2020	Germany		Sweden		Austria		Switzerland		Italy
Discount rate	0.55	%	1.05	%	1.00	%	0.15	%	0.33	%
Inflation rate	2.00	%	1.50	%	2.00	%	0.20	%	1.00	%
Rate of increase in salaries	2.80	%	2.50	%	2.00	%	0%-2.50%		2.63	%
Rate of increase for pensions in payment	1%-2%		1.50	%	—		—		—

Actuarial Assumptions Of Life Expectancy

These references are to the specific standard rates of mortality that are published and widely used in each country for the use of actuarial assessment of pension liabilities and take account of local current and future average life expectancy.

December 31, 2021 (years)	Germany	Sweden	Austria	Switzerland	Italy
Retiring at the end of the year:
Male	21	22	23	22	21
Female	24	24	26	24	22

December 31, 2020 (years)	Germany	Sweden	Austria	Switzerland	Italy
Retiring at the end of the year:
Male	21	22	23	21	21
Female	24	24	26	24	22

Disclosure Of Sensitivity Analysis For Actuarial Assumptions Explanatory

The effect of a 1 percentage point movement in the most significant assumptions for the year ended December 31, 2021 is as follows:

	Increase	Decrease
	€m	€m
Discount rate	(54.6)	71.9
Inflation rate	47.4	(38.7)
Rate of increase in salaries	15.2	(11.5)
Rate of increase for pensions in payment	47.6	(37.0)

XML

Provisions (Tables)

12 Months Ended

Dec. 31, 2021

Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]

Disclosure of Detailed Information About Provisions

	Restructuring	Onerous/ unfavorable contracts	Provisions related to other taxes	Other	Total
	€m	€m	€m	€m	€m
Balance at December 31, 2019	7.4	1.2	6.9	31.3	46.8
Additional provision in the period	15.6	—	0.1	13.4	29.1
Release of provision	—	(0.7)	(0.4)	(6.0)	(7.1)
Utilization of provision	(10.4)	(0.5)	—	(5.9)	(16.8)
Foreign exchange	0.3	—	—	(0.5)	(0.2)
Balance at December 31, 2020	12.9	—	6.6	32.3	51.8
Acquired through business combinations	—	—	0.3	3.8	4.1
Additional provision in the period	2.6	—	1.0	2.5	6.1
Release of provision	(0.1)	—	—	(4.0)	(4.1)
Utilization of provision	(9.8)	—	—	(6.9)	(16.7)
Foreign exchange	—	—	—	1.0	1.0
Balance at December 31, 2021	5.6	—	7.9	28.7	42.2
Analysis of total provisions:				December 31, 2021	December 31, 2020
Current				39.3	45.7
Non-current				2.9	6.1
Total				42.2	51.8

XML

Share capital and reserves (Tables)

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Share Capital, Reserves and Other Equity Interest [Abstract]

Schedule of Share Capital and Capital Reserve

Share capital and capital reserve

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Authorized:
Unlimited number of Ordinary Shares with nil nominal value issued at $10.00 per share	n/a	n/a
Unlimited number of Founder Preferred Shares with nil nominal value issued at $10.00 per share	n/a	n/a
Issued and fully paid:
173,559,173 (December 31, 2020: 172,180,897) Ordinary Shares with nil nominal value	1,639.6	1,636.9
1,500,000 (December 31, 2020: 1,500,000) Founder Preferred Shares with nil nominal value	10.6	10.6
Total share capital and capital reserve	1,650.2	1,647.5
Listing and share transaction costs	(27.1)	(27.0)
Total net share capital and capital reserve	1,623.1	1,620.5

Ordinary Shares

	Issued and Repurchased Ordinary shares  (in millions)
Balance at December 31, 2019	194.5
Shares issued in the year	7.6
Shares repurchased in the year	(29.9)
Balance at December 31, 2020	172.2
Shares issued in the year	5.0
Shares repurchased in the year	(3.6)
Balance at December 31, 2021	173.6

Summary of Listing and Share Transaction Costs

	€m
At December 31, 2019	24.9
Share transaction costs	2.1
At December 31, 2020	27.0
Share transaction costs	0.1
At December 31, 2021	27.1

XML

Share-based compensation reserve (Tables)

12 Months Ended

Dec. 31, 2021

Share Capital, Reserves and Other Equity Interest [Abstract]

Disclosure of detailed information about reserves within equity

	Share based compensation reserve
	€m
Balance as of January 1, 2021	8.3
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	4.3
Shares issued upon vesting of awards	(0.7)
Reclassification of awards for settlement of tax liabilities	(5.8)
Balance as of December 31, 2021	6.9

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2021	245.5
Settlement of dividend through share issue	(79.5)
Balance as of December 31, 2021	166.0

XML

Founder Preferred Shares Dividend Reserve (Tables)

12 Months Ended

Dec. 31, 2021

Share Capital, Reserves and Other Equity Interest [Abstract]

Disclosure of classes of share capital

	Share based compensation reserve
	€m
Balance as of January 1, 2021	8.3
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	4.3
Shares issued upon vesting of awards	(0.7)
Reclassification of awards for settlement of tax liabilities	(5.8)
Balance as of December 31, 2021	6.9

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2021	245.5
Settlement of dividend through share issue	(79.5)
Balance as of December 31, 2021	166.0

XML

Translation reserve Translation reserve table (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure of reserves within equity [line items]

Cash flow hedging reserve

Share-based compensation reserve

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

	Share based compensation reserve
	€m
Balance as of January 1, 2021	8.3
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	4.3
Shares issued upon vesting of awards	(0.7)
Reclassification of awards for settlement of tax liabilities	(5.8)
Balance as of December 31, 2021	6.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020.

On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021.

As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2021	245.5
Settlement of dividend through share issue	(79.5)
Balance as of December 31, 2021	166.0

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

	Year ended December 31,
	2021	2020	2019
	€m	€m	€m
Balance as of January 1	84.7	94.8	88.8
Adjustment on adoption of hedge accounting under IFRS 9	1.6	—	—
Restated balance as of January 1	86.3	94.8	88.8
Foreign currency translation adjustments	31.7	(23.6)	19.2
Net deferred (losses)/gains on net investment hedges (1)	(12.9)	13.5	(13.2)
Total presented in Other Comprehensive Income	18.8	(10.1)	6.0
Balance as of December 31	105.1	84.7	94.8

(1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments.

The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments.

reserves

Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33.

The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year.

	Cross currency interest rate swaps	Forward currency contracts	Total Cash flow hedge reserve	Cost of Hedging reserve	Total Other reserves
	€m	€m	€m	€m	€m
Balance as of January 1, 2019	0.9	7.6	8.5	—	8.5
Change in fair value of hedging instrument recognized in OCI for the year	28.1	3.8	31.9	—	31.9
Reclassified to cost of goods sold	—	(21.8)	(21.8)	—	(21.8)
Reclassified from OCI to finance costs	(37.4)	—	(37.4)	—	(37.4)
Deferred tax	1.6	4.0	5.6	—	5.6
Balance as of December 31, 2019	(6.8)	(6.4)	(13.2)	—	(13.2)
Change in fair value of hedging instrument recognized in OCI for the year	(63.7)	(20.0)	(83.7)	—	(83.7)
Reclassified to cost of goods sold	—	0.2	0.2	—	0.2
Reclassified from OCI to finance costs	66.2	—	66.2	—	66.2
Deferred tax	(0.2)	6.2	6.0	—	6.0
Balance as of December 31, 2020	(4.5)	(20.0)	(24.5)	—	(24.5)
Reallocation for IFRS 9 changes to policy (start of the year)	2.8	—	2.8	(4.4)	(1.6)
Transferred to the carrying value of inventory	—	27.6	27.6	—	27.6
Change in fair value of hedging instrument recognized in OCI for the year	73.3	9.3	82.6	2.4	85.0
Reclassified from OCI to finance costs	(64.1)	—	(64.1)	1.7	(62.4)
Deferred tax	(2.4)	(11.1)	(13.5)	(0.1)	(13.6)
Balance as of December 31, 2021	5.1	5.8	10.9	(0.4)	10.5

Reserve of exchange differences on translation [member]

Disclosure of reserves within equity [line items]

Cash flow hedging reserve

investment in a foreign subsidiary.

	Year ended December 31,
	2021	2020	2019
	€m	€m	€m
Balance as of January 1	84.7	94.8	88.8
Adjustment on adoption of hedge accounting under IFRS 9	1.6	—	—
Restated balance as of January 1	86.3	94.8	88.8
Foreign currency translation adjustments	31.7	(23.6)	19.2
Net deferred (losses)/gains on net investment hedges (1)	(12.9)	13.5	(13.2)
Total presented in Other Comprehensive Income	18.8	(10.1)	6.0
Balance as of December 31	105.1	84.7	94.8

(1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments.

The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments.

XML

Cash flow hedging reserve (Tables)

12 Months Ended

Dec. 31, 2021

Share Capital, Reserves and Other Equity Interest [Abstract]

Movement in cash flow hedging reserve

The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year.

	Cross currency interest rate swaps	Forward currency contracts	Total Cash flow hedge reserve	Cost of Hedging reserve	Total Other reserves
	€m	€m	€m	€m	€m
Balance as of January 1, 2019	0.9	7.6	8.5	—	8.5
Change in fair value of hedging instrument recognized in OCI for the year	28.1	3.8	31.9	—	31.9
Reclassified to cost of goods sold	—	(21.8)	(21.8)	—	(21.8)
Reclassified from OCI to finance costs	(37.4)	—	(37.4)	—	(37.4)
Deferred tax	1.6	4.0	5.6	—	5.6
Balance as of December 31, 2019	(6.8)	(6.4)	(13.2)	—	(13.2)
Change in fair value of hedging instrument recognized in OCI for the year	(63.7)	(20.0)	(83.7)	—	(83.7)
Reclassified to cost of goods sold	—	0.2	0.2	—	0.2
Reclassified from OCI to finance costs	66.2	—	66.2	—	66.2
Deferred tax	(0.2)	6.2	6.0	—	6.0
Balance as of December 31, 2020	(4.5)	(20.0)	(24.5)	—	(24.5)
Reallocation for IFRS 9 changes to policy (start of the year)	2.8	—	2.8	(4.4)	(1.6)
Transferred to the carrying value of inventory	—	27.6	27.6	—	27.6
Change in fair value of hedging instrument recognized in OCI for the year	73.3	9.3	82.6	2.4	85.0
Reclassified from OCI to finance costs	(64.1)	—	(64.1)	1.7	(62.4)
Deferred tax	(2.4)	(11.1)	(13.5)	(0.1)	(13.6)
Balance as of December 31, 2021	5.1	5.8	10.9	(0.4)	10.5

XML

Earnings/(loss) per share (Tables)

12 Months Ended

Dec. 31, 2021

Earnings per share [abstract]

Basic and diluted earnings/(loss) per share

Basic earnings per share

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Profit for the period attributable to equity owners of the parent (€m)	181.0	225.2	154.0
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	194,019,070	192,004,803
Basic earnings per share (€’s)	1.02	1.16	0.80

Diluted earnings (loss) per share

Diluted earnings per share

	Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
Profit for the period attributable to equity owners of the parent (€m)	181.0	225.2	154.0
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	197,894,106	198,425,877
Diluted earnings per share (€’s)	1.02	1.14	0.78

XML

Reconciliation of liabilities arising from financing activities (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure of reconciliation of liabilities arising from financing activities [abstract]

Disclosure of reconciliation of liabilities arising from financing activities [text block]

The table below details changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Company's consolidated statements of cash flows from financing activities.

	Cash / non-cash	Total loans and borrowings (Note 21)	Financial payables (Note 22)	Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	Derivatives: (Net) Fair value of cross currency interest rate swaps
		€m	€m	€m	€m
Opening balance January 1, 2021		1,758.8	3.3	0.2	72.3
Cash inflow (1)	Cash	800.0	—	0.3	1.4
Cash outflow (2)	Cash	(436.0)	(38.1)	—	(2.3)
Interest accretion (3)	Cash	2.2	57.6	—	—
Acquired through business combinations	Non-cash	19.6	—	—	—
Exchange movement	Non-cash	64.1	(0.2)	—	—
Fair value changes	Non-cash	—	—	(0.1)	(44.0)
Other non-cash adjustments	Non-cash	18.7	(2.9)	—	(6.8)
Closing balance December 31, 2021		2,227.4	19.7	0.4	20.6

	Cash / non-cash	Total loans and borrowings (Note 21)	Financial payables (Note 22)	Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	Derivatives: (Net) Fair value of cross currency interest rate swaps
		€m	€m	€m	€m
Opening balance January 1, 2020		1,875.3	4.1	(0.2)	15.3
Cash inflow (1)	Cash	—	—	—	6.8
Cash outflow (2)	Cash	(32.0)	(57.0)	(2.2)	(3.9)
Interest accretion (3)	Cash	5.2	58.8	—	—
Acquired through business combinations	Non-cash	0.4	—	—	—
Exchange movement	Non-cash	(71.7)	0.9	—	—
Fair value changes	Non-cash	—	—	2.6	54.1
Other non-cash adjustments	Non-cash	(18.4)	(3.5)	—	—
Closing balance December 31, 2020		1,758.8	3.3	0.2	72.3

(1) Cash inflows from cross currency interest rate swaps are part of effective cash flow hedging relationships and are

presented within interest paid within the Consolidated Statements of Cash Flows.

(2) Cash outflows from cross currency interest rate swaps are not part of a cash flow hedge and are presented within

proceeds on settlement of derivatives within the Consolidated Statements of Cash Flows.

XML

Cash flows from operating activities (Tables)

12 Months Ended

Dec. 31, 2021

Cash Flow Statement [Abstract]

Schedule of cash flow disclosures

		Year ended December 31, 2021	Year ended December 31, 2020	Year ended December 31, 2019
	Note	€m	€m	€m
Cash flows from operating activities
Profit for the period		181.0	225.1	153.6
Adjustments for:
Exceptional items	7	45.3	20.6	54.5
Non-cash fair value purchase price adjustment of inventory	5	8.4	—	—
Share based payments expense		5.1	9.0	14.9
Depreciation and amortization		71.6	67.6	68.3
Loss on disposal and impairment of property, plant and equipment		0.7	0.9	0.6
Net finance costs	10	106.0	63.7	73.2
Taxation	11	55.7	70.4	56.7
Operating cash flow before changes in working capital, provisions and exceptional items		473.8	457.3	421.8
(Increase)/decrease in inventories		(23.8)	(12.7)	23.5
Decrease/(increase) in trade and other receivables		24.1	(1.8)	(34.4)
(Decrease)/increase in trade and other payables		(25.0)	107.2	(40.6)
Increase in employee benefit and other provisions		1.2	2.0	6.6
Cash generated from operations before tax and exceptional items		450.3	552.0	376.9

XML

Financial risk management (Tables)

12 Months Ended

Dec. 31, 2021

Financial Instruments [Abstract]

Disclosure of financial instruments

The effects of the cash flow hedging instruments on the Company's financial position and performance are as follows:

All amounts stated in €m, unless otherwise stated	December 31, 2021	December 31, 2020
USD - cross currency interest rate swaps
Carrying amount of liability	(20.6)	(89.5)
Notional amount (USD)	$916.4	$926.0
Maturity date	5/15/2024	5/15/2022
Change in fair value of outstanding hedging instruments since January 1	68.9	(71.0)
(Gain)/loss in value of hedged item used to determine effectiveness	(69.6)	71.0
Weighted average hedged rate for the year	1.11	1.11

The effects of the net investment hedging instruments on the Company's financial position and performance are as follows:

All amounts stated in €m, unless otherwise stated	December 31, 2021	December 31, 2020
UK cross-currency interest rate swaps hedge
Carrying amount of cross-currency interest rate swaps	—	14.3
Notional amount (GBP)	—	£220.2
Maturity date	7/29/2021	5/15/2022
Change in fair value of cross-currency interest rate swaps as a result of foreign currency movements since January 1	(12.9)	13.5
Loss/(gain) in value of hedged item used to determine hedge effectiveness	12.9	(13.5)
Weighted average hedged rate for the year	1.19	1.19

position and performance are as follows:

As at December 31, 2021	EUR/USD	GBP/USD	GBP/EUR	SEK/EUR	SEK/USD	Other Currencies
	€m	€m	€m	€m	€m	€m
Derivative financial instruments - forward currency contracts
Carrying amount of (liability)/asset	17.5	1.2	(6.7)	0.5	0.1	0.3
Notional amount	343.6	58.4	244.7	70.4	4.5	96.4
Fair value (gains)/losses of outstanding hedging instruments since January 1	(26.3)	(0.5)	12.0	(0.9)	13.5	0.6
Weighted average hedge rate for the year	1.20	1.38	1.15	0.10	0.11	—

As at December 31, 2020	EUR/USD	GBP/USD	GBP/EUR	SEK/EUR	SEK/USD	Other Currencies
	€m	€m	€m	€m	€m	€m
Derivative financial instruments - forward currency contracts
Carrying amount of asset/(liability)	(21.9)	(3.7)	1.4	(4.0)	(2.6)	(0.5)
Notional amount	249.0	53.5	159.0	77.3	14.1	16.8
Fair value (gains)/losses of outstanding hedging instruments since January 1	(20.6)	(2.0)	8.5	(4.2)	(2.2)	0.8
Weighted average hedge rate for the year	1.13	1.28	1.12	0.09	0.10	0.21

Financial instruments

Categories of financial instruments

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2021	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	201.6	—	—	—	—	201.6
Derivative financial instruments	—	—	0.5	19.7	—	20.2
Cash and cash equivalents	254.2	—	—	—	—	254.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(647.1)	(647.1)
Derivative financial instruments	—	—	(0.1)	(28.0)	—	(28.1)
Loans and borrowings (1)	—	—	—	—	(2,236.8)	(2,236.8)
Total	455.8	—	0.4	(8.3)	(2,883.9)	(2,436.0)

(1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2020	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	141.2	—	—	—	—	141.2
Derivative financial instruments	—	—	2.9	19.8	—	22.7
Cash and cash equivalents	393.2	—	—	—	—	393.2
Short - term investments	—	25.0	—	—	—	25.0
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(601.1)	(601.1)
Derivative financial instruments	—	—	(0.2)	(124.8)	—	(125.0)
Loans and borrowings (2)	—	—	—	—	(1,765.7)	(1,765.7)
Total	534.4	25.0	2.7	(105.0)	(2,366.8)	(1,909.7)

(2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21.

Fair values

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values.

Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange.

Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. 

Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for non binding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed.

While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company.

(i)Derivative financial instruments

Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’.

(ii)Trade and other payables/receivables

The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash.

(iii)Cash and cash equivalents

The carrying value of cash and cash equivalents is deemed to equal fair value.

(iv)Short-term investments

Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. The Company has classified these as level 2 instruments as defined in IFRS 13 “Fair value measurement”.

(v)Interest bearing loans and liabilities

The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities.

On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028 (the “Notes”). Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Notes, eligible transaction costs of approximately €4.0 million were capitalized and will be amortized over the life of the debt.

On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75.

On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of approximately €3.8 million were capitalized and will be amortized over the life of the debt.

Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum and that includes a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions.

The Company continues to have outstanding senior USD loans as at December 31, 2021 of $916.4 million (€808.6 million) (the “Senior USD Loan”). The Senior USD Loan is repayable in May 2024. The Senior USD Loan requires a repayment of $9.6 million (€8.5 million) in May each year until maturity equivalent to 1.0% of the original issued notional.

Furthermore as part of the senior loan structure, the Company is additionally required to undertake an annual excess cash flow calculation whereby additional principal could be paid.

The Company uses cross currency interest rate swaps (“CCIRS”) to convert its $916.4 million of floating rate Senior USD Loans into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge.

On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior Secured USD Term Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction is considered to be a substantial modification of the hedging instruments, so is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that have previously been used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 10. The cash flow hedge reserve related to the previous hedge relationship will be released on a straight line basis until May 2022.

The senior loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries.

	Fair value		Carrying value
	December 31, 2021	December 31, 2020	December 31, 2021	December 31, 2020
	€m	€m	€m	€m
Senior EUR/USD loans	1,360.8	1,300.4	1,355.8	1,295.1
Other external debt	0.1	0.2	0.1	0.2
2024 fixed rate senior secured notes	—	405.8	—	400.0
2028 fixed rate senior secured notes	802.6	—	800.0	—
Less deferred borrowing costs	—	—	(9.4)	(6.9)
	2,163.5	1,706.4	2,146.5	1,688.4

Derivatives

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Cross Currency Interest Rate Swaps	—	17.2
Forward foreign exchange contracts	20.2	5.5
Total assets	20.2	22.7
Cross Currency Interest Rate Swaps	(20.6)	(89.5)
Forward foreign exchange contracts	(7.3)	(35.5)
Total liabilities	(27.9)	(125.0)
Total	(7.7)	(102.3)

Offsetting of derivatives

Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default.

The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements.

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2021	€m	€m	€m
Derivatives - assets	20.2	(10.8)	9.4
Derivatives - liabilities	(27.9)	10.8	(17.1)

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2020	€m	€m	€m
Derivatives - assets	22.7	(22.7)	—
Derivatives - liabilities	(125.0)	22.7	(102.3)

Disclosure of maturity analysis for derivative financial liabilities

The tables below show a maturity analysis of contractual undiscounted cash flows prepared using forward interest rates where applicable, showing items at the earliest date on which the Company could be required to pay the liability:

2021	2022	2023	2024	2025	2026	Over 5 years	Total
	€m	€m	€m	€m	€m	€m	€m
Borrowings-principal	8.5	8.5	791.7	—	—	1,353.2	2,161.9
Borrowings-interest	57.5	63.5	50.4	34.0	34.1	67.0	306.5
Forward contracts Sell	805.3	—	—	—	—	—	805.3
Forward contracts Buy	(818.0)	—	—	—	—	—	(818.0)
Cross Currency Interest Rate Swaps Pay	25.0	24.9	818.5	—	—	—	868.4
Cross Currency Interest Rate Swaps Receive	(30.8)	(38.0)	(808.0)	—	—	—	(876.8)
Lease Liabilities	23.1	18.2	11.2	7.3	5.6	25.2	90.6
Trade and other payables excluding non-financial liabilities	647.1	—	—	—	—	—	647.1
Total	717.7	77.1	863.8	41.3	39.7	1,445.4	3,185.0

2020	2021	2022	2023	2024	2025	Over 5 years	Total
	€m	€m	€m	€m	€m	€m	€m
Borrowings-principal	7.8	7.8	7.8	1,683.1	—	—	1,706.5
Borrowings-interest	46.6	46.8	47.2	20.4	—	—	161.0
Forward contracts Sell	677.3	—	—	—	—	—	677.3
Forward contracts Buy	(647.5)	—	—	—	—	—	(647.5)
Cross Currency Interest Rate Swaps Pay	38.5	1,135.9	—	—	—	—	1,174.4
Cross Currency Interest Rate Swaps Receive	(34.6)	(1,059.0)	—	—	—	—	(1,093.6)
Lease Liabilities	17.2	13.6	9.9	6.2	5.2	28.1	80.2
Trade and other payables excluding non-financial liabilities	601.1	—	—	—	—	—	601.1
Total	706.4	145.1	64.9	1,709.7	5.2	28.1	2,659.4

Disclosure of maturity analysis for non-derivative financial liabilities

The tables below show a maturity analysis of contractual undiscounted cash flows prepared using forward interest rates where applicable, showing items at the earliest date on which the Company could be required to pay the liability:

2021	2022	2023	2024	2025	2026	Over 5 years	Total
	€m	€m	€m	€m	€m	€m	€m
Borrowings-principal	8.5	8.5	791.7	—	—	1,353.2	2,161.9
Borrowings-interest	57.5	63.5	50.4	34.0	34.1	67.0	306.5
Forward contracts Sell	805.3	—	—	—	—	—	805.3
Forward contracts Buy	(818.0)	—	—	—	—	—	(818.0)
Cross Currency Interest Rate Swaps Pay	25.0	24.9	818.5	—	—	—	868.4
Cross Currency Interest Rate Swaps Receive	(30.8)	(38.0)	(808.0)	—	—	—	(876.8)
Lease Liabilities	23.1	18.2	11.2	7.3	5.6	25.2	90.6
Trade and other payables excluding non-financial liabilities	647.1	—	—	—	—	—	647.1
Total	717.7	77.1	863.8	41.3	39.7	1,445.4	3,185.0

2020	2021	2022	2023	2024	2025	Over 5 years	Total
	€m	€m	€m	€m	€m	€m	€m
Borrowings-principal	7.8	7.8	7.8	1,683.1	—	—	1,706.5
Borrowings-interest	46.6	46.8	47.2	20.4	—	—	161.0
Forward contracts Sell	677.3	—	—	—	—	—	677.3
Forward contracts Buy	(647.5)	—	—	—	—	—	(647.5)
Cross Currency Interest Rate Swaps Pay	38.5	1,135.9	—	—	—	—	1,174.4
Cross Currency Interest Rate Swaps Receive	(34.6)	(1,059.0)	—	—	—	—	(1,093.6)
Lease Liabilities	17.2	13.6	9.9	6.2	5.2	28.1	80.2
Trade and other payables excluding non-financial liabilities	601.1	—	—	—	—	—	601.1
Total	706.4	145.1	64.9	1,709.7	5.2	28.1	2,659.4

XML

Financial instruments (Tables)

12 Months Ended

Dec. 31, 2021

Financial Instruments [Abstract]

Disclosure of financial instruments

The effects of the cash flow hedging instruments on the Company's financial position and performance are as follows:

All amounts stated in €m, unless otherwise stated	December 31, 2021	December 31, 2020
USD - cross currency interest rate swaps
Carrying amount of liability	(20.6)	(89.5)
Notional amount (USD)	$916.4	$926.0
Maturity date	5/15/2024	5/15/2022
Change in fair value of outstanding hedging instruments since January 1	68.9	(71.0)
(Gain)/loss in value of hedged item used to determine effectiveness	(69.6)	71.0
Weighted average hedged rate for the year	1.11	1.11

The effects of the net investment hedging instruments on the Company's financial position and performance are as follows:

All amounts stated in €m, unless otherwise stated	December 31, 2021	December 31, 2020
UK cross-currency interest rate swaps hedge
Carrying amount of cross-currency interest rate swaps	—	14.3
Notional amount (GBP)	—	£220.2
Maturity date	7/29/2021	5/15/2022
Change in fair value of cross-currency interest rate swaps as a result of foreign currency movements since January 1	(12.9)	13.5
Loss/(gain) in value of hedged item used to determine hedge effectiveness	12.9	(13.5)
Weighted average hedged rate for the year	1.19	1.19

position and performance are as follows:

As at December 31, 2021	EUR/USD	GBP/USD	GBP/EUR	SEK/EUR	SEK/USD	Other Currencies
	€m	€m	€m	€m	€m	€m
Derivative financial instruments - forward currency contracts
Carrying amount of (liability)/asset	17.5	1.2	(6.7)	0.5	0.1	0.3
Notional amount	343.6	58.4	244.7	70.4	4.5	96.4
Fair value (gains)/losses of outstanding hedging instruments since January 1	(26.3)	(0.5)	12.0	(0.9)	13.5	0.6
Weighted average hedge rate for the year	1.20	1.38	1.15	0.10	0.11	—

As at December 31, 2020	EUR/USD	GBP/USD	GBP/EUR	SEK/EUR	SEK/USD	Other Currencies
	€m	€m	€m	€m	€m	€m
Derivative financial instruments - forward currency contracts
Carrying amount of asset/(liability)	(21.9)	(3.7)	1.4	(4.0)	(2.6)	(0.5)
Notional amount	249.0	53.5	159.0	77.3	14.1	16.8
Fair value (gains)/losses of outstanding hedging instruments since January 1	(20.6)	(2.0)	8.5	(4.2)	(2.2)	0.8
Weighted average hedge rate for the year	1.13	1.28	1.12	0.09	0.10	0.21

Financial instruments

Categories of financial instruments

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2021	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	201.6	—	—	—	—	201.6
Derivative financial instruments	—	—	0.5	19.7	—	20.2
Cash and cash equivalents	254.2	—	—	—	—	254.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(647.1)	(647.1)
Derivative financial instruments	—	—	(0.1)	(28.0)	—	(28.1)
Loans and borrowings (1)	—	—	—	—	(2,236.8)	(2,236.8)
Total	455.8	—	0.4	(8.3)	(2,883.9)	(2,436.0)

(1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2020	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	141.2	—	—	—	—	141.2
Derivative financial instruments	—	—	2.9	19.8	—	22.7
Cash and cash equivalents	393.2	—	—	—	—	393.2
Short - term investments	—	25.0	—	—	—	25.0
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(601.1)	(601.1)
Derivative financial instruments	—	—	(0.2)	(124.8)	—	(125.0)
Loans and borrowings (2)	—	—	—	—	(1,765.7)	(1,765.7)
Total	534.4	25.0	2.7	(105.0)	(2,366.8)	(1,909.7)

(2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21.

Fair values

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values.

Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange.

Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. 

Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for non binding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed.

While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company.

(i)Derivative financial instruments

Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’.

(ii)Trade and other payables/receivables

The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash.

(iii)Cash and cash equivalents

The carrying value of cash and cash equivalents is deemed to equal fair value.

(iv)Short-term investments

Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. The Company has classified these as level 2 instruments as defined in IFRS 13 “Fair value measurement”.

(v)Interest bearing loans and liabilities

The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities.

On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028 (the “Notes”). Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Notes, eligible transaction costs of approximately €4.0 million were capitalized and will be amortized over the life of the debt.

On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75.

On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of approximately €3.8 million were capitalized and will be amortized over the life of the debt.

Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum and that includes a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions.

The Company continues to have outstanding senior USD loans as at December 31, 2021 of $916.4 million (€808.6 million) (the “Senior USD Loan”). The Senior USD Loan is repayable in May 2024. The Senior USD Loan requires a repayment of $9.6 million (€8.5 million) in May each year until maturity equivalent to 1.0% of the original issued notional.

Furthermore as part of the senior loan structure, the Company is additionally required to undertake an annual excess cash flow calculation whereby additional principal could be paid.

The Company uses cross currency interest rate swaps (“CCIRS”) to convert its $916.4 million of floating rate Senior USD Loans into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge.

On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior Secured USD Term Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction is considered to be a substantial modification of the hedging instruments, so is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that have previously been used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 10. The cash flow hedge reserve related to the previous hedge relationship will be released on a straight line basis until May 2022.

The senior loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries.

	Fair value		Carrying value
	December 31, 2021	December 31, 2020	December 31, 2021	December 31, 2020
	€m	€m	€m	€m
Senior EUR/USD loans	1,360.8	1,300.4	1,355.8	1,295.1
Other external debt	0.1	0.2	0.1	0.2
2024 fixed rate senior secured notes	—	405.8	—	400.0
2028 fixed rate senior secured notes	802.6	—	800.0	—
Less deferred borrowing costs	—	—	(9.4)	(6.9)
	2,163.5	1,706.4	2,146.5	1,688.4

Derivatives

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Cross Currency Interest Rate Swaps	—	17.2
Forward foreign exchange contracts	20.2	5.5
Total assets	20.2	22.7
Cross Currency Interest Rate Swaps	(20.6)	(89.5)
Forward foreign exchange contracts	(7.3)	(35.5)
Total liabilities	(27.9)	(125.0)
Total	(7.7)	(102.3)

Offsetting of derivatives

Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default.

The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements.

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2021	€m	€m	€m
Derivatives - assets	20.2	(10.8)	9.4
Derivatives - liabilities	(27.9)	10.8	(17.1)

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2020	€m	€m	€m
Derivatives - assets	22.7	(22.7)	—
Derivatives - liabilities	(125.0)	22.7	(102.3)

Disclosure of Financial Assets

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2021	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	201.6	—	—	—	—	201.6
Derivative financial instruments	—	—	0.5	19.7	—	20.2
Cash and cash equivalents	254.2	—	—	—	—	254.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(647.1)	(647.1)
Derivative financial instruments	—	—	(0.1)	(28.0)	—	(28.1)
Loans and borrowings (1)	—	—	—	—	(2,236.8)	(2,236.8)
Total	455.8	—	0.4	(8.3)	(2,883.9)	(2,436.0)

(1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2020	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	141.2	—	—	—	—	141.2
Derivative financial instruments	—	—	2.9	19.8	—	22.7
Cash and cash equivalents	393.2	—	—	—	—	393.2
Short - term investments	—	25.0	—	—	—	25.0
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(601.1)	(601.1)
Derivative financial instruments	—	—	(0.2)	(124.8)	—	(125.0)
Loans and borrowings (2)	—	—	—	—	(1,765.7)	(1,765.7)
Total	534.4	25.0	2.7	(105.0)	(2,366.8)	(1,909.7)

(2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21.

Disclosure of Financial Liabilities

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2021	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	201.6	—	—	—	—	201.6
Derivative financial instruments	—	—	0.5	19.7	—	20.2
Cash and cash equivalents	254.2	—	—	—	—	254.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(647.1)	(647.1)
Derivative financial instruments	—	—	(0.1)	(28.0)	—	(28.1)
Loans and borrowings (1)	—	—	—	—	(2,236.8)	(2,236.8)
Total	455.8	—	0.4	(8.3)	(2,883.9)	(2,436.0)

(1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21.

	Financial assets at amortized cost	Financial Assets at Fair Value through profit or loss	Derivatives at fair value through profit or loss	Derivatives designated in hedge relationships	Financial liabilities at amortized cost	Total
2020	€m	€m	€m	€m	€m	€m
Assets
Trade and other receivables	141.2	—	—	—	—	141.2
Derivative financial instruments	—	—	2.9	19.8	—	22.7
Cash and cash equivalents	393.2	—	—	—	—	393.2
Short - term investments	—	25.0	—	—	—	25.0
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—	(601.1)	(601.1)
Derivative financial instruments	—	—	(0.2)	(124.8)	—	(125.0)
Loans and borrowings (2)	—	—	—	—	(1,765.7)	(1,765.7)
Total	534.4	25.0	2.7	(105.0)	(2,366.8)	(1,909.7)

(2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21.

	Fair value		Carrying value
	December 31, 2021	December 31, 2020	December 31, 2021	December 31, 2020
	€m	€m	€m	€m
Senior EUR/USD loans	1,360.8	1,300.4	1,355.8	1,295.1
Other external debt	0.1	0.2	0.1	0.2
2024 fixed rate senior secured notes	—	405.8	—	400.0
2028 fixed rate senior secured notes	802.6	—	800.0	—
Less deferred borrowing costs	—	—	(9.4)	(6.9)
	2,163.5	1,706.4	2,146.5	1,688.4

Disclosure of Derivatives

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Cross Currency Interest Rate Swaps	—	17.2
Forward foreign exchange contracts	20.2	5.5
Total assets	20.2	22.7
Cross Currency Interest Rate Swaps	(20.6)	(89.5)
Forward foreign exchange contracts	(7.3)	(35.5)
Total liabilities	(27.9)	(125.0)
Total	(7.7)	(102.3)

Disclosure of offsetting of financial assets and financial liabilities [text block]

The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements.

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2021	€m	€m	€m
Derivatives - assets	20.2	(10.8)	9.4
Derivatives - liabilities	(27.9)	10.8	(17.1)

	Gross amount of financial instruments as presented upon balance sheet	Related financial instruments that are offset	Net amount
As at Dec 31, 2020	€m	€m	€m
Derivatives - assets	22.7	(22.7)	—
Derivatives - liabilities	(125.0)	22.7	(102.3)

XML

Commitments (Tables)

12 Months Ended

Dec. 31, 2021

Leases1 [Abstract]

Future Aggregate Minimum Lease Payments for non-cancellable Service agreements and low value or short-lived Lease Rentals

on-cancellable service agreements and lease rentals for short-lived and low-value assets are payable as follows:

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Less than one year	2.2	1.9
Between one and three years	4.1	3.5
Between three and five years	2.2	2.0
More than five years	0.2	0.1
Total	8.7	7.5

XML

Capital commitments (Tables)

12 Months Ended

Dec. 31, 2021

Additional information [abstract]

Schedule of capital commitments

Capital expenditure contracted for at the end of the reporting period but not yet incurred is as follows:

	As at December 31, 2021	As at December 31, 2020
	€m	€m
Property, plant and equipment	21.3	13.6
Intangible assets	1.7	3.4
Total	23.0	17.0

XML

Impact of adoption of IFRS 9 for hedge accounting (Details) - EUR (€) € in Millions	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of initial application of standards or interpretations [line items]
Reserve of cash flow hedges	€ 10.5	€ (21.7)	€ (24.5)	€ (13.2)	€ 8.5
Reserve of change in value of forward elements of forward contracts		(4.4)	0.0
Other reserves		(26.1)	(24.5)
Translation reserve	€ 105.1	86.3	€ 84.7
Increase (decrease) due to changes in accounting policy [member]
Disclosure of initial application of standards or interpretations [line items]
Reserve of cash flow hedges		2.8
Reserve of change in value of forward elements of forward contracts		(4.4)
Other reserves		(1.6)
Translation reserve		€ 1.6

XML

Basis of preparation Impact of change in accounting standard IFRS16 (Details) - EUR (€) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of initial application of standards or interpretations [line items]
Disclosure of maturity analysis ofcommitments [text block]	8.7	7.5
Property, plant and equipment	€ 489.2	€ 373.2	€ 350.0
Other provisions	42.2	51.8	46.8
Retained earnings	387.4	191.6
Profit (loss) before tax	236.7	295.5	210.3
Depreciation, right-of-use assets	€ 16.6	€ 15.7	€ 16.1
Impact on Earnings per share	€ 1.02	€ 1.16	€ 0.80
Loans and borrowings	€ 2,198.3	€ 1,736.3
Current	39.3	45.7
Provisions	2.9	6.1
Trade and other payables	693.8	€ 649.4
Deferred hedging gains transferred to the carrying value of inventory	€ 27.6

XML

Basis of preparation (Details) - EUR (€) € in Millions	Dec. 31, 2021	Jun. 24, 2021	Dec. 31, 2020
Revolving Credit Facility (new)
Disclosure of initial application of standards or interpretations [line items]
Line of credit facility, maximum borrowing capacity		€ 175.0
Revolving Credit Facility (existing - replaced)
Disclosure of initial application of standards or interpretations [line items]
Line of credit facility, maximum borrowing capacity			€ 80.0
Senior USD Debt
Disclosure of initial application of standards or interpretations [line items]
Interest rate	2.25%

XML

Accounting policies (Details) € in Millions	12 Months Ended
	Dec. 31, 2021 EUR (€) segment	Dec. 31, 2020 EUR (€)	Jun. 01, 2015 EUR (€)
Disclosure of detailed information about property, plant and equipment [line items]
Trade receivables	€ 372.7	€ 341.7
Founder Preferred Shares Dividend Reserve	€ 166.0	245.5	€ 531.5
Number of operating segments | segment	1
Cost
Disclosure of detailed information about property, plant and equipment [line items]
Trade receivables	€ 376.3	€ 346.1
Buildings
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	40 years
Plant and equipment | Bottom of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	5 years
Plant and equipment | Top of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	14 years
Computer equipment | Bottom of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	3 years
Computer equipment | Top of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	5 years
Computer software | Bottom of range
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	5 years
Computer software | Top of range
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	10 years
Brands
Disclosure of detailed information about intangible assets [line items]
Years established	20 years
Customer relationships
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	14 years

XML

Accounting policies IFRS 16 disclosure (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure changes in accounting policy IFRS 16 [Line Items]
Right-of-use assets	€ 60.2	€ 49.0
Other provisions	42.2	51.8	€ 46.8
Increase (decrease) in accounting estimate	€ 236.7	€ 295.5	€ 210.3

XML

Segment reporting - Additional Information (Details) € in Millions	12 Months Ended
	Dec. 31, 2021 EUR (€) segment	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 EUR (€)
Operating Segments [Abstract]
Number of operating segments | segment	1
adjustments for share based payments including employer tax	€ 5.8	€ 12.1	€ 22.4
Adjustments for acquisition related costs	€ 12.9	€ 7.3	€ 3.3

XML

Segment reporting - Segment as Adjusted EBITDA (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of operating segments [line items]
Profit (loss)	€ 181.0	€ 225.1	€ 153.6
Profit (loss), attributable to owners of parent	181.0	225.2	154.0
adjustments for share based payments including employer tax	5.8	12.1	22.4
Taxation	55.7	70.4	56.7
Net financing costs	106.0	63.7	73.2
Depreciation and amortization	71.6	67.6	68.3
Exceptional items	45.3	20.6	54.5
Other add-backs			25.7
Material reconciling items
Disclosure of operating segments [line items]
Acquisition purchase price adjustments	8.4	0.0	0.0
Exceptional items	45.3	20.6	54.5
Other add-backs	18.7	19.4
Adjusted EBITDA	€ 486.7	€ 466.8	€ 432.0

XML

Segment reporting - Geographical information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of geographical areas [line items]
Revenue	€ 2,606.6	€ 2,515.9	€ 2,324.3
Non-current assets	598.8	479.2
Revenue	2,606.6	2,515.9	2,324.3
United Kingdom
Disclosure of geographical areas [line items]
Revenue	758.3	747.3	712.5
Non-current assets	139.6	132.1
Revenue	758.3	747.3	712.5
Italy
Disclosure of geographical areas [line items]
Revenue	417.9	426.3	394.1
Non-current assets	64.8	68.5
Revenue	417.9	426.3	394.1
Germany
Disclosure of geographical areas [line items]
Revenue	396.3	393.2	329.6
Non-current assets	140.0	135.5
Revenue	396.3	393.2	329.6
FRANCE
Disclosure of geographical areas [line items]
Revenue	188.6	203.8	176.6
Revenue	188.6	203.8	176.6
SWEDEN
Disclosure of geographical areas [line items]
Revenue	148.1	158.7	175.7
Non-current assets	29.8	28.5
Revenue	148.1	158.7	175.7
Austria
Disclosure of geographical areas [line items]
Revenue	129.3	127.9	108.2
Revenue	129.3	127.9	108.2
NORWAY
Disclosure of geographical areas [line items]
Revenue	121.7	115.6	120.4
Non-current assets	31.0	30.0
Revenue	121.7	115.6	120.4
Spain
Disclosure of geographical areas [line items]
Revenue	75.1	82.6	79.5
Revenue	75.1	82.6	79.5
Rest of Europe
Disclosure of geographical areas [line items]
Revenue	371.3	260.5	227.7
Non-current assets	72.3	52.7
Revenue	371.3	260.5	€ 227.7
SERBIA
Disclosure of geographical areas [line items]
Non-current assets	48.5	0.0
CROATIA
Disclosure of geographical areas [line items]
Non-current assets	38.5	0.0
IRELAND
Disclosure of geographical areas [line items]
Non-current assets	€ 34.3	€ 31.9

XML

Operating profit/(loss) (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Analysis of income and expense [abstract]
Staff costs	€ 340.6	€ 340.2	€ 308.6
Depreciation of property, plant and equipment	63.4	59.8	59.7
Impairment of property, plant and equipment	0.0	0.0	0.1
Impairment loss recognised in profit or loss, intangible assets and goodwill	1.7	0.0	0.0
Amortization of software and brands	8.2	7.8	8.6
Operating lease charges	6.1	3.0	4.5
Exchange losses/(gains)	27.0	(2.8)	(14.6)
Research & development expenditure	19.2	17.6	18.9
Inventories recognized as an expense within cost of goods sold	€ 1,694.3	€ 1,627.9	€ 1,536.0

XML

Exceptional items (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Unusual Or Infrequent Item1 [Line Items]
Expenses From Supply Chain Reconfiguration, Restructuring Activities	€ 0.0	€ (12.5)	€ (3.6)
Findus Group integration costs	0.0	0.0	3.5
Findus Switzerland integration costs	6.2	0.3	0.0
Brexit costs	5.3	1.6	1.6
Business Transformation Program	18.8	2.3	0.0
Information Technology Transformation Program	4.2	0.0	0.0
Goodfella's Pizza and Aunt Bessie's Integration Related Costs	0.0	4.0	12.5
Factory Optimization	4.9	10.0	5.7
Settlement of legacy matters	(2.6)	(2.9)	(9.2)
Remeasurement of indemnification assets	5.0	17.8	44.0
Adjustments For Exceptional Items	45.3	20.6	54.5
Fortenova Group Integration Costs	€ 3.5	€ 0.0	€ 0.0

XML

Exceptional items - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Analysis Of Income And Expense [Line Items]
Restructuring activities charges	€ 0.0	€ 12.5	€ 3.6
Integration costs	0.0	0.0	3.5
Income (charge) related to legacy matters	2.6	2.9	9.2
Contingent Consideration Arrangements And Indemnification Assets Recognised As Of Acquisition Date, Release of Provision	5.9	20.0
Gain from reassessment of sales tax provision			0.7
Tax impact of exceptional items	8.4	3.5	3.1
Cash flows used relating to exceptional items	48.8	12.1	15.9
Goodfella's Pizza and Aunt Bessie's Integration Related Costs	0.0	4.0	12.5
Factory Optimization	€ 4.9	€ 10.0	5.7
La Cocinera [Member]
Analysis Of Income And Expense [Line Items]
Contingent Consideration Arrangements And Indemnification Assets Recognised As Of Acquisition Date, Release of Provision			€ 2.7

XML

Payroll costs, share based payments and management incentive schemes - Information About the Number of Persons Employed by the Company (Details) - employee	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Employee Information [Line Items]
Average number of employees	5,503	4,690	4,756
Production
Employee Information [Line Items]
Average number of employees	3,310	3,043	3,308
Administration, distribution & sales
Employee Information [Line Items]
Average number of employees	2,193	1,647	1,448

XML

Payroll costs, share based payments and management incentive schemes - Number of Persons Employed by the Company (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Employee Benefits And Share-Based Payments [Abstract]
Wages and salaries	€ 266.4	€ 276.4	€ 250.4
Social security costs	56.1	49.2	45.2
Other pension costs	18.1	14.6	13.0
Total payroll costs	€ 340.6	€ 340.2	€ 308.6

XML

Payroll costs, share based payments and management incentive schemes - Non Executive Director Restricted Share Awards (Details)							1 Months Ended		12 Months Ended
	Jun. 30, 2021 EUR (€) shares	Jun. 30, 2021 $ / shares	Jun. 17, 2020 shares $ / shares	Jun. 14, 2019 EUR (€) shares	Jun. 14, 2019 $ / shares	Jun. 19, 2018 shares $ / shares	May 31, 2020 shares	Jul. 31, 2019 shares	Dec. 31, 2021 EUR (€) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 EUR (€) shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share based payment charge | €									€ 5,100,000		€ 9,000,000.0	€ 14,900,000
Share based compensation reserve
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share based payment charge | €									€ 5,100,000		9,000,000.0	14,900,000
Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
New awards granted in the period									820,202	820,202
Number of equity instruments exercised (in shares)									1,861,826	1,861,826
Non-Executive Director
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Expense from share-based payment transactions with employees | €									€ 800,000		€ 700,000	€ 900,000
Non-Executive Director | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of shares issued per director | $										$ 100,000
New awards granted in the period	24,759		32,140	39,370		32,172
Share price (in Dollars per share) | $ / shares		$ 30.14	$ 21.78		$ 20.74
Number of equity instruments exercised (in shares)	32,140		34,447	44,272			49,196	2,460				56,250
Reclassification of awards for settlement of tax liabilities	7,734		8,656	12,100
Exercise price (in dollars per share) | $ / shares		$ 28.27	$ 21.78		$ 20.32	$ 18.07
Non-Executive Director | Restricted Shares | Share based compensation reserve
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share based payment charge | €	€ 0.2			€ 100,000

XML

Payroll costs, share based payments and management incentive schemes - Director and Senior Management Share Awards (Details) - Restricted Shares - shares	1 Months Ended		12 Months Ended
	Jan. 31, 2020	Sep. 30, 2019	Dec. 31, 2021
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			3,178,400
New awards granted in the period			820,202
Awards vested and issued in the period			(1,861,826)
Forfeitures in the period			(119,921)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			2,016,855
January 1, 2016
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			1,041,953
New awards granted in the period			0
Awards vested and issued in the period			(1,041,953)
Forfeitures in the period			0
Number of other equity instruments outstanding in share-based payment arrangement at end of period			0
January 1, 2017
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			819,873
New awards granted in the period			0
Awards vested and issued in the period			(819,873)
Forfeitures in the period			0
Number of other equity instruments outstanding in share-based payment arrangement at end of period			0
January 1, 2018
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			446,575
New awards granted in the period			0
Awards vested and issued in the period			0
Forfeitures in the period			(14,785)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			431,790
January 1, 2019
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			159,561
New awards granted in the period		166,427	0
Awards vested and issued in the period			0
Forfeitures in the period			(6,866)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			152,695
January 1, 2020
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			710,438
New awards granted in the period	761,979		0
Awards vested and issued in the period			0
Forfeitures in the period			(65,345)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			645,093
january 1, 2021
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			0
New awards granted in the period			820,202
Awards vested and issued in the period			0
Forfeitures in the period			(32,925)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			787,277

XML

Payroll costs, share based payments and management incentive schemes - Director and Senior Management Share Awards Narrative (Details) € in Millions	1 Months Ended							12 Months Ended
	Feb. 28, 2021 shares	Jan. 31, 2021 shares	Sep. 30, 2020 shares	Feb. 29, 2020 shares	Jan. 31, 2020 shares	Sep. 30, 2019 shares	Jan. 31, 2019 shares	Dec. 31, 2021 EUR (€) shares	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 EUR (€)	Dec. 31, 2021 shares $ / shares	Feb. 01, 2021 $ / shares	Jan. 30, 2021 $ / shares	Jan. 01, 2021 $ / shares	Dec. 31, 2020 shares $ / shares	Sep. 01, 2020 $ / shares	Aug. 01, 2020 $ / shares	Feb. 01, 2020 $ / shares	Jan. 01, 2020 $ / shares
EBITDA
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period								3 years
Vesting period								3 years
Share price performance
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period								3 years
Vesting period								3 years
Cumulative net sales
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period								3 years
Vesting period								3 years
Ordinary shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share price (in Dollars per share) | $ / shares											$ 24.50		$ 25.29		$ 21.04		$ 25.50
Management Award 2018 | EBITDA
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period								4 years
Vesting period								4 years
Management Award 2018 | Share price performance
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period								3 years		2 years
Vesting period								3 years		2 years
Management Award 2018 | Share price performance | Bottom of range
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period								2 years
Vesting period								2 years
Management Award 2018 | Share price performance | Top of range
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period								5 years
Vesting period								5 years
Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments outstanding in share-based payment arrangement (in shares)											2,016,855				3,178,400
New awards granted in the period								820,202
Number of equity instruments exercised (in shares)								1,861,826
Restricted Shares | Key management personnel
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Expense from share-based payment transactions with employees | €								€ 4.3	€ 8.3	€ 14.0
Restricted Shares | Management Award 2017
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments exercised (in shares)	451,719	368,154					85,315
Reclassification of awards for settlement of tax liabilities	180,268	150,926					33,383
Share price (in Dollars per share) | $ / shares												$ 25.89		$ 25.42
Restricted Shares | Management Award 2017 | Ordinary shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments exercised (in shares)	271,451	217,228					51,932
Restricted Shares | Management Award 2016
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments exercised (in shares)		1,041,953		1,626,006	284,555
Reclassification of awards for settlement of tax liabilities		454,320		697,964	120,739
Share price (in Dollars per share) | $ / shares														$ 25.42				$ 19.53	$ 22.37
Restricted Shares | Management Award 2016 | Ordinary shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments exercised (in shares)		587,633		928,042	163,816
Restricted Shares | Management Award 2018
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments exercised (in shares)			42,825
Reclassification of awards for settlement of tax liabilities			17,170
Share price (in Dollars per share) | $ / shares																$ 25.30
Restricted Shares | Management Award 2018 | Ordinary shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments exercised (in shares)			25,655
January 1, 2016 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments outstanding in share-based payment arrangement (in shares)											0				1,041,953
New awards granted in the period								0
Number of equity instruments exercised (in shares)								1,041,953
January 1, 2017 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments outstanding in share-based payment arrangement (in shares)											0				819,873
New awards granted in the period								0
Number of equity instruments exercised (in shares)								819,873
January 1, 2019 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments outstanding in share-based payment arrangement (in shares)											152,695				159,561
New awards granted in the period						166,427		0
Number of equity instruments exercised (in shares)								0
January 1, 2020 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of equity instruments outstanding in share-based payment arrangement (in shares)											645,093				710,438
New awards granted in the period					761,979			0
Number of equity instruments exercised (in shares)								0

XML

Payroll costs, share based payments and management incentive schemes - Inputs and Assumptions Underlying the Monte Carlo Model (Details) $ / shares in Units, € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021 $ / shares	Dec. 31, 2020	Jan. 01, 2021 USD ($)	Jan. 01, 2021 EUR (€)	Jan. 01, 2020 USD ($)	Jan. 01, 2020 EUR (€)	Jan. 01, 2019 USD ($)	Jan. 01, 2019 EUR (€)	Jan. 01, 2018 USD ($)	Jan. 01, 2018 EUR (€)
Disclosure of terms and conditions of share-based payment arrangement [line items]
FV of equity instruments			$ 7.0	€ 5.8	$ 4.8	€ 4.3	$ 1.4	€ 1.2	$ 1.6	€ 1.3
January 1, 2018 | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in Dollar per share)	$ 16.72
Exercise price (in Dollar per share)	$ 0
Expected volatility of the share price	22.70%
Dividend yield expected	0.00%
Risk free rate	2.55%
Employee exit rate	14.00%
EBITDA Performance Target Condition	35.00%
January 1, 2018 | Minimum | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share	1 year 6 months
January 1, 2018 | Top of range | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share	4 years
January 1, 2019 | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in Dollar per share)	$ 20.15
Exercise price (in Dollar per share)	$ 0
Expected life of restricted share	4 years
Expected volatility of the share price	24.00%
Dividend yield expected	0.00%
Risk free rate	1.33%
Employee exit rate	14.00%
EBITDA Performance Target Condition	35.00%
January 1, 2020 | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in Dollar per share)	$ 22.37
Exercise price (in Dollar per share)	$ 0
Expected volatility of the share price	24.40%
Dividend yield expected	0.00%
Risk free rate	1.70%
Employee exit rate	27.30%
EBITDA Performance Target Condition	35.00%
january 1, 2021 | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in Dollar per share)	$ 25.42
Exercise price (in Dollar per share)	$ 0
Expected life of restricted share	3 years	3 years
Expected volatility of the share price	30.00%
Dividend yield expected	0.00%
Risk free rate	0.24%
Employee exit rate	14.00%
EBITDA Performance Target Condition	35.00%

XML

Payroll costs, share based payments and management incentive schemes - Initial Options (Details) € in Millions				1 Months Ended		12 Months Ended
	Jun. 30, 2021 shares	Jun. 17, 2020 shares	Jun. 14, 2019 shares	May 31, 2020 EUR (€) shares	Jul. 31, 2019 shares	Dec. 31, 2021 shares	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 EUR (€) shares	Dec. 31, 2014 $ / shares shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of shares reserved for issue under options and contracts for sale of shares (in shares) | shares									125,000
Vesting of Non-Executive Restricted Stock award | €							€ 0.0	€ (0.8)
Initial options exercise cost | €								€ 0.6
Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of equity instruments exercised (in shares) | shares						1,861,826
Non-Executive Director | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of equity instruments exercised (in shares) | shares	32,140	34,447	44,272	49,196	2,460			56,250
Initial options exercise cost | €				€ 0.6
Ordinary shares | Non-Executive Director
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exercise price of share options granted (in Dollar per share) | $ / shares									$ 11.50

XML

Directors and Key Management compensation (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Related Party [Abstract]
Short-term employee benefits	€ 2.2	€ 3.9	€ 2.8
Share-based payment expense	2.4	3.5	7.6
Non-Executive Director fees	0.3	0.3	0.4
Total Directors' and executive officers' compensation	€ 4.9	€ 7.7	€ 10.8

XML

Directors and Key Management compensation - Additional Information (Details)	12 Months Ended
	Dec. 31, 2021 director executive_officer	Dec. 31, 2020 director executive_officer	Dec. 31, 2019 director executive_officer
Related Party [Abstract]
Number of Members of Key Management Accruing Benefits Under Money Purchase Schemes | director	2	2	2
Number of executive Officers accruing benefits under share-based payment schemes | executive_officer	2	2	2

XML

Finance income and costs (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Analysis of income and expense [abstract]
Interest income	€ 0.1	€ 0.7	€ 2.5
Net foreign exchange gains on translation of financial assets and liabilities	0.0	4.0	0.0
Finance income	0.1	4.7	2.5
Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss (a)	(59.8)	(64.0)	(79.0)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity	1.6	5.9	21.8
Impairment loss recognised in profit or loss, loans and advances	(8.6)	0.0	0.0
Net pension interest costs	(1.7)	(2.7)	(3.8)
Amortization of borrowing costs	(2.0)	(2.0)	(2.0)
Net foreign exchange losses on translation of financial assets and liabilities	(4.0)	0.0	(3.9)
Net fair value losses on derivatives held at fair value through profit or loss (b)	(13.7)	(5.6)	(8.8)
Financing costs incurred in amendment of terms of debt	17.9	0.0	0.0
Finance costs	(106.1)	(68.4)	(75.7)
Net finance costs	(106.0)	€ (63.7)	€ (73.2)
Non-cash loss recognized in relation to cross currency interest rate swaps	7.8
Disclosure of attribution of expenses by nature to their function [line items]
Gains (Losses) on Restructuring of previous debt	€ (10.1)

XML

Taxation - Components of Tax Expense (Income) (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Current tax on profits for the period	€ (117.5)	€ (44.8)	€ (66.4)
Adjustments in respect of prior periods	0.6	(7.6)	0.0
Total current tax expense and adjustments	(116.9)	(52.4)	(66.4)
Origination and reversal of temporary differences	116.3	(1.2)	9.7
Impact of change in tax rates	(55.1)	(16.8)	0.0
Total deferred tax expense and adjustments	61.2	(18.0)	9.7
Total tax expense	€ (55.7)	€ (70.4)	€ (56.7)

XML

Taxation - Reconciliation of Effective Tax Rate (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Profit (loss) before tax	€ 236.7	€ 295.5	€ 210.3
Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%)	(45.0)	(56.1)	(39.9)
Difference in tax rates	22.7	(18.2)	(11.9)
Non tax deductible interest	0.1	(0.1)	0.6
Other income and expenses not taxable or deductible	2.5	(0.8)	(1.2)
Unrecognized tax assets	(1.5)	(6.3)	(0.9)
Provisions for uncertainties	(52.5)	35.5	(3.4)
Impact of change in tax rates	(55.1)	(16.8)	0.0
Change in tax base of assets due to step-up	(72.5)	0.0	0.0
Prior period adjustment	0.6	(7.6)	0.0
Total tax expense	€ (55.7)	€ (70.4)	€ (56.7)
Standard tax rate	19.00%	19.00%	19.00%
Current tax payable	€ 198.5	€ 166.2
Deferred tax assets	128.3	113.5
Provisions for tax uncertainties	€ 163.4	€ 103.9
Effective tax rate	23.50%	23.80%

XML

Taxation - Tax charge/(credit) Relating To Components Of Other Comprehensive Income (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Remeasurement of post-employment benefit liabilities, before tax	€ (36.1)	€ 27.8	€ 35.9
Remeasurement of post-employment benefit liabilities, tax charge/(credit)	10.2	(8.3)	(6.7)
Remeasurement of post-employment benefit liabilities, after tax	(25.9)	19.5	29.2
Net investment hedge, before tax	(18.8)	10.1	(6.0)
Net investment hedge, tax charge/(credit)	0.0	0.0	0.0
Net investment hedge, after tax	(18.8)	10.1	(6.0)
Cash flow hedges, before tax	(22.6)	17.3	27.3
Cash flow hedges, tax charge/(credit)	13.6	(6.0)	(5.6)
Cash flow hedges, after tax	(9.0)	11.3	21.7
Other comprehensive (income)/loss, before tax	(77.5)	55.2	57.2
Other comprehensive (income)/loss, tax charges/(credits)	23.8	(14.3)	(12.3)
Other comprehensive (income)/loss, after tax	(53.7)	40.9	44.9
Current and deferred tax relating to items charged or credited directly to equity [abstract]
Current tax	0.0	0.0	0.0
Deferred tax	23.8	(14.3)	(12.3)
Total current and deferred tax	€ 23.8	€ (14.3)	€ (12.3)
Standard tax rate	19.00%	19.00%	19.00%

XML

Property, plant and equipment (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about property, plant and equipment [line items]
Property, plant and equipment	€ 549.4	€ 422.2
Guarantor Group, Percentage Of Consolidated Gross Assets Or Adjusted EBITDA Individually Held	5.00%
Guarantor Group, Percentage Of Consolidated Gross Assets Or Adjusted EBITDA Held In Total	80.00%
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	€ 373.2	350.0
Acquisitions through business combinations	76.0
Depreciation	63.4	59.8	€ 59.7
Impairment loss recognised in profit or loss, property, plant and equipment	0.0	0.0	0.1
Impairment	0.0	0.0	(0.1)
Property, plant and equipment	489.2	373.2	350.0
Acquisitions through business combinations	76.0
Impairment loss recognised in profit or loss, property, plant and equipment	0.0	0.0	0.1
Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	556.7	501.9
Acquisitions through business combinations			8.6
Additions	81.1	63.5
Disposals	(6.0)	(3.0)
Effect of movements in foreign exchange	(22.8)	14.3
Disposals, property, plant and equipment	6.0	3.0
Property, plant and equipment	730.6	556.7	501.9
Acquisitions through business combinations			8.6
Disposals, property, plant and equipment	6.0	3.0
Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	(183.5)	(151.9)
Disposals	4.8	2.1
Effect of movements in foreign exchange	15.9	(10.4)
Depreciation	46.8	44.1
Disposals, property, plant and equipment	(4.8)	(2.1)
Property, plant and equipment	(241.4)	(183.5)	(151.9)
Disposals, property, plant and equipment	(4.8)	(2.1)
Land and buildings
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	136.1	133.2
Property, plant and equipment	176.2	136.1	133.2
Land and buildings | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	165.3	156.2
Acquisitions through business combinations	30.5		5.1
Additions	14.8	6.8
Disposals	(0.1)	(0.1)
Effect of movements in foreign exchange	(6.2)	2.7
Disposals, property, plant and equipment	0.1	0.1
Property, plant and equipment	216.7	165.3	156.2
Acquisitions through business combinations	30.5		5.1
Disposals, property, plant and equipment	0.1	0.1
Land and buildings | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	(29.2)	(23.0)
Disposals	0.0	0.0
Effect of movements in foreign exchange	2.9	(1.4)
Depreciation	8.4	7.6
Disposals, property, plant and equipment	0.0	0.0
Property, plant and equipment	(40.5)	(29.2)	(23.0)
Disposals, property, plant and equipment	0.0	0.0
Plant and equipment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	228.0	206.9
Property, plant and equipment	302.9	228.0	206.9
Plant and equipment | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	376.1	331.9
Acquisitions through business combinations	45.0		3.5
Additions	62.8	54.6
Disposals	(5.9)	(2.6)
Effect of movements in foreign exchange	(16.2)	11.3
Disposals, property, plant and equipment	5.9	2.6
Property, plant and equipment	494.2	376.1	331.9
Acquisitions through business combinations	45.0		3.5
Disposals, property, plant and equipment	5.9	2.6
Plant and equipment | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	(148.1)	(125.0)
Disposals	4.8	1.8
Effect of movements in foreign exchange	12.6	(8.6)
Depreciation	35.4	33.5
Disposals, property, plant and equipment	(4.8)	(1.8)
Property, plant and equipment	(191.3)	(148.1)	(125.0)
Disposals, property, plant and equipment	(4.8)	(1.8)
Computer equipment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	9.1	9.9
Property, plant and equipment	10.1	9.1	9.9
Computer equipment | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	15.3	13.8
Acquisitions through business combinations	0.5		0.0
Additions	3.5	2.1
Disposals	0.0	(0.3)
Effect of movements in foreign exchange	(0.4)	0.3
Disposals, property, plant and equipment	0.0	0.3
Property, plant and equipment	19.7	15.3	13.8
Acquisitions through business combinations	0.5		0.0
Disposals, property, plant and equipment	0.0	0.3
Computer equipment | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	(6.2)	(3.9)
Disposals	0.0	0.3
Effect of movements in foreign exchange	0.4	(0.4)
Depreciation	3.0	3.0
Disposals, property, plant and equipment	0.0	(0.3)
Property, plant and equipment	(9.6)	(6.2)	€ (3.9)
Disposals, property, plant and equipment	€ 0.0	€ (0.3)

XML

Property, plant and equipment - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about property, plant and equipment [line items]
Construction in progress	€ 40.5	€ 24.5
Percentage of consolidated gross assets or adjusted EBITDA held individually by companies in Guarantor Group	5.00%
Percentage of consolidated gross assets or adjusted EBITDA held by Guarantor Group in total	80.00%

XML

Property, plant and equipment Disclosure NBV of Right of Use Assets (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Asset Class of RIght of use Assets [Line Items]
Right-of-use assets	€ 60.2	€ 49.0
Additions to right-of-use assets	8.1
Acquisitions through business combinations,	19.0
Land and buildings [member]
Asset Class of RIght of use Assets [Line Items]
Right-of-use assets	44.8	38.5
Property, plant and equipment [member]
Asset Class of RIght of use Assets [Line Items]
Right-of-use assets	15.3	10.3
Computer equipment [member]
Asset Class of RIght of use Assets [Line Items]
Right-of-use assets	€ 0.1	€ 0.2

XML

Property, plant and equipment Disclosure Depreciation of Right of use Assets (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation, right-of-use assets	€ 16.6	€ 15.7	€ 16.1
Land and buildings [member]
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation, right-of-use assets	10.9	10.6	10.7
Property, plant and equipment [member]
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation, right-of-use assets	5.5	4.9	5.2
Computer equipment [member]
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation, right-of-use assets	€ 0.2	€ 0.2	€ 0.2

XML

Goodwill and Intangibles - Cost (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	€ 4,058.2	€ 3,946.0
Amortization of software and brands	8.2	7.8	€ 8.6
Intangible assets and goodwill	4,555.1	4,058.2	3,946.0
Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	4,094.9	3,974.8
Acquisitions through business combinations (restated)		494.5	106.2
Additions	5.8	8.8
Disposals, intangible assets and goodwill	(2.5)
Effect of movements in foreign exchange	7.0	5.1
Intangible assets and goodwill	4,599.7	4,094.9	3,974.8
Additions	5.8	8.8
Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	(36.7)	(28.8)
Disposals, intangible assets other than goodwill	(1.7)
Effect of movements in foreign exchange	0.3	(0.1)
Amortization of software and brands	(8.2)	(7.8)
Intangible assets and goodwill	(44.6)	(36.7)	(28.8)
Disposals, intangible assets other than goodwill	(1.7)
Goodwill
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	1,902.5	1,862.9
Intangible assets and goodwill	2,099.4	1,902.5	1,862.9
Goodwill | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	1,902.5	1,862.9
Acquisitions through business combinations (restated)		192.6	40.1
Additions	0.0	0.0
Disposals, intangible assets and goodwill	0.0
Effect of movements in foreign exchange	4.3	(0.5)
Intangible assets and goodwill	2,099.4	1,902.5	1,862.9
Additions	0.0	0.0
Goodwill | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	0.0	0.0
Disposals, intangible assets other than goodwill	0.0
Effect of movements in foreign exchange	0.0	0.0
Amortization of software and brands	0.0	0.0
Intangible assets and goodwill	0.0	0.0	0.0
Disposals, intangible assets other than goodwill	0.0
Brands
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	2,116.8	2,046.7
Intangible assets and goodwill	2,415.3	2,116.8	2,046.7
Brands | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	2,122.4	2,051.1
Acquisitions through business combinations (restated)	296.5		66.0
Additions	0.0	0.0
Disposals, intangible assets and goodwill	0.0
Effect of movements in foreign exchange	3.2	5.3
Intangible assets and goodwill	2,422.1	2,122.4	2,051.1
Additions	0.0	0.0
Brands | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	(5.6)	(4.4)
Disposals, intangible assets other than goodwill	0.0
Effect of movements in foreign exchange	0.0	0.0
Amortization of software and brands	(1.2)	(1.2)
Intangible assets and goodwill	(6.8)	(5.6)	(4.4)
Disposals, intangible assets other than goodwill	0.0
Computer software
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	19.3	14.6
Intangible assets and goodwill	18.9	19.3	14.6
Computer software | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	39.0	29.8
Acquisitions through business combinations (restated)	1.1		0.1
Additions	5.8	8.8
Disposals, intangible assets and goodwill	(2.5)
Effect of movements in foreign exchange	(0.5)	0.3
Intangible assets and goodwill	42.9	39.0	29.8
Additions	5.8	8.8
Computer software | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	(19.7)	(15.2)
Disposals, intangible assets other than goodwill	(1.7)
Effect of movements in foreign exchange	0.3	(0.1)
Amortization of software and brands	(4.6)	(4.4)
Intangible assets and goodwill	(24.0)	(19.7)	(15.2)
Disposals, intangible assets other than goodwill	(1.7)
Customer relationships
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	19.6	21.8
Intangible assets and goodwill	21.5	19.6	21.8
Customer relationships | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	31.0	31.0
Acquisitions through business combinations (restated)	4.3		0.0
Additions	0.0	0.0
Disposals, intangible assets and goodwill	0.0
Effect of movements in foreign exchange	0.0	0.0
Intangible assets and goodwill	35.3	31.0	31.0
Additions	0.0	0.0
Customer relationships | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	(11.4)	(9.2)
Disposals, intangible assets other than goodwill	0.0
Effect of movements in foreign exchange	0.0	0.0
Amortization of software and brands	(2.4)	(2.2)
Intangible assets and goodwill	(13.8)	€ (11.4)	€ (9.2)
Disposals, intangible assets other than goodwill	€ 0.0

XML

Goodwill and Intangibles - Accumulated Amortization and Impairment (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	€ (4,058.2)	€ (3,946.0)
Amortisation, intangible assets other than goodwill	(8.2)	(7.8)	€ (8.6)
Intangible assets and goodwill	(4,555.1)	(4,058.2)	(3,946.0)
Intangible assets and goodwill	4,555.1	4,058.2	3,946.0
Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	36.7	28.8
Amortisation, intangible assets other than goodwill	8.2	7.8
Impairment loss recognised in profit or loss, intangible assets other than goodwill	(1.7)
Disposals, intangible assets other than goodwill	(1.7)
Increase (decrease) through net exchange differences, intangible assets and goodwill	(0.3)	0.1
Intangible assets and goodwill	44.6	36.7	28.8
Intangible assets and goodwill	(44.6)	(36.7)	(28.8)
Goodwill
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	(1,902.5)	(1,862.9)
Intangible assets and goodwill	(2,099.4)	(1,902.5)	(1,862.9)
Intangible assets and goodwill	2,099.4	1,902.5	1,862.9
Goodwill | Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	0.0	0.0
Amortisation, intangible assets other than goodwill	0.0	0.0
Impairment loss recognised in profit or loss, intangible assets other than goodwill	0.0
Disposals, intangible assets other than goodwill	0.0
Increase (decrease) through net exchange differences, intangible assets and goodwill	0.0	0.0
Intangible assets and goodwill	0.0	0.0	0.0
Intangible assets and goodwill	0.0	0.0	0.0
Customer relationships
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	(19.6)	(21.8)
Intangible assets and goodwill	(21.5)	(19.6)	(21.8)
Intangible assets and goodwill	21.5	19.6	21.8
Customer relationships | Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	11.4	9.2
Amortisation, intangible assets other than goodwill	2.4	2.2
Impairment loss recognised in profit or loss, intangible assets other than goodwill	0.0
Disposals, intangible assets other than goodwill	0.0
Increase (decrease) through net exchange differences, intangible assets and goodwill	0.0	0.0
Intangible assets and goodwill	13.8	11.4	9.2
Intangible assets and goodwill	(13.8)	(11.4)	(9.2)
Brands
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	(2,116.8)	(2,046.7)
Intangible assets and goodwill	(2,415.3)	(2,116.8)	(2,046.7)
Intangible assets and goodwill	2,415.3	2,116.8	2,046.7
Brands | Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	5.6	4.4
Amortisation, intangible assets other than goodwill	1.2	1.2
Impairment loss recognised in profit or loss, intangible assets other than goodwill	0.0
Disposals, intangible assets other than goodwill	0.0
Increase (decrease) through net exchange differences, intangible assets and goodwill	0.0	0.0
Intangible assets and goodwill	6.8	5.6	4.4
Intangible assets and goodwill	(6.8)	(5.6)	(4.4)
Computer software
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	(19.3)	(14.6)
Intangible assets and goodwill	(18.9)	(19.3)	(14.6)
Intangible assets and goodwill	18.9	19.3	14.6
Computer software | Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	19.7	15.2
Amortisation, intangible assets other than goodwill	4.6	4.4
Impairment loss recognised in profit or loss, intangible assets other than goodwill	(1.7)
Disposals, intangible assets other than goodwill	(1.7)
Increase (decrease) through net exchange differences, intangible assets and goodwill	(0.3)	0.1
Intangible assets and goodwill	24.0	19.7	15.2
Intangible assets and goodwill	€ (24.0)	€ (19.7)	€ (15.2)

XML

Goodwill and Intangibles - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Amortization	€ (8.2)	€ (7.8)	€ (8.6)
Discount rate	6.40%	5.80%
Long-term growth rate	1.00%	1.00%
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss	€ 9.9	€ 7.8	€ 8.6
Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Amortization	€ 8.2	€ 7.8

XML

Acquisitions - Findus Switzerland (Details) - EUR (€) € in Millions	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Disclosure of detailed information about business combination [line items]
Assets	€ 6,170.8		€ 5,580.6
Total liabilities	3,871.8		3,454.5
Goodwill	2,099.4		1,902.5
Intangibles	2,455.7		2,155.7
Inventories	410.6		344.3
Deferred tax liabilities	(437.6)		(427.1)
Trade and other current payables	(692.0)		(647.2)
Other assets			(1,202.1)
Assets (liabilities)	2,299.0		2,126.1
Increase (decrease) due to corrections of prior period errors [member]
Disclosure of detailed information about business combination [line items]
Goodwill			(35.5)
Intangibles			41.6
Inventories			1.1
Deferred tax liabilities			6.4
Trade and other current payables			0.8
Other assets			0.0
Assets (liabilities)			0.0
Previously stated [member]
Disclosure of detailed information about business combination [line items]
Goodwill			1,938.0
Intangibles			2,114.1
Inventories			343.2
Deferred tax liabilities			(420.7)
Trade and other current payables			(646.4)
Other assets			(1,202.1)
Assets (liabilities)			2,126.1
Findus Switzerland
Disclosure of detailed information about business combination [line items]
Cash transferred	0.8		€ 112.8
Intangible assets	66.1
Property, plant and equipment, including Right-of-use assets	8.9
Current assets	0.2
Inventories	12.6
Assets	87.8
Current liabilities	0.3
Non-current liabilities	6.8
Deferred tax liabilities	8.0
Total liabilities	15.1
Total identifiable net assets acquired	72.7
Total purchase consideration	112.8
Goodwill	40.1	€ 40.1
Findus Switzerland | Increase (decrease) due to corrections of prior period errors [member]
Disclosure of detailed information about business combination [line items]
Intangible assets	41.6
Property, plant and equipment, including Right-of-use assets	0.0
Current assets	0.0
Inventories	1.1
Assets	42.7
Current liabilities	0.0
Non-current liabilities	0.0
Deferred tax liabilities	6.4
Total liabilities	6.4
Total identifiable net assets acquired	36.3
Total purchase consideration	0.8
Goodwill	(35.5)
Findus Switzerland | Previously stated [member]
Disclosure of detailed information about business combination [line items]
Intangible assets	24.5
Property, plant and equipment, including Right-of-use assets	8.9
Current assets	0.2
Inventories	11.5
Assets	45.1
Current liabilities	0.3
Non-current liabilities	6.8
Deferred tax liabilities	1.6
Total liabilities	8.7
Total identifiable net assets acquired	36.4
Total purchase consideration	112.0
Goodwill	€ 75.6
Fortenova Group
Disclosure of detailed information about business combination [line items]
Cash transferred		640.1
Intangible assets		301.9
Property, plant and equipment, including Right-of-use assets		95.0
Current assets		71.7
Inventories		46.9
Assets		573.9
Current liabilities		62.1
Non-current liabilities		16.6
Deferred tax liabilities		47.7
Total liabilities		126.4
Total identifiable net assets acquired		447.5
Total purchase consideration		640.1
Goodwill		€ 192.6

XML

Acquisitions (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about business combination [line items]
Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination	€ 12.9	€ 4.8
Revenue of combined entity as if combination occurred at beginning of period	2,851.7
Profit (loss) of combined entity as if combination occurred at beginning of period	279.9
Cash consideration	640.9	113.0	€ 0.0
Less cash acquired	(43.6)	(0.1)	0.0
Contingent consideration paid related to acquisitions	0.0	0.0	1.5
Net outflow of cash - investing activities	€ 597.3	€ 112.9	€ 1.5

XML

Acquisitions (Fortenova) (Details) - EUR (€) € in Millions	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Disclosure of detailed information about business combination [line items]
Total assets	€ 6,170.8		€ 5,580.6
Total liabilities	3,871.8		€ 3,454.5
Findus Switzerland
Disclosure of detailed information about business combination [line items]
Intangible assets	66.1
Property, plant and equipment, including Right-of-use assets	8.9
Current assets	0.2
Inventories	12.6
Total assets	87.8
Current liabilities	0.3
Non-current liabilities	6.8
Deferred tax liabilities	8.0
Total liabilities	15.1
Total identifiable net assets acquired	(72.7)
Total purchase consideration	112.8
Goodwill	€ 40.1	€ 40.1
Fortenova Group
Disclosure of detailed information about business combination [line items]
Intangible assets		301.9
Property, plant and equipment, including Right-of-use assets		95.0
Current assets		71.7
Cash and cash equivalents recognised as of acquisition date		43.6
Inventories		46.9
Deferred tax assets recognised as of acquisition date		14.8
Total assets		573.9
Current liabilities		62.1
Non-current liabilities		16.6
Deferred tax liabilities		47.7
Total liabilities		126.4
Total identifiable net assets acquired		(447.5)
Total purchase consideration		640.1
Goodwill		€ 192.6

XML

Investments (Details)	12 Months Ended
	Dec. 31, 2021
Nomad Foods Europe Holdings Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Holdco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Finco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Midco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Bondco Plc
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Lux S.à.r.l.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Birds Eye Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Finance Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Birds Eye Ireland Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Holding GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Nederland B.V.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Belgium S.A.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Portugal
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Austria Holdings GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
C.S.I. Compagnia Surgelati Italiana S.R.L
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Sverige Holdings AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Frozen Fish International GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Liberator Germany Newco GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Austria GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Sverige AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Frionor Sverige AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Holdings France SAS
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus France SAS
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Espana SLU
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Danmark A/S
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Finland Oy
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Norge AS
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Norge Holding AS [Member] [Domain]
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Topprys AB [Domain]
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Switzerland
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
LEDO plus d.o.o.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
LEDO d.o.o. Čitluk
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
IRIDA d.o.o.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.)
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga “Ledo” d.o.o. Podgorica)
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Ledo Sh.p.k.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
FRIKOM BEOGRAD DOOEL Čučer Sandevo
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%

XML

Deferred tax assets and liabilities - Summary of Deferred Tax Assets and Liabilities (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	€ 128.3	€ 113.5
Deferred tax liabilities	(437.6)	(427.1)
Tax assets/(liabilities)	(309.3)	(313.6)	€ (301.8)
Deferred tax assets not recognized in the financial statements	70.4	72.7
Deferred tax items credited (charged) to equity	(23.8)	14.3	12.3
Property, plant and equipment
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	8.9	20.6
Deferred tax liabilities	(34.4)	(27.3)
Tax assets/(liabilities)	(25.5)	(6.7)	(6.3)
Intangible assets
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	33.8	0.9
Deferred tax liabilities	(382.9)	(384.4)
Tax assets/(liabilities)	(349.1)	(383.5)	(356.6)
Employee benefits
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	36.4	48.3
Deferred tax liabilities	0.0	(0.3)
Tax assets/(liabilities)	36.4	48.0	39.8
Tax value of loss carry forwards
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	40.4	24.6
Deferred tax liabilities	0.0	0.0
Tax assets/(liabilities)	40.4	24.6	20.7
Derivative financial instruments
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	1.7	9.3
Deferred tax liabilities	(7.0)	(0.1)
Tax assets/(liabilities)	(5.3)	9.2	2.9
Other
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	7.1	9.8
Deferred tax liabilities	(13.3)	(15.0)
Tax assets/(liabilities)	€ (6.2)	€ (5.2)	€ (2.3)

XML

Deferred tax assets and liabilities - Changes in Deferred tax (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	€ (313.6)	€ (301.8)
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	(32.9)	(8.0)
Recognized  in Statement of Profit or Loss	61.2	(18.0)
Recognized in Other Comprehensive Income	(23.8)	14.3	€ 12.3
Movement in foreign exchange	(0.2)	(0.1)
Closing balance	(309.3)	(313.6)	(301.8)
Property, plant and equipment
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	(6.7)	(6.3)
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	(2.2)	(1.3)
Recognized  in Statement of Profit or Loss	(17.2)	1.0
Recognized in Other Comprehensive Income	0.0	0.0
Movement in foreign exchange	0.6	(0.1)
Closing balance	(25.5)	(6.7)	(6.3)
Intangible assets
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	(383.5)	(356.6)
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	(30.1)	(6.3)
Recognized  in Statement of Profit or Loss	64.5	(20.6)
Recognized in Other Comprehensive Income	0.0	0.0
Movement in foreign exchange	0.0	0.0
Closing balance	(349.1)	(383.5)	(356.6)
Employee benefits
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	48.0	39.8
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	0.0	0.0
Recognized  in Statement of Profit or Loss	(1.2)	0.0
Recognized in Other Comprehensive Income	(10.2)	8.3
Movement in foreign exchange	(0.2)	(0.1)
Closing balance	36.4	48.0	39.8
Tax value of loss carry forwards
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	24.6	20.7
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	0.0	0.0
Recognized  in Statement of Profit or Loss	15.8	3.9
Recognized in Other Comprehensive Income	0.0	0.0
Movement in foreign exchange	0.0	0.0
Closing balance	40.4	24.6	20.7
Derivative financial instruments
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	9.2	2.9
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	0.0	0.0
Recognized  in Statement of Profit or Loss	(0.3)	0.3
Recognized in Other Comprehensive Income	(13.6)	6.0
Movement in foreign exchange	(0.6)	0.0
Closing balance	(5.3)	9.2	2.9
Other
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	(5.2)	(2.3)
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	(0.6)	(0.4)
Recognized  in Statement of Profit or Loss	(0.4)	(2.6)
Recognized in Other Comprehensive Income	0.0	0.0
Movement in foreign exchange	0.0	0.1
Closing balance	€ (6.2)	€ (5.2)	€ (2.3)

XML

Inventories (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Inventories [Abstract]
Raw materials and consumables	€ 95.8	€ 80.5
Work in progress	64.9	46.5
Finished goods and goods for resale	249.9	217.3
Total inventories	410.6	344.3
Inventory write-down	€ 8.3	€ 8.5	€ 9.0

XML

Trade and other receivables (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Subclassifications of assets, liabilities and equities [abstract]
Revenue from performance obligations satisfied or partially satisfied in previous periods	€ 18.9	€ 18.0
Recognised assets representing continuing involvement in derecognised financial assets	0.0	0.0
Current Trade Receivables, Reduction in Trade Terms	189.9	200.5
Current trade payables, relating to trade terms	(93.8)	(89.7)
Total trade terms liabilities	(283.7)	(290.2)
Current assets
Trade receivables	182.8	141.2
Prepayments and accrued income	15.4	9.2
Other receivables	32.3	31.2
Tax receivable	4.1	3.4
Total current trade and other receivables	234.6	185.0
Non-current assets
Other non-current assets	8.9	1.1
Total non-current trade and other receivables	8.9	1.1
Total trade and other receivables	€ 243.5	€ 186.1

XML

Trade and other receivables - Aging of Trade Receivables (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Trade Receivables [Line Items]
Trade receivables	€ 372.7	€ 341.7
Reduction in trade-terms	(189.9)	(200.5)
Total trade receivables	182.8	141.2
Not past due
Trade Receivables [Line Items]
Trade receivables	343.7	308.3
Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	19.8	20.3
Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	4.6	3.9
Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	2.3	1.0
Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	2.3	8.2
Gross
Trade Receivables [Line Items]
Trade receivables	376.3	346.1
Gross | Not past due
Trade Receivables [Line Items]
Trade receivables	343.8	308.6
Gross | Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	19.9	20.5
Gross | Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	5.2	4.0
Gross | Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	2.4	1.1
Gross | Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	5.0	11.9
Impaired
Trade Receivables [Line Items]
Trade receivables	(3.6)	(4.4)
Impaired | Not past due
Trade Receivables [Line Items]
Trade receivables	(0.1)	(0.3)
Impaired | Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	(0.1)	(0.2)
Impaired | Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	(0.6)	(0.1)
Impaired | Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	(0.1)	(0.1)
Impaired | Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	€ (2.7)	€ (3.7)

XML

Indemnification assets (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about business combination [line items]
Indemnification assets		€ 9.5	€ 15.4	€ 35.4
Release of indemnified provision		(5.9)	(20.0)
Goodfella's Pizza [Member]
Disclosure of detailed information about business combination [line items]
Indemnification Assets Recognised As Of Acquisition Date		2.5	3.4
Release of indemnified provision		(0.9)
Findus
Disclosure of detailed information about business combination [line items]
Indemnification assets		7.0	€ 12.0
Release of indemnified provision	€ (7.0)	€ (5.0)

XML

Indemnification assets - Additional Information (Details) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2022 EUR (€)	Dec. 31, 2021 EUR (€) € / shares shares	Dec. 31, 2020 EUR (€) € / shares shares	Dec. 31, 2019 EUR (€)	Jan. 01, 2022 shares	Dec. 31, 2021 $ / shares	Dec. 31, 2020 $ / shares
Disclosure of detailed information about business combination [line items]
Release of indemnified provision		€ 5.9	€ 20.0
Indemnification assets		9.5	15.4	€ 35.4
Remeasurement of indemnification assets		5.0	17.8	€ 44.0
Findus
Disclosure of detailed information about business combination [line items]
Release of indemnified provision	€ 7.0	5.0
Indemnification assets		€ 7.0	€ 12.0
Shares held in escrow as a result of indemnification asset | shares		342,190	618,099
Value of shares held in escrow as a result of indemnification asset (price per share) | (per share)		€ 22.40	€ 20.69			$ 25.39	$ 25.42
Contingent Consideration Arrangements And Indemnification Assets Recognised as of Acquisition Date, shares released from escrow | shares		275,909			342,190
Goodfella's Pizza [Member]
Disclosure of detailed information about business combination [line items]
Release of indemnified provision		€ 0.9
Indemnification Assets Recognised As Of Acquisition Date		€ 2.5	€ 3.4

XML

Cash and cash equivalents (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Subclassifications of assets, liabilities and equities [abstract]
Cash and cash equivalents	€ 254.0	€ 393.1
Restricted cash	0.2	0.1
Cash and cash equivalents	254.2	393.2	€ 824.8	€ 327.6
Bank overdrafts	0.0	(10.7)
Cash and cash equivalents if different from statement of financial position	€ 254.2	€ 382.5	€ 824.8

XML

Loans and borrowings - Repayment Profile (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	€ 29.1	€ 22.5
Loans and borrowings	2,198.3	1,736.3
Borrowings	2,227.4	1,758.8
Gross | Syndicated loans
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	8.5	7.8
Loans and borrowings	1,347.4	1,287.5
Gross | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	0.0	400.0
Lease Liabilities | Less than one year
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	22.6	16.7
Lease Liabilities | Later than one year [member]
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	58.3	53.7
Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	9.4	6.9
Deferred borrowing costs | Less than one year
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	(2.0)	(2.0)
Deferred borrowing costs | 2 to 5 years
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	(5.7)	(4.9)
Deferred borrowing costs | More than five years
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	€ (1.7)	€ 0.0

XML

Loans and borrowings - Details of Individual Loans (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	€ 29.1	€ 22.5
Total non-current loans and borrowings	2,198.3	1,736.3
Borrowings	2,227.4	1,758.8
Gross | Syndicated loans
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	8.5	7.8
Total non-current loans and borrowings	1,347.4	1,287.5
Gross | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	0.0	400.0
Gross | Twenty Twenty-Eight Fixed Rate Senior Secured Notes
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	800.0	0.0
Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	9.4	6.9
Less than one year | Lease Liabilities
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	22.6	16.7
Less than one year | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	(2.0)	(2.0)
Later than one year [member] | Lease Liabilities
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	58.3	53.7
2 to 5 years | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	(5.7)	(4.9)
More than five years | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	€ (1.7)	€ 0.0

XML

Loans and borrowings - Additional Information (Details) kr in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021 EUR (€)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 EUR (€)	Dec. 31, 2022 EUR (€)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2021 SEK (kr)	Jul. 29, 2021 EUR (€)	Jul. 09, 2021 EUR (€)	Jun. 24, 2021 EUR (€)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 SEK (kr)
Disclosure of detailed information about borrowings [line items]
Annual principal payment	€ 0
Percentage of consolidated gross assets or adjusted EBITDA held individually by companies in Guarantor Group	5.00%	5.00%
Percentage of consolidated gross assets or adjusted EBITDA held by Guarantor Group in total	80.00%	80.00%
Guarantee amount	€ 62,400,000		€ 44,700,000					kr 640					kr 450
Financing costs incurred in amendment of terms of debt	(17,900,000)		0	€ 0
Findus Sverige AB
Disclosure of detailed information about borrowings [line items]
Guarantee amount	29,300,000		29,800,000					kr 300
Senior USD Debt
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 808,600,000					$ 916.4	$ 916.4		€ 827,800,000			$ 926.0
Interest rate	2.25%						2.25%	2.25%
Repayments of non-current borrowings	€ 8,500,000	$ 9.6
Repayments Of Non-current Borrowings - percentage of original issued notional	1.00%						1.00%	1.00%
Senior EURO Debt
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 553,200,000
Interest rate	2.50%						2.50%	2.50%
Financing costs incurred in amendment of terms of debt	€ 3,800,000
2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Notional amount											€ 400,000,000
Interest rate											3.25%
Revolving Credit Facility
Disclosure of detailed information about borrowings [line items]
Letters of credit, overdrafts, customer bonds and bank guarantees utilized against the credit facility	€ 2,800,000		€ 16,100,000
Twenty Twenty-Eight Fixed Rate Senior Secured Notes
Disclosure of detailed information about borrowings [line items]
Notional amount										€ 50,000,000	€ 750,000,000
Interest rate	2.50%						2.50%	2.50%
Financing costs incurred in amendment of terms of debt	€ 4,000,000
Issued price of Senior Secured Notes (2028)										€ 100.75
Derivative financial instruments | Cross currency interest rate swap | Cash flow hedges
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 827,800,000				€ 827,800,000
Findus Sverige AB
Disclosure of detailed information about borrowings [line items]
Proportion of ownership interest in subsidiary	100.00%	100.00%

XML

Trade and other payables (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Current liabilities
Trade payables	€ 413.2	€ 363.7
Accruals and deferred income	120.4	134.5
Current trade payables, relating to trade terms	93.8	89.7
Social security and other taxes	24.6	24.1
Other payables	20.3	21.2
Financial payables	19.7	3.3
Bank overdrafts	0.0	10.7
Total current trade and other payables	692.0	647.2
Non-current liabilities
Accruals and deferred income	1.8	2.2
Total non-current trade and other payables	1.8	2.2
Total trade and other payables	€ 693.8	€ 649.4

XML

Employee benefits - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of defined benefit plans [line items]
Post-employment benefit expense, defined contribution plans	€ 10.2	€ 8.3	€ 9.0
Recognized liability for net employee benefit obligations	244.2	276.2	237.5
Estimate of contributions expected to be paid to plan for next annual reporting period	€ 6.7
Weighted average duration of defined benefit obligation	18 years 10 months 24 days
Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Recognized liability for net employee benefit obligations	€ 352.6	374.1	€ 323.9
Present value of defined benefit obligation | Other countries
Disclosure of defined benefit plans [line items]
Recognized liability for net employee benefit obligations	€ 8.7	€ 4.0

XML

Employee benefits - Defined Benefit Plans (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	€ 244.2	€ 276.2	€ 237.5
Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	352.6	374.1	€ 323.9
Germany | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	149.3	181.2
SWEDEN | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	70.3	74.1
Austria | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	5.5	5.6
SWITZERLAND | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	5.8	6.6
Italy | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	4.6	4.7
Other countries | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	€ 8.7	€ 4.0

XML

Employee benefits - Amount Included in the Statement of Financial Position Arising from the Company's Obligations (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	€ 352.6	€ 374.1
Present value of defined benefit obligation | Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	341.5	365.1
Present value of defined benefit obligation | Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	11.1	9.0
Present value of defined benefit obligation | Unfunded Plan
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	88.6	88.6
Present value of defined benefit obligation | Unfunded Plan | Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	77.5	79.6
Present value of defined benefit obligation | Unfunded Plan | Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	11.1	9.0
Present value of defined benefit obligation | Funded Plan
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	264.0	285.5
Present value of defined benefit obligation | Funded Plan | Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	264.0	285.5
Present value of defined benefit obligation | Funded Plan | Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	0.0	0.0
Plan assets
Disclosure of defined benefit plans [line items]
Plan assets, at fair value	(108.4)	(97.9)
Plan assets | Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Plan assets, at fair value	(108.4)	(97.9)
Plan assets | Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Plan assets, at fair value	0.0	0.0
Plan assets, at fair value	108.4	97.9
Net defined benefit liability (asset)	244.2	276.2	€ 237.5
Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	233.1	267.2	€ 228.5
Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	€ 11.1	€ 9.0

XML

Employee benefits - Reconciliation of Opening and Closing Balances of Net Employee Benefit Plans and Components (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of net defined benefit liability (asset) [line items]
Balance at January 1	€ 276.2	€ 237.5
Current service cost	7.9	6.6
Interest cost (income)	1.7	2.7
Post-employment benefit expense, defined benefit plans	9.6	9.3
Demographic assumptions	(1.5)	0.0
Financial assumptions	26.8	(29.1)
Actuarial experience (gains) losses	(1.8)	0.8
Return on plan assets, excluding interest income	(9.6)	(0.4)
Exchange adjustments	(0.9)	2.8
Gain (loss) on remeasurement, net defined benefit liability (asset)	(37.0)	30.7
Acquired through business combinations	3.5	6.6
Contributions by employer	(1.2)	(0.5)
Contributions by members	0.0	(0.1)
Benefits paid	(6.9)	(7.3)
Increase (decrease) in net defined benefit liability (asset) resulting from other changes	(4.6)	(1.3)
Balance at December 31	244.2	276.2
Present value of defined benefit obligation
Disclosure of net defined benefit liability (asset) [line items]
Balance at January 1	374.1	323.9
Current service cost	7.9	6.6
Interest cost (income)	2.2	3.7
Post-employment benefit expense, defined benefit plans	10.1	10.3
Demographic assumptions	(1.5)	0.0
Financial assumptions	26.8	(29.1)
Actuarial experience (gains) losses	(1.8)	0.8
Exchange adjustments	(0.3)	2.8
Gain (loss) on remeasurement, net defined benefit liability (asset)	(26.8)	31.1
Acquired through business combinations	3.5	18.4
Contributions by employer	0.0
Contributions by members	0.8	0.4
Benefits paid	(9.1)	(10.0)
Increase (decrease) in net defined benefit liability (asset) resulting from other changes	(4.8)	8.8
Balance at December 31	352.6	374.1
Plan assets
Disclosure of net defined benefit liability (asset) [line items]
Balance at January 1	(97.9)	(86.4)
Interest cost (income)	(0.5)	(1.0)
Post-employment benefit expense, defined benefit plans	(0.5)	(1.0)
Return on plan assets, excluding interest income	(9.6)	(0.4)
Exchange adjustments	(0.6)	0.0
Gain (loss) on remeasurement, net defined benefit liability (asset)	(10.2)	(0.4)
Acquired through business combinations	0.0	(11.8)
Contributions by employer	(1.2)	(0.5)
Contributions by members	(0.8)	(0.5)
Benefits paid	2.2	2.7
Increase (decrease) in net defined benefit liability (asset) resulting from other changes	0.2	(10.1)
Balance at December 31	€ (108.4)	€ (97.9)

XML

Employee benefits - Actuarial Losses Recognized (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Employee Benefits [Abstract]
Other Comprehensive Income, Before Tax, Cumulative Gain (Loss) On Remeasurements Of Defined Benefit Plans	€ 40.5	€ 77.5

XML

Employee benefits - Fair Value of Plan Assets (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Employee Benefits [Abstract]
Equities	€ 32.7	€ 24.5
Debt instruments	42.7	44.1
Property	20.3	17.1
Other	12.7	12.2
Total	€ 108.4	€ 97.9

XML

Employee benefits - Actuarial Assumptions (Details)	Dec. 31, 2021	Dec. 31, 2020
Bottom of range | Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase for pensions in payment	1.00%	1.00%
Bottom of range | SWITZERLAND | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase in salaries		0.00%
Top of range | Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase for pensions in payment	2.00%	2.00%
Top of range | SWITZERLAND | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase in salaries		2.50%
Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	1.10%	0.55%
Inflation rate	2.00%	2.00%
Rate of increase in salaries	2.80%	2.80%
SWEDEN | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	1.80%	1.05%
Inflation rate	2.20%	1.50%
Rate of increase in salaries	3.20%	2.50%
Rate of increase for pensions in payment	2.20%	1.50%
Austria | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	0.90%	1.00%
Inflation rate	2.00%	2.00%
Rate of increase in salaries	2.00%	2.00%
Rate of increase for pensions in payment	0.00%	0.00%
Italy
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	0.35%	0.33%
Inflation rate	1.50%	1.00%
Rate of increase in salaries	2.63%	2.63%
Rate of increase for pensions in payment	0.00%	0.00%
SWITZERLAND | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	0.10%	0.15%
Inflation rate	1.00%	0.20%
Rate of increase in salaries	1.50%
Rate of increase for pensions in payment	0.00%	0.00%

XML

Employee benefits - Average Life Expectancy After Retirement (Details) - Defined benefit retirement plans - yr	Dec. 31, 2021	Dec. 31, 2020
Germany
Disclosure of defined benefit plans [line items]
Male	21	21
Female	24	24
SWEDEN
Disclosure of defined benefit plans [line items]
Male	22	22
Female	24	24
Austria
Disclosure of defined benefit plans [line items]
Male	23	23
Female	26	26
Italy
Disclosure of defined benefit plans [line items]
Male	21	21
Female	22	22
SWITZERLAND
Disclosure of defined benefit plans [line items]
Male	22	21
Female	24	24

XML

Employee benefits - History of Experience Adjustments From Inception (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	€ 244.2	€ 276.2	€ 237.5
Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	233.1	267.2	228.5
Experience losses/(gains) on plan liabilities	1.8	(0.8)	0.2
Experience gains on plan assets	(9.6)	(0.4)	(5.1)
Present value of defined benefit obligation
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	352.6	374.1	323.9
Present value of defined benefit obligation | Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	341.5	365.1	314.9
Plan assets
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	(108.4)	(97.9)	(86.4)
Plan assets | Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	€ (108.4)	€ (97.9)	€ (86.4)

XML

Employee benefits - Defined Benefit Obligation Sensitivity Analysis (Details) € in Millions	Dec. 31, 2021 EUR (€)
Discount rate
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Effect on the post-employment benefit obligation with a 1% increase	€ (54.6)
Effect on the post-employment benefit obligation with a 1% decrease	71.9
Actuarial assumption of expected rates of inflation [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Effect on the post-employment benefit obligation with a 1% increase	47.4
Effect on the post-employment benefit obligation with a 1% decrease	(38.7)
Actuarial assumption of expected rates of salary increases [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Effect on the post-employment benefit obligation with a 1% increase	15.2
Effect on the post-employment benefit obligation with a 1% decrease	(11.5)
Actuarial assumption of expected rates of pension increases [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Effect on the post-employment benefit obligation with a 1% increase	47.6
Effect on the post-employment benefit obligation with a 1% decrease	€ (37.0)

XML

Provisions (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	€ 51.8	€ 46.8
Acquisitions through business combinations, other provisions	4.1
Additional provision in the period	6.1	29.1
Release of provision	(4.1)	(7.1)
Utilization of provision	(16.7)	(16.8)
Foreign exchange	1.0	(0.2)
Provisions, ending balance	42.2	51.8
Provisions	42.2	51.8
Current	39.3	45.7
Non-current	(2.9)	(6.1)
Provisions	(42.2)	(51.8)
Restructuring
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	12.9	7.4
Acquisitions through business combinations, other provisions	0.0
Additional provision in the period	2.6	15.6
Release of provision	(0.1)	0.0
Utilization of provision	(9.8)	(10.4)
Foreign exchange	0.0	0.3
Provisions, ending balance	5.6	12.9
Onerous/ unfavorable contracts
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	0.0	1.2
Acquisitions through business combinations, other provisions	0.0
Additional provision in the period	0.0	0.0
Release of provision	0.0	(0.7)
Utilization of provision	0.0	(0.5)
Foreign exchange	0.0	0.0
Provisions, ending balance	0.0	0.0
Provisions related to other taxes
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	6.6	6.9
Acquisitions through business combinations, other provisions	0.3
Additional provision in the period	1.0	0.1
Release of provision	0.0	(0.4)
Utilization of provision	0.0	0.0
Foreign exchange	0.0	0.0
Provisions, ending balance	7.9	6.6
Other
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	32.3	31.3
Acquisitions through business combinations, other provisions	3.8
Additional provision in the period	2.5	13.4
Release of provision	(4.0)	(6.0)
Utilization of provision	(6.9)	(5.9)
Foreign exchange	1.0	(0.5)
Provisions, ending balance	€ 28.7	€ 32.3

XML

Provisions - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of other provisions [line items]
Provisions	€ 42.2	€ 51.8	€ 46.8
Acquisitions through business combinations, other provisions	4.1
Provision used	16.7	16.8
Release of provision	4.1	7.1
Restructuring
Disclosure of other provisions [line items]
Provisions	5.6	12.9	7.4
Acquisitions through business combinations, other provisions	0.0
Provision used	9.8	10.4
Release of provision	0.1	0.0
Onerous/ unfavorable contracts
Disclosure of other provisions [line items]
Provisions	0.0	0.0	1.2
Acquisitions through business combinations, other provisions	0.0
Provision used	0.0	0.5
Release of provision	0.0	0.7
Provisions related to other taxes
Disclosure of other provisions [line items]
Provisions	7.9	6.6	6.9
Acquisitions through business combinations, other provisions	0.3
Provision used	0.0	0.0
Release of provision	0.0	0.4
Other provision
Disclosure of other provisions [line items]
Provisions	28.7	32.3	€ 31.3
Acquisitions through business combinations, other provisions	3.8
Provision used	6.9	5.9
Release of provision	4.0	6.0
Asset retirement obligation [Member]
Disclosure of other provisions [line items]
Provisions	4.6	6.1
Goodfella's Pizza [Member] | indemnification asset liability with customers
Disclosure of other provisions [line items]
Provisions	3.9	4.4
Italy | Other provision
Disclosure of other provisions [line items]
Provisions	4.3	4.7
Aunt Bessie's [Member] [Member] | Other provision
Disclosure of other provisions [line items]
Provisions	1.3	1.9
Restricted Shares | Provisions related to other taxes
Disclosure of other provisions [line items]
Provisions	€ 2.4	€ 6.6

XML

Share capital and reserves - Schedule of Share Capital and Capital Reserve (Details) € in Millions	Dec. 31, 2021 $ / shares	Dec. 31, 2021 EUR (€) shares	Dec. 31, 2020 $ / shares	Dec. 31, 2020 EUR (€) shares	Dec. 31, 2019 EUR (€)
Disclosure of classes of share capital [line items]
Total share capital and capital reserve		€ 1,650.2		€ 1,647.5
Listing and share transaction costs		(27.1)		(27.0)	€ (24.9)
Total net share capital and capital reserve		1,623.1		1,620.5
Ordinary shares
Disclosure of classes of share capital [line items]
Total share capital and capital reserve		1,639.6		1,636.9
Founder Preferred shares
Disclosure of classes of share capital [line items]
Total share capital and capital reserve		€ 10.6		€ 10.6
Issued Capital and Capital Reserve | Ordinary shares
Disclosure of classes of share capital [line items]
Par value per share | $ / shares	$ 10.00		$ 10.00
Number of shares issued and fully paid (in shares) | shares		173,559,173		172,180,897
Issued Capital and Capital Reserve | Founder Preferred shares
Disclosure of classes of share capital [line items]
Par value per share | $ / shares	$ 10.00		$ 10.00
Number of shares issued and fully paid (in shares) | shares		1,500,000		1,500,000

XML

Share capital and reserves - Ordinary Shares (Details) - Ordinary shares - shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of number of shares outstanding [abstract]
Number of shares outstanding, beginning balance (in shares)	172.2	194.5
Shares issued in the year	5.0	7.6
Shares repurchased in the year	3.6	29.9
Number of shares outstanding, ending balance (in shares)	173.6	172.2

XML

Share capital and reserves - Ordinary Shares Narrative (Details)									1 Months Ended				2 Months Ended		12 Months Ended
	Aug. 05, 2021 USD ($) shares	Jun. 30, 2021 shares $ / shares	Jan. 30, 2021 EUR (€) shares	Jan. 30, 2021 USD ($) $ / shares shares	Jun. 17, 2020 shares $ / shares	Mar. 13, 2020 EUR (€) shares	Mar. 13, 2020 USD ($) shares	Jun. 14, 2019 shares $ / shares	Aug. 31, 2020 EUR (€) shares	Aug. 31, 2020 USD ($) shares	May 31, 2020 shares	Jul. 31, 2019 shares	Mar. 02, 2022 EUR (€) shares	Mar. 02, 2022 USD ($) shares	Dec. 31, 2021 EUR (€) shares	Dec. 31, 2021 USD ($) shares $ / shares	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 EUR (€) shares	Aug. 05, 2021 EUR (€)	Dec. 31, 2020 $ / shares	Aug. 01, 2020 $ / shares
Disclosure of classes of share capital [line items]
Share repurchase programme | $	$ 500,000,000						$ 300,000,000			$ 500,000,000
Proceeds from issuance of Ordinary Shares | €															€ 0		€ 600,000	€ 354,100,000
Payments to acquire or redeem entity's shares | €															77,600,000		608,600,000	0
Share based payment charge | €															€ 5,100,000		€ 9,000,000.0	€ 14,900,000
Shares repurchased, payable | €																			€ 3,000,000
Events after Reporting Period
Disclosure of classes of share capital [line items]
Number of shares repurchased (in shares) | shares	135,621
Restricted Shares
Disclosure of classes of share capital [line items]
Number of equity instruments exercised (in shares) | shares															1,861,826	1,861,826
Non-Executive Director | Restricted Shares
Disclosure of classes of share capital [line items]
Share price (in dollars per share) | $ / shares		$ 30.14			$ 21.78			$ 20.74
Number of equity instruments exercised (in shares) | shares		32,140			34,447			44,272			49,196	2,460						56,250
Ordinary shares
Disclosure of classes of share capital [line items]
Share price (in dollars per share) | $ / shares				$ 25.29												$ 24.50				$ 21.04	$ 25.50
Costs related to transactions | €						€ 200,000			€ 1,900,000						€ 100,000
Number of shares repurchased (in shares) | shares			507,396	507,396		11,913,682	11,913,682		18,061,952	18,061,952					3,090,082	3,090,082
Payments to acquire or redeem entity's shares			€ 10.5	$ 12.8		€ 217,400,000	$ 250,900,000		€ 389,300,000	$ 460,600,000					€ 67,100,000	$ 75,800,000
Ordinary shares | Events after Reporting Period
Disclosure of classes of share capital [line items]
Number of shares repurchased (in shares) | shares													1,160,547	1,160,547
Payments to acquire or redeem entity's shares													€ 26,900,000	$ 30,500,000

XML

Share capital and reserves - Listing and Share Transaction Costs (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share Capital, Reserves and Other Equity Interest [Abstract]
Share issue related cost, beginning balance	€ 27.0	€ 24.9
Share transaction costs	0.1	2.1
Share issue related cost, ending balance	€ 27.1	€ 27.0

XML

Share capital and reserves - Founder Preferred Shares Annual Dividend Amount and Warrant Redemption Amount (Details)			12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2021 vote $ / shares shares	Dec. 31, 2018	Dec. 31, 2015 $ / shares	Dec. 31, 2020 $ / shares
Disclosure of classes of share capital [line items]
Preferred stocks issued (in shares) | shares			1,500,000
Number of votes per Founder Preferred Share | vote			1
Preference shares, dividend payment terms, weighted average share price, minimum term required					10 days
Preferred stock, conversion terms, weighted average share price (in dollars per share) | $ / shares					$ 11.50
Percentage increase in dividend price	20.00%	20.00%	20.00%
Preference shares, conversion ratio				1
Founder Preferred shares | Issued Capital and Capital Reserve
Disclosure of classes of share capital [line items]
Par value per share | $ / shares			$ 10.00			$ 10.00
Founder entities
Disclosure of classes of share capital [line items]
Preferred stocks issued (in shares) | shares			750,000

XML

Share-based compensation reserve (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of reserves within equity [line items]
Beginning balance, Reserve of share-based payments	€ 8.3
Increase (decrease) through share-based payment transactions, equity	5.1	€ 9.0	€ 14.9
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity		0.0	(0.8)
Reclassification of awards for settlement of tax liabilities	(16.9)	(14.7)	€ 0.4
Ending balance, Reserve of share-based payments	6.9	8.3
Share based compensation reserve
Disclosure of reserves within equity [line items]
Beginning balance, Reserve of share-based payments	8.3
Ending balance, Reserve of share-based payments	6.9	€ 8.3
Non-Executive Director | Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase (decrease) through share-based payment transactions, equity	0.8
Key management personnel | Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase (decrease) through share-based payment transactions, equity	4.3
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity	0.7
Restricted Shares | Non-Executive Director
Disclosure of reserves within equity [line items]
Reclassification of awards for settlement of tax liabilities	€ (5.8)

XML

Share-based compensation reserve - Additional Information (Details) - EUR (€)				12 Months Ended
	Jun. 30, 2021	Jun. 17, 2020	Jun. 14, 2019	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of reserves within equity [line items]
Vesting of Non-Executive Restricted Stock award					€ 0	€ (800,000)
Share based payment charge				€ 5,100,000	9,000,000.0	14,900,000
Non-Executive Director | Share based compensation reserve
Disclosure of reserves within equity [line items]
Share based payment charge				800,000
Non-Executive Director | Restricted Shares
Disclosure of reserves within equity [line items]
Shares paid for tax withholding for share based compensation	7,734	8,656	12,100
Key management personnel | Share based compensation reserve
Disclosure of reserves within equity [line items]
Vesting of Non-Executive Restricted Stock award				700,000
Share based payment charge				4,300,000
Share based compensation reserve
Disclosure of reserves within equity [line items]
Vesting of Non-Executive Restricted Stock award				(600,000)	(700,000)	(800,000)
Share based payment charge				€ 5,100,000	€ 9,000,000.0	€ 14,900,000
Share based compensation reserve | Non-Executive Director | Restricted Shares
Disclosure of reserves within equity [line items]
Share based payment charge	€ 0.2		€ 100,000

XML

Founder Preferred Shares Dividend Reserve - Narrative (Details)				12 Months Ended
	Dec. 31, 2021 $ / shares	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2021 shares	Dec. 31, 2020 $ / shares shares	Dec. 31, 2019 $ / shares shares	Jan. 12, 2016	Dec. 31, 2015 $ / shares
Disclosure of classes of share capital [line items]
Preferred stock, conversion terms, weighted average share price (in dollars per share) | $ / shares								$ 11.50
Dividends recognised as distributions to owners per share (in dollars per share) | $ / shares	$ 25.2127				$ 25.2127	$ 21.7289
Preferred share dividend equivalent							140,220,619
Percentage increase in dividend price		20.00%	20.00%	20.00%
Ordinary shares
Disclosure of classes of share capital [line items]
Ordinary shares excluded | shares				13,700,000
Founder entities | Ordinary shares
Disclosure of classes of share capital [line items]
Share dividend issued (in shares) | shares					3,875,036	6,421,074

XML

Founder Preferred Shares Dividend Reserve (Details) € in Millions	12 Months Ended
	Dec. 31, 2021 EUR (€)	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 EUR (€)	Dec. 31, 2018 USD ($)
Disclosure of classes of share capital [line items]
Equity, beginning balance	€ 2,126.1	€ 2,556.7	€ 2,059.1
Settlement of dividend through share issue | $				$ 16.7538
Equity, ending balance	2,299.0	2,126.1	2,556.7
Founder preferred shares dividend reserve
Disclosure of classes of share capital [line items]
Equity, beginning balance	245.5	370.1	372.6
Settlement of dividend through share issue	(79.5)	(124.6)	(2.5)
Equity, ending balance	166.0	245.5	€ 370.1
Founder preferred shares dividend reserve | Founder Preferred shares
Disclosure of classes of share capital [line items]
Equity, beginning balance	245.5
Settlement of dividend through share issue	79.5
Equity, ending balance	€ 166.0	€ 245.5

XML

Translation reserve Translation reserve table (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of reserves within equity [line items]
Equity	€ 2,299.0	€ 2,126.1	€ 2,556.7	€ 2,059.1
Equity (restated)		2,126.1		2,090.4
Gains (losses) on exchange differences on translation, before tax	31.7	(23.6)	19.2
Gains (losses) on hedges of net investments in foreign operations, net of tax	(12.9)	13.5	(13.2)
Other comprehensive income/(loss) for the year	53.7	(40.9)	(44.9)
Reserve of exchange differences on translation, hedging relationships for which hedge accounting is no longer applied	50.8	46.4
Increase (decrease) due to changes in accounting policy required by IFRSs
Disclosure of reserves within equity [line items]
Equity				31.3
Hedges of net investment in foreign operations
Disclosure of reserves within equity [line items]
Reserve of exchange differences on translation, continuing hedges		17.3
Reserve of exchange differences on translation, continuing hedges		17.3
Translation reserve
Disclosure of reserves within equity [line items]
Equity attributable to owners of the parent (restated)		84.7
Equity	105.1	84.7	94.8	88.8
Equity (restated)		86.3	94.8	88.8
Other comprehensive income/(loss) for the year	18.8	(10.1)	6.0
Translation reserve | Increase (decrease) due to changes in accounting policy required by IFRSs
Disclosure of reserves within equity [line items]
Equity		1.6	0.0	€ 0.0
GBP net investments [Member]
Disclosure of reserves within equity [line items]
Gains (losses) on exchange differences on translation, net of tax	€ 24.6	€ (25.7)	€ 19.0

XML

Cash flow hedging reserve (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 01, 2021	Dec. 31, 2018
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	€ 10.5	€ (24.5)	€ (13.2)	€ (21.7)	€ 8.5
Increase (decrease) due to changes in accounting policy required by IFRSs		(1.6)
Deferred hedging gains transferred to the carrying value of inventory	27.6
Change in fair value of hedging instrument recognized in OCI in the year	85.0	(83.7)	31.9
Reclassified to cost of goods sold		0.2	(21.8)
Reclassified from other comprehensive income to finance costs	(62.4)	66.2	(37.4)
Deferred tax income (expense) on cash flow hedge reserve	(13.6)	6.0	5.6
Swap contract [member]
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	5.1	(4.5)	(6.8)		0.9
Increase (decrease) due to changes in accounting policy required by IFRSs		2.8
Change in fair value of hedging instrument recognized in OCI in the year	73.3	(63.7)	28.1
Reclassified to cost of goods sold		0.0	0.0
Reclassified from other comprehensive income to finance costs	(64.1)	66.2	(37.4)
Deferred tax income (expense) on cash flow hedge reserve	(2.4)	(0.2)	1.6
Forward contract [member]
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	5.8	(20.0)	(6.4)		€ 7.6
Deferred hedging gains transferred to the carrying value of inventory	27.6
Change in fair value of hedging instrument recognized in OCI in the year	9.3	(20.0)	3.8
Reclassified to cost of goods sold		0.2	(21.8)
Reclassified from other comprehensive income to finance costs	0.0	0.0	0.0
Deferred tax income (expense) on cash flow hedge reserve	(11.1)	6.2	€ 4.0
Other reserves*
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	10.9
Increase (decrease) due to changes in accounting policy required by IFRSs		2.8
Deferred hedging gains transferred to the carrying value of inventory	27.6
Change in fair value of hedging instrument recognized in OCI in the year	82.6
Reclassified from other comprehensive income to finance costs	(64.1)
Deferred tax income (expense) on cash flow hedge reserve	(13.5)
Cost of Hedging reserve
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	(0.4)
Increase (decrease) due to changes in accounting policy required by IFRSs		€ (4.4)
Change in fair value of hedging instrument recognized in OCI in the year	2.4
Reclassified from other comprehensive income to finance costs	1.7
Deferred tax income (expense) on cash flow hedge reserve	€ (0.1)

XML

Earnings/(loss) per share (Details) - EUR (€) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings per share [abstract]
Profit (loss), attributable to owners of parent	€ 181.0	€ 225.2	€ 154.0
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	194,019,070	192,004,803
Basic earnings per share (in euros per share)	€ 1.02	€ 1.16	€ 0.80
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	197,894,106	198,425,877
Diluted earnings per share (in euros per share)	€ 1.02	€ 1.14	€ 0.78
Profit (loss)	€ 181.0	€ 225.1	€ 153.6

XML

Earnings/(loss) per share - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings per share [abstract]
Profit (loss), attributable to owners of parent	€ 181.0	€ 225.2	€ 154.0
Weighted average number of ordinary shares (in shares)	176,570,770	192,519,070	190,504,803
Weighted average number of founder preferred shares (in shares)	1,500,000	1,500,000	1,500,000
Adjusted shares for dilutive impact of 2018 non-executive restricted stock awards (in shares)	0

XML

Reconciliation of liabilities arising from financing activities (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Total loans and borrowings (Note 21)
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance	€ 1,758.8	€ 1,875.3
Cash inflow	800.0	0.0
Cash outflow	(436.0)	(32.0)
Interest accretion	2.2	5.2
Financial liabilities recognised as of acquisition date	19.6	0.4
Exchange movement	64.1	(71.7)
Fair value changes	0.0	0.0
Other non-cash adjustments	18.7	(18.4)
Closing balance	2,227.4	1,758.8
Interest accretion	2.2	5.2
Financial payables (Note 22)
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance	3.3	4.1
Cash inflow	0.0	0.0
Cash outflow	(38.1)	(57.0)
Interest accretion	57.6	58.8
Financial liabilities recognised as of acquisition date	0.0	0.0
Exchange movement	(0.2)	0.9
Fair value changes	0.0	0.0
Other non-cash adjustments	(2.9)	(3.5)
Closing balance	19.7	3.3
Interest accretion	57.6	58.8
Forward foreign exchange and currency swap contract | Derivatives
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance	0.2	(0.2)
Cash inflow	0.3	0.0
Cash outflow	0.0	(2.2)
Interest accretion	0.0	0.0
Financial liabilities recognised as of acquisition date	0.0	0.0
Exchange movement	0.0	0.0
Fair value changes	(0.1)	2.6
Other non-cash adjustments	0.0	0.0
Closing balance	0.4	0.2
Interest accretion	0.0	0.0
Cross currency interest rate swap | Derivatives
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance	72.3	15.3
Cash inflow	1.4	6.8
Cash outflow	(2.3)	(3.9)
Interest accretion	0.0	0.0
Financial liabilities recognised as of acquisition date	0.0	0.0
Exchange movement	0.0	0.0
Fair value changes	(44.0)	54.1
Other non-cash adjustments	(6.8)	0.0
Closing balance	20.6	72.3
Interest accretion	€ 0.0	€ 0.0

XML

Cash flows from operating activities (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Profit (loss)	€ 181.0	€ 225.1	€ 153.6
Adjustments for:
Exceptional items	45.3	20.6	54.5
Non-cash fair value purchase price adjustment of inventory	8.4	0.0	0.0
Share based payments expense	5.1	9.0	14.9
Depreciation and amortization	71.6	67.6	68.3
Loss on disposal and impairment of property, plant and equipment	0.7	0.9	0.6
Net finance costs	106.0	63.7	73.2
Taxation	55.7	70.4	56.7
Operating cash flow before changes in working capital, provisions and exceptional items	473.8	457.3	421.8
(Increase)/decrease in inventories	(23.8)	(12.7)	23.5
Decrease/(increase) in trade and other receivables	24.1	(1.8)	(34.4)
(Decrease)/increase in trade and other payables	(25.0)	107.2	(40.6)
Increase in employee benefit and other provisions	1.2	2.0	6.6
Cash generated from operations before tax and exceptional items	450.3	552.0	376.9
Material reconciling items [member]
Adjustments for:
Exceptional items	€ 45.3	€ 20.6	€ 54.5

XML

Financial risk management - Derivatives and Hedging (Details) € in Millions, £ in Millions, $ in Millions				12 Months Ended
	May 15, 2024	May 15, 2022	Jul. 29, 2021 EUR (€)	Dec. 31, 2021 USD ($)	Dec. 31, 2021 EUR (€)	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 EUR (€)	Dec. 31, 2022 USD ($)	Dec. 31, 2022 EUR (€)	Dec. 31, 2021 EUR (€)	Dec. 31, 2021 GBP (£)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 EUR (€)	Dec. 31, 2020 GBP (£)
Disclosure of nature and extent of risks arising from financial instruments [line items]
Repayment of current borrowings in future years				$ 9.6	€ 8.7	€ 8.7
Hedges of net investment in foreign operations
Disclosure of nature and extent of risks arising from financial instruments [line items]
Gain (loss) on hedge ineffectiveness recognised in profit or loss					0.0	0.0
Gain (loss) on hedge ineffectiveness recognised in profit or loss					0.0	0.0
Foreign exchange forward contract | Derivative financial instruments | EUR/USD
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					17.5	(21.9)
Notional amount										€ 343.6			€ 249.0
Change in fair value of outstanding hedging instruments					(26.3)	(20.6)
Weighted average hedged rate for the year				120.00%						120.00%	120.00%	113.00%	113.00%	113.00%
Notional amount										€ 343.6			€ 249.0
Foreign exchange forward contract | Derivative financial instruments | GBP/USD
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					1.2	(3.7)
Notional amount										€ 58.4			€ 53.5
Change in fair value of outstanding hedging instruments					(0.5)	(2.0)
Weighted average hedged rate for the year				138.00%						138.00%	138.00%	128.00%	128.00%	128.00%
Notional amount										€ 58.4			€ 53.5
Foreign exchange forward contract | Derivative financial instruments | GBP/EUR
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					(6.7)	1.4
Notional amount										€ 244.7			€ 159.0
Change in fair value of outstanding hedging instruments					12.0	8.5
Weighted average hedged rate for the year				115.00%						115.00%	115.00%	112.00%	112.00%	112.00%
Notional amount										€ 244.7			€ 159.0
Foreign exchange forward contract | Derivative financial instruments | SEKEUR
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					0.5	(4.0)
Notional amount										€ 70.4			€ 77.3
Change in fair value of outstanding hedging instruments					(0.9)	(4.2)
Weighted average hedged rate for the year				10.00%						10.00%	10.00%	9.00%	9.00%	9.00%
Notional amount										€ 70.4			€ 77.3
Foreign exchange forward contract | Derivative financial instruments | SEK/USD
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					0.1	(2.6)
Notional amount										€ 4.5			€ 14.1
Change in fair value of outstanding hedging instruments					13.5	(2.2)
Weighted average hedged rate for the year				11.00%						11.00%	11.00%	10.00%	10.00%	10.00%
Notional amount										€ 4.5			€ 14.1
Foreign exchange forward contract | Derivative financial instruments | Other currencies
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					0.3	(0.5)
Notional amount										€ 96.4			€ 16.8
Change in fair value of outstanding hedging instruments					0.6	0.8
Weighted average hedged rate for the year				0.00%						0.00%	0.00%	21.00%	21.00%	21.00%
Notional amount										€ 96.4			€ 16.8
Cross currency interest rate swap | Cash flow hedges | Derivative financial instruments
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount									€ 827.8	€ 827.8
Maturity date of cross currency interest rate swaps (GBP)		May 15, 2022	Jul. 29, 2021
Maturity date of cross currency interest rate swaps	May 15, 2024	May 15, 2022
Change in fair value of outstanding hedging instruments					68.9	(71.0)
Weighted average hedged rate for the year				111.00%						111.00%	111.00%	111.00%	111.00%	111.00%
Change in value of hedged item					(69.6)	71.0
Carrying amount of cross currency interest rate swaps										€ (20.6)			€ (89.5)
Change in value of hedged item					(69.6)	71.0
Notional amount									€ 827.8	827.8
Carrying amount of cross currency interest rate swaps										€ (20.6)			€ (89.5)
Cross currency interest rate swap | Hedges of net investment in foreign operations | Derivative financial instruments
Disclosure of nature and extent of risks arising from financial instruments [line items]
Change in fair value of outstanding hedging instruments					(12.9)	13.5
Weighted average hedged rate for the year				119.00%						119.00%	119.00%	119.00%	119.00%	119.00%
Change in value of hedged item					12.9	(13.5)
Carrying amount of cross currency interest rate swaps										€ 0.0			€ 14.3
Change in value of hedged item					12.9	(13.5)
Carrying amount of cross currency interest rate swaps										0.0			€ 14.3
Forward foreign exchange and currency swap contract | Cash flow hedges
Disclosure of nature and extent of risks arising from financial instruments [line items]
Gains (losses) on change in fair value of derivatives					0.6	(2.4)	€ 4.8
Gains (losses) on change in fair value of derivatives					0.6	(2.4)	4.8
Forward foreign exchange and currency swap contract | Foreign exchange swap
Disclosure of nature and extent of risks arising from financial instruments [line items]
Gains (losses) on change in fair value of derivatives					(14.3)	(3.2)	(13.6)
Gains (losses) on change in fair value of derivatives					€ (14.3)	€ (3.2)	€ (13.6)
Senior USD Debt
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount			€ 827.8	$ 916.4				$ 916.4		808.6		$ 926.0
Notional amount			€ 827.8	$ 916.4				$ 916.4		€ 808.6		$ 926.0
Senior GBP Debt
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount | £											£ 0.0			£ 220.2
Notional amount | £											£ 0.0			£ 220.2

XML

Financial risk management - Market Risk (Details) £ in Millions	12 Months Ended
	Dec. 31, 2021 EUR (€)	Dec. 31, 2020 EUR (€)	Dec. 31, 2019	Dec. 31, 2021 GBP (£)	Dec. 31, 2020 GBP (£)
Senior GBP Debt
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount | £				£ 0.0	£ 220.2
Notional amount | £				£ 0.0	£ 220.2
Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, percent	1.00%
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ 2,600,000	€ 5,600,000
Liquidity risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Line of credit facility, maximum borrowing capacity	175,000,000
Letters of credit, overdrafts, customer bonds and bank guarantees utilized against the credit facility	€ 2,800,000
Currency risk | Pound Sterling
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent	7.30%	(5.20%)	5.30%
Currency risk | Pound Sterling | Foreign exchange forward contract
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ 0	€ 700,000
Currency risk | US dollar
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent	7.80%	(9.60%)	2.00%
Currency risk | US dollar | Foreign exchange forward contract
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ 0	€ 0
Currency risk | US dollar | Foreign exchange forward contract | Derivative financial instruments
Disclosure of nature and extent of risks arising from financial instruments [line items]
Percentage of financial instruments designated as hedging instruments	95.10%	87.90%		95.10%	87.90%
Financial assets	€ 18,800,000
Financial liabilities		€ 28,300,000
Currency risk | Euro | Foreign exchange forward contract | Derivative financial instruments
Disclosure of nature and extent of risks arising from financial instruments [line items]
Percentage of financial instruments designated as hedging instruments	77.20%	84.90%		77.20%	84.90%
Financial liabilities	€ 5,900,000	€ 3,100,000
Currency risk | Swedish Krona
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent	(1.80%)	3.80%	(2.20%)
Currency risk | Swedish Krona | Foreign exchange forward contract
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ (400,000)	€ (400,000)
Bottom of range | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Interest rate	0.00%			0.00%

XML

Financial risk management - Maturity Analysis (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2021 EUR (€)	Dec. 31, 2020 EUR (€)
Disclosure of maturity analysis for derivative financial liabilities [line items]
Loan repayment percentage	1.00%	1.00%
Repayment of current borrowings in future years	$ 9.6	€ 8,700,000	€ 8,700,000
Financial liabilities, undiscounted cash flows		3,185,000,000	2,659,400,000
2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		717,700,000	706,400,000
2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		77,100,000	145,100,000
2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		863,800,000	64,900,000
2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		41,300,000	1,709,700,000
2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		39,700,000	5,200,000
More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		1,445,400,000	28,100,000
Borrowings-principal
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		2,161,900,000	1,706,500,000
Borrowings-principal | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		8,500,000	7,800,000
Borrowings-principal | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		8,500,000	7,800,000
Borrowings-principal | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		791,700,000	7,800,000
Borrowings-principal | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	1,683,100,000
Borrowings-principal | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Borrowings-principal | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		1,353,200,000	0
Borrowings-interest
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		306,500,000	161,000,000.0
Borrowings-interest | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		57,500,000	46,600,000
Borrowings-interest | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		63,500,000	46,800,000
Borrowings-interest | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		50,400,000	47,200,000
Borrowings-interest | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		34,000,000.0	20,400,000
Borrowings-interest | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		34,100,000	0
Borrowings-interest | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		67,000,000.0	0
Lease Liabilities
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		90,600,000	80,200,000
Lease Liabilities | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		23,100,000	17,200,000
Lease Liabilities | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		18,200,000	13,600,000
Lease Liabilities | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		11,200,000	9,900,000
Lease Liabilities | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		7,300,000	6,200,000
Lease Liabilities | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		5,600,000	5,200,000
Lease Liabilities | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		25,200,000	28,100,000
Trade and other payables excluding non-financial liabilities
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		647,100,000	601,100,000
Trade and other payables excluding non-financial liabilities | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		647,100,000	601,100,000
Trade and other payables excluding non-financial liabilities | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Trade and other payables excluding non-financial liabilities | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Trade and other payables excluding non-financial liabilities | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Trade and other payables excluding non-financial liabilities | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Trade and other payables excluding non-financial liabilities | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		805,300,000	677,300,000
Sell | Foreign exchange forward contract | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		805,300,000	677,300,000
Sell | Foreign exchange forward contract | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Cross currency interest rate swap
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		868,400,000	1,174,400,000
Sell | Cross currency interest rate swap | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		25,000,000.0	38,500,000
Sell | Cross currency interest rate swap | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		24,900,000	1,135,900,000
Sell | Cross currency interest rate swap | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		818,500,000	0
Sell | Cross currency interest rate swap | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Cross currency interest rate swap | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Cross currency interest rate swap | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(818,000,000.0)	(647,500,000)
Pay | Foreign exchange forward contract | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(818,000,000.0)	(647,500,000)
Pay | Foreign exchange forward contract | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Cross currency interest rate swap
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(876,800,000)	(1,093,600,000)
Pay | Cross currency interest rate swap | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(30,800,000)	(34,600,000)
Pay | Cross currency interest rate swap | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(38,000,000.0)	(1,059,000,000)
Pay | Cross currency interest rate swap | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(808,000,000.0)	0
Pay | Cross currency interest rate swap | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Cross currency interest rate swap | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Cross currency interest rate swap | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Forecast
Disclosure of maturity analysis for derivative financial liabilities [line items]
Repayment based on excess cashflow calculation		€ 0	€ 0

XML

Financial instruments - Categories of Financial Instruments (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	€ 0.0	€ (25.0)
Derivatives at fair value through profit or loss	0.4	2.7
Financial assets at amortised cost	455.8	534.4
Financial liabilities at amortised cost	(2,883.9)	(2,366.8)
Financial assets (liabilities) at fair value through other comprehensive income	(8.3)	(105.0)
Total	(2,436.0)	(1,909.7)
Total non-current loans and borrowings	2,198.3	1,736.3
Borrowings	2,227.4	1,758.8
Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	2,163.5	1,706.4
Financial liabilities	(2,146.5)	(1,688.4)
Trade and other payables excluding non-financial liabilities
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0.0	0.0
Derivatives at fair value through profit or loss	0.0	0.0
Financial assets at amortised cost	0.0	0.0
Financial liabilities at fair value through other comprehensive income	0.0	0.0
Financial liabilities at amortised cost	(647.1)	(601.1)
Financial liabilities	(647.1)	(601.1)
Derivative financial instruments
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0.0	0.0
Derivatives at fair value through profit or loss	0.1	0.2
Financial assets at amortised cost	0.0	0.0
Financial liabilities at fair value through other comprehensive income	28.0	124.8
Financial liabilities at amortised cost	0.0	0.0
Financial liabilities	(28.1)	(125.0)
Loans and borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0.0	0.0
Derivatives at fair value through profit or loss	0.0	0.0
Financial assets at amortised cost	0.0	0.0
Financial liabilities at fair value through other comprehensive income	0.0	0.0
Financial liabilities at amortised cost	(2,236.8)	(1,765.7)
Financial liabilities	(2,236.8)	(1,765.7)
Trade receivables
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0.0	0.0
Derivatives at fair value through profit or loss	0.0	0.0
Financial assets at fair value through other comprehensive income	0.0	0.0
Financial assets	201.6	141.2
Financial assets at amortised cost	201.6	141.2
Financial liabilities at amortised cost	0.0
Derivative financial instruments
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0.0	0.0
Derivatives at fair value through profit or loss	0.5	2.9
Financial assets at fair value through other comprehensive income	19.7	19.8
Financial assets	20.2	22.7
Financial assets at amortised cost	0.0	0.0
Financial liabilities at amortised cost	0.0
Cash and cash equivalents
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0.0	0.0
Derivatives at fair value through profit or loss	0.0	0.0
Financial assets at fair value through other comprehensive income	0.0	0.0
Financial assets	254.2	393.2
Financial assets at amortised cost	254.2	393.2
Financial liabilities at amortised cost	0.0
Short-term investments not cash and cash equivalents [Domain]
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss		(25.0)
Financial assets		25.0
Deferred borrowing costs
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Total non-current loans and borrowings	9.4	6.9
Deferred borrowing costs | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	0.0	0.0
Financial liabilities	9.4	6.9
Senior EUR/USD loans | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities	(1,355.8)	(1,295.1)
Other borrowings [Domain] | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	0.1	0.2
Financial liabilities	(0.1)	(0.2)
2024 fixed rate senior secured notes | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities	0.0	(400.0)
Twenty Twenty-Eight Fixed Rate Senior Secured Notes | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities	(800.0)	0.0
Level 2 | Senior EUR/USD loans | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	1,360.8	1,300.4
Level 1 of fair value hierarchy [member] | 2024 fixed rate senior secured notes | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	0.0	405.8
Level 1 of fair value hierarchy [member] | Twenty Twenty-Eight Fixed Rate Senior Secured Notes | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	€ 802.6	€ 0.0

XML

Financial instruments - Derivative Financial Instruments (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2022
Disclosure of financial assets [line items]
Loans and borrowings	€ 2,198.3	€ 1,736.3
Borrowings	2,227.4	1,758.8
Gross amount of financial instruments as presented upon balance sheet	20.2	22.7
Gross financial liabilities set off against financial assets subject to offsetting, enforceable master netting arrangements or similar agreements	10.8	22.7
Net financial assets subject to offsetting, enforceable master netting arrangements or similar agreements in statement of financial position	9.4	0.0
Gross financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements	27.9	125.0
Related financial instruments that are offset	10.8	22.7
Net financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements in statement of financial position	17.1	102.3
Derivative financial instruments | Cash flow hedges | Cross currency interest rate swap
Disclosure of financial assets [line items]
Notional amount	827.8		€ 827.8
Change in fair value of outstanding hedging instruments	€ 68.9	€ (71.0)
Weighted average hedged rate for the year	111.00%	111.00%
EUR/USD | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ 17.5	€ (21.9)
Notional amount	343.6	249.0
Change in fair value of outstanding hedging instruments	€ (26.3)	€ (20.6)
Weighted average hedged rate for the year	120.00%	113.00%
GBP/USD | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ 1.2	€ (3.7)
Notional amount	58.4	53.5
Change in fair value of outstanding hedging instruments	€ (0.5)	€ (2.0)
Weighted average hedged rate for the year	138.00%	128.00%
GBP/EUR | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ (6.7)	€ 1.4
Notional amount	244.7	159.0
Change in fair value of outstanding hedging instruments	€ 12.0	€ 8.5
Weighted average hedged rate for the year	115.00%	112.00%
SEKEUR | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ 0.5	€ (4.0)
Notional amount	70.4	77.3
Change in fair value of outstanding hedging instruments	€ (0.9)	€ (4.2)
Weighted average hedged rate for the year	10.00%	9.00%
Other currencies | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ 0.3	€ (0.5)
Notional amount	96.4	16.8
Change in fair value of outstanding hedging instruments	€ 0.6	€ 0.8
Weighted average hedged rate for the year	0.00%	21.00%
Deferred Financing Costs [Member]
Disclosure of financial assets [line items]
Loans and borrowings	€ 9.4	€ 6.9

XML

Financial instruments - Derivatives (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about financial instruments [line items]
Loans and borrowings	€ 2,198.3	€ 1,736.3
Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Total assets	20.2	22.7
Total liabilities	(27.9)	(125.0)
Total	(7.7)	(102.3)
Foreign exchange forward contract | Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Total assets	20.2	5.5
Total liabilities	(7.3)	(35.5)
Cross currency interest rate swap | Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Total assets	0.0	17.2
Total liabilities	(20.6)	(89.5)
Deferred Financing Costs [Member]
Disclosure of detailed information about financial instruments [line items]
Loans and borrowings	€ 9.4	€ 6.9

XML

Financial instruments - Offsetting of Derivatives (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivatives - assets
Gross amount of financial instruments as presented upon balance sheet	€ 20.2	€ 22.7
Related financial instruments that are offset	(10.8)	(22.7)
Net amount	9.4	0.0
Derivatives - liabilities
Gross amount of financial instruments as presented upon balance sheet	(27.9)	(125.0)
Related financial instruments that are offset	10.8	22.7
Net amount	€ (17.1)	€ (102.3)

XML

Commitments - Non-cancellable Operating Lease Rentals (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	8.7	7.5
Less than one year
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	2.2	1.9
Between one and three years
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	4.1	3.5
Between three and five years
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	2.2	2.0
More than five years
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	0.2	0.1

XML

Capital commitments (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Capital Commitment [Line Items]
Total capital commitments	€ 23.0	€ 17.0
Property, plant and equipment
Capital Commitment [Line Items]
Total capital commitments	21.3	13.6
Intangible assets
Capital Commitment [Line Items]
Total capital commitments	€ 1.7	€ 3.4

XML

Related parties (Details)							1 Months Ended		12 Months Ended
	Jan. 01, 2022 USD ($)	Jan. 30, 2021 EUR (€)	Jan. 30, 2021 USD ($) $ / shares	Mar. 13, 2020 EUR (€)	Mar. 13, 2020 USD ($)	Jun. 15, 2015 USD ($)	Aug. 31, 2020 EUR (€)	Aug. 31, 2020 USD ($)	Dec. 31, 2021 EUR (€) shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 EUR (€) shares	Dec. 31, 2019 EUR (€)	Jun. 30, 2021 $ / shares	Dec. 31, 2020 $ / shares	Aug. 01, 2020 $ / shares	Jun. 17, 2020 $ / shares	Jun. 14, 2019 $ / shares
Disclosure of transactions between related parties [line items]
Payments to acquire or redeem entity's shares									€ 77,600,000		€ 608,600,000	€ 0
Non-Executive Director
Disclosure of transactions between related parties [line items]
Travel expenses reimbursed to related party									400,000		300,000
Travel expenses reimbursed to related party									€ 400,000		€ 300,000
Ordinary shares
Disclosure of transactions between related parties [line items]
Share price (in dollars per share) | $ / shares			$ 25.29							$ 24.50				$ 21.04	$ 25.50
Shares repurchased and canceled | shares									(3,600,000)	(3,600,000)	(29,900,000)
Payments to acquire or redeem entity's shares		€ 10.5	$ 12.8	€ 217,400,000	$ 250,900,000		€ 389,300,000	$ 460,600,000	€ 67,100,000	$ 75,800,000
Restricted Shares | Key management personnel
Disclosure of transactions between related parties [line items]
Number of shares issued (in shares) | shares										2,016,855
Restricted Shares | Non-Executive Director
Disclosure of transactions between related parties [line items]
Share price (in dollars per share) | $ / shares													$ 30.14			$ 21.78	$ 20.74
Mariposa Capital and TOMS Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Advisory Services Agreement, annual fee | $	$ 4					$ 2,000,000
Advisory Services Agreement, expiration notice term	90 days					90 days
Advisory Services Agreement, termination term	6 months					6 months
Mariposa Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Travel expenses reimbursed to related party									800,000		€ 1,000,000
Travel expenses reimbursed to related party									800,000		1,000,000
TOMS Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Travel expenses reimbursed to related party									800,000		900,000
Travel expenses reimbursed to related party									€ 800,000		€ 900,000

XML

Significant events after the Statement of Financial Position date (Details)									1 Months Ended		2 Months Ended		12 Months Ended
	Dec. 31, 2021 $ / shares	Aug. 05, 2021 shares	Jan. 30, 2021 EUR (€) shares	Jan. 30, 2021 USD ($) shares	Mar. 13, 2020 EUR (€) shares	Mar. 13, 2020 USD ($) shares	Dec. 31, 2019	Dec. 31, 2018	Aug. 31, 2020 EUR (€) shares	Aug. 31, 2020 USD ($) shares	Mar. 02, 2022 EUR (€) shares	Mar. 02, 2022 USD ($) shares	Dec. 31, 2021 EUR (€) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 EUR (€) shares	Dec. 31, 2020 $ / shares	Dec. 31, 2019 EUR (€) shares	Dec. 31, 2019 $ / shares
Disclosure of non-adjusting events after reporting period [line items]
Percentage increase in dividend price							20.00%	20.00%					20.00%	20.00%
Dividend price per share (in dollars per share) | $ / shares	$ 25.2127															$ 25.2127		$ 21.7289
Repurchase of ordinary shares (in shares) | €													€ 77,600,000		€ 608,600,000
Payments to acquire or redeem entity's shares | €													€ 77,600,000		€ 608,600,000		€ 0
Events after Reporting Period
Disclosure of non-adjusting events after reporting period [line items]
Number of shares repurchased (in shares)		135,621
Ordinary shares
Disclosure of non-adjusting events after reporting period [line items]
Number of shares repurchased (in shares)			507,396	507,396	11,913,682	11,913,682			18,061,952	18,061,952			3,090,082	3,090,082
Payments to acquire or redeem entity's shares			€ 10.5	$ 12.8	€ 217,400,000	$ 250,900,000			€ 389,300,000	$ 460,600,000			€ 67,100,000	$ 75,800,000
Ordinary shares | Events after Reporting Period
Disclosure of non-adjusting events after reporting period [line items]
Number of shares repurchased (in shares)											1,160,547	1,160,547
Payments to acquire or redeem entity's shares											€ 26,900,000	$ 30,500,000
Founder Entities [Member] | Ordinary shares
Disclosure of non-adjusting events after reporting period [line items]
Share dividend issued (in shares)															3,875,036		6,421,074

XML

Label

Element

Value

Cash flow hedges [member]

Non-cash loss recognized in relation to cross currency interest rate swaps

nomd_NonCashLossRecognizedInRelationToCrossCurrencyInterestRateSwaps

€ 6,800,000

Present value of defined benefit obligation [member]

Disclosure of analysis of present value of defined benefit obligation [Table Text Block]

nomd_DisclosureofanalysisofpresentvalueofdefinedbenefitobligationTableTextBlock

	Defined benefit retirement plans	Post-employment medical benefits and other benefits	Total
December 31, 2021	€m	€m	€m
Present value of unfunded employee benefit obligations	77.5	11.1	88.6
Present value of funded employee benefit obligations	264.0	—	264.0
Subtotal present value of employee benefit obligations	341.5	11.1	352.6
Fair value of plan assets	(108.4)	—	(108.4)
Recognized liability for net employee benefit obligations	233.1	11.1	244.2

	Defined benefit retirement plans	Post-employment medical benefits and other benefits	Total
December 31, 2020	€m	€m	€m
Present value of unfunded employee benefit obligations	79.6	9.0	88.6
Present value of funded employee benefit obligations	285.5	—	285.5
Subtotal present value of employee benefit obligations	365.1	9.0	374.1
Fair value of plan assets	(97.9)	—	(97.9)
Recognized liability for net employee benefit obligations	267.2	9.0	276.2

United Kingdom, Pounds | Forward contract [member] | Currency risk [member]

Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact

nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact

€ 3,000,000

Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact

nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact

3,300,000

Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity

nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity

1,500,000

Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity

nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity

2,800,000

United States of America, Dollars | Forward contract [member] | Currency risk [member]

Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact

nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact

3,000,000

Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact

nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact

3,000,000

Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity

nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity

(2,000,000.0)

Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity

nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity

(1,400,000)

Sweden, Kronor | Forward contract [member] | Currency risk [member]

Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact

nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact

1,000,000

Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact

nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact

1,100,000

Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity

nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity

400,000

Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity

nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity

500,000

Reserve of exchange differences on translation [member]

Other comprehensive income, before tax, hedges of net investments in foreign operations

ifrs-full_OtherComprehensiveIncomeBeforeTaxHedgesOfNetInvestmentsInForeignOperations

18,800,000

Reserve of cash flow hedges [member]

Amount removed from reserve of cash flow hedges and included in initial cost or other carrying amount of non-financial asset (liability) or firm commitment for which fair value hedge accounting is applied

ifrs-full_AmountRemovedFromReserveOfCashFlowHedgesAndIncludedInInitialCostOrOtherCarryingAmountOfNonfinancialAssetLiabilityOrFirmCommitmentForWhichFairValueHedgeAccountingIsApplied

€ 2,100,000